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Abstract
Risk Adjustment In Neurocritical care (RAIN) – prospective 
validation of risk prediction models for adult patients 
with acute traumatic brain injury to use to evaluate the 
optimum location and comparative costs of neurocritical 
care: a cohort study
DA Harrison,1* G Prabhu,1 R Grieve,2 SE Harvey,1 MZ Sadique,2 
M Gomes,2 KA Griggs,1 E Walmsley,1 M Smith,3 P Yeoman,4 
FE Lecky,5 PJA Hutchinson,6 DK Menon6 and KM Rowan1
1Intensive Care National Audit and Research Centre, London, UK
2Department of Health Services Research and Policy, London School of Hygiene and Tropical 
Medicine, London, UK
3National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS 
Foundation Trust, London, UK
4Queen’s Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK
5School of Health and Related Research, University of Sheffield, Sheffield, UK
6University of Cambridge, Cambridge, UK
*Corresponding author
Objectives: To validate risk prediction models for acute traumatic brain injury (TBI) and to use the best 
model to evaluate the optimum location and comparative costs of neurocritical care in the NHS.
Design: Cohort study.
Setting: Sixty-seven adult critical care units.
Participants: Adult patients admitted to critical care following actual/suspected TBI with a Glasgow Coma 
Scale (GCS) score of < 15.
Interventions: Critical care delivered in a dedicated neurocritical care unit, a combined neuro/general 
critical care unit within a neuroscience centre or a general critical care unit outside a neuroscience centre.
Main outcome measures: Mortality, Glasgow Outcome Scale – Extended (GOSE) questionnaire and 
European Quality of Life-5 Dimensions, 3-level version (EQ-5D-3L) questionnaire at 6 months following TBI.
Results: The final Risk Adjustment In Neurocritical care (RAIN) study data set contained 3626 admissions. 
After exclusions, 3210 patients with acute TBI were included. Overall follow-up rate at 6 months was 81%. 
Of 3210 patients, 101 (3.1%) had no GCS score recorded and 134 (4.2%) had a last pre-sedation GCS 
score of 15, resulting in 2975 patients for analysis. The most common causes of TBI were road traffic 
accidents (RTAs) (33%), falls (47%) and assault (12%). Patients were predominantly young (mean age 
45 years overall) and male (76% overall). Six-month mortality was 22% for RTAs, 32% for falls and 17% for 
assault. Of survivors at 6 months with a known GOSE category, 44% had severe disability, 30% moderate 
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disability and 26% made a good recovery. Overall, 61% of patients with known outcome had an 
unfavourable outcome (death or severe disability) at 6 months. Between 35% and 70% of survivors 
reported problems across the five domains of the EQ-5D-3L. Of the 10 risk models selected for validation, 
the best discrimination overall was from the International Mission for Prognosis and Analysis of Clinical 
Trials in TBI Lab model (IMPACT) (c-index 0.779 for mortality, 0.713 for unfavourable outcome). The model 
was well calibrated for 6-month mortality but substantially underpredicted the risk of unfavourable 
outcome at 6 months. Baseline patient characteristics were similar between dedicated neurocritical care 
units and combined neuro/general critical care units. In lifetime cost-effectiveness analysis, dedicated 
neurocritical care units had higher mean lifetime quality-adjusted life-years (QALYs) at small additional 
mean costs with an incremental cost-effectiveness ratio (ICER) of £14,000 per QALY and incremental net 
monetary benefit (INB) of £17,000. The cost-effectiveness acceptability curve suggested that the 
probability that dedicated compared with combined neurocritical care units are cost-effective is around 
60%. There were substantial differences in case mix between the ‘early’ (within 18 hours of presentation) 
and ‘no or late’ (after 24 hours) transfer groups. After adjustment, the ‘early’ transfer group reported 
higher lifetime QALYs at an additional cost with an ICER of £11,000 and INB of £17,000.
Conclusions: The risk models demonstrated sufficient statistical performance to support their use in 
research but fell below the level required to guide individual patient decision-making. The results suggest 
that management in a dedicated neurocritical care unit may be cost-effective compared with a combined 
neuro/general critical care unit (although there is considerable statistical uncertainty) and support current 
recommendations that all patients with severe TBI would benefit from transfer to a neurosciences centre, 
regardless of the need for surgery. We recommend further research to improve risk prediction models; 
consider alternative approaches for handling unobserved confounding; better understand long-term 
outcomes and alternative pathways of care; and explore equity of access to postcritical care support for 
patients following acute TBI.
Funding: The National Institute for Health Research Health Technology Assessment programme.
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Harrison et al. under the terms of a commissioning contract issued by the Secretary of State for 
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
DOI: 10.3310/hta17230 HealtH tecHnOlOgy assessment 2013 VOl. 17 nO. 23
ix
Contents
List of abbreviations   xi
Executive summary   xiii
Chapter 1 Introduction   1
Chapter 2 Selection of risk prediction models for critically ill patients with acute 
traumatic brain injury   3
Introduction   3
Methods   3
Results   4
Discussion   10
Chapter 3 The Risk Adjustment In Neurocritical care study   15
Introduction   15
Methods   15
Results   22
Discussion   26
Chapter 4 Case mix and outcomes at 6 months for critically ill patients with acute 
traumatic brain injury   29
Introduction   29
Methods   29
Results   30
Discussion   46
Chapter 5 External validation of risk prediction models for acute traumatic brain 
injury among critically ill patients   49
Introduction   49
Methods   49
Results   53
Discussion   69
Chapter 6 Evaluation of the costs, consequences and cost-effectiveness of 
alternative locations of care for critically ill patients with acute traumatic 
brain injury   75
Introduction   75
Methods overview   76
Motivating the comparators chosen for the research objectives   77
Methods for the cost–consequence analysis of alternative care locations at 6 months   79
Results of the cost–consequence analysis of alternative care locations at 6 months   84
Methods for the lifetime cost-effectiveness analysis   94
Results of the lifetime cost-effectiveness analysis   101
Discussion   106
Chapter 7 Conclusions   111
Implications for health care   111
Recommendations for future research   111
NIHR Journals Library www.journalslibrary.nihr.ac.uk
cOntents
x
Acknowledgements   115
References   119
Appendix 1 Search strategy for updated systematic review of risk prediction models   129
Appendix 2 Risk Adjustment In Neurocritical care study protocol version 1.4   131
Appendix 3 Risk Adjustment In Neurocritical care study data definitions   161
Appendix 4 Risk Adjustment In Neurocritical care study data collection form 
and data set flow   281
Appendix 5 Risk Adjustment In Neurocritical care study follow-up materials   319
Appendix 6 Sensitivity analysis: external validation of risk prediction models in original 
(non-imputed) data sets   347
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Harrison et al. under the terms of a commissioning contract issued by the Secretary of State for 
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
DOI: 10.3310/hta17230 HealtH tecHnOlOgy assessment 2013 VOl. 17 nO. 23
xi
List of abbreviations
AIC Akaike information criterion
APACHE Acute Physiology And Chronic 
Health Evaluation
BIC Bayesian information criterion
CCMDS Critical Care Minimum Data Set
CEA cost-effectiveness analysis
CEAC cost-effectiveness 
acceptability curve
CI confidence interval
CMP Case Mix Programme
CRASH Corticosteroid Randomisation 
After Significant Head injury
CRN Clinical Research Network
CT computerised tomography
DVR data validation report
EBIC European Brain Injury Consortium
ECC Ethics and 
Confidentiality Committee
EQ-5D-3L European Quality of Life-5 
Dimensions, 3-level version
FiO2 fraction of inspired oxygen
GCS Glasgow Coma Scale
GOS Glasgow Outcome Scale
GOSE Glasgow Outcome Scale 
– Extended
GP general practitioner
HDU high-dependency unit
HRG Healthcare Resource Group
ICER incremental 
cost-effectiveness ratio
ICNARC Intensive Care National Audit and 
Research Centre
ICU intensive-care unit
IMD Index of Multiple Deprivation
IMPACT International Mission for 
Prognosis and Analysis of Clinical 
Trials in TBI
INB incremental net monetary benefit
IQR interquartile range
ISS injury severity score
LOS length of stay
MICE Multivariate Imputation by 
Chained Equations
MRC Medical Research Council
MRIS Medical Research 
Information Service
NCCNet Neurocritical Care Network
NICE National Institute for Health and 
Care Excellence
NIGB National Information 
Governance Board
NIHR National Institute for 
Health Research
PaCO2 partial pressure of carbon dioxide
PaO2 partial pressure of oxygen
QALY quality-adjusted life-year
QOL quality of life
R&D research and development
RAIN Risk Adjustment In 
Neurocritical care
RCT randomised controlled trial
REC Research Ethics Committee
ROC receiver operating characteristic
RTA road traffic accident
SAH subarachnoid haemorrhage
SF-36 Short Form 
questionnaire-36 items
SICSAG Scottish Intensive Care Society 
Audit Group
NIHR Journals Library www.journalslibrary.nihr.ac.uk
lIst Of abbreVIatIOns
xii
SSI site-specific information
TARN Trauma Audit and 
Research Network
TBI traumatic brain injury
TCDB Trauma Coma Data Bank
UKCCTF UK Critical Care Trials Forum
WBIC Wolfson Brain Imaging Centre
All abbreviations that have been used in this report are listed here unless the abbreviation 
is well known (e.g. NHS), or it has been used only once, or it is a non-standard 
abbreviation used only in figures/tables/appendices, in which case the abbreviation is 
defined in the figure legend or in the notes at the end of the table.
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Harrison et al. under the terms of a commissioning contract issued by the Secretary of State for 
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
DOI: 10.3310/hta17230 HealtH tecHnOlOgy assessment 2013 VOl. 17 nO. 23
xiii
Executive summary
Background
Where adult patients with traumatic brain injury (TBI) should be optimally managed is an important 
question for the NHS, both in terms of outcomes and costs. Notwithstanding the lack of evidence, 
it has been recommended that patients with a severe TBI should be managed within a neuroscience 
centre. Currently, many (particularly those without surgically remedial lesions) are neither treated in, nor 
transferred to, one. A combination of geography, bed availability, local variation and clinical assessment of 
prognosis can often determine the location of definitive critical care for adult patients with TBI.
Recent research has suggested benefit from managing severe head injury in specialist centres; however, 
the results are inconclusive owing to lack of adjustment for all known confounders, no data on costs 
of care, only having follow-up data to hospital discharge, and not addressing whether provision should 
be in dedicated neurocritical care units or combined neurocritical/general critical care units within 
neuroscience centres.
Variation in the way services are organised and delivered can allow them to be compared using 
observational methods. This is only possible; however, if a valid, reliable, appropriate and accurate risk 
prediction model exists. A number of specific models for TBI exist but these models require further 
prospective validation, and potentially recalibration, before they can be applied with confidence for 
research and audit in neurocritical care in the NHS.
The primary aim of the Risk Adjustment In Neurocritical care (RAIN) study was to validate risk prediction 
models for acute TBI and to use the best model(s) to evaluate the optimum location and comparative costs 
of neurocritical care in the NHS.
Objectives
Specific, detailed objectives to achieve this aims were to:
1. identify existing risk prediction models for acute TBI
2. collect data for the selected risk prediction models
3. describe the case mix and outcomes, to 6 months, from TBI
4. validate the selected risk prediction models
5. compare the relative costs, consequences and cost-effectiveness of care for adult patients with 
TBI admitted to dedicated neurocritical care units within a neuroscience centre, combined 
neuro/general critical care units within a neuroscience centre, and general critical care units outside a 
neuroscience centre
6. make recommendations for policy, practice and future research in the NHS.
Methods
Selection of candidate risk prediction models for acute TBI was conducted through a systematic review 
of the literature, consultation with clinical experts and methodological assessment. A detailed data set 
was produced (based on publications of the selected risk prediction models plus location of care details) 
to describe and cost the patient journey; short-term outcomes; and contact details, to provide the 
information required for 6-month follow-up.
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All neurocritical care units in the UK and adult general critical care units participating in the Case Mix 
Programme (CMP) were invited to participate. Data set familiarisation courses were held to explain the 
background, aims and rationale for the study and provide a detailed explanation of the data set.
All adult patients admitted to participating critical care units following an actual or suspected TBI, and 
with a Glasgow Coma Scale (GCS) score of < 15 following resuscitation were included. A sample size 
calculation indicated 3400 patients were required. Data were entered locally on to a dedicated, secure, 
web-based data entry system. To avoid duplication of data collection, the RAIN study was linked to two 
national clinical audits: the CMP for units in England and Wales and the Scottish Intensive Care Society 
Audit Group (SICSAG) for units in Scotland. Data validation was ongoing throughout and regular contact 
was maintained with all participating units.
Six-month patient follow-up was conducted centrally and was carefully conducted to prevent distress to 
either the patient or their carer(s). Surviving patients were sent, by post, an introductory letter, information 
sheet, consent form, questionnaires, freepost return envelope and pen. Carer(s) were asked to assist with 
completion of the consent form and, where relevant, questionnaires. Non-responders were followed 
up. Two questionnaires were included: one included the European Quality of life (EuroQol) 5-dimension, 
3-level version (EQ-5D-3L) and the Glasgow Outcome Scale – Extended (GOSE) and the other included 
questions about use of health services following discharge from acute hospital.
Patients were included in the analysis if their last GCS score prior to sedation/admission to critical care was 
< 15. Case mix, length of stay (LOS) and outcomes were summarised overall and for subgroups defined 
by the cause of TBI – road traffic accident (RTA), fall or assault. GOSE responses were used to assign each 
patient to a GOSE category.
With respect to model validation, the case mix and outcomes of patients for each family of models was 
compared with those for patients in the RAIN study. Univariable analyses were conducted to assess the 
relationship between risk factors and outcomes. Each risk prediction model was then validated using 
measures of calibration, discrimination and overall fit. A nested, inter-rater reliability study was conducted 
on a sample of computerised tomography (CT) scans.
For the evaluation of alternative care locations, two distinct research objectives were identified 
that addressed separate decision problems, to compare the relative costs, consequences and 
cost-effectiveness of:
1. management in a dedicated neurocritical care unit compared with a combined neuro/general critical 
care unit; and
2. ‘early’ (within 18 hours of hospital presentation) transfer to a neuroscience centre compared with ‘no 
or late’ (after 24 hours) transfer, for patients who initially present at a non-neuroscience centre and do 
not require neurosurgery.
The evaluation was undertaken in two phases. In the first phase, risk-adjusted costs and consequences 
of alternative care locations at 6 months were compared. EQ-5D-3L profiles were combined with 
health-state preference values from the UK general population, to give an EQ-5D-3L utility index score and 
quality-adjusted life-years (QALYs) at 6 months were calculated by combining survival and utility score at 
6 months. Each item of resource use was combined with the appropriate unit cost to report a cost per 
patient for each cost category (inpatient, outpatient, community and total costs) in 2010–11 prices. For 
research objective 2, subgroup analyses were undertaken by age, presence of major extracranial injury, 
and GCS score. In the second phase, estimates from the 6-month end points and the literature were used 
to project lifetime cost-effectiveness. Incremental net monetary benefits (INBs) were estimated by valuing 
incremental QALYs at a threshold of £20,000 per QALY and subtracting from this the incremental costs. 
The robustness of results to alternative assumptions was tested in extensive sensitivity analyses.
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Missing data were addressed with multiple imputation.
Results
Ten risk prediction models, developed and validated in three studies – Hukkelhoven et al. (Hukkelhoven: 
Hukkelhoven CW, Steyerberg EW, Habbema JD, Farace E, Marmarou A, Murray GD, et al. Predicting 
outcome after traumatic brain injury: development and validation of a prognostic score based on 
admission characteristics. J Neurotrauma 2005;22:1025–39), the Medical Research Council (MRC) CRASH 
(Corticosteroid Randomisation After Significant Head injury) trial collaborators (CRASH: MRC CRASH trial 
collaborators. Predicting outcome after traumatic brain injury: practical prognostic models based on 
large cohort of international patients. BMJ 2008;336:425–9) and Steyerberg et al. [IMPACT (International 
Mission for Prognosis and Analysis of Clinical Trials in TBI): Steyerberg EW, Mushkudiani N, Perel P, Butcher 
I, Lu J, McHugh GS, et al. Predicting outcome after traumatic brain injury: development and international 
validation of prognostic scores based on admission characteristics. PLoS Med 2008;5:e165] were selected 
for external validation in the RAIN study. Four models were developed for predicting mortality at 6 months 
(one Hukkelhoven and three IMPACT) and six for predicting unfavourable outcome at 6 months (one 
Hukkelhoven, two CRASH and three IMPACT).
A total of 67 critical care units participated in the RAIN study: 31 within a neuroscience centre 
(13 dedicated neurocritical care units; 14 combined neurocritical/general critical units, and four additional 
critical care units admitting overflow patients from the neurocritical care unit); and 36 general critical care 
units outside a neuroscience centre.
The final RAIN study data set contained 3626 admissions; a highly representative sample of patients 
receiving critical care following acute TBI in the UK. After exclusions, 3210 patients remained. Of 2323 
patients not reported by the Medical Research Information Service (MRIS) as having died, 1834 (79%) 
were successfully followed up [paper, n = 1245 (68%), or telephone, n = 589 (32%) questionnaire]. When 
combined with the 786 patients known to have died, this resulted in an overall follow-up rate of 82% 
(2620/3210).
Of 3210 patients, 101 (3.1%) had no GCS score recorded and 134 (4.2%) had a last pre-sedation GCS 
score of 15, which resulted in a data set of 2975 patients for analysis. The most common causes of TBI 
were RTA (33%), fall (47%) and assault (12%), with 3% other and 5% unknown cause. Major extracranial 
injury was present in 41% and intoxication confirmed/suspected in 45%. Patients were predominantly 
young (mean age 45 years) and male (76%).
A substantial burden of poor neurological outcomes and quality of life (QOL) 6 months after TBI was 
demonstrated. Mortality at discharge from acute hospital was 16% for assault, 21% for RTA and 30% 
for falls, rising to 17%, 22% and 32%, respectively, at 6 months. Of survivors at 6 months with a known 
GOSE category, 44% had severe disability, 30% had moderate disability, and only 26% had made a good 
recovery. When combined with the 26% mortality at 6 months, 61% of patients with known outcome had 
an unfavourable outcome (death or severe disability) at 6 months. Between 35% and 70% of survivors 
reported problems across the five domains of the EQ-5D-3L at 6 months.
Median total LOS in critical care was 7 days; this differed between survivors (median 8 days) and non-
survivors (median 3 days). Median total LOS in acute hospital was 30 days for survivors compared with 
5 days for non-survivors.
In terms of the statistical assessment of model performance, there was very little to choose between 
models of similar complexity from Hukkelhoven, CRASH and IMPACT. The best discrimination overall was 
from the IMPACT Lab model (c-index 0.779 for mortality and 0.713 for unfavourable outcome) – the only 
one of the models to include laboratory parameters – however, the improvement in performance over the 
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models of the next level of complexity (Hukkelhoven, CRASH CT, IMPACT Extended) was very small. There 
was a larger difference in performance between these models and the simplest models using core data 
only (CRASH Basic and IMPACT Core), suggesting that there is important prognostic information within the 
CT scan and the presence or absence of pre-hospital hypoxia/hypotension. The Hukkelhoven and IMPACT 
Lab models were well calibrated for mortality at 6 months but all models substantially underpredicted 
the risk of unfavourable outcome at 6 months. The substudy on inter-rater reliability of CT scan reporting 
suggested that the CT findings included in the models could be assessed with acceptable reliability.
For subsequent analyses, we therefore selected the IMPACT Lab model as the primary model for risk 
adjustment in the base-case analyses, with the CRASH CT model used for sensitivity analyses (chosen over 
the Hukkelhoven model as it included more substantially different predictor variables from the IMPACT 
Lab model).
In the evaluation of alternative locations of care, baseline patient characteristics were similar between 
dedicated neurocritical care units and combined neuro/general critical care units. At 6 months, mortality 
was similar between the groups (24% vs 25%) but the dedicated neurocritical care unit group had higher 
mean EQ-5D-3L utility index score for survivors (0.48 vs 0.43) and higher mean QALYs (0.18 vs 0.16), 
although none of these differences was statistically significant after case mix adjustment. Critical care 
length of stay was longer for the dedicated neurocritical care unit group (mean 13 vs 11 days) resulting in 
higher mean total costs at 6 months (incremental cost £3694 after case mix adjustment).
There were substantial differences in case mix between patients in the ‘early’ and the ‘no or late’ transfer 
groups; patients in the ‘early’ transfer group were on average younger and with less severe case mix 
(median predicted risk of death at 6 months 18.3% vs 24.6%). At 6 months, patients in the ‘early’ 
transfer group had substantially lower mortality (19% vs 41%), higher mean EQ-5D-3L utility index score 
for survivors (0.55 vs 0.44) and higher mean QALYs (0.22 vs 0.13). These differences were reduced but 
remained significant after case mix adjustment. All categories of resource use in the ‘early’ transfer group 
were approximately double that of the ‘no or late’ transfer group, resulting in substantially higher mean 
total costs at 6 months (incremental cost £15,001 after case mix adjustment).
In the lifetime cost-effectiveness analysis (CEA), dedicated neurocritical care units had higher mean lifetime 
QALYs at small additional mean costs, with an incremental cost-effectiveness ratio (ICER) of £14,000 per 
QALY and INB of £1300. The cost-effectiveness acceptability curve (CEAC) suggested that the probability 
that dedicated compared with combined neurocritical care units are cost-effective is around 60%.
After adjusting for differences in baseline characteristics, the ‘early’ transfer group reported higher lifetime 
QALYs, at an additional cost, with an ICER of £11,000 per QALY and INB of £17,000. The CEAC suggested 
that the probability that ‘early’ transfer was cost-effective is close to 100%. The results for the subgroup 
analyses suggested that ‘early’ transfer has a very low probability of being cost-effective for patients aged 
> 70 years, around 60% probability of being cost-effective for patients without major extracranial injury, 
and 60–80% probability of being cost-effective for patients with mild to moderate TBI (GCS score of 
9–14). The results in the alternative subgroup were close to 100% in each case.
The results of the lifetime CEA were robust to alternative assumptions.
Conclusions
The risk prediction models evaluated in the RAIN study demonstrated sufficient statistical performance to 
support their use in research studies but fell below the level that would be required to recommend their 
use to guide individual patient decision-making.
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Harrison et al. under the terms of a commissioning contract issued by the Secretary of State for 
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
DOI: 10.3310/hta17230 HealtH tecHnOlOgy assessment 2013 VOl. 17 nO. 23
xvii
Although the results of the RAIN study suggest that, within a neuroscience centre, management in a 
dedicated neurocritical care unit may be cost-effective compared with management in a combined neuro/
general critical care unit, there was considerable statistical uncertainty in this finding. The results of the 
RAIN study support current recommendations that all patients with severe TBI (GCS score of 3–8) would 
benefit from transfer to a neuroscience centre, regardless of their need for neurosurgery. However, caution 
should be exercised with regard to the risk of residual confounding. Benefit was also found for patients 
with mild or moderate TBI (GCS score of 9–14) requiring critical care. The only exception was in patients 
aged of > 70 years, for whom transfer was associated with increased risk of death, and the most cost-
effective strategy was management within the hospital at which they presented.
We recommend further research to:
1. explore the potential to improve on the current risk prediction models for acute TBI
2. consider alternative approaches for handling the potential impact of unobserved confounders on the 
RAIN study results
3. continue to follow up the RAIN study cohort to obtain data on long-term mortality, functional 
outcomes and QOL
4. better understand the alternative pathways of care for patients following acute TBI and the impact of 
these on costs and outcomes, and
5. explore equity of access to post-critical care support for patients following acute TBI.
The RAIN study should inform future research studies in the neurocritical care of adult patients following 
acute TBI through provision of reliable data for sample size calculations and exploratory analyses, and 
informing the choice of risk adjustment methods and data set design.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National 
Institute for Health Research.
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Chapter 1 Introduction
Risk prediction models have been in established use in adult general critical care units for > 30 years, since the publication of the original Acute Physiology And Chronic Health Evaluation (APACHE) model 
in 1981.1 In the UK, the first large-scale validation of a risk prediction model was the Intensive Care 
Society’s APACHE II study in Britain and Ireland (1987–9).2,3 This study produced recalibrated coefficients 
for the APACHE II model, and led, in 1994, to the formation of the Intensive Care National Audit and 
Research Centre (ICNARC) and the Case Mix Programme (CMP), the national clinical audit of adult general 
critical care units in England, Wales and Northern Ireland. ICNARC has continued to pioneer developments 
in risk prediction in the CMP, most recently through the validation and recalibration of a number of general 
risk prediction models4 and subsequent development of a new model – the ICNARC model.5
Unlike adult general critical care, no data are routinely collected in the NHS for risk-adjusted comparison 
of outcomes from neurocritical care. Consequently, a number of dedicated neurocritical care units 
currently participate in the CMP. However, there are significant limitations to using models developed and 
validated for general critical care for patients receiving neurocritical care. Using a spectrum of measures 
for calibration and discrimination, risk prediction models – successfully developed and validated for 
adult admissions to general critical care units – showed significant departure from perfect calibration in 
admissions with head injuries to adult general and dedicated neurocritical care units.6 The inclusion and 
handling within general risk models of variables of specific prognostic importance in acute traumatic 
brain injury (TBI) is often poor.6 For example, the APACHE II model assumes that any patient who is 
sedated for the entire first 24 hours in the critical care unit is deemed neurologically normal, which is 
unlikely to be correct for TBI patients and has led to that the use of pre-sedation values of the Glasgow 
Coma Scale (GCS) for such patients.7 The only general model to take any account of changes detected 
on computerised tomography (CT) scan is the Mortality Prediction Model (MPM) II, and the inclusion 
of CT information in this model is limited to the presence of an intracranial mass effect. Furthermore, 
all risk prediction models for adult general critical care use an outcome of mortality at discharge from 
acute hospital, which is not considered adequate for neurocritical care when longer-term (e.g. 6-month) 
mortality and, importantly, functional outcome are more valid.8
Although a large number of risk prediction models for TBI exist, a systematic review found that most 
models are limited by being based on small samples of patients, having poor methodology, and rarely 
being validated on external populations.9 Despite the more recent development of models based on larger, 
more representative data sources,10 these models require further prospective validation, and potentially 
recalibration, before they can be applied with confidence for research and audit in neurocritical care in 
the NHS.
In the NHS, adult patients with TBI are rarely managed by a single service. They are usually managed by 
a succession of services from first contact to definitive critical care and the latter is not always within in 
a dedicated neurocritical care unit within a neuroscience centre. Despite guidelines recommending that 
all patients with severe TBI be treated within a neuroscience centre,11 many (particularly those without 
surgically remedial lesions) are currently neither treated in nor transferred to one. A combination of 
geography, bed availability, local variation and clinical assessment of prognosis can often determine 
the location of definitive critical care for an adult patient with TBI. The Neurocritical Care Stakeholder 
Group, established to offer expert advice to Department of Health and Commissioners, indicated in its 
audit report that, within the NHS, only 67% of beds that are ring-fenced for neurocritical care were in 
dedicated neurocritical care units and that neurocritical care unit occupancy rates exceeded 90% (especially 
for Level 3 beds).12 Most neurocritical care for adult patients with TBI was delivered either in dedicated 
neurocritical care units (42%) or in combined neuro/general critical care units within a neuroscience centre 
(35%). However, despite clear guidelines and the progressive regionalisation of neurosurgical care since 
1948, 23% of patients with TBI were treated in general critical care units outside a neuroscience centre. 
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Local critical care consultant opinion indicated that at least 83% of these patients required transfer to a 
neuroscience centre. No data were available, or are routinely collected even in 2012, within the NHS for 
risk-adjusted comparisons.
Where adult patients with TBI should be optimally managed is an important question for the NHS, in 
terms of both outcomes and costs. Belief and limited evidence has underpinned the establishment, and 
continuing expansion, of dedicated, neurocritical care facilities in the UK13,14 but no formal evaluation 
has been undertaken. Increased centralisation has been hypothesised to improve outcomes through 
concentration of knowledge and expertise, higher volumes of patients and greater adherence to 
evidence-based protocols. Recent research has suggested benefit from managing severe head injury in 
specialist centres;15,16 however, the results are inconclusive owing to lack of adjustment for all known 
confounders, no data on costs of care, and having follow-up data only to hospital discharge. The 
existing research also does not address the issue of dedicated compared with combined critical care units 
within neuroscience centres. A key issue for policy-makers is whether the additional initial costs of more 
specialised care are justified by subsequent reductions in morbidity costs and/or improvements in patient 
outcomes. Although conventional randomised controlled trial (RCT) methodology may be impractical in 
this setting, the presence of variation in the way services are organised and delivered can allow them to be 
compared using observational methods. This is possible only if a valid, reliable, appropriate and accurate 
risk prediction model exists.
The Risk Adjustment In Neurocritical care (RAIN) study was originally conceived in 2001. At its inaugural 
meeting in February 2007, the newly formed Neurocritical Care Network (NCCNet), a network of units and 
staff providing neurocritical care to patients in both dedicated and general units, identified establishing 
a risk prediction model to investigate and evaluate the location and outcomes of care for adult patients 
with TBI as their first, and top, priority. It was recognised that this aim could only be achieved through 
validation of an accurate risk prediction model for adult patients with TBI and the RAIN study was 
therefore adopted by NCCNet.
The primary aims of the RAIN study were to validate risk prediction models for acute TBI in the setting of 
neurocritical care in the NHS, and to use these models to evaluate the optimum location and comparative 
costs of neurocritical care in the NHS. Specific, detailed objectives to achieve these aims were to:
1. identify, from the literature, the existing risk prediction models for acute TBI most likely to be 
applicable to a neurocritical care setting, and identify a full list of variables required in order to be able 
to calculate these models (see Chapter 2)
2. collect complete, valid and reliable data for the variables identified above for consecutive adult 
admissions with TBI to dedicated neurocritical care units within a neuroscience centre, combined 
neuro/general critical care units within a neuroscience centre and general critical care units outside a 
neuroscience centre within the NHS (see Chapter 3)
3. describe the case mix of these patients and their survival, neurological outcome and quality of life 
(QOL) at 6 months following the TBI (see Chapter 4)
4. undertake a prospective, external validation of existing models for adult patients with TBI admitted to 
critical care, to identify the strengths and weaknesses of each model, and, if possible, to identify the 
best model to use for risk adjustment in this setting (see Chapter 5)
5. describe and compare adjusted outcomes and cost-effectiveness of care for adult admissions with 
TBI between dedicated neurocritical care units within a neuroscience centre, combined neuro/general 
critical care units within a neuroscience centre and general critical care units outside a neuroscience 
centre within the NHS (see Chapter 6)
6. make recommendations for policy and practice within the NHS (see Chapter 7).
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Chapter 2 Selection of risk prediction models for 
critically ill patients with acute traumatic brain injury
Introduction
This chapter reports the process that was undertaken to select the most appropriate risk prediction models 
for external validation in the RAIN study. The aim was to identify the models most likely to be applicable in 
a neurocritical care setting in the NHS.
Methods
Selection of candidate risk prediction models was conducted in two phases. First, a systematic review of 
the literature was conducted to identify existing risk prediction models for acute TBI that are most likely to 
be applicable to a critical care setting and to identify the variables required to be able to calculate these 
models. Second, eligible models identified by the systematic review were reviewed by the RAIN Study 
Steering Group (see Acknowledgements) to determine if there were any relevant models that had been 
missed and to select the most appropriate models for external validation in the RAIN study.
Perel et al.9 previously conducted a systematic review to identify and assess existing risk prediction models 
for TBI.9 The first stage of the systematic review therefore was to update the existing review to identify 
relevant risk prediction models that had been published since 2006. The second stage was to assess the 
eligibility of studies previously identified by Perel et al.9 and by the updated searches for the RAIN study.
Search strategy
The electronic search strategy was based on that used by Perel et al.9 (see Appendix 1) and was performed 
using EMBASE (incorporating MEDLINE) to identify eligible studies, published in English, from 2006 to 
2008, which (1) gave an overall prognostic estimation by combining the predictive information from at 
least two variables – studies could develop new prognostic models (derivation studies) or evaluate previous 
ones (validation studies); (2) used variables collected before hospital discharge, which were therefore 
considered as predictors; (3) included patients of any age; (4) included patients with any type or severity 
of TBI; and (5) predicted any outcome, such as neurological impairment, disability, survival, etc. There was 
no time restriction for the evaluation of outcomes. Three search themes were combined: ‘traumatic brain 
injury’; ‘brain/coma/consciousness/craino/skull’; and ‘prognosis/predicts’. One reviewer (GPr) examined 
titles, abstracts and keywords of records identified by the electronic database searches for eligibility. 
The full text of all potentially eligible papers was obtained and independently assessed by two reviewers 
(GPr and DAH) for eligibility using the pre-defined inclusion criteria described above. Disagreement was 
resolved by a third reviewer (KMR). The reference lists of all full-text papers reviewed were checked for any 
additional potentially eligible studies.
The studies previously identified by Perel et al.9 and by the updated searches were then independently 
assessed by two reviewers (GPr and DAH) for eligibility for the RAIN study. Studies were eligible for 
inclusion if they (1) were based on adult (> 16 years) populations; (2) had a sample size of greater than 
500 patients in either the development or validation data set; (3) aimed to evaluate outcome regardless of 
care received during the hospital stay; and (4) were UK based or multicentre. Disagreement was resolved 
by a third reviewer (KMR).
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Assessment of methodological quality
There is no gold standard tool for quality assessment of either RCTs or observational studies. Assessment of 
the methodological quality of studies eligible for the RAIN study was conducted using the same approach 
as Perel et al.9 considering two domains: (1) internal validity, which refers to systematic error and is related 
to the study design and (2) external validity, which refers to the generalisability of the study and whether 
the results can be extrapolated to other populations and settings. Eighteen questions related to internal 
and external validity were considered for each of the studies, as follows:
Internal validity
 z Did the study have adequate follow-up?
 z Was a discussion included about the rationale to include predictors?
 z Were the predictive variables clearly defined?
 z Were the outcomes predicted valid?
 z Were missing data adequately managed?
 z Was an adequate strategy performed to build the multivariable model?
 z Were interactions between the variables examined?
 z Were the continuous variables handled appropriately?
 z Were there > 10 events per variable included?
External validity
 z Was a description of the sample population reported?
 z Was there a clear explanation on how to estimate the prognosis provided?
 z Were measures of discrimination reported?
 z Were measures of calibration reported?
 z Were confidence intervals (CIs) reported?
 z Was the model validated?
 z Was the model internally validated?
 z Was the model externally validated?
 z Was the effect of the model established?
Expert review
All studies eligible for the RAIN study were then reviewed by the RAIN Study Steering Group to identify any 
additional studies, either published or ongoing, of relevance, and to select the most appropriate models 
for validation in a UK critical care setting.
Results
The electronic database searches identified a total of 1832 citations. After screening of titles and abstracts, 
23 potentially eligible papers were identified for full-text review.17–39 In addition, the electronic database 
searches identified seven review articles,40–46 the references lists of which did not identify any further 
potentially eligible papers. Of the 23 full-text papers reviewed, 13 were excluded because either they were 
not studies that had developed or evaluated prognostic models for TBI or they were prognostic models 
that included predictors measured after discharge from hospital (Figure 1).
A total of 53 studies reporting 102 models were identified by Perel et al.9 However, of these, the authors 
considered the models developed by Signorini et al.47 and Hukkelhoven et al.48 to be the most clinically 
useful for patients from high-income countries with moderate and severe TBI, as they fulfilled the majority 
of the methodological requirements and showed acceptable performance in the external validation. They 
were also considered to be available in a user-friendly way. A total of 12 potentially eligible studies were 
therefore identified from Perel et al.9 and from the updated searches (see Figure 1).
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Of the 12 potentially eligible studies, eight did not fulfil the RAIN study eligibility criteria because the 
models had been developed in paediatric populations, were based on samples of fewer than 500 patients, 
adjusted for care received within hospital or had been conducted in a single-centre, non-UK setting 
(Figure 2). This resulted in four eligible studies for review by the RAIN Study Steering Group.
Description of eligible studies
Four studies,30,35,47,48 reporting a total of 17 risk prediction models, met the RAIN study eligibility criteria. A 
brief description of each is given below and a summary is provided in Table 1.
Signorini et al.
Signorini et al.47 developed a risk prediction model in a cohort of consecutive patients admitted to 
a regional trauma centre with moderate or severe head injury (n = 372) between January 1989 and 
July 1991. The criteria for enrolment into the study were (1) age ≥ 14 years and (2) admission or last 
known GCS score of < 12, or of 13–15 with concomitant systemic injuries giving an injury severity score 
(ISS) of ≥ 16. The outcome assessed was mortality at 1 year. The variables included in the model are 
detailed in Table 1. The model was externally validated in a similar cohort of patients in the same centre 
accrued as part of an almost identical study between July 1991 and April 1996 (n = 520).
Papers identified through
electronic database searches
(n = 1832)
Full text assessed
(n = 23)
Excluded (n = 13)
- did not develop/evaluate
 prognostic models (n = 8)
- included post-hospital
 predictors (n = 5)
Excluded
(n = 1802) (title/abstract screening)
Identified by
Perel et al.9
(n = 2)
Eligible based on
Perel et al.9
(n = 10)
Potentially eligible
for RAIN study
(n = 12)
FIGURE 1 Stage 1 of the selection process: update of Perel et al.9 systematic review.
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Hukkelhoven et al.
Hukkelhoven et al.48 developed two risk prediction models using data from two multicentre RCTs: 
(1) the International Tirilazad trial (n = 1120) conducted in 40 centres in Europe, Israel and Australia 
from 1992 to 199449 and (2) the North America Tirilazad trial (n = 1149) conducted in 36 centres in the 
USA and Canada from 1991 to 1994.50 Patients were included who (1) were aged ≤ 65 years; (2) had a 
total GCS score of < 9 or a total GCS score of 9–12 and an abnormal CT scan; (3) had a GCS motor score 
available; (4) had a CT scan available; and (5) had been admitted to hospital within 4 hours of the TBI. 
The outcomes assessed were mortality at 6 months and unfavourable outcome (death, vegetative state 
or severe disability) at 6 months, defined using the Glasgow Outcome Scale (GOS). The variables included 
in the models are detailed in Table 1. The model for mortality at 6 months was externally validated in 
two populations of patients: the core data survey conducted by the European Brain Injury Consortium 
(EBIC), which included 796 patients with severe or moderate TBI consecutively collected between February 
and April 1995 from 55 European centres in which the 6-month outcome assessment was routinely 
performed,51 and the Traumatic Coma Data Bank (TCDB), which contained data collected on 746 patients 
with non-penetrating severe TBI admitted to four centres in the USA between 1984 and 1988.52 The 
model for unfavourable outcome at 6 months was externally validated in the EBIC data set only.
Medical Research Council CRASH trial collaborators
The Medical Research Council (MRC) Corticosteroid Randomisation After Significant Head injury (CRASH) 
trial collaborators30 developed eight risk prediction models using data from the MRC CRASH trial, a 
large international RCT which enrolled 10,008 patients between 1999 and 2004.53,54 Risk models were 
developed for death at 14 days and unfavourable outcome at 6 months in patients with TBI in low-/
middle- and high-income countries. The risk models that were eligible for the RAIN study were those 
developed using data from high-income countries (n = 2482). The outcome of interest for the RAIN 
study was unfavourable outcome at 6 months. Two models were developed: (1) the Basic model, which 
included only clinical and demographic variables, and (2) the CT model, which also included CT scan 
results. Patients were included who (1) were aged ≥ 16 years; (2) had a total GCS score of < 15; and 
FIGURE 2 Stage 2 of the selection process: selection of models for external validation in the RAIN study. (a) Studies 
were excluded for more than one reason.
Assessed by RAIN
Study Steering Group
(n = 4)
Excluded by RAIN
Study Steering Group
(n = 1)
Excluded (n = 8)a
- paediatric data (n = 3)
- sample < 500 (n = 6)
- adjusted for care within
 hospital (n = 1)
- non-UK/single centre (n = 6)
Selected for RAIN study
(n = 3)
Potentially eligible
for RAIN study
(n = 12)
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(3) were within 8 hours of the TBI. The variables included in the model are detailed in Table 1. The models, 
with some modifications, were externally validated in a cohort of 8509 patients with moderate to severe 
TBI from the International Mission for Prognosis and Analysis of Clinical Trials in TBI [IMPACT (International 
Mission for Prognosis and Analysis of Clinical Trials in TBI)] database (described below). For validation 
of the Basic model, the ‘variable major extracranial injury’ was excluded, and for validation of the CT 
model, the ‘variable petechial haemorrhages’ was excluded, as these variables were not available in the 
validation sample.
Steyerberg et al.
Steyerberg et al.35 developed three risk models using data from the IMPACT database,55 which includes 
data from eight RCTs and three observational studies conducted between 1984 and 1997. Patients were 
included who had a GCS score of < 13. The outcomes assessed were mortality and unfavourable outcome 
at 6 months. Three models were developed for each outcome: a Core model, an Extended model and a 
Laboratory model. The variables included in each of the models are detailed in Table 1. The Core model 
and a variant of the Extended model were validated using data from the CRASH trial (described above). 
For validation of the Extended model, the variables ‘hypoxia’, ‘hypotension’ and ‘extradural haemorrhage’ 
were excluded, as these were not available in the validation sample. It was not possible to externally 
validate the Laboratory model, as laboratory values were not recorded in the CRASH trial.
Assessment of methodological quality
The quality assessment of the four studies,30,35,47,48 using the criteria of Perel et al.,9 is summarised in 
Table 2. Neither the MRC CRASH trial collaborators30 nor Steyerberg et al.35 reported completeness of 
follow-up in their respective papers reporting development of the CRASH and IMPACT models. However, 
for the CRASH trial, a separate paper reporting the trial results indicated overall follow-up of 95% for GOS 
at 6 months,54 and a paper reporting the design of the IMPACT database indicated overall follow-up of 
95% for GOS at 6 months (including last observation carried forward imputation of 18% of values from 
3 months).55
All of the studies30,35,47,48 provided some justification for the predictors included in the models, reflecting a 
combination of an existing established relationship with outcome and ease of collection and use. However, 
none of the investigators reported clear definitions for the predictors. All of the studies30,35,47,48 used valid 
outcomes (mortality and/or GOS) in the models. Handling of missing data varied. In two studies,30,47 
complete case analyses were used. The final number of patients included in the model of Signorini et 
al.47 was not reported; however, 20% of patients were missing CT assessment alone and, therefore, a 
maximum of 80% of the original sample of 365 patients can have been used in fitting the final model. 
The MRC CRASH trial collaborators30 cited low levels of missing data as justification for their complete case 
approach; however, this approach resulted in only 88% of the original sample being included in the Basic 
model for high-risk countries and 79% in the CT model. In contrast, for the remaining two studies,35,48 
statistical imputation methods were used, resulting in all patients being included in the final models. 
Hukkelhoven et al.48 used regression imputation to impute the 4.8% of missing values, acknowledging that 
such an approach would slightly underestimate the true variability and Steyerberg et al.35 used the gold 
standard method of multiple imputation.
In all four studies,30,35,47,48 risk prediction models were developed using logistic regression, although the 
approach to variable selection varied. Signorini et al.47 used a form of forward stepwise selection but with 
the order of variables being added to the model based on a combination of data completeness and clinical 
criteria rather than statistical significance alone. Hukkelhoven et al.48 fitted a full model and used backward 
stepwise selection to remove variables with p > 0.2. The MRC CRASH trial collaborators30 included variables 
in the final models if they were significant at the 5% level in a full multivariable model. Finally, Steyerberg 
et al.35 based inclusion in their final models on partial Nagelkerke R2-values from a previous multivariable 
analysis of the same database.57 The only authors who reported evaluating interactions between predictors 
were Steyerberg et al.;35 however, it was unclear which, or how many, potential interactions were 
examined. All of the studies30,35,47,48 used continuous modelling for continuous variables, and all either 
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included or considered some degree of non-linearity. The criterion of at least 10 events per predictor 
variable included in the modelling process was met by three of the four studies.30,35,48 Signorini et al.47 
reported approximately eight events per predictor variable included in the model.
A description of the sample population, including important case mix variables, was reported for all four 
studies.30,35,47,48 In addition, simple methods for calculating predictions, including a nomogram, simple 
clinical scores, web calculators and a spreadsheet calculator, were provided. Measures of discrimination 
were reported in all papers, although only Hukkelhoven et al.48 included a CI on the c-index [area under 
the receiver operating characteristic (ROC) curve]. In all papers, calibration was summarised graphically and 
tested for perfect calibration with the Hosmer–Lemeshow test, with CIs reported on model estimates.
All models were validated either internally and/or externally as described above and summarised in Table 1. 
None of the models was evaluated for its effect in clinical practice.
Internal validation was performed by Hukkelhoven et al.48 and the MRC CRASH trial collaborators30 using 
bootstrap methods, and by Steyerberg et al.35 using cross-validation across the 11 separate study data 
sets comprising the IMPACT database. The model of Signorini et al.47 was externally validated using data 
from a further 520 patients admitted to the same single centre. The models of Hukkelhoven et al.48 were 
externally validated using data from approximately 1500 patients from observational registries. Modified 
versions of the CRASH models were validated using the IMPACT database.30 The IMPACT Core models and 
modified versions of the IMPACT Extended models were validated in the CRASH trial data set; however, 
it was not possible to externally validate the IMPACT Lab models, as the CRASH trial did not record the 
required laboratory values.35
Expert review
The RAIN Study Steering Group did not identify any further studies (either published or ongoing) that 
would be potentially eligible for the RAIN study. The four studies identified by the systematic review 
reported development and validation of 17 risk prediction models. Of these, 11 were potentially eligible for 
validation in the RAIN study; the models developed by the MRC CRASH trial collaborators30 for low-income 
countries and predicting mortality at 14 days were excluded. Following review by the RAIN Study Steering 
Group, 10 risk prediction models were selected for external validation in the RAIN study. The model 
developed by Signorini et al.47 was excluded because the model was developed using data from a relatively 
small single-centre study with mortality at 1 year as the outcome. The remaining three studies were large 
multicentre studies, which considered functional outcome as well as mortality at 6 months. There was also 
concern about the data burden associated with the ISS included in the Signorini et al. model.47
Discussion
Principal findings
The systematic review of the literature identified four studies30,35,47,48 reporting development and validation 
of 17 risk prediction models for TBI. Of the 17 models, 11 were eligible for the RAIN study. Following 
assessment of their methodological quality and review by the RAIN Study Steering Group, 10 models, 
developed and validated in three studies,30,35,48 were selected for external validation in the RAIN study. Four 
models were developed for mortality at 6 months35,48 and six models were developed for unfavourable 
outcome, using the GOS, at 6 months.30,35,48
The variables included across the 10 selected models were age, GCS score, GCS motor score, pupil 
reactivity, presence of major extracranial injury, hypoxia, hypotension, glucose, haemoglobin, Marshall 
CT classification,56 presence of traumatic subarachnoid haemorrhage (SAH), presence of extradural 
haematoma, presence of petechial haemorrhages, obliteration of the third ventricle or basal cisterns, 
midline shift and non-evacuation of haematoma. The outcomes assessed were mortality and unfavourable 
outcome, using the GOS, at 6 months.
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TABLE 2 Quality assessment of studies meeting RAIN study eligibility criteria
Quality criteria, Perel et al. 
(2006)9
Signorini et al. 
(1999)47
Hukkelhoven et 
al. (2005)48
MRC 
CRASH trial 
collaborators 
(2008)30
Steyerberg et al. 
(2008)35
Internal validity – study 
1 Did the study have adequate 
follow-up?
Yes (> 90%) Yes (> 90%) Yes (> 90%) Yes (> 90%)
Internal validity – variables
2 Was a discussion included 
about rationale to include 
the predictors?
Yes Yes Yes Yes
3 Were the predictive variables 
clearly defined?
No No No No
4 Were the outcomes 
predicted valid?
Yes (mortality) Yes (mortality/GOS) Yes (GOS) Yes (mortality/
GOS)
5 Were missing data 
adequately managed?
No (complete 
case analysis)
Yes (regression 
imputation)
No (complete 
case analysis)
Yes (multiple 
imputation)
Internal validity – analysis
6 Was an adequate strategy 
performed to build the 
multivariable model?
Forward selection 
based on clinical 
criteria and 
completeness
Backward stepwise 
selection (p < 0.2)
p < 0.05 in full 
model
Partial R2 from 
previous analysis 
of same database
7 Were interactions between 
the variables examined?
Not reported No Noa Yes
8 Were continuous variables 
handled appropriately?
Yes Yes Yes Yes
9 Were > 10 events per 
variable included?
No No Yes Yes
External validity
10 Was the description of the 
sample reported?
Yes Yes Yes Yes
11 Was it clearly explained how 
to estimate the prognosis?
Yes (nomogram) Yes (simple score) Yes (web 
calculator)
Yes (simple score, 
web calculator and 
spreadsheet)
12 Were measures of 
discrimination reported?
Yes (with CI) Yes Yes Yes
13 Were measures of calibration 
reported?
Yes Yes Yes Yes
14 Were CIs presented? Yes Yes Yes Yes
15 Was the model validated? Yes Yes Yes Yes
16 Was the model internally 
validated?
No Yes (bootstrap) Yes (bootstrap) Yes (cross-
validation)
17 Was the model externally 
validated?
Yes Yes Yesb Yes/noc
18 Was the effect of using the 
model established?
No No No No
a Except for interactions with high- vs low-/middle-income countries.
b Modified versions of models for unfavourable outcome at 6 months validated.
c Core models and modified version of extended models validated; laboratory models not validated.
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Strengths and weaknesses
A major strength of this systematic review was being built on a previous, rigorous systematic review.9 One 
of the strengths of the Perel et al.9 review is that there was no restriction on the types of patients, i.e. 
any age and any severity of TBI, or on the setting. Interestingly, although the burden of trauma is much 
greater in low-income countries, only 2% of the models identified included patients from these countries. 
The MRC CRASH trial collaborators30 identified significant interactions between the country’s income 
level and several predictors and so developed separate models for low-/middle-income countries and for 
high-income countries. Given that the RAIN study was seeking to validate prognostic models for use in a 
UK NHS setting, models developed for low-/middle-income countries were excluded.
There are some limitations to the systematic review. The original literature search by Perel et al.9 was 
restricted to 1990 onwards. However, this was on the basis that changes in management and diagnostic 
technology in recent years means that prognostic models developed before 1990 are unlikely to be 
relevant for the current medical care of patients with TBI. In addition, only studies that explicitly combined 
at least two predictors were included, which means that studies that used multivariable analysis to 
investigate individual predictors but did not report an overall estimation were excluded. Similarly, studies 
that assessed clinical prediction rules considering more than one variable were excluded if they did not 
combine them.
Methodological quality of the risk prediction models
The original systematic review by Perel et al.9 and the recent update reveal that a large number of 
prognostic models for TBI have been published. However, their methodological quality is relatively poor. 
Limitations include, small sample sizes (fewer than 10 events per variable), loss to follow-up rates in 
excess of 10%, inappropriate handling of missing data (i.e. not using statistical imputation methods), and 
rarely being validated in external populations. Perel et al.9 reported that of the 102 models (in 53 studies) 
identified, they considered only the three models developed by Signorini et al.47 and Hukkelhoven et al.48 
to be clinically useful for patients from high-income countries. All three models fulfilled the eligibility 
criteria for inclusion in the RAIN study. The updated search identified an additional eight models (from two 
studies30,35) that were also eligible. In general, the methodological quality of these 11 models was good. 
However, eight models35,48 were developed using data from multiple sources and may therefore be limited 
by differences between data sets in eligibility criteria, definitions of variables and timings of measurements. 
Although all of the studies included discussion about the rationale for including specific predictors, none 
reported clear definitions for predictive variables. In addition, there was variation in how missing data 
were handled: two of the four studies used regression or multiple imputation and two used complete case 
analysis on the basis that there were few missing data; however, this meant that for at least one of the 
models, only 79% of the original sample was included.30
Of the 11 eligible models, 10 risk prediction models were selected by the RAIN Study Steering Group 
for validation in the RAIN study.30,35,48 All were developed using some or all data from RCTs, which may 
limit their external validity. Even in large pragmatic RCTs, such as the CRASH trial,30 external validity may 
be affected by self-selection of centres and patients to participate in the trial, as well as the potential for 
patients enrolled in a trial (in both the active and control arms) to receive better standard of care than in 
usual clinical practice.58,59 To assess whether a model is generalisable to other populations, it is important 
to conduct external validation. Of the 10 models, all except two were validated on patients from different 
centres. However, for four of the remaining eight models, a limitation was that some variables had to be 
excluded from the models for validation as they were not available in the validation sample. Therefore, only 
four of the 10 models – those by Hukkelhoven et al.48 and the Core models from Steyerberg et al.35 – have 
been externally validated without undergoing any modifications.
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Summary
In summary, three families of risk prediction models including 10 individual models were identified that 
are most likely to be applicable to a UK critical care setting.30,35,48 These models require further prospective 
validation, and potentially recalibration, before they can be applied with confidence in neurocritical care in 
the NHS.
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Chapter 3 The Risk Adjustment In Neurocritical 
care study
Introduction
The systematic review of the literature identified three families of risk prediction models for acute TBI that 
were likely to be applicable to a neurocritical care setting. In order to externally validate these models and 
to use them to evaluate the optimum location and comparative costs of neurocritical care in the NHS, a 
prospective cohort study was undertaken in dedicated neurocritical care units, combined neuro/general 
critical care units within a neuroscience centre and general critical care units outside a neuroscience centre. 
Data were collected on consecutive adult patients admitted to critical care with suspected acute TBI. This 
chapter reports the RAIN study set-up from research governance, through design and development of the 
data set, recruitment of sites and patients, data management, and 6-month follow-up of neurological 
outcomes and QOL.
Methods
Research governance
The RAIN study was sponsored by ICNARC. The contract for the study was signed in December 2008 and, 
once the study co-ordinator was appointed, the process of completing research governance approvals 
commenced. Owing to the inclusion of adults with incapacity, two separate applications were made to the 
NHS Research Ethics Committee (REC) for Wales, covering sites in England and Wales under the Mental 
Capacity Act 2005, and to the Scotland A REC, covering sites in Scotland under the Adults with Incapacity 
(Scotland) Act 2000. Favourable opinions were received on 13 March 2009 (ref. 09/MRE09/10) and 
30 March 2009 (ref. 09/MRE00/15), respectively.
In response to the unique problems faced by patients with acute TBI in critical care, we delayed the 
request for consent until 6 months after the TBI at the point of follow-up. At hospital/critical care unit 
admission these patients are often unconscious and their level of consciousness continues to vary during 
their stay in the critical care unit. Generally, treatment needs to be started urgently, so there is little time 
for health-care staff to adequately explain research studies to patients or their families. This is, of course, 
a stressful and emotional time for families. In view of these difficulties in gaining informed consent, an 
application was made to the National Information Governance Board (NIGB) Ethics and Confidentiality 
Committee (ECC) for support under Section 251 of the NHS Act 2006 for permission to hold sufficient 
patient identifiable data, prior to patient consent, in order for us to contact the patient at 6 months post 
TBI and gain their consent. Section 251 support, covering sites in England and Wales, was obtained on 4 
August 2009 [ref. ECC 2–06(d)/2009]. For the two sites in Scotland, falling outside the remit of the NHS 
Act 2006, approval was sought from the Caldicott Guardian and was granted on 10 November 2009 and 
25 March 2010.
Central Research and Development (R&D) approval was gained on 4 August 2009. Site-specific information 
(SSI) forms were submitted for each for each NHS Trust, with the last form submitted on 3 November 2009 
and the final approval gained on 28 January 2010.
The National Institute for Health Research (NIHR) Clinical Research Network (CRN) Portfolio details 
high-quality clinical research studies that are eligible for support from the NIHR CRN in England. The RAIN 
study was adopted on to the NIHR CRN Portfolio on 27 August 2009 (ref. 7349).
NIHR Journals Library www.journalslibrary.nihr.ac.uk
tHe rIsk aDjustment In neurOcrItIcal care stuDy
16
Changes to protocol
The initial RAIN study protocol submitted for approvals was Version 1.3 (21 January 2009). Amendments 
to the RAIN study follow-up documentation, not requiring changes to the study protocol, were 
submitted in March 2009, May 2009, July 2009 and November 2009, and approved by the RECs. A final 
non-substantial amendment to the Study Protocol (Version 1.4, 1 February 2011; see Appendix 2) was 
submitted in February 2011, clarifying explicitly that participating critical care units would be required 
to submit anonymised CT scans to the Wolfson Brain Imaging Centre (WBIC) at Addenbrooke’s Hospital 
(University of Cambridge/Cambridge University Hospitals NHS Foundation Trust) for the purpose of the 
substudy on inter-rater reliability of CT scan reporting.
Design and development of data set
The initial RAIN study data set was developed and produced by the RAIN study team from the original 
model publications. Definitions for some of the fields were refined through discussion and consultation 
with the clinical experts on the RAIN Study Steering Group. There were five elements to the data set: 
(1) characteristics of the patients and their injury; (2) risk factors for the selected risk prediction models; 
(3) location of care details, to describe and cost the patient journey in order to investigate the effect of 
location of neurocritical care; (4) short-term outcomes at discharge from critical care and acute hospital; 
and (5) contact details, to provide the information required for the 6-month follow-up.
To avoid duplication of data collection, the RAIN study was piggybacked on to the CMP in England and 
Wales and linked with data provided by the Scottish Intensive Care Society Audit Group (SICSAG) in 
Scotland. Both the CMP and SICSAG databases have been independently assessed to be of high quality 
against 10 criteria for coverage and accuracy by the Directory of Clinical Databases at docdat.ic.nhs.uk. 
Critical care units in England and Wales that were not participating in the CMP recorded all required fields 
within the RAIN study data set.
The publications reporting each risk prediction model, other associated publications and, where available, 
original study documentation relating to the data sources were examined for definitions for each field 
to be included in the data set. The definitions and, in particular, the time points for data collection were 
often not clearly defined and/or varied both between risk models and between different data sources 
used for the development of the same risk model. Clinical experts from the RAIN Study Steering Group 
also identified a small number of additional fields that they felt to be important predictors of outcome 
following TBI that were not included in any of the risk prediction models, the collection of which was 
considered valuable for informing future work in this area.
The full RAIN study data set and definitions are provided in Appendix 3. A brief summary is given below.
Characteristics
Patients were characterised by their age, sex, residential postcode (permitting linkage to small area 
deprivation statistics), residence prior to hospital admission and prior dependency. The injury was 
characterised by timing, cause, intoxication at the time of injury and presence, and site(s) of major 
extracranial injury.
Risk factors
Pupil reactivity and GCS score data were collected both pre-hospital (prior to attendance at first hospital) 
and at admission to the first hospital (within 12 hours of attendance at the first hospital). GCS score was 
collected additionally as the last value prior to sedation, and pupil reactivity at the point of admission to 
the critical care unit. CT scan data were evaluated based on the first CT scan performed after the TBI.
Location of care details
The patient journey prior to admission to the critical care unit was recorded using the immediate prior 
location and, for patients who were admitted from a more transient location (e.g. theatre, imaging, 
emergency department), their location prior to this. Data for resource use was based on the total numbers 
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of calendar days of both organ support and levels of care as defined for the Department of Health Critical 
Care Minimum Data Set (CCMDS).
Short-term outcomes
Survival status at discharge from the critical care unit was recorded in the RAIN study for all admissions. 
For survivors, subsequent information on location following discharge (including critical care transfers), 
and outcomes at final discharge from critical care and acute hospital were also collected.
Contact details
The patient’s full name, address and any telephone number(s) were included to permit the follow-up of 
patients by postal (or telephone) questionnaire at 6 months following the TBI. The patient's NHS number 
was included to ensure accurate linkage to national death registration using the ‘list cleaning’ service of 
the Medical Research Information Service (MRIS) at the NHS Information Centre for Health and Social Care. 
Name and contact details for the patient’s general practitioner (GP) were included to confirm from the GP 
that the patient was still alive prior to sending the questionnaire.
Sample size calculation
We performed a simulation study to assess the power to detect a difference in the c-index (area under 
the ROC curve) between two different risk prediction models applied to the same population. Simulations 
were based on the following assumptions: the rate of unfavourable outcome (death or severe disability) 
at 6 months in the population will be 40% (based on the observed rate of unfavourable outcomes in 
high-income countries in the CRASH trial30 and consistent with the results of a regional audit in East 
Anglia60); statistical tests will be based on a two-sided p-value of p = 0.05; and the ability to detect, with 
80% power, a 10% relative difference in c-index from the value of 0.83 observed for the CRASH model in 
the development sample.30 A total of 17,500 data sets were simulated at different sample sizes using a 
binormal model61 and the empirical power was assessed at each sample size as the proportion of data sets 
in which a statistically significant difference was detected (see Appendix 2).
Based on these simulations, a sample size of 3100 patients was required for model validation. To allow 
for 8% loss to follow-up [based on the observed follow-up rates from the CRASH62 and Randomised 
Evaluation of Surgery with Craniectomy for Uncontrollable Evaluation of Intra-Cranial Pressure (RESCUEicp) 
RCTs63], we aimed to recruit 3400 patients.
Using data from the CMP database, we anticipated the rate of admission of adult patients following acute 
TBI to be approximately eight per unit per month for dedicated neurocritical care units, six per unit per 
month for combined neuro/general critical care units, and 0.5 per unit per month for general critical care 
units outside a neuroscience centre. We therefore aimed to recruit at least 12 dedicated neurocritical care 
units, 13 combined neuro/general critical care units and 30 general critical care units outside neuroscience 
centres to complete recruitment within 18 months.
Recruitment of sites and patients
Recruitment of sites
All neurocritical care units in the UK and adult general critical care units participating in the CMP were 
invited to participate in the RAIN study. Standalone high-dependency units (HDUs) were not eligible for 
participation in the study. The RAIN study was publicised to critical care units via the CMP, NCCNet, the 
Intensive Care Society and the UK Critical Care Trials Forum (UKCCTF).
Maintenance and motivation of sites
Regular contact was maintained with all participating critical care units during the course of the RAIN 
study. Newsletters were sent on a monthly to quarterly basis, depending on the stage of the study, to 
maintain motivation and encourage involvement by keeping data collectors informed of study progress. 
Newsletters were also used as an opportunity to clarify any data issues and remind local collaborators to 
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enrol all eligible patients. The study co-ordinator maintained close contact with all sites by telephone and 
e-mail throughout the study and was available to answer queries.
Updates on study progress were also given at meetings of the CMP, NCCNet, the Neuroanaesthesia Society 
of Great Britain and Ireland and the UKCCTF in order to maintain the profile of the RAIN study in the 
critical care community. Regular updates on study progress were also provided to the NIHR Comprehensive 
CRN Critical Care Specialty Group. Members of the RAIN Study Steering Group also publicised the study at 
relevant conferences.
Recruitment of patients
All adult patients (defined as aged ≥ 16 years) admitted to participating adult critical care units following 
an actual or suspected TBI, and with a GCS score of < 15, following resuscitation, were identified.
Data management
Start-up meetings/data set familiarisation courses
The start-up meetings/data set familiarisation courses were 1-day events, at which the background, aims 
and rationale for the RAIN study were discussed with the collaborating clinicians, research nurses and 
data clerks. This was followed by a detailed explanation of the definition for each field in the data set with 
opportunities for questions and examples. At least one member of staff from each site was required to 
attend a RAIN study start-up meeting/data set familiarisation course to ensure that they understood the 
aims of the RAIN study and the precise rules and definitions of the data set. Each delegate was given a 
RAIN study Data Collection Manual to take back with them to their site for reference purposes.
The Data Collection Manual contained precise, standardised definitions for each field (see Appendix 3), 
along with data collection forms and flows (see Appendix 4), to guide them through the data collection 
process. The Data Collection Manual was regularly reviewed and new versions released to ensure clarity 
and to answer common queries.
Data entry and monitoring of recruitment
From the data collection forms, data were entered by members of the research team at participating sites 
on to a dedicated, secure, web-based data entry system (‘web portal’) developed and hosted by ICNARC. 
A guide to using the web portal was produced and sent to research staff to assist in data entry. Data 
Collection Manuals, flows and forms, definitions and error checking were also available from the web 
portal, either for download or built into the design.
Data management was an ongoing process. Data were monitored throughout the data collection period in 
order to ensure that the database was as complete as possible and the rate of recruitment was as expected 
to minimise the time between the end of data collection and the start of data analysis. For each site, the 
number of patients entered on to the web portal and the date the last patient was entered was monitored. 
Neurocritical care units were contacted if no patients had been admitted in one calendar month. General 
critical care units outside a neuroscience centre received monthly e-mails to remind them to monitor for 
eligible patients. Quarterly CMP data submissions were reviewed to identify any admissions recorded in the 
CMP with a reason for admission to that critical care unit that potentially indicated a TBI that had not been 
entered on to the RAIN web portal.
Every patient initially thought to have TBI was entered on to the RAIN web portal to ensure completeness 
of recruitment. However, any patient that was subsequently found to have a different cause for their 
neurological impairment (e.g. cerebrovascular accident) was excluded from analyses.
Data validation reports
Two data validation reports (DVRs) were sent regularly to participating critical care units. The purpose of 
the first DVR was to ensure complete data entry of the fields required for patient follow-up. This DVR was 
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sent on a weekly to fortnightly basis and checked all patients reaching 4 weeks post TBI to ensure that 
complete identifiers and contact details (full name and postal address, contact telephone number, NHS 
number, date of birth and GP details) were available. Data collectors were asked to enter data, where 
missing, or confirm with the RAIN study team that data were unavailable.
The second DVR checked data accuracy. These checks identified any incomplete data (missing values) and 
inconsistent data (unusual, although not impossible, data that must be confirmed as correct by the data 
collectors) both within individual fields and across fields. Following receipt of a DVR, data collectors either 
updated/corrected the data on the web portal or responded to the RAIN study team to confirm the data 
were correct in order to clear queries.
Data linkage with the Case Mix Programme
RAIN study data were linked with the corresponding CMP data using the CMP admission number and 
checked using date of birth, sex, NHS number, date and time of admission to the critical care unit and 
status on discharge from the critical care unit. Any discrepancies between the two databases were 
resolved with the respective data collectors. Data linkage between the RAIN study database and CMP 
database was performed regularly, to ensure outcome data required for the 6-month follow-up of patients 
were available.
Data linkage with the Scottish Intensive Care Society Audit Group
RAIN study data were linked with the corresponding SICSAG data using the SICSAG Key (unique identifier) 
and checked using the age in years, sex, and date and time of admission to the critical care unit. Data 
linkage between the RAIN study database and SICSAG database was performed once at the end of 
the study.
External validation against the Trauma Audit and Research Network database
The Trauma Audit and Research Network (TARN; www.tarn.ac.uk) is the trauma registry for England and 
Wales with coverage of approximately 70% of trauma-receiving hospitals. For hospital sites in TARN with 
a critical care unit participating in the RAIN study, TARN provided data on the number of admissions to 
critical care associated with TBI as an external data source to verify the completeness of recruitment to the 
RAIN study.
Data linkage with death registration
The follow-up of patients was carefully monitored to prevent any potential distress to those who care 
for the patient from receiving a letter addressed to a deceased relative or partner. In order to obtain an 
outcome for patients at 6 months after acute TBI, the follow-up process started at 4.5 months to allow 
for the administrative processes. On a weekly basis, the status of any patient that had reached 4.5 months 
post TBI was checked on the web portal. A list of patients who were not indicated as ‘dead’ was then sent 
to the MRIS to confirm the mortality status of patients. Patients indicated as having died were logged and 
the follow-up process ended; all other patients started the 6-month follow-up process to ascertain their 
neurological outcome and QOL. At the end of the study, a final file was sent to the MRIS to confirm the 
final survival status of all patients in the RAIN study.
Six-month follow-up of neurological outcome and quality of life
Patients identified as not having died at 4.5 months using data from the critical care unit and from MRIS 
followed the process shown in Figure 3.
Patient outcomes were collected centrally by the RAIN study team at ICNARC, using methods based on 
those undertaken in previous research studies, including the CRASH62 and RESCUEicp RCTs.63 For patients 
registered with a general practice, their GP was sent a letter explaining the RAIN study and a form to 
complete to confirm that the patient had not died and to verify the patient’s address. GPs could confirm 
the patient’s status and address in a variety of ways: by returning the form by post or fax, completing a 
secure on-line response form or telephoning the RAIN study team. If no response was received, a follow-up 
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telephone call was made to ensure the original information had been received. In cases where patients 
were not registered with a GP, REC approval allowed for them to be contacted directly. When informed 
that a patient was no longer registered with the GP contacted, attempts were made to ascertain the 
patient’s current GP.
Patients were then sent, by post, an introductory letter, information sheet, consent form, questionnaires, 
freepost return envelope and pen (see Appendix 5), following best evidence-based practice to maximise 
response.64 In instances where the patient was unable to consent, a boxed section on the letter 
addressing their carer asked them to offer what they feel would be the presumed will of the patient. 
Two questionnaires were included: the Your Health Questionnaire and the Health Services Questionnaire. 
The Your Health Questionnaire included the required questions to evaluate the European Quality of life 
(EuroQol) 5-dimension, 3-level version (EQ-5D-3L)65 and the Glasgow Outcome Scale – Extended (GOSE)66 
measures. The EQ-5D-3L was included to enable the calculation of quality-adjusted life-years (QALYs) as 
the best available global measure of health outcome.67 The GOSE questionnaire is the most widely used 
measure of functional outcome following acute TBI,68 and has been used in most of the large, recent and 
ongoing RCTs.54,63 Use of a postal questionnaire to collect the GOSE questionnaire responses has been 
MRIS identifies patient
is not dead
GP confirms patient alive and
patient contact details
First letter sent to patient
with information sheet,
questionnaires, pen and
return envelope
No response after 2 weeks 
Patient telephoned 
Patient not
registered
with a GP 
No reply from GP:
GP telephoned to
confirm patient status
Letter returned,
e.g. not known
at this address:
patient’s
contact details
checked
Letter sent to GP surgery to
confirm patient status
Second letter sent to patient
with information sheet,
questionnaires, pen and
return envelope
No response after 4 weeks
FIGURE 3 Patient follow-up process.
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Harrison et al. under the terms of a commissioning contract issued by the Secretary of State for 
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
DOI: 10.3310/hta17230 HealtH tecHnOlOgy assessment 2013 VOl. 17 nO. 23
21
found to have high reliability.69 The Health Services Questionnaire included questions about the patients 
use of health services following discharge from acute hospital and was used to cost subsequent use of 
health services (see Chapter 6). Patients were asked to complete the consent form and questionnaires if 
they wished to take part in the RAIN study, or to return the questionnaires blank to indicate that they did 
not wish to take part. Non-responders were followed up with a second letter after 4 weeks, including the 
same enclosures as the original.
If no postal response was received after a further 2 weeks following the second letter, then patients were 
telephoned if contact details were available. A telephone interview template was used to explain the RAIN 
study and to ask for informed consent. In order not to overburden the interviewee, the telephone interview 
included only the GOSE questionnaire as the primary outcome for the RAIN study. Telephone calls were 
made at various times from Monday to Saturday between 0900 and 2030 hours to maximise the chances 
of contacting the patient.
Follow-up ended when a postal questionnaire was returned, either complete or blank, or when a 
telephone interview was completed or refusal obtained. When post was returned (e.g. not known at this 
address, no longer at this address, address inaccessible, etc.) the critical care unit and GP were contacted 
to check the address details and to elicit any updates to the patient information.
When patients were identified either as discharged to or subsequently moved to a care home, 
rehabilitation centre or another hospital, these institutions were contacted to establish the status of the 
patient and the most appropriate way to proceed with follow-up. If a patient had capacity to consent but 
required assistance in reading and/or completing the questionnaire then health-care professionals would 
often assist the patient. For those unable to consent, institutions advised on the most appropriate person 
to contact to gain consent. In cases in which a patient did not have the capacity to consent and either 
there was no next-of-kin or the next-of-kin was also unable to consent, where possible, an Independent 
Mental Capacity Advocate was identified.
If patients were identified as having no fixed abode but were registered with a GP or had regular contact 
with a homeless shelter then letters were sent to be passed (when appropriate) to them at their next 
appointment or visit. The usual process was then followed and if telephone contact details were available 
then this approach would also be attempted.
When attempts to make contact by telephone were repeatedly unsuccessful, for example where telephone 
numbers would ring through to an answering service or a mobile telephone was continually switched 
off, and attempts had been made on various days and at various times of day over at least a month, and 
no alternative contact information was available, if an answering service was available, a message with 
information to contact the RAIN study team was left and if the call was not returned then the patient was 
considered lost to follow-up.
Data management of 6-month follow-up data
Two databases were set up for central data entry of questionnaire responses: one for the Your Health 
Questionnaire and one for the Health Services Questionnaire. Ambiguous responses (e.g. two boxes 
ticked, responses written instead of ticked, alterations made to questions, etc.) were initially left blank for 
subsequent review. Following data entry, all GOSE questionnaires with blank responses (except for those 
where responses were unnecessary for scoring, e.g. return to work for patients who were retired prior 
to the injury) were identified and manually reviewed to determine whether (1) the response was clearly 
indicated by the information available on the questionnaire (e.g. the word ‘yes’ or ‘very’ written next to a 
box rather than the box being ticked); (2) the response could be imputed with reasonable confidence from 
the other information on the questionnaire; or (3) there was insufficient information to assume a response. 
Changes to data owing to situations (1) or (2) were identified separately on the database, such that the 
data could be reanalysed with imputed GOSE responses excluded.
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Glasgow Outcome Scale–Extended responses were used to assign each patient to a GOSE category based 
on their worst response using an algorithm supplied by the original developers of the postal questionnaire. 
Following guidelines for the application of the questionnaire,69,70 all of those assigned to the categories of 
upper or lower severe disability were reviewed if other responses appeared to contradict this categorisation 
(e.g. return to the same work as prior to the injury). In addition, all questionnaires for patients assigned 
to the category of pre-existing severe disability or severe disability not due to the injury were reviewed 
to confirm whether the questionnaire responses were consistent with this categorisation. When 
questionnaires were reviewed, the entire response to all questions, including the EQ-5D-3L when available, 
was used to assign the patient to the most appropriate GOSE category.
For a few patients, two separate responses were received (either two paper questionnaires or one paper 
questionnaire and one telephone interview). These were reviewed to determine the most appropriate 
questionnaire to use for the analysis, taking into account the respondent (patient preferred over family 
member preferred over carer), timing of the response (favouring responses closer to/after 6 months) and 
completeness of questionnaire (favouring more complete responses).
All questionnaire reviews were performed by two investigators with any areas of ambiguity or 
disagreement reviewed and discussed with a third.
Results
Recruitment of sites
Recruitment of sites took place between December 2008 and December 2009. In total, 74 critical care 
units expressed an interest in taking part in the study and were sent an SSI form to complete. Of these, 
one neurocritical care unit was unable to take part owing to a conflicting, ongoing research study and 
a further four general critical care units outside a neuroscience centre did not reach the R&D submission 
stage. Local R&D approval was sought and gained for 69 critical care units. R&D approvals took a 
median of 68 days [interquartile range (IQR) 32 to 237] from submission of SSI form. R&D approval to 
start of RAIN study data collection took a median of 27 days (IQR 13 to 119). Two neurocritical care 
units withdrew, as they were unable to meet the study start date giving a total of 67 critical care units. 
This exceeded the recruitment targets with 13 dedicated neurocritical care units, 14 combined neuro/
general critical units, four additional critical care units within a neuroscience centre (admitting overflow 
patients from the neurocritical care unit) and 36 general critical care units outside a neuroscience centre 
participating in the RAIN study (Table 3). One neurocritical care unit (and an additional critical care unit 
within the same neuroscience centre) withdrew from the study in August 2010 owing to research staffing 
shortages. All other critical care units collected data until March 2011 (Figure 4).
Each critical care unit was represented at a start-up meeting/data set familiarisation course. In total, seven 
start-up meetings/data set familiarisation courses were held between May 2009 and March 2010.
Recruitment of patients
The first patient was recruited to the RAIN study on 19 August 2009 and patient recruitment continued 
until 31 March 2011. The final RAIN study data set contained a total of 3626 critical care unit admissions. 
After excluding multiple admissions of the same patient and patients who did not prove finally to have a 
TBI, 3210 patients remained (Figure 5). Of these, 28 patients were homeless, 61 were non-UK residents 
and for 12 patients (military) the address details were withheld, resulting in a cohort of 3109 patients 
(97%) that were followed up for 6-month survival by data linkage with death registrations.
As a result of the regular feedback to critical care units participating in the CMP, four instances of a missed 
admission for TBI were identified after recruitment of patients had closed and these were, therefore, 
unable to be included in the study. There were also six admissions for which the research team at the 
unit was unable to confirm whether or not the patient had a TBI. Validation against figures from TARN 
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TABLE 3 Distribution and representativeness of critical care units across UK by neuroscience vs 
non-neuroscience centres
Geographical region
Neuroscience centresa Non-neuroscience centres
Number (%) in 
RAINb
Total number in 
region
Number (%) in 
RAIN
Total number in 
region
UK 27 (84) 32 36 (16) 223
England 23 (92) 25 34 (19) 180
East Midlands SHA 1 (100) 1 4 (33) 12
East of England SHA 1 (100) 1 7 (41) 17
London SHA 6 (86) 7 3 (11) 28
North East SHA 2 (100) 2 2 (13) 15
North West SHA 2 (67) 3 6 (24) 25
South Central SHA 2 (100) 2 1 (9) 11
South East Coast SHA 1 (100) 1 2 (11) 18
South West SHA 2 (100) 2 3 (18) 17
West Midlands SHA 3 (100) 3 3 (16) 19
Yorkshire and the Humber SHA 3 (100) 3 3 (17) 18
Wales 2 (100) 2 2 (14) 14
Northern Ireland 0 (0) 1 0 (0) 9
Scotland 2 (50) 4 0 (0) 20
SHA, Strategic Health Authority.
a Including those with dedicated neurocritical care units and with combined neuro/general critical care units.
b Four additional critical care units admitting overflow patients not counted within these figures.
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FIGURE 4 Recruitment timeline.
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indicated similar numbers of patients recruited to the RAIN study as reported through TARN. In some sites, 
the number of patients in the RAIN study exceeded the number reported to TARN by a small amount and, 
in other sites, the reverse was true, reflecting different definitions for TBI in the two projects.
Six-month follow-up of neurological outcome and quality of life
Of 2323 patients not reported as dead by MRIS, 242 (10%) refused follow-up and 247 (11%) were lost to 
follow-up (the first patient was recruited to the RAIN study on 19 August 2009 and patient recruitment 
continued until 31 March 2011). 
A breakdown of the 242 patients for whom outcome data were refused is shown in Table 4. The majority 
of refusals (177, 73%) were by return of a blank questionnaire (from which no further information 
was available).
A breakdown of the 247 patients lost to follow-up is shown in Table 5. The largest number of patients lost 
to follow-up (122, 49%) were those with whom we were unable to make any contact, despite exhausting 
all options available to us. On four occasions, contact to a patient was blocked by their GP because 
the patient had not consented in advance, despite NIGB and REC approval for the follow-up process 
used in the study. Eight requests were received from GPs not to contact the patient or family, either on 
compassionate grounds or because the GP had spoken to the patient or family and they did not wish to be 
Patients with known
survival status at 6 months
(n = 3109) (96.9%)
Patients recruited
(n = 3210)
Patients with known neurological
outcome at 6 months
(n = 2620) (81.6%)
Not for follow-up
- no fixed abode
- non-UK
- address refused
Dead
(n = 786)
Alive
(n = 2323)
(n = 101) (3.1%)
(n = 28)
(n = 61)
(n = 12)
No questionnaire received
- refused
- lost to follow-up
(n = 489) (21.1%)
(n = 242)
(n = 247)
Questionnaire receiveda
(n = 1834) (78.9%) 
Paper
Telephone
(n = 1245)
(n = 589)
FIGURE 5 Patient flow. a, Paper questionnaire included full Your Health Questionnaire (GOSE and EQ-5D-3L) and 
Health Services Questionnaire; telephone questionnaire included GOSE only.
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contacted, and on six occasions family members did not want us to contact their relative. All such requests 
were respected.
Questionnaires were completed a median of 199 days (IQR 166 to 239 days) after the TBI (Figure 6). 
Two questionnaires were received very early, owing to data entry errors in the date of TBI that were not 
TABLE 4 Breakdown of refusals to participate in 6-month follow-up
Method of/reason for refusal
Number of 
patients
Return of blank questionnaire 177
During telephone follow-up 65
By patient 29
Patient refused before study could be explained 2
Patient refused without giving reason 23
Patient found questionnaire distressing or confusing 4
By family member or carer 36
Family member could not determine whether relative was able to consent 7
Family member did not wish to answer on behalf of relative who was unable to consent 9
Family member or friend blocked access to a patient who would have had capacity to consent 5
Family member or carer informed us that patient did not wish to take part 10
Carer informed us that family member did not wish the patient to take part 5
TABLE 5 Breakdown of patients lost to follow-up
Reason for loss to follow-up
Number of 
patients
Follow-up stopped by health-care professional 20
GP blocked access to patient because the patient had not consented in advance 4
GP requested we should not contact the patient or family 8
Health-care professional informed us patient was unable to consent and no next-of-kin available 8
Other reasons 222
Patient died after 6 months while attempts to make contact were ongoing 21
Family member informed us that patient had capacity to consent but did not want us to contact them 6
Patient or family member informed us that a postal questionnaire had been returned but this was 
never received
26
Patient or family member informed us that they had received a postal questionnaire but wished to 
consider the study and did not want to complete the questionnaire by telephone or be contacted again
39
Adequate communication prevented by poor understanding of English 4
Unable to contact the patient – prisoner 4
Unable to contact the patient or family despite repeated attempts 122
Processing errors 5
Incorrect data entry on web portal – patient reported to have died 5
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identified until follow-up had commenced. There was an initial peak at around 160 days corresponding 
to postal questionnaires returned following the initial posting, a second peak at around 200 days 
corresponding to postal questionnaires returned following the second posting, and a subsequent heavy tail 
of the patients followed up by telephone that were often difficult to contact. A total of 30 patients were 
eventually contacted for the 6-month follow-up more than 1 year after their TBI.
Discussion
Principal findings
The RAIN study has provided case mix data from the time of injury and presentation at hospital and 
outcomes data at 6 months following injury on a highly representative sample of patients receiving critical 
care following acute TBI in the UK.
Challenges in conducting the study
Patients with TBI present a challenging population for obtaining reliable, longer-term outcome data. 
The reasons for this are wide ranging and must be considered when discussing those who were lost to 
follow-up. Identifying the current location of the patient is not straightforward because of the frequent 
movement between hospitals and health-care institutions, entry into rehabilitation programmes and 
moving back to live with family and friends after TBI, as well as a relatively high proportion of homeless 
patients and those from overseas. Other challenges include ascertaining whether a patient has the capacity 
to consent and to accurately answer the questions. For example, in some instances, we were informed by 
health-care professionals or family that while the patient had the capacity to consent following the TBI 
they had tendencies to confabulate and that answers provided may not have been accurate.
Throughout the follow-up process, every effort was taken to avoid causing unnecessary distress to 
patients or their families. Following MRIS confirmation, for those registered with a GP, it was necessary to 
send a letter to confirm the patient’s status. There were a small number of cases where the GP blocked 
contact with the patient or refused to provide the information because prior patient consent had not 
been obtained. This was despite GPs being fully informed, by letter and telephone, about the study and 
the governance and ethics approvals. There were also instances where the GP contacted the patient and 
the patient requested not to be contacted by the Study Team. This raises possible questions whether 
such patients were fully informed about the study. However, the benefits of contacting GPs do appear 
to outweigh these possible missed follow-ups. In 28 cases, patients were not reported as having died by 
MRIS but, on contacting the GP, were found to have died. Despite this being a relatively small number 
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FIGURE 6 Distribution of days from TBI to completion of questionnaire. Vertical line indicates 6 months post TBI.
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in comparison with the resources and time required to collect GP responses, the prevention of distress 
to these families by this intervention cannot be ignored. In cases where GPs requested that we did not 
contact the patient or family for compassionate reasons, this was respected. Despite the dual safeguards 
of checking for reported deaths both with MRIS and GPs, there were seven cases in which, on making 
contact with the family, we were informed the patient had recently died. It is inevitable, when following 
up a high-risk population, that such situations will occur, but it is the responsibility of the researcher to do 
everything possible to keep these to a minimum.
The use of postal questionnaires may have been a factor in our response rate. Twenty-six patient 
questionnaires were reported to have been posted by the patient or family but were never received and, 
once it appeared that undelivered mail could potentially be influencing response rates and fluctuations in 
the returns were noticed, Royal Mail was contacted. The registered freepost envelope presented a possible 
issue. Considering this, and research indicating that stamped addressed envelopes may improve response 
rates over reply-paid envelopes,64 we switched to using stamps during the course of the study. Additionally, 
when patients indicated during telephone follow-up that they had already returned a questionnaire 
by post, we requested that they also complete a telephone interview so that in the event the postal 
questionnaire was not received an outcome would still be available.
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Chapter 4 Case mix and outcomes at 6 months for 
critically ill patients with acute traumatic brain injury
Introduction
This chapter describes the case mix of patients in the RAIN study admitted to critical care units following 
acute TBI and their survival, neurological outcome and QOL at 6 months following TBI.
Methods
Selection of patients
Despite a GCS score of < 15 being an inclusion criterion for the RAIN study, some patients with suspected 
TBI were recruited with no GCS score recorded, and others who had an initial GCS score of < 15, either 
pre-hospital or on presentation at hospital, subsequently improved prior to sedation. Patients from the 
RAIN study database were included in the analysis if their last GCS score prior to sedation/admission to 
critical care was < 15.
Statistical methods
Case mix, length of stay (LOS) and outcomes were summarised overall and for subgroups defined by the 
cause of TBI – road traffic accident (RTA), fall or assault. Patients with other or unknown causes of injury 
were included in the overall group but excluded from the subgroups. All analyses were descriptive and no 
statistical testing was undertaken.
Case mix
For presentation, case mix variables are categorised by causal factors; pre-injury status; date/time of TBI; 
hospital source of admission to critical care; age/sex; neurological dysfunction; and physiology.
Causal factors include the cause of TBI, categorised as above, with RTA details, height of fall (where 
relevant), presence and site(s) of major extracranial injury (defined as an injury that would require hospital 
admission in its own right) and presence of confirmed or suspected intoxication (with alcohol, drugs, etc.) 
at the time of injury.
Pre-injury status includes residence prior to admission to acute hospital, dependency prior to admission 
to acute hospital and deprivation status. Deprivation was assessed using the English Index of Multiple 
Deprivation (IMD) 201071 and the Welsh IMD 200872 for patients with a valid residential postcode. IMD 
quintiles of deprivation within Wales were assumed similar to the quintiles in England. Patients resident 
outside England and Wales were excluded from the assessment of deprivation, as sufficiently equivalent 
measures of deprivation were not available.
Date/time of TBI was categorised by the day of the week and hour of the day. Hospital source of admission 
to critical care was described by the location immediately prior to admission to the critical care unit. Age 
and sex were summarised both separately and by describing the overall age/sex distribution.
Neurological dysfunction includes the total GCS score, motor score component of the GCS score, pupil 
reactivity, Marshall CT classification56 and presence of traumatic SAH. GCS score, motor score and pupil 
reactivity were summarised for each time point at which they were recorded for all patients with an 
assessment available at that time point. Marshall CT classification and presence of traumatic SAH were 
assessed from the first CT scan following the injury.
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Physiology includes the first recorded-at-hospital values of core physiology, arterial blood gases and 
laboratory parameters. Core physiological parameters recorded were temperature, systolic blood 
pressure, heart rate and oxygen saturation. Arterial blood gas parameters were partial pressure of oxygen 
(PaO2), fraction of inspired oxygen (FiO2), partial pressure of carbon dioxide (PaCO2) and pH. Laboratory 
parameters were serum glucose, haemoglobin and platelet count.
Length of stay
Length of stay in critical care was summarised by the median and IQR of the total stay in critical care, 
including transfers between critical care units, and stratified by the survival status at final discharge from 
critical care. Similarly, LOS in acute hospital was summarised by the median and IQR of the total stay in 
acute hospital, including transfers between acute hospitals, and stratified by the survival status at final 
discharge from acute hospital.
Outcomes
The outcomes reported were mortality, neurological outcome and QOL. Mortality was reported at final 
discharge from critical care, final discharge from acute hospital, and at 6 months following the TBI. 
Survival over time to 6 months following the TBI was displayed using Kaplan–Meier plots. Neurological 
outcome was summarised by the GOSE category at 6 months, and dichotomised as favourable (GOSE 
category of good recovery or moderate disability) or unfavourable (GOSE category of death or severe 
disability; note that the questionnaire used for collection of GOSE responses did not distinguish vegetative 
state from lower severe disability). Quality of life at 6 months was described by the responses to the five 
domains of the EQ-5D-3L and by the patients’ self-rated current health on a visual analogue scale from 
0 (worst imaginable) to 100 (best imaginable).
Results
Selection of patients
Of the 3210 patients in the RAIN study data set, 101 (3.1%) had no GCS score recorded, and 134 (4.2%) 
had a last pre-sedation GCS score of 15, resulting in a data set for analysis of 2975 patients.
Case mix
Causal factors
The most common causes of TBI were RTA (33%), fall (47%) and assault (12%), with 3% from other causes 
and 5% of unknown cause (Figure 7). RTA details are shown in Figure 8 and fall height in Figure 9.
A major extracranial injury, sufficient to require hospital admission in its own right, was present in 41% 
and was particularly common for RTAs (70% compared with 28% for falls and 22% for assaults). Among 
assaults, major extracranial injuries were predominantly of the head and neck, whereas for falls and 
particularly for RTAs the sites of major extracranial injury were more widespread (Figure 10). Intoxication 
was either confirmed or suspected in almost half (45%), and varied by cause of TBI (26% for RTAs, 49% for 
falls and 74% for assaults; Figure 11).
Pre-injury status
Table 6 reports the pre-injury status of patients, overall and by cause of TBI. The vast majority of patients 
were living independently prior to the TBI, indicated by 96% with a prior residence of ‘home’ and 95% 
able to live without assistance in activities of daily living. Figure 12 shows the distribution of deprivation by 
quintiles of IMD. There was a marked socioeconomic gradient that was strongest for assault (38% in the 
most deprived quintile vs 9% in the least deprived) and weakest for RTA (22% vs 19%).
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FIGURE 8 Road traffic accident details.
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FIGURE 10 Major extracranial injury by site, overall and by cause of TBI. (a) Overall; (b) RTA; (c) fall; (d) assault.
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FIGURE 11 Confirmed or suspected intoxication at time of TBI, overall and by cause of TBI. (a) Overall; (b) RTA; (c) fall; 
(d) assault.
TABLE 6 Pre-injury status, overall and by TBI cause
Case mix factors
Overall 
(n = 2975a)
RTA 
(n = 976)
Fall 
(n = 1399)
Assault 
(n = 353)
Residence prior to admission, n (%) [N] [2971] [975] [1398] [351]
Home 2846 (95.8) 948 (97.2) 1345 (96.2) 330 (94.0)
No fixed abode or temporary abode 57 (1.9) 15 (1.5) 20 (1.4) 13 (3.7)
Residential place of work/education 27 (0.9) 8 (0.8) 3 (0.2) 4 (1.1)
Nursing home or equivalent 18 (0.6) 1 (0.1) 16 (1.1) 0 (0)
Health-related institution 13 (0.4) 2 (0.2) 10 (0.7) 0 (0)
Non-health-related institution 10 (0.3) 1 (0.1) 4 (0.3) 4 (1.1)
Prior dependency, n (%) [N] [2895] [944] [1376] [337]
Able to live without assistance in daily activities 2742 (94.7) 921 (97.6) 1258 (91.4) 333 (98.8)
Minor assistance with some daily activities 132 (4.6) 19 (2.0) 102 (7.4) 3 (0.9)
Major assistance with majority of/all daily activities 19 (0.7) 4 (0.4) 15 (1.1) 0 (0)
Total assistance with all daily activities 2 (0.1) 0 (0) 1 (0.1) 1 (0.3)
a Includes 95 patients with other causes of TBI and 152 with unknown cause.
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FIGURE 12 Deprivation, overall and by cause of TBI. (a) Overall; (b) RTA; (c) fall; (d) assault.
Date/time of traumatic brain injury
Figure 13 shows the day of TBI, overall and by cause. TBI was more common at the weekend (37% overall), 
particularly for assaults (50%). TBI occurred throughout the day with a distribution that varied considerably 
by cause of TBI (Figure 14). For RTA, there were peaks corresponding to the morning and evening rush 
hours and a further peak in the late evening. Falls occurred throughout the day, particularly during waking 
hours. Assaults were much more common in the late evening and early hours of the morning, with almost 
half of all assaults occurring between 2300 and 0300 hours.
Hospital source of admission to critical care
The majority of patients in the RAIN study were admitted to the critical care unit either from an emergency 
department (56%) or from theatre and recovery (27%; Table 7). The distribution of source of admission 
was similar by cause of TBI, although more patients were admitted from theatre following a fall or assault 
than following an RTA. Overall, 9% of patients were transferred to the critical care unit directly from 
another critical care area; two-thirds of these were from a level 3 bed in another critical care unit (not 
participating in the RAIN study).
Age and sex
Patients were predominantly young (mean age 45 years overall) and male (76% overall; Table 8). The 
overall distribution of age was bimodal with peaks in the twenties and forties (Figure 15). This was, 
however, very much driven by different distributions by cause of TBI. For RTA, age of admissions peaked for 
males in their late teens and twenties, for falls the peak was among males in their forties, and for assaults, 
which were almost exclusively (95%) male, the peak was in the twenties.
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FIGURE 13 Day of TBI, overall and by cause. (a) Overall; (b) RTA; (c) fall; (d) assault.
Neurological dysfunction
Glasgow Coma Scale score was assessed and recorded pre-hospital for 2252 (76%) patients, including 
9% with a pre-hospital GCS score of 15 that subsequently deteriorated such that the last pre-sedation 
GCS score was < 15. For 576 patients (19%), the pre-hospital GCS score was their last pre-sedation 
GCS score. The remaining 2399 patients all had a first at hospital GCS score recorded (within 12 hours 
following initial presentation at hospital), including 7% with a first recorded-at-hospital GCS score of 15 
that subsequently deteriorated such that the last pre-sedation GCS score was < 15. For 1275 patients 
(43%), the first recorded-at-hospital GCS score was their last pre-sedation GCS score and the remaining 
1124 (38%) patients had a subsequent last pre-sedation GCS score documented. The severity of TBI, as 
assessed by the GCS score, was generally worst for RTA, followed by assault and then fall (Figure 16). 
The motor score component of GCS score showed a U-shaped distribution with the highest proportions 
observed at the most extreme (low and high) values (Figure 17). Pupil reactivity was assessed pre-hospital, 
within 12 hours of initial presentation at hospital and on admission to the critical care unit for 52%, 
90% and 97% of patients, respectively. For 20 (0.7%), 11 (0.4%) and 8 (0.3%) patients at each time 
point, respectively, neither pupil was able to be assessed, whereas the majority of missing data were not 
documented. Patients admitted following an RTA were more likely to have unreactive pupils than those 
admitted following either a fall or an assault (Figure 18).
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FIGURE 14 Time of TBI, overall and by cause. (a) Overall; (b) RTA; (c) fall; (d) assault.
A first CT scan was available for 2817 (95%) patients and, of these, sufficient data were available to assign 
a Marshall CT classification for 2773 (98%; Figure 19). Very few patients (< 5%) had no abnormalities on 
the CT scan. The most common Marshall categories, each accounting for about one-third of patients, were 
diffuse injury II (basal cisterns present, midline shift 0–5 mm, no high- or mixed-density lesion > 25 ml) and 
evacuated mass lesion. Evacuation of a mass lesion was approximately twice as common among patients 
admitted following a fall (43%) or an assault (40%) than an RTA (20%). Overall, 56% of patients with a 
CT scan available had a traumatic SAH, and this was similar across the different causes of TBI (RTA 54%, 
fall 58%, assault 55%).
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TABLE 7 Hospital source of admission to the critical care unit, overall and by cause of TBI
Case mix factors
Overall 
(n = 2975a)
RTA 
(n = 976)
Fall 
(n = 1399)
Assault 
(n = 353)
Hospital source of admission, n (%) [N] [2972] [975] [1397] [353]
Emergency department 1676 (56.4) 605 (62.1) 734 (52.5) 215 (60.9)
Theatre and recovery 805 (27.1) 222 (22.8) 408 (29.2) 100 (28.3)
Recovery onlyb 37 (1.2) 9 (0.9) 23 (1.7) 4 (1.1)
Level 3 bed in other ICU or ICU/HDU 193 (6.5) 74 (7.6) 80 (5.7) 17 (4.8)
Level 2 bed in other ICU or ICU/HDU 14 (0.5) 3 (0.3) 9 (0.6) 0 (0)
Paediatric ICU/HDU 2 (0.1) 1 (0.1) 1 (0.1) 0 (0)
Adult HDU 13 (0.4) 0 (0) 12 (0.9) 0 (0)
Intermediate care area 53 (1.8) 23 (2.4) 16 (1.2) 5 (1.4)
Ward 110 (3.7) 13 (1.3) 76 (5.4) 8 (2.3)
Imaging 59 (2.0) 20 (2.1) 35 (2.5) 3 (0.9)
Specialist treatment area 9 (0.3) 5 (0.5) 3 (0.2) 0 (0)
Not in hospital 1 (< 0.1) 0 (0) 0 (0) 1 (0.3)
ICU, intensive-care unit.
a Includes 95 patients with other causes of TBI and 152 with unknown cause.
b Recovery used as a temporary critical care area.
TABLE 8 Age and sex, overall and by TBI cause
Case mix factors Overall (n = 2975a) RTA (n = 976) Fall (n = 1399) Assault (n = 353)
Age [N] [2975] [976] [1399] [353]
Mean (SD) 44.7 (18.9) 36.3 (17.6) 53.4 (17.5) 33.9 (12.6)
Median (IQR) 44 (28 to 59) 31 (22 to 47) 54 (42 to 67) 30 (24 to 42)
Sex, n (%) [N] [2975] [976] [1399] [353]
Male 2263 (76.1) 727 (74.5) 985 (70.4) 334 (94.6)
Female 712 (23.9) 249 (25.5) 414 (29.6) 19 (5.4)
SD, standard deviation.
a Includes 95 patients with other causes of TBI and 152 with unknown cause.
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FIGURE 15 Age and sex distribution, overall and by cause of TBI. (a) Overall; (b) RTA; (c) fall; (d) assault.
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FIGURE 18 Pupil reactivity, overall and by cause of TBI. (a) Overall; (b) RTA; (c) fall; (d) assault.
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FIGURE 19 Marshall CT classification, overall and by cause of TBI. (a) Overall; (b) RTA; (c) fall; (d) assault.
Physiology
Table 9 summarises the first recorded physiological parameters following presentation at hospital. 
Core physiological parameters were available for between 87% and 95% of patients, arterial blood 
gas parameters were available for between 72% and 80% of patients, and laboratory parameters were 
available for between 84% and 90% of patients. There was little difference in the degree of physiological 
derangement by cause of TBI.
Length of stay
Table 10 reports the LOS overall and by cause of TBI. The median total LOS in critical care was 7 days but 
this differed substantially between survivors (median 8 days) and non-survivors (median 3 days) of critical 
care. The critical care LOS distribution was similar for non-survivors across different causes of TBI, but for 
survivors was longer for patients admitted following an RTA (median 11 days) than for a fall or assault 
(median 7 and 6 days, respectively). The median total LOS in acute hospital was 30 days for survivors 
compared with 5 days for non-survivors. The LOS in acute hospital for survivors again varied substantially 
by cause of TBI, with the longest stay for patients admitted following an RTA (median 37 days), followed 
by for a fall (median 30 days), and for an assault (median 20 days).
Mortality
Mortality at final discharge from critical care was 18% and was highest for falls (21%) followed by RTAs 
(18%) and assaults (14%) (Table 11). At final discharge from acute hospital, mortality had increased 
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TABLE 9 First recorded-at-hospital physiology, overall and by cause of TBI
Case mix factors Overall (n = 2975a) RTA (n = 976) Fall (n = 1399) Assault (n = 353)
Core physiology, median (IQR) [N]
Temperature (°C) 36.0 (35.2 to 36.7) 
[2590]
35.9 (35.0 to 36.5) 
[829]
36.0 (35.3 to 36.8) 
[1235]
36.0 (35.3 to 36.5) 
[311]
Systolic blood 
pressure (mmHg)
139 (121 to 157) 
[2829]
136 (120 to 153) 
[933]
142 (123 to 161) 
[1333]
133 (120 to 149) 
[335]
Heart rate (beats per 
minute)
87 (72 to 105) [2830] 93 (76 to 114) [934] 85 (70 to 102) [1334] 84 (70 to 100) [334]
Oxygen saturation (%) 99 (97 to 100) [2797] 99 (97 to 100) [920] 98 (96 to 100) [1322] 99 (97 to 100) [333]
Arterial blood gas parameters, median (IQR) [N]
PaO2 (kPa) 28.7 (15.0 to 45.5) 
[2375]
31.7 (15.3 to 50.5) 
[811]
26.8 (14.2 to 41.4) 
[1106]
31.7 (16.6 to 49.6) 
[271]
FiO2 0.8 (0.5 to 1.0) 
[2131]
1.0 (0.5 to 1.0) [729] 0.7 (0.5 to 1.0) [992] 0.6 (0.5 to 1.0) [245]
PaCO2 (kPa) 5.2 (4.5 to 6.1) 
[2378]
5.3 (4.6 to 6.2) [812] 5.2 (4.4 to 6.0) 
[1108]
5.2 (4.6 to 6.0) [271]
pH 7.4 (7.3 to 7.4) 
[2360]
7.4 (7.3 to 7.4) [806] 7.4 (7.3 to 7.4) 
[1099]
7.4 (7.3 to 7.4) [271]
Laboratory parameters, median (IQR) [N]
Serum glucose 
(mmol/l)
7.6 (6.3 to 9.5) 
[2496]
7.7 (6.4 to 9.7) [817] 7.6 (6.4 to 9.4) 
[1180]
7.2 (6.1 to 8.8) [303]
Haemoglobin (g/dl) 13.4 (11.9 to 14.6) 
[2683]
13.4 (11.7 to 14.6) 
[896]
13.2 (11.8 to 14.5) 
[1259]
14.0 (12.8 to 14.9) 
[315]
Platelet count 
(× 109/l)
219 (169 to 273) 
[2608]
224 (178 to 274) 
[878]
213 (157 to 271) 
[1216]
222 (180 to 274) 
[307]
a Includes 95 patients with other causes of TBI and 152 with unknown cause.
TABLE 10 Length of stay, overall and by cause of TBI
Length of stay Overall (n = 2975a) RTA (n = 976) Fall (n = 1,399) Assault (n = 353)
LOS (days), median (IQR) [N]
Total LOS in critical care
Survivors 8 (3 to 17) [2416] 11 (4 to 20) [801] 7 (2 to 16) [1099] 6 (2 to 13) [304]
Non-survivors 3 (1 to 6) [540] 3 (1 to 7) [169] 2 (1 to 6) [291] 3 (1 to 5) [49]
All 7 (2 to 15) [2956] 9 (3 to 18) [970] 6 (2 to 14) [1390] 4 (1 to 12) [353]
Total LOS in acute hospital
Survivors 30 (14 to 59) [2163] 37 (17 to 68) [741] 30 (14 to 58) [941] 20 (9 to 44) [290]
Non-survivors 5 (2 to 12) [696] 5 (1 to 11) [195] 5 (2 to 12) [403] 3 (1 to 7) [55]
All 22 (8 to 50) [2859] 28 (9 to 60) [936] 20 (7 to 46) [1344] 16 (6 to 39) [345]
a Includes 95 patients with other causes of TBI and 152 with unknown cause.
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TABLE 11 Mortality at discharge from critical care and acute hospital and mortality and unfavourable outcome at 
6 months following TBI, overall and by TBI cause
Outcomes Overall (n = 2975a) RTA (n = 976) Fall (n = 1399) Assault (n = 353)
Mortality, deaths (%) [N]
At final discharge 
from critical care
546 (18.4) [2962] 171 (17.6) [972] 295 (21.2) [1394] 49 (13.9) [353]
At final discharge 
from acute hospital
705 (24.5) [2883] 197 (20.9) [944] 410 (30.2) [1358] 55 (15.9) [346]
At 6 months 748 (26.0) [2881] 204 (21.5) [948] 439 (32.0) [1370] 56 (16.8) [333]
Unfavourable outcome 
at 6 months,b n (%) [N]
1481 (61.2) [2422] 466 (57.3) [813] 776 (66.7) [1164] 137 (51.7) [265]
a Includes 95 patients with other causes of TBI and 152 with unknown cause.
b Denominator includes 24 patients who could not be assigned to a specific GOSE category, but where the 
questionnaire responses, although incomplete, were sufficient to indicate the patient did not have an unfavourable 
outcome.
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FIGURE 20 Kaplan–Meier survival curves to 6 months following TBI. (a) Overall; (b) by cause of TBI.
to 24%, with the differential outcomes by cause of TBI maintained. Of the patients who survived to 
discharge from acute hospital, very few died before 6 months following the TBI, with 6-month mortality 
of 26%. The Kaplan–Meier survival curve (Figure 20) indicates that the majority of deaths occurred within 
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FIGURE 21 Glasgow Outcome Scale – Extended at 6 months following TBI as a percentage of survivors with known 
GOSE category, overall and by cause of TBI. (a) Overall; (b) RTA; (c) fall; (d) assault.
the first 30 days following the TBI, with a slow decline in survival thereafter. The same was true across each 
cause of TBI, with the differential mortality by cause established by 30 days and maintained to 6 months.
Neurological outcome at 6 months
There was a substantial burden of disability at 6 months, with only 26% of surviving patients with a known 
GOSE category reporting a good recovery compared with 44% reporting severe disability (Figure 21). 
In addition to the 26% of patients who had died by 6 months, a similar proportion was known to have 
severe disability (Figure 22). When presented as a percentage of those with a known GOSE category, 
this corresponds to a rate of unfavourable outcome (death or severe disability) at 6 months of 61% 
(see Table 11). Outcomes were worst for falls, then for RTAs and assaults, with unfavourable outcome 
rates of 67%, 57% and 52%, respectively. The GOSE categories were reported for all patients with known 
survival status at 6 months (n = 2881) to avoid biasing the proportions towards deaths. Unfavourable 
outcome at 6 months is reported only for those with a known GOSE category (n = 2422) and, therefore, 
the reported rate of 61% is likely to represent an overestimate of the actual percentage with unfavourable 
outcome at 6 months because deaths will be over-represented owing to more complete follow-up. This is 
addressed in the following chapter using multiple imputation.
Quality of life at 6 months
European Quality of Life-5 Dimensions (3-level version) responses were available for 1132 patients (53% of 
those known to be alive at 6 months). Figure 23 summarises the EQ-5D-3L responses for each of the five 
domains. The EQ-5D-3L responses indicated substantial issues with QOL at 6 months, including 70% of 
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FIGURE 22 Glasgow Outcome Scale – Extended at 6 months following TBI as a percentage of all patients with known 
survival status, overall and by cause of TBI. Denominator includes 483 (17%) patients who were alive at 6 months 
following TBI but with unknown GOSE category. (a) Overall; (b) RTA; (c) fall; (d) assault.
patients reporting problems with performing usual activities, around 60% reporting problems with pain 
or discomfort and anxiety or depression, around 50% reporting problems with mobility and around 35% 
reporting problems with self care. There was little difference across the EQ-5D-3L domains by cause of 
TBI, although those admitted following an RTA reported slightly higher proportions in the worst categories 
for physical functioning (mobility, self care and usual activities), whereas patients admitted following 
assault reported slightly higher proportions in the worst categories for pain or discomfort, and anxiety 
or depression.
Figure 24 summarises the self-rated health from the visual analogue scale for the 1078 patients who 
completed this section of the questionnaire, overall and by cause of TBI. The overall median self-rated 
health was 70 (IQR 50 to 85). Self-rated health was lower for patients following assault (median 60, 
IQR 45 to 80) than for either RTA or fall (both 70, 50 to 85).
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FIGURE 23 European Quality of Life-5 Dimensions (3-level version) responses by domain, overall and by TBI cause. 
(a) Mobility; (b) self-care; (c) usual activities; (d) pain/discomfort; (e) anxiety/depression.
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FIGURE 24 Self-rated health at 6 months following TBI, overall and by cause. (a) Overall; (b) RTA; (c) fall; (d) assault.
Discussion
Principal findings
Patients with acute TBI admitted to UK critical care units participating in the RAIN study were 
predominantly admitted following RTA (33%), fall (47%) or assault (12%). Characteristics and outcomes 
varied markedly by cause of TBI. The RAIN study demonstrated a substantial burden of poor neurological 
outcomes and QOL 6 months after TBI for adult patients admitted to critical care. Mortality at discharge 
from acute hospital was 16% for assault, 21% for RTA and 30% for falls, rising to 17%, 22% and 32%, 
respectively, at 6 months following the TBI. Of survivors at 6 months with known a known GOSE catgory, 
44% had severe disability, 30% had moderate disability, and only 26% had made a good recovery. 
When combined with the 26% mortality at 6 months, 61% of patients with known outcome had an 
unfavourable outcome (death or severe disability) at 6 months. In addition, between 35% and 70% of 
survivors reported problems across the five domains of the EQ-5D-3L. Despite this, self-rated health was 
remarkably good, with an overall median of 70 out of 100 and 22% of respondents rating their current 
health as 90 out of 100 or higher.
Comparison with other studies
Little literature exists reporting specifically on multicentre cohorts of patients with acute TBI receiving 
critical care. A previous study from the CMP reported on over 11,000 admissions to 169 general critical 
care units (including combined neuro/general critical care units) and two dedicated neurocritical care units 
between 1995 and 2005 with a primary reason for admission to the critical care unit of ‘primary brain 
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injury’, ‘extradural haematoma’ or ‘subdural haematoma’.6 Three-quarters of admissions were male and 
the mean age was 44 years, corresponding very closely with the overall figures in the RAIN study. Patients 
were followed up to ultimate discharge from acute hospital, with mortality of 33.5% – considerably higher 
than the 24.5% acute hospital mortality observed in the RAIN study. A prospective study from Australia 
and New Zealand reported on 635 patients admitted to the critical care units of 16 major trauma centres 
following acute TBI.73 The age and sex distribution was again similar to that of the RAIN study (mean age 
42 years, 74% male). However, there was a different distribution of cause of TBI with 61% RTA, 25% falls, 
8% assault and 8% other/unknown; 57% of TBIs were severe (GCS score 3–8) based on the first at hospital 
GCS score compared with 46% of those in the RAIN study with a first at hospital GCS score recorded. A 
remarkably high proportion of patients had no visible pathology on CT scan (24% overall including 23% of 
severe TBI) and of those with abnormal CT scans, diffuse injuries predominated (63%), consistent with 
the higher proportion of patients admitted following RTA. Mortality was similar to that in the RAIN study 
(15.1% vs 18.4% at discharge from the critical care unit and 24.4% vs 26.0% at 6 months following TBI).
The proportion of survivors with severe disability at 6 months in the RAIN study (44%) is high compared 
with previous studies, for example 26% for patients with severe TBI from a study in the Netherlands74 and 
27% among critically ill patients following TBI in Australia and New Zealand.73 Some of these patients will 
still be on a trajectory of improving neurological outcome; the proportion with a good recovery increased 
from 38% at 6 months to 46% at 12 months in the study from the Netherlands,74 and from 27% to 42% 
in the study from Australia and New Zealand.73 However, for many patients, these are likely to represent 
long-term disabilities, for example a long-term follow-up study in Glasgow found that of 96 patients 
with severe disability at 1 year following TBI, 44 (46%) had died, 30 (31%) still had severe disability, 
15 (16%) had moderate disability and seven (7%) had made a good recovery when followed up 5–7 years 
following injury.75
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Chapter 5 External validation of risk prediction 
models for acute traumatic brain injury among 
critically ill patients
Introduction
This chapter reports the statistical validation of the risk prediction models identified following the updated 
systematic review (see Chapter 2) using the data collected for the RAIN study (see Chapters 3 and 4). In 
addition, this chapter reports a nested substudy testing the inter-rater reliability (reproducibility) of CT scan 
reporting in the RAIN study.
Methods
Summary of risk prediction models
Following the updated systematic review (see Chapter 2) and review by the RAIN Study Steering Group, 
three families of risk prediction models were selected for validation in the RAIN study – the models of 
Hukkelhoven et al. (Hukkelhoven models);48 the MRC CRASH trial collaborators (CRASH models);30 and 
Steyerberg et al. (IMPACT models).35 A total of 10 models were included in the RAIN study validation 
(Figure 25): four predicting mortality at 6 months (one Hukkelhoven and three IMPACT) and six predicting 
unfavourable outcome at 6 months (one Hukkelhoven, two CRASH and three IMPACT). Details of 
the development and validation of these models were reported in Chapter 2. A brief summary of the 
development data sources, inclusion/exclusion criteria and included variables is presented for each 
model below.
Hukkelhoven models
The Hukkelhoven models were developed using data from two multicentre RCTs, one from North America 
and one from Europe.49,50 Inclusion criteria for both trials were patients aged 15–65 years with severe 
TBI (GCS score of < 9) regardless of CT findings or moderate TBI (GCS score of 9–12) with an abnormal 
CT scan. Patients with an absent motor score were excluded. Randomisation had to take place within 
4 hours of injury. Two risk prediction models were developed: one for mortality at 6 months and one 
for unfavourable outcome at 6 months.48 The variables included in the risk prediction models were: 
age (linear and quadratic terms); motor score; pupil reactivity; pre-hospital hypotension; pre-hospital 
hypoxia; Marshall CT classification; and traumatic SAH. Model coefficients were obtained from the 
published paper.48
Hukkelhoven
CRASH
IMPACT
Mortality at 6 months
(n = 4)
Unfavourable outcome at 6 months
(n = 6)
OutcomesModel families
(n = 1)
(n = 1)
(n = 2)
(n = 3) (n = 3)
FIGURE 25 Overview of risk prediction models.
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CRASH models
The CRASH models were developed using data from one multinational, multicentre RCT.53,54,62 Inclusion 
criteria for the trial were patients aged ≥ 16 years with TBI and a GCS score of < 15 and no clear 
contraindication to receiving corticosteroids. Randomisation had to take place within 8 hours of injury. 
In total, eight risk prediction models were developed, for each combination of setting (low-/middle- and 
high-income countries), outcome (mortality at 14 days and unfavourable outcome at 6 months) and 
model complexity (‘Basic’ and ‘CT’ models).30 Patients with no CT scan available were excluded from the 
development samples for the CT models. As the setting for the RAIN study was the UK NHS, and the 
importance of longer-term outcomes was identified at the outset of the study, the models of interest for 
the RAIN study were the two models based on data from high-income countries predicting unfavourable 
outcome at 6 months. The variables included in the Basic models were age (linear > 40 years); GCS score 
(linear); pupil reactivity; and major extracranial injury (requiring hospital admission independent of the 
TBI). The additional variables included in the CT models were one or more small petechial haemorrhages; 
obliteration of the third ventricle or basal cisterns; subarachnoid bleed (traumatic SAH); midline shift of 
> 5 mm; and non-evacuated haematoma. Model coefficients were obtained from the authors.
IMPACT models
The IMPACT models were developed using data from the IMPACT database, a pooled database of data 
from eight RCTs and three observational studies of patients with moderate or severe TBI (GCS score of 
< 13).55 Individual data sets had different inclusion criteria. Six risk prediction models were developed for 
each combination of outcome (mortality at 6 months and unfavourable outcome at 6 months) and model 
complexity (‘Core’, ‘Extended’ and ‘Lab’ models).35 Patients from one of the constituent data sets of the 
IMPACT database, which did not record hypoxia, hypotension or CT classification, were excluded from 
the development sample for the extended models and patients from a further six data sets, which did not 
record laboratory values, were excluded from the development sample for the Laboratory models. Missing 
data for individual patients in the development samples for each model were imputed. The variables 
included in the Core models were age (linear); motor score; and pupil reactivity. The additional variables 
included in the Extended models were Marshall CT classification; traumatic SAH; epidural (extradural) 
haematoma; pre-hospital hypoxia; and pre-hospital hypotension. The additional variables included in the 
Laboratory models were glucose (linear); and haemoglobin (linear). Model coefficients were obtained from 
the published paper.35
Data sources and risk factors definitions
Patients were selected from the RAIN study database if their last pre-sedation GCS score was < 15. 
Definitions for fields in the RAIN study are provided in Appendix 3. Risk factor variables were calculated 
from the raw data as follows:
 z Age Age in whole years at the time of TBI, calculated from the date of birth and date of TBI.
 z GCS score The last recorded GCS score prior to sedation, which may have been either the pre-hospital 
GCS score, the first recorded-at-hospital GCS score or a subsequent measurement prior to sedation 
and admission to the critical care unit.
 z Motor score The motor score component of the last pre-sedation GCS score.
 z Pupil reactivity The first recorded-at-hospital pupil reactivity, if available, or the pre-hospital pupil 
reactivity if no first at hospital value was available. Pupil reactivity was recorded for the left and right 
eye separately and combined as either ‘both reactive’, ‘one reactive’ or ‘neither reactive’. If only one 
eye could be assessed, pupil reactivity was assigned as ‘both reactive’ if this eye was reactive, and 
‘neither reactive’ if this eye was not reactive.
 z Major extracranial injury Recorded as a specific field in the RAIN study data set, defined as an injury 
requiring hospital admission in its own right.
 z Pre-hospital hypoxia Defined as either a pre-hospital oxygen saturation of < 90%, or pre-hospital 
hypoxia strongly suspected if there was clinical evidence of hypoxia (e.g. tension pneumothorax) but 
no pre-hospital oxygen saturation was recorded.
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Harrison et al. under the terms of a commissioning contract issued by the Secretary of State for 
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
DOI: 10.3310/hta17230 HealtH tecHnOlOgy assessment 2013 VOl. 17 nO. 23
51
 z Pre-hospital hypotension Defined as either a pre-hospital systolic blood pressure of < 90 mmHg, or 
pre-hospital hypotension strongly suspected if there was clinical evidence of hypotension (e.g. multiple 
trauma with massive blood loss) but no pre-hospital systolic blood pressure was recorded.
 z Marshall CT classification Based on the first CT scan following the TBI, and defined as (1) diffuse 
injury I – no visible pathology seen on CT scan (first CT scan result normal); (2) diffuse injury II – basal 
cisterns present, midline shift of 0–5 mm, no high- or mixed-density lesion of > 25 ml; (3) diffuse 
injury III – basal cisterns compressed or absent, midline shift of 0–5 mm, no high- or mixed-density 
lesion of > 25 ml; (4) diffuse injury IV – midline shift of > 5 mm, no high- or mixed-density lesion 
> 25 ml; (5) evacuated mass lesion – any high- or mixed-density lesion of > 1 ml – surgically 
evacuated; (6) non-evacuated mass lesion of > 25 ml – high- or mixed-density lesion of > 25 ml not 
surgically evacuated.56
 z Traumatic SAH Recorded as a specific field in the RAIN study data set.
 z One or more small petechial haemorrhages Recorded as a specific field in the RAIN study data set.
 z Obliteration of the third ventricle or basal cisterns Third ventricle recorded as ‘obliterated’ or basal 
cisterns recorded as ‘absent’.
 z Midline shift of  > 5 mm Recorded as a specific field in the RAIN study data set.
 z Non-evacuated haematoma Any high- or mixed-density lesion of > 1 ml – not surgically evacuated.
 z Extradural haematoma Recorded as a specific field in the RAIN study data set.
 z First at hospital glucose Recorded as a specific field in the RAIN study data set.
 z First at hospital haemoglobin Recorded as a specific field in the RAIN study data set.
Handling of missing data
Missing data in the RAIN study data set were addressed with multiple imputation.76,77 Multiple imputation 
aims to allow for the uncertainty about missing data by creating multiple copies of the data set with the 
missing values in each data set replaced by imputed values, sampled from their predicted distribution.78 
Analyses are conducted on each of the imputed data sets and combined together. As GOSE category is 
conditional on survival status, the imputation was conducted in two stages. In the first stage, imputation 
models were specified for risk factors and mortality at 6 months, according to observed covariates. In 
the second stage, for each of the previously imputed data sets, imputation models were specified for 
GOSE category for those patients who were either known to be alive at 6 months or were predicted to be 
alive by the first stage imputation model. Each multiple imputation model assumed that the data were 
‘missing at random’, i.e. conditional on the variables included in the imputation models.76 Each imputation 
model considered including, for example baseline characteristics (e.g. age) and resource use at 6 months 
(e.g. LOS in critical care). Five imputed data sets were generated for each stage of the imputation,78 giving 
25 imputed data sets in total. All multiple imputation models were implemented in R (The R Foundation 
for Statistical Computing, Vienna, Austria: www.r-project.org) using Multivariate Imputation by Chained 
Equations (MICE).79
Validation data sets
For the primary analyses, each model was validated in the multiply imputed data sets, using (1) all patients 
in the RAIN study with a last pre-sedation GCS score of < 15 and (2) only those patients meeting the 
original inclusion criteria for each model. As secondary analyses, and to reflect use of the models in real life 
settings, the validation was repeated in the original RAIN study data set prior to imputation using (3) all 
patients; (4) only those patients meeting the original inclusion criteria for each model; and (5) only those 
patients meeting the original inclusion criteria for each model and with complete data for all variables 
in the model. For analyses 3 and 4, missing values were assumed to be in the lowest risk category and 
laboratory data were singly imputed to a normal value.
As a sensitivity analysis, the analysis for models predicting unfavourable outcome in all patients in the RAIN 
study data set [data set (1) above] was repeated excluding those patients assigned to the GOSE category of 
severe disability that was either pre-existing or not due to the TBI.
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Statistical analysis
The case mix and outcomes of patients reported for the original development sample for each family of 
models (Hukkelhoven, CRASH and IMPACT) was compared with those for the patients in the RAIN study 
data set that met the original inclusion criteria for the particular family of models, and with all patients in 
the RAIN study data set. The case mix factors included in these comparisons were those included in the 
papers reporting development of the models. Owing to the level of detail of reporting in the papers, it was 
possible to summarise the overall case mix and outcome for only each full development sample, and not 
specifically to the patients actually included in each development sample for each individual model.
The completeness of data for each risk factor included in each of the risk prediction models and the 
outcomes of mortality and unfavourable outcome at 6 months was assessed in the full RAIN study 
data set. Univariable analyses were conducted to assess the relationship between each risk factor and 
the outcomes.
Each risk prediction model was then validated in each of the five RAIN study validation data sets using 
measures of calibration, discrimination and overall fit, as described below. For the validation of risk 
prediction models for mortality at 6 months, the five data sets from the first stage imputation were used. 
For the validation of risk prediction models for unfavourable outcome at 6 months, the 25 data sets from 
the second stage imputation were used. In each case, measures of model performance were calculated in 
each imputed data set and combined using Rubin’s rules,76 which recognise uncertainty both within and 
between imputations.
Discrimination describes the ability of the model to correctly separate the patients into different groups 
(survivors from non-survivors or favourable from unfavourable outcomes). Discrimination was assessed 
by the c-index,80 which is equivalent to the area under the ROC curve.81 When c = 1 there is perfect 
discrimination between the groups (i.e. every patient that died has a higher predicted risk than every 
patient that survived, or every patient with an unfavourable outcome has a higher predicted risk than every 
patient with a favourable outcome) and when c = 0.5 the discrimination is no better than chance.
Calibration describes the degree of correspondence between the probability predicted by the model, and 
the observed proportion with the outcome. Calibration was assessed by graphical plots of observed against 
expected risk in 10 equal-sized groups by predicted risk. The Hosmer–Lemeshow test was used to test the 
hypothesis of perfect calibration.82 However, the Hosmer–Lemeshow test does not provide a measure of 
the magnitude of miscalibration and is highly sensitive to sample size.83 Therefore, the magnitude and 
direction of miscalibration was assessed using Cox’s calibration regression.84 Cox’s calibration regression 
fits a logistic regression model to the predicted log odds from the risk prediction model to estimate 
the intercept, α, and slope, β. If the model is perfectly calibrated then α = 0 and β = 1. The value of α 
represents the calibration at a predicted risk of 0.5, and calibration more generally if β = 1. If 0 < β < 1, the 
predictions vary too much; if β > 1, the predictions ‘show the right general pattern of variation but do not 
vary enough’.
The overall fit (or accuracy) of the model describes how close the predictions are to the actual outcomes 
for individual patients. Overall fit was assessed using Brier’s score, the mean squared error between the 
outcome and prediction.85 Lower values of Brier’s score represent better fit, with perfect predictions 
corresponding to B = 0 and a constant prediction of 0.5 for all patients corresponding to B = 0.25.
Inter-rater reliability of computerised tomography scan reporting
It is essential to know whether the data obtained from local reporting of CT scans are adequate for 
accurate risk adjustment, as this will have significant implications on the practicability of using any 
particular risk prediction model. Data collectors were therefore asked to record appropriate identifiers to 
allow access to CT scans for rereview at a later date, and were requested not to discard or destroy the 
films or digital imaging data for these patients until 5 years after entry into the RAIN study. Copies of the 
first CT scan following presentation at hospital were requested for a randomly selected sample of 10% of 
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patients, weighted to include more patients from outside neuroscience centres, where patient throughput 
was lower, and including at least one patient from each site participating in the RAIN study (provided at 
least one patient had CT data available). Data collectors were requested to send anonymised CT scans to 
the WBIC. Images were transferred either electronically using the Image Exchange Portal or by recorded 
delivery or secure courier. The images were centrally viewed and assessed by four neurosurgical specialist 
registrars/research fellows experienced in assessing CT scans, working under the supervision of two of the 
clinical co-investigators (DKM, PJH). Each CT scan was assessed independently by two raters, working in 
two teams of two, and data were recorded using the same secure, web-based data entry system as for the 
original RAIN study data entry. Each rater was blinded to the site from which the CT scan originated, the 
original RAIN study data reported by that site, and the assessment of their co-rater.
Inter-rater reliability (reproducibility) was assessed by κ-statistics86 for each individual CT field in the RAIN 
study data set between:
1. each group of three ratings comprising the original RAIN study data and the two independent ratings 
from WBIC; and
2. each pair of ratings: RAIN compared with WBIC rater 1, RAIN compared with WBIC rater 2 and WBIC 
rater 1 compared with WBIC rater 2, separately for the two teams of two raters within WBIC.
Subgroup analyses were conducted to compare inter-rater reliability by the specialty and grade of 
assessor in the original RAIN study data, and by whether the scan was from a neuroscience centre or a 
non-neuroscience centre.
Confidence intervals for κ-statistics were calculated using the method of Donner and Eliasziw87 for two 
raters rating a binary outcome, the method of Zou and Donner88 for more than two raters rating a binary 
outcome, and using bootstrap resampling for more than two raters rating an outcome with more than 
two levels.89
All statistical analyses were conducted using Stata/SE version 10.1 (StataCorp LP, College Station, TX, USA).
Results
Comparison of model development samples with the RAIN study data set
Tables 12–14 describe the case mix and outcomes of the development samples for the families of 
Hukkelhoven, CRASH and IMPACT models compared with patients from the RAIN study, both those 
meeting the original inclusion criteria for the respective model and all patients in the RAIN study data 
set. Compared with patients in the Hukkelhoven development sample (see Table 12), patients in the RAIN 
study were, on average, older (mean 45 years vs 33 years), more likely to have had a fall (47% vs 17%) 
and less likely to have had an RTA (33% vs 58%) as the cause of their TBI, had worse GCS motor scores 
(32% vs 13% with motor score 1 or 2) and were more likely to have had either an evacuated or non-
evacuated mass lesion (Marshall class 5/6, 50% vs 32%). They were, however, less likely to have either 
pre-hospital hypoxia (13% vs 21%) or hypotension (7% vs 18%). These differences remained, but were 
generally reduced, after applying the Hukkelhoven inclusion criteria to the RAIN study data set, with 
the exception of the GCS motor score in which the difference became more extreme (42% vs 13% with 
motor score 1 or 2). Mortality at 6 months was slightly higher in the RAIN study than in the Hukkelhoven 
development sample (26% vs 22%) but was similar (23% vs 22%) after applying the inclusion criteria. 
Unfavourable outcome at 6 months was substantially higher in the RAIN study both before (61% vs 40%) 
and after (60% vs 40%) applying the inclusion criteria.
Compared with patients in the CRASH development sample (see Table 13), patients in the RAIN study were, 
on average, slightly older (mean 45 vs 41 years), more likely to have had a fall (47% vs 20%) and less likely 
to have had an RTA (33% vs 50%) as the cause of their TBI, had worse GCS scores (59% vs 44% severe TBI, 
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TABLE 12 Case mix and 6-month outcomes for the Hukkelhoven models development sample compared with the 
RAIN study data set
Case mix and outcomes Hukkelhoven
RAIN (meeting 
Hukkelhoven inclusion) RAIN (all)
Number of admissions 2269 1806 2975
Age (years), mean (SD) [N] 33.2 (13.5) [2269] 38.0 (14.4) [1806] 44.7 (18.9) [2975]
Male, n (%) [N] 1757 (77.4) [2269] 1414 (78.3) [1806] 2263 (76.1) [2975]
Cause of TBI, n (%) [N] [2269] [1806] [2975]
RTA 1319 (58.1) 708 (39.2) 971 (32.6)
Fall 386 (17.0) 699 (38.7) 1399 (47.0)
Othera 564 (24.9) 399 (22.1) 605 (20.3)
GCS motor score, n (%) [N] [2269] [1806] [2907]
5/6 (localises/obeys) 933 (41.1) 672 (37.2) 1409 (48.5)
4 (normal flexion) 659 (29.0) 242 (13.4) 349 (12.0)
3 (abnormal flexion) 374 (16.5) 140 (7.8) 209 (7.2)
1/2 (none/extension) 303 (13.4) 752 (41.6) 940 (32.3)
Pupil reactivity, n (%) [N] [2269] [1806] [2975]
Both reactive 1401 (61.7) 1275 (70.6) 2215 (74.5)
One reactive 279 (12.3) 122 (6.8) 167 (5.6)
Neither reactive 308 (13.6) 283 (15.7) 378 (12.7)
Unable/not assessed 281 (12.4) 126 (7.0) 215 (7.2)
Hypoxia, n (%) [N] 429 (21.4) [2006] 260 (15.2) [1709] 354 (12.6) [2800]
Hypotension, n (%) [N] 395 (17.9) [2208] 141 (8.3) [1703] 190 (6.8) [2791]
Marshall CT classification, n (%) [N] [2249] [1710] [2773]
1/2 (diffuse injury I/II) 1006 (44.7) 674 (39.4) 1051 (37.9)
3 (diffuse injury III) 426 (18.9) 193 (11.3) 248 (8.9)
4 (diffuse injury IV) 88 (3.9) 51 (3.0) 78 (2.8)
5/6 (evacuated mass lesion/non-
evacuated mass lesion > 25 ml)
729 (32.4) 792 (46.3) 1396 (50.3)
Traumatic SAH, n (%) [N] 1090 (49.0) [2223] 1006 (58.4) [1724] 1565 (56.0) [2797]
Six-month outcome, n (%) [N]:
Mortality 500 (22.0) [2269] 397 (22.7) [1746] 748 (26.0) [2881]
Unfavourable outcome 862 (40.1) [2149] 867 (60.0) [1444] 1481 (61.3) [2420]
SD, standard deviation.
a Includes ‘Assault’ and ‘Unknown’.
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TABLE 13 Case mix and 6-month outcome for the CRASH models development sample compared with the RAIN study 
data set
Case mix and outcomes CRASHa
RAIN (meeting CRASH 
inclusion) RAIN (all)
Number of admissions 2,482 2710 2975
Age (years), mean (SD) [N] 40.6 (19.4) 43.9 (18.8) [2710] 44.7 (18.9) [2975]
Male, n (%) [N] (78.9) 2069 (76.4) [2710] 2263 (76.1) [2975]
Cause of TBI, n (%) [N] [2710] [2975]
RTA (50.2) 949 (35.0) 971 (32.6)
Fall (20.0) 1218 (44.9) 1399 (47.0)
Otherb (29.8) 543 (20.0) 605 (20.3)
Hours since injury, mean (SD) [N] 2.8 (2.0) 0.4 (4.1) [2710] 7.1 (46.6) [2975]
GCS score, n (%) [N] [2710] [2975]
13–14 (mild TBI) (32.6) 398 (14.7) 447 (15.0)
9–12 (moderate TBI) (23.6) 677 (25.0) 765 (25.7)
3–8 (severe TBI) (43.8) 1635 (60.3) 1763 (59.3)
Pupil reactivity, n (%) [N] [2710] [2975]
Both reactive (80.7) 2016 (74.4) 2215 (74.5)
One reactive (6.3) 154 (5.7) 167 (5.6)
Neither reactive (9.1) 350 (12.9) 378 (12.7)
Unable/not assessed (3.9) 190 (7.0) 215 (7.2)
Major extracranial injury, n (%) [N] (22.5) 1163 (42.9) [2709] 1213 (40.8) [2974]
CT scan available, n (%) [N] (88.0) 2583 (95.3) [2710] 2817 (94.7) [2975]
Traumatic SAH, n (%) [N] (26.4) 1456 (56.8) [2563] 1565 (56.0) [2797]
Obliteration of third ventricle or basal 
cisterns, n (%) [N]
(9.6) 641 (25.0) [2560] 717 (25.7) [2793]
Midline shift, n (%) [N] (11.1) 753 (29.4) [2563] 880 (31.5) [2796]
Haematoma, n (%) [N] [2580] [2813]
Evacuated (7.9) 831 (32.2) 964 (34.3)
Non-evacuated (26.5) 1341 (52.0) 1432 (50.9)
Six-month outcome, n (%) [N]
Unfavourable outcome (38.5) 1340 (61.0) [2198] 1481 (61.3) [2420]
SD, standard deviation.
a Note that absolute numbers were not reported, only percentages.
b Includes ‘Assault’ and ‘Unknown’.
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TABLE 14 Case mix and 6-month outcome for the IMPACT models development sample compared with the RAIN study 
data set
Case mix and outcomes IMPACT
RAIN (meeting IMPACT 
inclusion) RAIN (all)
Number of admissions 8509 2528 2975
Age (years), median (IQR) [N] 30 (21 to 45) [8509] 44 (28 to 59) [2528] 44 (28 to 59) [2975]
GCS motor score, n (%) [N] [8509] [2528] [2975]
5/6 (localises/obeys) 2591 (30.5) 974 (38.5) 1409 (47.4)
4 (normal flexion) 1940 (22.8) 345 (13.6) 349 (11.7)
3 (abnormal flexion) 1085 (12.8) 209 (8.3) 209 (7.0)
2 (extension) 1042 (12.2) 219 (8.7) 219 (7.4)
1 (none) 1395 (16.4) 721 (28.5) 721 (24.2)
Untestable/missing 456 (5.4) 60 (2.4) 68 (2.3)
Pupil reactivity, n (%) [N] [8509] [2528] [2975]
Both reactive 4486 (52.7) 1828 (72.3) 2215 (74.5)
One reactive 886 (10.4) 152 (6.0) 167 (5.6)
Neither reactive 1754 (20.6) 367 (14.5) 378 (12.7)
Unable/not assessed 1383 (16.3) 181 (7.2) 215 (7.2)
Hypoxia, n (%) [N] 1116 (20.5) [5452] 327 (13.8) [2379] 354 (12.6) [2800]
Hypotension, n (%) [N] 1171 (18.2) [6420] 169 (7.1) [2370] 190 (6.8) [2791]
Marshall CT classification, n (%) 
[N]
[5192] [2355] [2773]
1 (diffuse injury I) 360 (6.9) 94 (4.0) 113 (4.1)
2 (diffuse injury II) 1838 (35.4) 770 (32.7) 938 (33.8)
3 (diffuse injury III) 863 (16.6) 214 (9.1) 248 (8.9)
4 (diffuse injury IV) 187 (3.6) 64 (2.7) 78 (2.8)
5 (evacuated mass lesion) 1435 (27.6) 834 (35.4) 964 (34.8)
6 (non-evacuated mass lesion 
> 25 ml)
509 (9.8) 379 (16.1) 432 (15.6)
Traumatic SAH, n (%) [N] 3313 (44.8) [7393] 1365 (57.5) [2375] 1565 (56.0) [2797]
Extradural haematoma(s), n (%) 
[N]
999 (13.5) [7409] 373 (15.6) [2392] 469 (16.7) [2816]
Glucose (mmol/l), median (IQR) 
[N]
8.2 (6.7 to 10.4) [4830] 7.7 (6.3 to 9.5) [2142] 7.6 (6.3 to 9.5) [2496]
Haemoglobin (g/dl), median 
(IQR) [N]
12.7 (10.8 to 14.3) [4376] 13.4 (11.8 to 14.6) [2280] 13.4 (11.9 to 14.6) 
[2683]
Six-month outcome, n (%) [N]
Mortality 2396 (28.2) [8509] 685 (27.9) [2455] 748 (26.0) [2881]
Unfavourable outcome 4082 (48.0) [8509] 1323 (64.3) [2059] 1481 (61.3) [2420]
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GCS score 3–8; 15% vs 33% mild TBI, GCS score 13–14), were more likely to have unreactive pupils (13% 
vs 9%) and major extracranial injury (41% vs 23%), and had higher rates of all risk factors on CT. The rate 
of unfavourable outcome at 6 months was substantially higher in the RAIN study (61% vs 39%). There was 
very little change after applying the CRASH inclusion criteria to the RAIN study data set, as the majority of 
patients in the RAIN study met CRASH inclusion.
Compared with patients in the IMPACT development sample (see Table 14), patients in the RAIN study 
were, on average, older (median 44 vs 30 years), more likely to have GCS motor scores at the extremes 
of the range (24% vs 16% with motor score 1 and 47% vs 30% with motor score 6), and were less 
likely to have unreactive pupils (13% vs 21%), hypoxia (13% vs 21%) and hypotension (7% vs 18%). 
The distributions of CT findings and laboratory results were broadly similar. Mortality at 6 months was 
similar (26% vs 28%) but the rate of unfavourable outcome at 6 months was higher in the RAIN study 
(61% vs 48%). There was little change after applying the IMPACT inclusion criteria to the RAIN study 
data set.
Data completeness
Table 15 reports the data completeness for risk factors and outcomes in the RAIN study data set. Age 
and GCS score were 100% complete (due to their requirement for meeting RAIN study inclusion criteria), 
and major extracranial injury was missing for only one patient (and assumed absent). All other risk 
factors and outcomes were included in the multiple imputation. The core risk factors were available for 
between 92.8% (pupil reactivity) and 97.7% (motor score) of patients. The first CT scan was available for 
2817 patients (94.7%) and the majority of these had all CT fields recorded. Overall, 93.2% of CT scans 
could be assigned to a Marshall class; of the remaining 6.8%, 5.3% could not be assigned as no CT data 
were available and 1.5% were due to individual missing CT fields. Laboratory variables were the least 
complete with 83.9% completeness for glucose and 90.2% for haemoglobin. There was 96.8% follow-up 
for mortality at 6 months (being unknown only for patients who were homeless or a non-UK resident 
and could not be linked with the MRIS database; see Chapter 3). There was 81.4% follow-up overall for 
unfavourable outcome at 6 months (see Chapter 4). Following multiple imputation, the overall mortality 
at 6 months was estimated to be 25.7% and the rate of unfavourable outcomes 57.4% (note that this is 
lower than the observed rate owing to being more likely to observe outcomes for non-survivors).
Univariable associations between risk factors and outcomes
Tables 16–18 report the univariable associations between risk factors and outcomes for core, CT and 
laboratory variables. The majority of core risk factors demonstrated similar patterns of associations with 
outcomes as in the risk prediction models (see Table 16). Mortality at 6 months was relatively flat below 
the age of 40 years and increased from the age of 40 years (reflecting the structure used in the CRASH 
models), whereas unfavourable outcome increased across the whole range of age (reflecting the structure 
used in the IMPACT models). The range of outcomes across categories of GCS motor score (16–40% for 
mortality and 45–75% for unfavourable outcome) was almost as wide as that seen across the total GCS 
score (15–43% and 44–78%), reflecting the consensus that the majority of prognostic information in 
the GCS score, for patients with TBI, comes from the motor score component. Non-reactive pupils and 
pre-hospital hypoxia and hypotension were associated with substantially worse outcomes. However, major 
extracranial injury was not associated with any increase in mortality or unfavourable outcome at 6 months.
For CT variables (see Table 17), mortality increased substantially across the four categories of diffuse injury 
in the Marshall CT classification, was lower for category 5 (evacuated mass lesion) and substantially higher 
for category 6 (non-evacuated mass lesion > 25 ml). This pattern does not appear to support the modelling 
approach taken in both the Hukkelhoven and IMPACT models of combining categories 5 and 6, although 
the relationship may be different once adjusted for other variables (e.g. the separate variable for extradural 
haematoma included in the IMPACT models). All other CT factors were associated with increased mortality 
and unfavourable outcome except small petechial haemorrhages and extradural haematoma. There was 
no univariable association between small petechial haemorrhages and outcomes. However, it should be 
noted that in the CRASH CT model, this variable was associated only with a small, and not statistically 
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significant, increase in risk in high-income countries and was retained in the model because of the more 
substantial effect observed in low- and middle-income countries. Extradural haematoma was associated 
with a decreased risk of mortality and unfavourable outcome, consistent with the negative coefficient for 
this variable in the IMPACT Extended and IMPACT Lab models.
For the laboratory variables (see Table 18), there was a substantial increasing risk of both mortality and 
unfavourable outcome at 6 months associated with both increasing glucose and decreasing haemoglobin, 
consistent with the relationships in the IMPACT Lab models.
TABLE 15 Data completeness for variables included in the risk prediction models (n = 2975)
Variable Hukkelhoven
CRASH 
Basic
CRASH 
CT
IMPACT 
Core
IMPACT 
Extended
IMPACT 
Lab
Completeness, 
n (%)
Predictors
Age ü ü ü ü ü ü 2975 (100)
GCS score ü ü 2975 (100)
GCS motor score ü ü ü ü 2907 (97.7)
Pupil reactivity ü ü ü ü ü ü 2760 (92.8)
Major 
extracranial 
injury
ü ü 2974 (> 99.9)
Hypoxia ü ü ü ü 2800 (94.1)
Hypotension ü ü ü ü 2791 (93.8)
Marshall CT 
classification
ü ü ü 2773 (93.2)
Traumatic SAH ü ü ü ü 2797 (94.0)
Small petechial 
haemorrhages
ü 2814 (94.6)
Obliteration of 
third ventricle/
basal cisterns
ü 2793 (93.9)
Midline shift ü 2796 (94.0)
Non-evacuated 
haematoma
ü 2813 (94.6)
Extradural 
haematoma
ü ü 2816 (94.7)
Glucose ü 2496 (83.9)
Haemoglobin ü 2683 (90.2)
Outcomes
Mortality at 
6 months
ü ü ü ü 2881 (96.8)
Unfavourable 
outcome at 
6 months
ü ü ü ü ü ü 2422 (81.4)
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TABLE 16 Univariable associations between risk factors and outcomes for variables included in the risk prediction 
models: core variables
Variable
Mortality at 6 months Unfavourable outcome at 6 months
n/N % (95% CI) n/N % (95% CI)
Age (years)
16–29 125/807 15.5 (13.2 to 18.1) 303/669 45.3 (41.6 to 49.1)
30–39 61/394 15.5 (12.2 to 19.4) 181/325 55.7 (50.3 to 61.0)
40–49 109/533 20.5 (17.2 to 24.1) 269/444 60.6 (56.0 to 65.0)
50–59 115/421 27.3 (23.3 to 31.8) 228/343 66.5 (61.3 to 71.3)
60–69 149/362 41.2 (36.2 to 46.3) 232/315 73.7 (68.5 to 78.2)
70–79 127/258 49.2 (43.2 to 55.3) 186/229 81.2 (75.7 to 85.8)
80+ 62/106 58.5 (49.0 to 67.4) 82/97 84.5 (76.0 to 90.4)
GCS score
13–14 63/426 14.8 (11.7 to 18.5) 158/362 43.6 (38.6 to 48.8)
9–12 135/740 18.2 (15.6 to 21.2) 308/613 50.2 (46.3 to 54.2)
4–8 301/1137 26.4 (24.0 to 29.1) 625/944 66.2 (63.1 to 69.2)
3 249/578 43.1 (39.1 to 47.1) 390/503 77.5 (73.7 to 81.0)
GCS motor score
6 78/486 16.0 (13.1 to 19.6) 189/416 45.4 (40.7 to 50.2)
5 166/871 19.1 (16.6 to 21.8) 377/713 52.9 (49.2 to 56.5)
4 76/341 22.3 (18.2 to 27.0) 173/283 61.1 (55.3 to 66.6)
3 59/200 29.5 (23.6 to 36.2) 112/166 67.5 (60.0 to 74.1)
2 77/215 35.8 (29.7 to 42.4) 141/176 80.1 (73.6 to 85.3)
1 282/701 40.2 (36.7 to 43.9) 453/608 74.5 (70.9 to 77.8)
Pupil reactivity
Both reactive 450/2146 21.0 (19.3 to 22.7) 996/1785 55.8 (53.5 to 58.1)
One reactive 41/159 25.8 (19.6 to 33.1) 92/135 68.1 (59.9 to 75.4)
Neither reactive 202/371 54.4 (49.4 to 59.4) 282/328 86.0 (81.8 to 89.3)
Major extracranial injury
No 460/1714 26.8 (24.8 to 29.0) 872/1429 61.0 (58.5 to 63.5)
Yes 288/1166 24.7 (22.3 to 27.3) 608/992 61.3 (58.2 to 64.3)
Pre-hospital hypoxia
No 577/2361 24.4 (22.7 to 26.2) 1184/1978 59.9 (57.7 to 62.0)
Yes 133/347 38.3 (33.4 to 43.5) 209/297 70.4 (64.9 to 75.3)
Pre-hospital hypotension
No 631/2516 25.1 (23.4 to 26.8) 1264/2105 60.0 (57.9 to 62.1)
Yes 76/184 41.3 (34.4 to 48.5) 124/163 76.1 (69.0 to 82.0)
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TABLE 17 Univariable associations between risk factors and outcomes for variables included in the risk prediction 
models: CT variables
Variable
Mortality at 6 months Unfavourable outcome at 6 months
n/N % (95% CI) n/N % (95% CI)
Marshall CT classification
1 7/109 6.4 (3.1 to 12.7) 36/85 42.4 (32.4 to 53.0)
2 117/896 13.1 (11.0 to 15.4) 337/727 46.4 (42.8 to 50.0)
3 79/240 32.9 (27.3 to 39.1) 136/211 64.5 (57.8 to 70.6)
4 30/78 38.5 (28.4 to 49.6) 50/74 67.6 (56.3 to 77.1)
5 252/948 26.6 (23.9 to 29.5) 523/797 65.6 (62.3 to 68.8)
6 212/420 50.5 (45.7 to 55.2) 299/372 80.4 (76.0 to 84.1)
Traumatic SAH
No 239/1193 20.0 (17.9 to 22.4) 546/987 55.3 (52.2 to 58.4)
Yes 462/1522 30.4 (28.1 to 32.7) 846/1298 65.2 (62.5 to 67.7)
Small petechial haemorrhages
No 422/1614 26.1 (24.1 to 28.3) 834/1366 61.1 (58.4 to 63.6)
Yes 284/1118 25.4 (22.9 to 28.0) 568/935 60.7 (57.6 to 63.8)
Obliteration of third ventricle/basal cisterns
No 383/1999 19.2 (17.5 to 20.9) 906/1650 54.9 (52.5 to 57.3)
Yes 315/712 44.2 (40.6 to 47.9) 483/631 76.5 (73.1 to 79.7)
Midline shift of > 5 mm  
No 363/1843 19.7 (17.9 to 21.6) 840/1529 54.9 (52.4 to 57.4)
Yes 338/871 38.8 (35.6 to 42.1) 552/755 73.1 (69.8 to 76.2)
Non-evacuated haematoma
No 313/1350 23.2 (21.0 to 25.5) 690/1133 60.9 (58.0 to 63.7)
Yes 394/1381 28.5 (26.2 to 31.0) 714/1170 61.0 (58.2 to 63.8)
Extradural haematoma
No 612/2278 26.9 (25.1 to 28.7) 1203/1926 62.5 (60.3 to 64.6)
Yes 94/456 20.6 (17.2 to 24.6) 200/377 53.1 (48.0 to 58.0)
External validation of the risk prediction models
For the primary analysis, following multiple imputation, all 2975 patients were included in the validation of 
the risk models among all patients in the RAIN study data set and between 1868 (63%) and 2711 (91%) 
were included in the validation among patients eligible for each model (Table 19). Owing to multiple 
imputation of missing data, the sample sizes were the same for the validation data sets for mortality and 
for unfavourable outcome for each model, where relevant.
The discrimination (c-index) of the four models predicting mortality at 6 months is reported in Table 20. 
Discrimination was similar for the Hukkelhoven, IMPACT Extended and IMPACT Lab models (c-index 0.78) 
and higher than that for the IMPACT Core model (0.75). Inspection of the calibration plots (Figure 26) 
showed good calibration for the Hukkelhoven and IMPACT Lab models, whereas the IMPACT Core and 
Extended models tended to overestimate the risk of mortality at 6 months (i.e. observed mortality was 
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TABLE 18 Univariable associations between risk factors and outcomes for variables included in the risk prediction 
models: laboratory variables
Variable
Mortality at 6 months Unfavourable outcome at 6 months
n/N % (95% CI) n/N % (95% CI)
First at hospital glucose (mmol/l)
< 6 68/459 14.8 (11.9 to 18.4) 178/377 47.2 (42.2 to 52.3)
6–6.9 80/449 17.8 (14.6 to 21.6) 190/362 52.5 (47.3 to 57.6)
7–7.9 114/446 25.6 (21.7 to 29.8) 225/373 60.3 (55.3 to 65.2)
8–9.9 162/554 29.2 (25.6 to 33.2) 303/473 64.1 (59.6 to 68.3)
10+ 203/509 39.9 (35.7 to 44.2) 346/449 77.1 (73.0 to 80.7)
First at hospital haemoglobin (g/dl)
< 10 100/235 42.6 (36.4 to 48.9) 160/204 78.4 (72.3 to 83.5)
10–11.9 146/429 34.0 (29.7 to 38.6) 261/362 72.1 (67.3 to 76.5)
12–12.9 101/390 25.9 (21.8 to 30.5) 225/332 67.8 (62.6 to 72.6)
13–13.9 123/539 22.8 (19.5 to 26.5) 237/462 51.3 (46.7 to 55.8)
14–14.9 122/488 25.0 (21.4 to 29.0) 258/420 61.4 (56.7 to 66.0)
15+ 97/516 17.6 (14.6 to 21.2) 202/408 49.5 (44.7 to 54.3)
TABLE 19 Numbers of admissions and events included in validation data sets for the primary analysis, post imputation
Risk model
All patients,  
validation data set (1)
Eligible for model,  
validation data set (2)
Number of admissions
Hukkelhoven 2975 1868
CRASH Basic 2975 2711
CRASH CT 2975 2584
IMPACT Core 2975 2528
IMPACT Extended 2975 2393
IMPACT Lab 2975 2393
Mortality at 6 months (%)
Hukkelhoven 25.7 22.2
IMPACT Core 25.7 27.6
IMPACT Extended 25.7 27.6
IMPACT Lab 25.7 27.6
Unfavourable outcome at 6 months (%)
Hukkelhoven 57.4 55.9
CRASH Basic 57.4 57.0
CRASH CT 57.4 56.9
IMPACT Core 57.4 60.0
IMPACT Extended 57.4 59.9
IMPACT Lab 57.4 59.9
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TABLE 20 Discrimination: mortality at 6 months
Risk model All patients Eligible for model
c-index (95% CI)
Hukkelhoven 0.784 (0.764 to 0.805) 0.773 (0.745 to 0.801)
IMPACT Core 0.754 (0.733 to 0.774) 0.750 (0.728 to 0.772)
IMPACT Extended 0.780 (0.760 to 0.799) 0.780 (0.760 to 0.801)
IMPACT Lab 0.777 (0.756 to 0.798) 0.779 (0.758 to 0.800)
FIGURE 26 Calibration plots: mortality at 6 months. Each point represents the observed mortality (with 95% CI) 
plotted against the predicted mortality from the model for 10 equal-sized groups based on the predicted mortality. 
Bars at the foot of each figure (‘rug plots’) illustrate the distribution of predictions for survivors and non-survivors. 
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FIGURE 26 Calibration plots: mortality at 6 months. Each point represents the observed mortality (with 95% CI) 
plotted against the predicted mortality from the model for 10 equal-sized groups based on the predicted mortality. 
Bars at the foot of each figure (‘rug plots’) illustrate the distribution of predictions for survivors and non-survivors. 
(Continued.)
lower than predicted). This visual interpretation is supported by the measures and tests of calibration 
(Table 21). Brier’s score (Table 22), summarising the overall fit of the predictions, was best for the 
Hukkelhoven model and worst for the IMPACT Core model. There was little difference in any measures of 
model performance between assessment among all patients and among those eligible for the model.
Each point represents the observed mortality (with 95% CI) plotted against the predicted mortality from 
the model for 10 equal-sized groups based on the predicted mortality. Bars at the foot of each figure (‘rug 
plots’) illustrate the distribution of predictions for survivors and non-survivors.
The discrimination of the models for predicting unfavourable outcome at 6 months was worse than 
for mortality at 6 months, with c-index values ranging from 0.69 to 0.71 (Table 23). The IMPACT Lab 
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model had slightly better discrimination (0.714), followed by the models making use of CT findings 
(Hukkelhoven, CRASH CT and IMPACT Extended; c-index 0.708) with the models using only core variables 
(CRASH Basic and IMPACT Core) having the worst discrimination (c-index 0.69–0.70). All models were 
poorly calibrated, substantially underestimating the risk of unfavourable outcome at 6 months, particularly 
at low predicted risk (Figure 27 and Table 24). The lack of calibration resulted in very poor values for Brier’s 
score – little better than (and, in the case of the CRASH Basic model, worse than) the value of 0.25 that 
would be observed from predicting a constant risk of 0.5 for all patients (Table 25). The sensitivity analysis 
excluding patients with severe disability – either pre-existing or not due to the TBI – resulted in very small 
improvements in discrimination and no discernible change to calibration or overall fit (Table 26). Results 
were very similar when the analyses were repeated for the secondary analyses in the data sets prior to 
multiple imputation (see Appendix 6).
Each point represents the observed proportion with unfavourable outcome (with 95% CI) plotted against 
the predicted risk of unfavourable outcome from the model for 10 equal-sized groups based on the 
predicted risk. Bars at the foot of each figure (‘rug plots’) illustrate the distribution of predictions for 
patients with favourable and unfavourable outcomes.
TABLE 21 Calibration: mortality at 6 months
Risk model All patients Eligible for model
Hosmer–Lemeshow test, chi-squared statistic (p-value)
Hukkelhoven 18.8 [0.042] 15.3 [0.12]
IMPACT Core 117 [< 0.001] 112 [< 0.001]
IMPACT Extended 76.7[(< 0.001] 74.8 [< 0.001]
IMPACT Lab 10.6 [0.39] 14.0 [0.17]
Cox calibration regression, α (95% CI) β (95% CI) [p-value]
Hukkelhoven –0.01 (–0.13 to 0.11)  
1.06 (0.96 to 1.16)  
[0.22]
–0.13 (–0.29 to 0.04)  
1.06 (0.92 to 1.20)  
[0.011]
IMPACT Core –0.50 (–0.60 to –0.40)  
0.95 (0.86 to 1.05)  
[< 0.001]
–0.51 (–0.61 to –0.40)  
0.94 (0.84 to 1.05)  
[< 0.001]
IMPACT Extended –0.37 (–0.48 to –0.27)  
1.02 (0.92 to 1.11)  
[< 0.001]
–0.39 (–0.50 to –0.28)  
1.03 (0.93 to 1.13)  
[< 0.001]
IMPACT Lab –0.11 (–0.23 to 0.01)  
1.00 (0.90 to 1.11)  
[0.051]
–0.11 (–0.23 to 0.01)  
1.01 (0.90 to 1.12)  
[0.059]
TABLE 22 Overall fit: mortality at 6 months
Risk model All patients Eligible for model
Brier’s score
Hukkelhoven 0.150 0.141
IMPACT Core 0.166 0.175
IMPACT Extended 0.156 0.163
IMPACT Lab 0.153 0.159
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TABLE 23 Discrimination: unfavourable outcome at 6 months
Risk model All patients Eligible for model
c-index (95% CI)
Hukkelhoven 0.708 (0.686 to 0.730) 0.688 (0.660 to 0.716)
CRASH Basic 0.699 (0.677 to 0.721) 0.697 (0.675 to 0.720)
CRASH CT 0.708 (0.686 to 0.729) 0.710 (0.687 to 0.733)
IMPACT Core 0.693 (0.671 to 0.716) 0.689 (0.665 to 0.713)
IMPACT Extended 0.708 (0.686 to 0.730) 0.706 (0.683 to 0.730)
IMPACT Lab 0.714 (0.692 to 0.736) 0.713 (0.689 to 0.737)
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FIGURE 27 Calibration plots: unfavourable outcome at 6 months. Each point represents the observed proportion with 
unfavourable outcome (with 95% CI) plotted against the predicted risk of unfavourable outcome from the model for 
10 equal-sized groups based on the predicted risk. Bars at the foot of each figure (‘rug plots’) illustrate the distribution 
of predictions for patients with favourable and unfavourable outcomes. (Continued.)
NIHR Journals Library www.journalslibrary.nihr.ac.uk
external ValIDatIOn Of rIsk preDIctIOn mODels
66
Unfavourable
Favourable
0
20
40
60
80
100
O
b
se
rv
ed
 u
n
fa
vo
u
ra
b
le
 o
u
tc
o
m
e 
at
6 
m
o
n
th
s 
(%
) 
w
it
h
 9
5%
 C
I
0 20 40 60 80 100
Predicted unfavourable
outcome at 6 months (%)
CRASH CT – all patients
Unfavourable
Favourable
0
20
40
60
80
100
O
b
se
rv
ed
 u
n
fa
vo
u
ra
b
le
 o
u
tc
o
m
e 
at
6 
m
o
n
th
s 
(%
) 
w
it
h
 9
5%
 C
I
0 20 40 60 80 100
Predicted unfavourable
outcome at 6 months (%)
CRASH CT – eligible for model
Unfavourable
Favourable
0
20
40
60
80
100
O
b
se
rv
ed
 u
n
fa
vo
u
ra
b
le
 o
u
tc
o
m
e 
at
6 
m
o
n
th
s 
(%
) 
w
it
h
 9
5%
 C
I
0 20 40 60 80 100
Predicted unfavourable
outcome at 6 months (%)
IMPACT Core – all patients
Unfavourable
Favourable
0
20
40
60
80
100
O
b
se
rv
ed
 u
n
fa
vo
u
ra
b
le
 o
u
tc
o
m
e 
at
6 
m
o
n
th
s 
(%
) 
w
it
h
 9
5%
 C
I
0 20 40 60 80 100
Predicted unfavourable
outcome at 6 months (%)
IMPACT Core – eligible for model
(e) (f)
(g) (h)
FIGURE 27 Calibration plots: unfavourable outcome at 6 months. Each point represents the observed proportion with 
unfavourable outcome (with 95% CI) plotted against the predicted risk of unfavourable outcome from the model for 
10 equal-sized groups based on the predicted risk. Bars at the foot of each figure (‘rug plots’) illustrate the distribution 
of predictions for patients with favourable and unfavourable outcomes.
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FIGURE 27 Calibration plots: unfavourable outcome at 6 months. Each point represents the observed proportion with 
unfavourable outcome (with 95% CI) plotted against the predicted risk of unfavourable outcome from the model for 
10 equal-sized groups based on the predicted risk. Bars at the foot of each figure (‘rug plots’) illustrate the distribution 
of predictions for patients with favourable and unfavourable outcomes. (Continued.)
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TABLE 24 Calibration: unfavourable outcome at 6 months
Risk model All patients Eligible for model
Hosmer–Lemeshow test, chi-squared statistic [p-value]
Hukkelhoven 401 [< 0.001] 272 [< 0.001]
CRASH Basic 1102 [< 0.001] 997 [< 0.001]
CRASH CT 437 [< 0.001] 362 [< 0.001]
IMPACT Core 253 [< 0.001] 219 [< 0.001]
IMPACT Extended 341 [< 0.001] 252 [< 0.001]
IMPACT Lab 515 [< 0.001] 384 [< 0.001]
Cox calibration regression, α (95% CI) β (95% CI) [p-value]
Hukkelhoven 0.44 (0.35 to 0.53)  
0.60 (0.52 to 0.68)  
[< 0.001]
0.39 (0.28 to 0.50)  
0.57 (0.47 to 0.66)  
[< 0.001]
CRASH Basic 0.74 (0.64 to 0.85)  
0.59 (0.52 to 0.67)  
[< 0.001]
0.73 (0.62 to 0.84)  
0.60 (0.52 to 0.67)  
[< 0.001]
CRASH CT 0.40 (0.31 to 0.49)  
0.56 (0.49 to 0.63)  
[< 0.001]
0.38 (0.28 to 0.47)  
0.57 (0.50 to 0.64)  
[< 0.001]
IMPACT Core 0.41 (0.32 to 0.50)  
0.66 (0.58 to 0.75)  
[< 0.001]
0.43 (0.34 to 0.52)  
0.65 (0.55 to 0.74)  
[< 0.001]
IMPACT Extended 0.47 (0.38 to 0.56)  
0.66 (0.58 to 0.75)  
[< 0.001]
0.48 (0.38 to 0.58)  
0.66 (0.57 to 0.75)  
[< 0.001]
IMPACT Lab 0.58 (0.48 to 0.67)  
0.65 (0.57 to 0.73)  
[< 0.001]
0.59 (0.49 to 0.74)  
0.65 (0.56 to 0.74)  
[< 0.001]
TABLE 25 Overall fit: unfavourable outcome at 6 months
Risk model All patients Eligible for model
Brier’s score
Hukkelhoven 0.232 0.239
CRASH Basic 0.262 0.262
CRASH CT 0.232 0.230
IMPACT Core 0.232 0.230
IMPACT Extended 0.230 0.227
IMPACT Lab 0.236 0.233
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TABLE 26 Sensitivity analysis: discrimination, calibration and overall fit for unfavourable outcome at 6 months, for all 
patients excluding severe disability, pre-existing or not due to the TBI (n = 2918)
Model c-index (95% CI)
Hosmer–Lemeshow 
test, c2 (p-value)
Cox calibration 
regression, α, β 
(p-value) Brier’s score
Hukkelhoven 0.711 (0.689 to 0.733) 353 (< 0.001) 0.40 to 0.61 (< 0.001) 0.230
CRASH Basic 0.701 (0.679 to 0.722) 1015 (< 0.001) 0.71 to 0.60 (< 0.001) 0.259
CRASH CT 0.710 (0.689 to 0.732) 394 (< 0.001) 0.36 to 0.57 (< 0.001) 0.230
IMPACT Core 0.695 (0.672 to 0.717) 224 (< 0.001) 0.37 to 0.67 (< 0.001) 0.231
IMPACT Extended 0.711 (0.689 to 0.733) 302 (< 0.001) 0.44 to 0.67 (< 0.001) 0.228
IMPACT Lab 0.718 (0.696 to 0.740) 454 (< 0.001) 0.54 to 0.66 (< 0.001) 0.233
Inter-rater reliability of computerised tomography scan reporting
Computerised tomography scans were available for 312 (91%) of 342 patients randomly selected for 
inclusion in the substudy evaluating inter-rater reliability of CT scan reporting, including at least one 
scan from 64 of the 66 critical care units that recruited at least one patient to the RAIN study. The main 
reason cited for failure to provide a CT scan was the need to obtain the scan from a referring hospital. 
κ-Statistics ranged from 0.19 to 0.78 across the individual CT fields (Table 27). The majority of fields used 
in the risk model were found to have moderate to good inter-rater reliability (κ-statistic 0.4–0.8). The 
worst inter-rater reliability was found for the presence of small petechial haemorrhages, which may partly 
explain why no association was found between this factor and outcomes. Agreement between the WBIC 
assessors (WBIC1 vs WBIC2 and WBIC3 vs WBIC4; median κ-statistic 0.70, IQR 0.58 to 0.76) was generally 
better than between the original RAIN study data and the WBIC assessors (RAIN vs WBIC1, RAIN vs WBIC2, 
etc.; 0.52, 0.37–0.62). κ-Statistics for subgroup analyses are reported in Tables 28 and 29. There was little 
discernible variation in inter-rater reliability of CT scan assessments according to the specialty and grade 
of the assessor for the original RAIN study data (see Table 28). CT scans that originated from RAIN study 
critical care units within neuroscience centres had similar inter-rater reliability compared with CT scans that 
originated from non-neuroscience centres (see Table 29).
Discussion
Principal findings
The RAIN study has demonstrated that the Hukkelhoven, CRASH and IMPACT risk prediction models 
for mortality and unfavourable outcome at 6 months have acceptable levels of discrimination when 
applied in a UK cohort of adult patients admitted to critical care units following acute TBI. Although the 
Hukkelhoven and IMPACT Lab models for mortality at 6 months had good calibration, the other IMPACT 
models for mortality at 6 months overpredicted risk, and all models for unfavourable outcome at 6 months 
underpredicted risk particularly at the lower end of the risk spectrum.
Strengths and weaknesses
The main strengths of the RAIN study are the large, representative sample with high levels of data 
completeness and the rigorous statistical methods. The RAIN study included 84% of all neuroscience 
centres in the UK plus representation from the important, but often overlooked, cohort of critically ill 
patients with acute TBI managed outside neuroscience centres. Although the completeness of follow-up 
for unfavourable outcome at 6 months (81%) was lower than ideal, this reflects the difficulties inherent 
in following up such a population (see Chapter 4). Furthermore, consent was obtained at the point of 
follow-up rather than prior to enrolment (as would be the case in an RCT), so patients who declined 
follow-up were still included within the initial study population. The low follow-up rate was addressed 
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by implementing a two-stage multiple imputation process – first imputing risk factors and mortality, and 
subsequently, for those alive or imputed to be alive at 6 months, imputing the GOSE categories.
Strengths and weaknesses in comparison with other studies
The RAIN study is the first prospective external validation of these risk prediction models, with all previous 
validations having been undertaken using existing data sources from either RCTs or trauma registries. 
Consequently, although many previous validation studies have been restricted to validating modified 
and refitted versions of the models due to differences between the available data for validation and the 
data used for model development, the RAIN study was able to define variables in advance to accurately 
implement all risk models as originally reported.
The discrimination of the risk prediction models in the RAIN study was generally within the range observed 
in previous development and validation populations. The Hukkelhoven models had c-indices of 0.78 and 
0.71 for mortality and unfavourable outcome at 6 months, respectively, in the RAIN study compared 
with 0.78 and 0.80 in the original development sample.48 The Hukkelhoven models have been validated 
in four external existing data sources. The model development paper reported validation of the model 
for mortality at 6 months in observational data sets from the EBIC and the TCDB with a c-index of 0.87 
and 0.89, respectively.48 The model for unfavourable outcome at 6 months was validated in the EBIC 
data set only (as the timing of GOS reporting in the TCDB data set was variable) with a c-index of 0.83. 
Subsequently, Hukkelhoven et al.90 presented validation data from one further data source, the Selfotel 
RCT, with a c-index of 0.74 for both mortality and unfavourable outcome at 6 month. A recently reported 
study from a 10-year cohort of patients admitted to a single UK neuroscience centre reported a c-index 
around 0.83 for both mortality and unfavourable outcome at 1 year.91
The CRASH Basic model and CT model for unfavourable outcome at 6 months had c-indices of 0.70 and 
0.71, respectively, in the RAIN study compared with 0.81 and 0.83 in the original development sample.30 
The model development paper reported validation of modified versions of both models (excluding major 
TABLE 29 κ-Statistics (95% CIs) for inter-rater reliability of CT scan reporting by origin of scan
CT variable
Neuroscience centre
Yes (n = 194) No (n = 117)
CT scan result (normal/abnormal) 0.57 (0.35 to 0.74) 0.58 (0.41 to 0.72)
Traumatic SAH 0.40 (0.30 to 0.50) 0.51 (0.38 to 0.62)
Brainstem pathology 0.26 (0.12 to 0.43) 0.10 (–0.00 to 0.32)
Basal cisterns (absent/compressed/present) 0.53 (0.42 to 0.61) 0.61 (0.50 to 0.71)
Obliteration of third ventricle 0.52 (0.38 to 0.64) 0.75 (0.57 to 0.86)
Midline shift of > 5 mm 0.76 (0.67 to 0.83) 0.82 (0.67 to 0.91)
One or more small petechial haemorrhage(s) 
of ≤ 1 ml
0.14 (0.05 to 0.24) 0.25 (0.13 to 0.37)
High/mixed density lesion(s) of > 1 ml 0.68 (0.56 to 0.77) 0.64 (0.52 to 0.74)
Extradural haematoma 0.61 (0.47 to 0.72) 0.56 (0.31 to 0.75)
Subdural haematoma 0.67 (0.58 to 0.74) 0.66 (0.54 to 0.76)
Intracerebral haematoma/haemorrhage/
contusion
0.48 (0.39 to 0.57) 0.54 (0.41 to 0.66)
Posterior fossa haematoma 0.38 (0.16 to 0.61) 0.30 (0.06 to 0.65)
Volume of largest high-/mixed-density lesion 
(> 25 ml/≤ 25 ml)
0.65 (0.56 to 0.73) 0.60 (0.45 to 0.72)
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extracranial injury and small petechial haemorrhages) in the IMPACT database with a c-index of 0.77 for 
both models. The CRASH models have subsequently been validated in three further existing data sources 
from previous RCTs in a joint study by the IMPACT, CRASH and TARN groups.92 These were, again, modified 
versions of the original models, refitted using only patients in the CRASH trial with GCS score of ≤ 8 and 
replacing total GCS with motor score and the CRASH CT variables with Marshall classification, resulting in 
a model structure substantially more similar to the Hukkelhoven and IMPACT models. The c-index for the 
modified CRASH Basic model in these three data sets was 0.68, 0.74 and 0.76, respectively; the c-index for 
the modified CRASH CT model was 0.71 in the only data set for which this could be calculated.
The IMPACT Core, Extended and Laboratory models for mortality at 6 months had c-indices of 0.75, 0.78 
and 0.78, respectively, in the RAIN study compared with values of 0.66–0.84, 0.71–0.87 and 0.72–0.80 
in cross-validation among the original data sets used for model development.35 The corresponding figures 
for the models for unfavourable outcome at 6 months were 0.69, 0.71 and 0.71, respectively, in the 
RAIN study compared with 0.74–0.82, 0.73–0.84 and 0.75–0.82 in cross-validation among the original 
development data sets. The model development paper reported validation of the IMPACT Core model 
and a modified version of the Extended model (the ‘Core + CT’ model, excluding hypoxia, hypotension 
and extradural haematoma) in the CRASH trial data set with c-indices of 0.78 and 0.80, respectively, for 
mortality at 6 months, and the same results for unfavourable outcome at 6 months. The IMPACT models 
have subsequently been validated in six further data sets – a study from a single trauma centre in the 
USA,93 and the joint study from the IMPACT, CRASH and TARN groups using data from three RCTs (as for 
the validation of the CRASH models) and two observational studies.92 The single-centre US study reported 
c-indices of 0.78, 0.83 and 0.83 for mortality at 6 months, and 0.76, 0.79 and 0.76 for unfavourable 
outcome at 6 months for the Core, Extended and Laboratory models, respectively.93 The IMPACT/CRASH/
TARN study reported a c-index for the IMPACT Core model ranging from 0.65–0.83 for mortality at 
6 months across the five data sets, and 0.66–0.76 for unfavourable outcome at 6 months across four 
data sets in which this outcome was available.92 The best discrimination for mortality was from the UK 
TARN data set; however, the outcome assessed in this data set was mortality at discharge from hospital 
not mortality at 6 months. The IMPACT Extended model had a c-index of 0.86 for hospital mortality in the 
TARN data set, and 0.71 for both mortality and unfavourable outcome at 6 months in the one RCT data 
set in which it could be applied. The IMPACT Lab model had c-index of 0.71 and 0.70 for mortality and 
unfavourable outcome at 6 months, respectively, in the same data set.
In the RAIN study, the presence of major extracranial injury was found not to be associated with an 
increased risk of either mortality or unfavourable outcome at 6 months and this is at variance with some 
previous studies. A recent meta-analysis on the effect of major extracranial injury on mortality in TBI found 
an inverse relationship between major extracranial injury and mortality according to the severity of the TBI 
with odds ratios of 2.14, 1.46 and 1.18 in mild (GCS score of 13–14), moderate (GCS score of 9–12) and 
severe (GCS score of 3–8) TBI, respectively.94 Although there are patients with a range of severity of TBI 
within the RAIN study, approximately two-thirds had GCS scores of 3–8 and all patients were admitted to 
a critical care unit, which may also represent an additional marker of severity. One may therefore anticipate 
that the effect of major extracranial injury within the RAIN study would be small. It is also possible, 
however, that the lack of effect of major extracranial injury in the RAIN study may be due to a lack of 
consistent application of the definition, taken from the CRASH trial, which was somewhat subjective. 
Collection of more detailed injury severity scoring, although time consuming, would permit more detailed 
investigation of the effect of major extracranial injury both more consistently across sites and according 
to severity.
Advantages and disadvantages of the alternative risk prediction models
In terms of the statistical assessment of model performance, there was very little to choose between 
models of similar complexity from Hukkelhoven, CRASH and IMPACT. The best discrimination overall was 
from the IMPACT Lab model – the only one of the models to include laboratory parameters – however, 
the improvement in performance over the models of the next level of complexity (Hukkelhoven, CRASH 
CT, IMPACT Extended) was very small. There was a larger difference in performance between these 
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models and the simplest models using core data only (CRASH Basic and IMPACT Core), suggesting that 
there is important prognostic information within the CT scan and the presence/absence of pre-hospital 
hypoxia/hypotension. The substudy on inter-rater reliability of CT scan reporting suggested that the CT 
findings included in the models could be assessed with acceptable reliability. The CRASH models included 
two variables – major extracranial injury and small petechial haemorrhages – that did not demonstrate any 
association with outcomes in the RAIN study. This may be seen as a reason to prefer the Hukkelhoven and 
IMPACT Extended models over the CRASH CT model; however, despite the inclusion of these apparently 
non-prognostic fields, the overall performance of the CRASH CT model was similar. For the subsequent 
analyses within the RAIN study, we therefore selected the IMPACT Lab model as the primary model for risk 
adjustment in the base-case analyses, with the CRASH CT model used for sensitivity analyses. The CRASH 
CT model was chosen over the Hukkelhoven model for sensitivity analyses as it included more substantially 
different predictor variables from the IMPACT Lab model.
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Chapter 6 Evaluation of the costs, consequences 
and cost-effectiveness of alternative locations of care 
for critically ill patients with acute traumatic brain 
injury
Introduction
Acute TBI is a major cause of death and long-term disability.75,95–99 The economic burden of TBI is 
considerable; studies in the USA have reported societal costs of approximately US$60B per year.100 Care 
pathways for adult patients after acute TBI vary widely across regions within publicly funded health-care 
systems.101,102 These clinical practice variations are not informed by evidence on the relative costs and 
outcomes following alternative care pathways. Instead, the location of critical care following TBI may 
reflect bed availability, local variation and clinical assessment of the patient’s prognosis. Variations in the 
care pathway may be important determinants of mortality and morbidity following TBI. Studies have 
reported that management of adult TBI patients in specialist neuroscience centres is associated with 
improved outcomes compared with non-neuroscience centres.15,16,103 Several case series have suggested 
that dedicated algorithms and protocols of care in neurocritical care settings can improve mortality and 
functional outcome following TBI.14,104,105 Possible improvements from more specialised care for patients 
with TBI may reflect more concentrated knowledge among health professionals, and greater numbers 
of patients.14,106 However, a common concern is that the evidence base on alterative locations of care 
following TBI is weak; in the absence of RCTs, confounding is a key concern, and previous studies have 
failed to undertake adequate risk-adjustment when comparing outcomes across settings. Further, few 
studies have compared the relative costs and cost-effectiveness of alternative locations of care following 
acute TBI.107–109
Notwithstanding the lack of evidence, it has been recommended that, following a severe TBI, patients 
should be managed within a neuroscience centre.11 Even within neuroscience centres, there are alternative 
models of critical care, with a recent report suggesting most TBI patients admitted to neuroscience centres 
are managed in neurocritical care units (about two-thirds of beds), or combined units that included 
neuro/general critical care beds (about one-third).12
The distinction between these two models of care within neuroscience centres is potentially important. 
Recent expansion of dedicated neurocritical care facilities13,14 has been based on evidence of the potential 
benefits from managing severe head injury in specialist centres.16 However, such evidence remains 
inconclusive, as these studies rely on risk prediction models that have not been validated, and fail to 
differentiate between any effects of specialist neurocritical care, per se, compared with rapid access 
to neurosurgical care. A key issue is whether any additional initial costs of dedicated compared with 
combined neuro/general critical care units, are justified by subsequent reductions in morbidity costs, 
mortality, or disability. Although there is some evidence that specific interventions for patients with TBI, 
such as aggressive intracranial pressure monitoring, can improve outcomes,14 these can be provided in 
either combined neuro/general critical care units or in dedicated neurocritical care units. The RAIN study 
compared the risk-adjusted costs, consequences and cost-effectiveness of dedicated neurocritical care 
units compared with combined neuro/general critical care units in neuroscience centres. In both settings, 
patients had access to other specialist resources, such as neurosurgery and neuroradiology.
A second key policy question is whether adult patients with TBI without an acute ‘neurosurgical’ 
lesion benefit from an ‘early’ decision to transfer to a neuroscience centre. The available evidence is 
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inconclusive.110–114 Although there is a consensus that those patients who have a space-occupying 
intracranial haematoma with worsening mass effect should be rapidly transferred to a neurosurgical 
centre,115 for other adult patients with TBI, there is little evidence on any relative gains from ‘early’ 
transfer. For critically ill TBI patients, in whom neurosurgery is not indicated, the risks from ‘early’ transfer 
and subsequent aggressive protocols of care may be substantial.116,117 Indeed, for adult TBI patients the 
relatively aggressive approaches adopted in neurocritical care within neuroscience compared with non-
neuroscience centres could lead to worse outcomes,118 higher costs and may not be cost-effective.119 
An alternative view is that an early decision to keep the patient within the non-neuroscience centre can 
lead to delayed transfers, for example if a critical lesion develops subsequently, with potentially higher 
risks.120 Previous National Institute for Health and Care Excellence (NICE) guidelines for ‘non-neurosurgical’ 
patients with TBI recognised the importance of the issue of ‘early’ transfer by listing it as a key topic for 
future research.11
A key challenge for such an evaluation is to choose an appropriate time point that reflects an ‘early’ 
decision to transfer. Here, an ‘early’ decision of whether or not to transfer the patient, is defined as one 
made immediately after the TBI has been diagnosed and the patient stabilised for transfer. Although 
limited NHS resources could delay transfer by several hours, transfer within 18 hours of hospital 
presentation still implies an early decision to transfer. A transfer more than 24 hours after hospital 
presentation implies a decision to delay transfer, rather than an intended early transfer delayed by logistics. 
In many cases the patient may not be transferred at all.16
We therefore had two distinct research objectives that addressed separate decision problems of key policy 
relevance but were complementary in using risk prediction models to adjust for observed confounders 
when assessing the costs, consequences and cost-effectiveness of alternative care locations following TBI. 
These objectives were to compare the relative costs, consequences and cost-effectiveness of:
1. management in a dedicated neurocritical care unit compared with a combined neuro/general critical 
care unit for adult patients with TBI presenting at a neuroscience centre
2. ‘early’ (within 18 hours of hospital presentation) transfer to a neuroscience centre compared with ‘no 
or late’ (after 24 hours) transfer, for adult patients with TBI who initially present at a non-neuroscience 
centre and do not require surgery for evacuation of a mass lesion.
These objectives are not easily addressed by RCTs but the variation in neurocritical care services across the 
NHS allowed us to undertake a rigorous non-randomised study. Such a non-randomised study requires 
valid, reliable and accurate risk prediction models. Earlier sections of this report suggest that pre-existing 
risk prediction models for patients with TBI can provide appropriate adjustment for patient factors 
at presentation.
Methods overview
This evaluation compared alternative care locations for adult patients admitted to critical care following 
TBI. The evaluation was undertaken in two phases. In the first phase, we compared the costs and 
consequences of the alternative care locations at 6 months following the TBI. In the second phase, we 
used estimates from these 6-month end points to project the lifetime cost-effectiveness of alternative 
care locations. The first phase cost–consequence study compared risk-adjusted 6-month health outcomes 
(mortality, GOSE and EQ-5D-3L) and costs across alternative care locations using data from the RAIN study. 
In the second phase, the cost-effectiveness analysis (CEA) followed NICE methods guidance and took a 
health and personal social perspective,67 and reported cost-effectiveness over the lifetime. Future costs and 
outcomes were discounted at the current recommended rates of 3.5%.
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The subsequent sections motivate the alternative care pathways and comparators considered, report the 
methods and results of the cost–consequence analysis and then report the methods and results of the 
lifetime CEA. Finally, we discuss the findings from both phases of the evaluation.
Motivating the comparators chosen for the research objectives
Alternative care pathways in the NHS for adult patients with traumatic 
brain injury
There are many possible pathways for patients admitted to NHS critical care units following acute TBI, but 
the vast majority of patients can broadly be classified into one of four pathways (Figure 28). Patients may 
either present at a non-neuroscience centre (pathways A, B and C), or directly to a neuroscience centre 
(pathway D). Patients who present to a non-neuroscience centre may either receive all of their critical care 
within that centre (pathway A) or transfer to a neuroscience centre either directly from the emergency 
department (pathway B), or critical care within the non-neuroscience centre (pathway C). (Note that 
pathway C will include both patients for whom the initial decision is to transfer to a neuroscience centre 
but who receive a period of critical care within the non-neuroscience centre either for stabilisation 
prior to transfer or while a suitable bed is located, and also patients for whom the initial decision is to 
manage within the non-neuroscience centre but a subsequent decision is made to transfer, e.g. owing 
to deterioration.) Patients who present directly to a neuroscience centre are generally managed within 
a neurocritical care unit in that neuroscience centre (pathway D), which may be either a dedicated 
neurocritical care unit or a combined neuro/general critical care unit. (Occasionally, when beds are 
unavailable patients may be transferred to a general critical care unit in a neuroscience centre.)
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FIGURE 28 Simplified patient pathways.
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Comparators for addressing research objective 1
Research objective 1 considered alternative ways of organising and delivering neurocritical care services 
within a neuroscience centre for patients admitted following acute TBI (Figure 29). The population of 
interest was defined by all RAIN study patients who were admitted to critical care within a neuroscience 
centre, regardless of whether they initially presented at a neuroscience centre (pathway D) or were 
transferred from a non-neuroscience centre (pathways B or C). Patients who received all their critical care 
within a non-neuroscience centre were excluded (i.e. pathway A). The decision problem contrasted care in 
neuroscience centres with a dedicated neurocritical care unit (see Figure 29a) compared with a combined 
neuro/general critical care unit (see Figure 29b). Hence, patients within each neuroscience centre were only 
included in one of the comparator groups, analogous to a cluster randomised trial in which individuals 
within a cluster are all randomised to the same ‘treatment’.
Comparators for addressing research objective 2
The second research objective considered whether, for those patients who presented at a non-neuroscience 
centre, the intention to undertake an early transfer to a neuroscience centre was cost-effective. This 
population was characterised by all RAIN study patients who presented at a non-neuroscience centre 
(i.e. pathways A, B and C) apart from those who underwent neurosurgery for evacuation of a mass lesion 
within 24 hours following presentation. These comparators were selected to contrast an initial decision to 
transfer the patient to a neuroscience centre (Figure 30a) compared with an initial decision to manage the 
patient within the non-neuroscience centre (see Figure 30b). The ‘early’ transfer group comprised patients 
transferred directly to a neuroscience centre from an emergency department in a non-neuroscience centre, 
and transfers from a critical care unit that were within 18 hours of initial hospital presentation. The ‘no 
or late’ transfer group comprised patients who received all their critical care within a non-neuroscience 
centre, and also patients from critical care units in non-neuroscience centres, who were transferred to a 
neuroscience centre more than 24 hours after initial hospital presentation. To ensure separation between 
the comparator arms, we excluded patients transferred between 18 and 24 hours following initial hospital 
presentation. The cut-off times were chosen by consensus among the clinical experts on the RAIN Study 
Steering Group. Patients within each participating critical care unit could be included within either 
comparator group.
As part of research objective 2, three sets of prespecified subgroup analyses were undertaken: the first 
according to age, the second according to presence of major extracranial injury and the third by GCS 
score at baseline. The justification for reporting results by age group was that several recent studies 
have reported worse outcomes following TBI for older patients, defined as those above an age threshold 
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FIGURE 29 Comparators for research objective 1: organisation of care within neuroscience centres. (a) Dedicated 
neuro unit; (b) combined neuro/general unit.
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ranging from 65 to 80 years.121–124 This raises the hypothesis that ‘early’ transfer for an older subgroup may 
not be cost-effective. We categorised age groups according to a cut-off of 70 years, which is in the middle 
of the range of age thresholds used previously, and was anticipated to ensure sufficient sample sizes in 
each subgroup.
Major extracranial injury frequently accompanies TBI and can increase mortality.16,94,125–127 However, it is 
unclear whether the presence of major extracranial injury will modify the effect of an early transfer to 
neuroscience centres on mortality, morbidity or cost. Hence, we reported the costs, consequences and 
cost-effectiveness of ‘early’ compared with ‘no or late’ transfer for subgroups with and without major 
extracranial injury, defined as an injury that would require hospital admission in its own right.
The third subgroup analysis was motivated by NICE guidance, which recommended transfer to a 
neuroscience centre for all patients with severe TBI, defined as a TBI with GCS score of ≤ 8, regardless 
of the need for neurosurgery.11 We therefore reported the costs, consequences and cost-effectiveness 
of ‘early’ compared with ‘no or late’ transfer for subgroups with a last pre-sedation GCS scores of 3–8 
and 9–14.
Methods for the cost–consequence analysis of alternative care 
locations at 6 months
Settings, inclusion criteria and measurement of case mix
Each critical care unit within the RAIN study was classified according to whether they were in a 
neuroscience centre and, if so, whether they were a dedicated neurocritical care unit or a combined 
neuro/general critical care unit (Table 30). (The one ‘major injuries unit’ participating in the RAIN study 
was classified as a dedicated neurocritical care unit due to the specialist nature of their case mix and the 
presence of a separate general critical care unit within the same hospital.) All dedicated neurocritical care 
units in the UK participated in the RAIN study, along with 74% of combined neuro/general critical care 
units and 16% of general critical care units in non-neuroscience centres. Dedicated neurocritical care 
units had a similar distribution of bed numbers to general critical care units in non-neuroscience centres, 
whereas combined neuro/general critical care units were larger. The throughput of TBI cases was similar for 
dedicated neurocritical care units and combined neuro/general critical care units, and substantially higher 
than for general critical care units in non-neuroscience centres.
Data were extracted from the RAIN study data set for all patients with acute TBI and a last pre-sedation 
GCS score of < 15. For research objective 1, all patients with RAIN study data submitted from a 
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FIGURE 30 Comparators for research objective 2: ‘early’ vs ‘no or late’ transfer to a neuroscience centre. (a) Early 
transfer; (b) no or late transfer.
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neuroscience centre were included in the analysis. All patients who met the inclusion criteria within 
an eligible critical care unit were then assigned to either comparator group according to whether the 
neurocritical care unit met the criteria for a dedicated critical care or combined neuro/general critical 
care unit.13,14
For research objective 2, all patients initially presenting at a non-neuroscience centre were included in 
the analysis. Patients included in this analysis came from RAIN study data submitted either from non-
neuroscience centres or from neuroscience centres where the location prior to admission field indicated 
that the patient had been transferred from another acute hospital. Patients were assigned to either 
comparison group according to the time of transfer to a neuroscience centre. Patients transferred to a 
neuroscience centre between 18 and 24 hours following initial presentation at an acute hospital were 
excluded from the analysis.
Risk factor data for the IMPACT Lab35 and CRASH CT30 models were taken from the time of injury and initial 
presentation at acute hospital, and were defined in the same way as for the external validation of the risk 
prediction models (see Chapter 5).
Resource use before 6 months
For research objective 1, resource use was considered from the first admission to critical care within the 
neuroscience centre, i.e. any resource use before this critical care admission, was excluded. For the second 
research objective, resource use was considered from the first critical care admission following the TBI. For 
both research objectives, the RAIN study prospectively recorded the LOS in critical care for each admission, 
according to days in a dedicated neurocritical care unit within a neuroscience centre, days in a combined 
neuro/general critical care unit within a neuroscience centre, and days in a general critical care unit within 
a non-neuroscience centre. The RAIN study also recorded whether or not the patient had intracranial 
neurosurgery for evacuation of a mass lesion. We recorded the LOS following transfer to other wards, 
both within the same acute hospital or to other hospitals including rehabilitation centres (all termed LOS 
on general medical wards). Any readmissions to critical care within the RAIN study were recorded. We 
also extracted data on readmissions to critical care units that were not in the RAIN study via data linkage 
TABLE 30 Description of critical care units participating in the RAIN study
Hospital type Neuroscience centrea Non-neuroscience centre
Unit type
Dedicated neurocritical 
care unit
Combined neuro/general 
critical care unit General critical care unit
Number of units (% of all in UK) 13 (100) 14 (73.7) 36 (16.1)
Number of beds, n (%)
5–9 5 (38.5) 0 (0) 17 (47.2)
10–14 5 (38.5) 1 (7.1) 14 (38.9)
15–19 3 (23.1) 5 (35.7) 4 (11.1)
20+ 0 (0) 8 (57.1) 1 (2.8)
Number of admissions in RAIN 
study
1565 1621 440
Admissions per unit per year 
(IQR across units)
90 (60 to 103) 84 (54 to 110) 9 (6 to 11)
Number of patients in analysis 1324 1341 310
a Includes data from four additional critical care units within neuroscience centres (i.e. not the unit where patients with 
TBI would routinely be managed); these units have not been included in the reported numbers of units and their 
admissions have been counted with those of the neurocritical care unit.
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with the CMP database. Each day during critical care was assigned to the appropriate Healthcare Resource 
Group (HRG) using daily organ support data recorded for the CCMDS.
The 6-month follow-up in the RAIN study (see Chapter 3) included a Health Services Questionnaire to 
ascertain use of other hospital and personal social services up to 6 months following the TBI. These postal 
questionnaires asked patients or their carers to report any hospital and personal service use between 
discharge from hospital and 6 months. We adapted a questionnaire128 to report service use following a 
TBI. The items of service use included subsequent hospital readmissions (excluding critical care), visits to 
hospital outpatients, and community health services (contacts with the GP, health visitor, district nurse, 
physiotherapist, occupational therapist, psychologist and speech therapist) (see Appendix 5). The patients 
eligible for this questionnaire were those known to be alive, and discharged from hospital by the date of 
the 6-month follow-up.
Health outcomes at 6 months
Data on 6-month outcomes were collected centrally as detailed in Chapter 3. EQ-5D-3L profiles were 
combined with health-state preference values from the UK general population, to give an EQ-5D-3L utility 
index score on a scale anchored at 0 (death) and 1 (perfect health).129 QALYs at 6 months were then 
reported for each patient by combining information on survival and utility score at 6 months. Patients 
who died before 6 months were assigned zero QALYs. For patients alive at 6 months who completed an 
EQ-5D-3L questionnaire, their utility score at 6 months was multiplied by 0.5 life-years (6/12 months) to 
give their 6-month QALY.
Unit costs
For all critical care admissions, each bed-day was costed with the corresponding unit cost per bed-day 
from the ‘Payment by Results’ database.130 Each set of unit costs distinguished between the alternative 
care locations; for research objective 1, separate unit costs were extracted for neuroscience centres with 
dedicated neurocritical care units compared with neuroscience centres with combined neuro/general 
critical care units (Table 31). For research objective 2, separate unit costs were applied to critical care 
in non-neuroscience centres (general critical care) compared with neuroscience centres (dedicated 
neurocritical care or combined neuro/general critical care). The unit cost of transfer to a neuroscience 
centre was taken as the cost of an emergency transfer.130 For those admissions that included an intracranial 
procedure, to recognise the additional costs of theatre time and consumables, we included an additional 
unit cost corresponding to neurosurgery for cases with complications or comorbidities.130 Each set of unit 
costs was reported as an average across the centres in the RAIN study. Unit costs for general medical bed-
days were taken across all categories of elective, excess bed-days, weighted for their relative prevalence.131 
Other unit costs of health and personal social services were taken from the literature (Table 32).132 All unit 
costs were reported in 2010–11 prices.
Each item of resource use was combined with the appropriate unit cost to report a cost per patient for 
each cost category (inpatient, outpatient, community and total costs). Resource use was estimated at the 
individual patient-level for each specific location of care. The unit costs were average unit costs across the 
centres in the RAIN study specific to each location of care (see Table 32).
Analysis of 6-month costs and consequences
For both research objectives, we described baseline characteristics, unadjusted outcomes, resource use 
and costs for each comparator. For each end point we employed regression analysis to adjust for baseline 
differences between the comparators using the individual risk factor variables from the IMPACT Laboratory 
model.35 For the mortality and unfavourable outcome end points, we report odds ratios with logistic 
regression. For research objective 1, where each patient within a critical care unit was by definition within 
the same comparison group, we specified multilevel models that included random effects for centre 
to recognise any between-centre differences.133,134 For the EQ-5D-3L, QALY and cost end points, the 
multilevel model reported incremental effects of the alternative care locations, after adjusting for case mix. 
The multilevel models assumed that both individual and centre level residuals were drawn from normal 
NIHR Journals Library www.journalslibrary.nihr.ac.uk
eValuatIOn Of tHe cOsts
82
distributions. For research objective 2, where patients within each critical care unit could be assigned to 
either comparison arm, we repeated the above analysis but with single-level regression models estimated 
by maximum likelihood. These models reported incremental effects of the alternative care locations, 
together with 95% CIs, assuming that individual level residuals followed normal distributions. For research 
objective 2, we undertook prespecified subgroup analyses to report: incremental effects according to 
age (aged ≤ 70 years or > 70 years), major extracranial injury (yes or no) and GCS score (3–8 or 9–14). All 
analyses were implemented in R using the General Linearized Models (GLM) package.135
For those patients who did not complete the 6-month follow-up questionnaires, data were unavailable 
for GOSE (approximately 20%), EQ-5D-3L and health service use (both approximately 50%). For a minority 
of patients, information was missing for baseline characteristics (between 2% and 17%) and mortality 
(3%). We addressed missing data with multiple imputation following a similar approach to that applied 
in Chapter 5.76,78,136 The EQ-5D-3L, GOSE and cost end points were conditional on survival status, so we 
conducted the imputation in two stages. In the first stage, we specified imputation models for baseline 
characteristics and mortality according to observed covariates. In the second stage, for each of the 
previously imputed data sets, we specified imputation models for GOSE, EQ-5D-3L and health service use 
for those patients who were either known to be alive at 6 months, or were predicted to be alive by the first 
stage imputation model. (Owing to the high number of health service use categories, we specified multiple 
imputation models only for three aggregated categories: inpatient, outpatient and ‘other’ service use. In 
order to present disaggregated descriptions of mean service use across all the patients sampled in each 
arm, we also undertook mean imputation. Here we replaced missing observations in each category with 
the unconditional mean resource use for each category by treatment arm, among those patients with the 
relevant resource use observed.)
TABLE 31 Unit costs (£) of inpatient care
Resource use
Unit costs (£) of inpatient care
Neuroscience centre 
with dedicated 
neurocritical care unit
Neuroscience centre 
with combined neuro/
general critical care unit
Non-neuroscience 
centre with general 
critical care unit
Critical care bed-day
One organ supported 865 800 738
Two organs supported 888 1269 899
Three organs supported 1354 1181 1348
Four organs supported 1369 1324 1553
Five organs supported 1433 1360 1685
Six organs supported 1481 1570 1895
Seven organs supported 1448 1570 2204
General medical bed-daya 252 252 252
Transfer to neuroscience centre 253 253 N/A
Intracranial procedure 5796 4570 6174b
N/A, not applicable.
a Cost of excess bed-day.
b National average of NHS reference cost.
Source: NHS reference costs 2010–11.130
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Each multiple imputation model assumed that the data were ‘missing at random’, that is conditional on 
the variables included in each imputation model.76 Each imputation model considered including baseline 
covariates (e.g. risk factor variables from the IMPACT Lab model), resource use (e.g. LOS in critical care), 
and end points (e.g. we used data for those patients who completed the GOSE questionnaire to predict 
missing EQ-5D-3L). For research objective 1, we developed multilevel imputation models to recognise the 
hierarchical structure of the data.137 For research objective 2, we used standard multiple imputation.77 As 
the missingness pattern may differ across treatment groups, we specified separate imputation models 
for each comparator, and five imputed data sets were generated for each stage of the imputation, 
giving a total of 25 imputed data sets for each arm. After imputation, we applied the analytical models 
to each imputed data set, and combined the resultant estimates with Rubin’s rules,76 which recognise 
uncertainty both within and between imputations. All multiple imputation models were implemented in R 
using MICE.79
TABLE 32 Unit cost (£) of contacts with outpatient and community health services
Community health service Unit cost (£)
Hospital outpatient 147
GP practice visit 47
GP home visit 99
GP practice nurse 11
Hospital staff nurse 11
Health visitor 11
District nurse 11
Psychologist 16
Speech and language 
therapist
8
Occupational therapist 10
Physiotherapist 8
Counsellor 60
Hospital discharge 
co-ordinator
8
Child psychologist 16
Dietitian 8
Mental health service 27
Cognitive–behavioural 
therapist
8
Social worker 9
Art therapy 10
Source: Curtis.132
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Results of the cost–consequence analysis of alternative care 
locations at 6 months
Research objective 1: Dedicated neurocritical care unit compared with 
combined neuro/general critical care unit
The baseline characteristics of the patients were broadly similar between the dedicated neurocritical care 
units and combined neuro/general critical care units (Table 33). In particular, the median predicted risk of 
unfavourable outcome, according to the IMPACT Lab model, was 40% for those dedicated critical care 
units compared with 41% in the combined units.
Table 34 describes the main items of hospital resource use recorded from the RAIN study and the CMP 
database. Although the overall mean hospital LOS was similar between the groups, the dedicated 
neurocritical care unit group had a higher average LOS in critical care.
Table 35 shows the flow of patients through the study. As the EQ-5D-3L and the Health Services 
Questionnaire were administered only by post, and not by telephone, the completion rates were lower for 
these questionnaires.
Mortality at 6 months was similar between the groups (Table 36). The dedicated neurocritical care unit 
group had a higher mean EQ-5D-3L utility index score for survivors, a lower proportion of patients with 
unfavourable outcomes and higher mean QALYs, although none of these differences was statistically 
significant, after case mix adjustment.
Table 37 reports the results from the Health Services Questionnaire for all patients sampled in each 
comparison group. The mean numbers of contacts were similar between the groups. For both groups, 
relatively low use, on average, was made of community health services.
Table 38 reports the mean total costs at 6 months for each comparison arm. On average, critical care costs 
were higher for the dedicated neurocritical care units, and this led to a positive incremental cost compared 
with combined neuro/general critical care units.
TABLE 33 Description of baseline covariates included in the risk models and additional potential confounders for 
research objective 1
Baseline covariates
Combined neuro/general 
critical care unit
Dedicated neurocritical care 
unit
Number of admissions 1341 1324
Age (years)
Mean (SD) 44.4 (18.8) 43.9 (18.7)
Median (IQR) 43 (28 to 58) 43 (26 to 59)
Male, n (%) 1023 (76.3) 1002 (75.7)
Major extracranial injury, n (%) 590 (44.0) 488 (36.9)
Pre-hospital hypoxia,a %b 13.4 11.5
Pre-hospital hypotension,a %b 8.1 4.8
Last pre-sedation GCS score, n (%)
13–14 (mild TBI) 166 (12.4) 232 (17.5)
9–12 (moderate TBI) 352 (26.2) 340 (25.7)
3–8 (severe TBI) 823 (61.4) 752 (56.8)
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Baseline covariates
Combined neuro/general 
critical care unit
Dedicated neurocritical care 
unit
GCS motor score, %b
6 (obeys) 15.9 19.8
5 (localises) 32.2 30.8
4 (normal flexion) 12.3 12.0
3 (abnormal flexion) 8.1 6.9
2 (extension) 8.3 6.7
1 (none) 23.2 23.7
Pupil reactivity,c %b
Both reactive 79.8 80.9
One reactive 6.4 6.8
Neither reactive 13.8 12.3
Marshall CT classification,d %b
1 (diffuse injury I) 2.7 4.3
2 (diffuse injury II) 35.0 30.4
3 (diffuse injury III) 8.4 9.6
4 (diffuse injury IV) 2.5 3.3
5 (evacuated mass lesion) 37.3 39.3
6 (non-evacuated mass lesion > 25 ml) 14.1 13.1
Traumatic SAH,d %b 57.1 56.6
Extradural haematoma,d %b 16.7 17.5
Predicted risk (%) at 6 months, median (IQR)b
Death (IMPACT Lab model) 22.8 (11.5 to 39.6) 22.5 (11.3 to 36.9))
Unfavourable outcome (IMPACT Lab model) 41.0 (22.9 to 64.2) 40.0 (21.1 to 60.7)
Unfavourable outcome (CRASH CT model) 44.2 (24.3 to 72.2) 42.5 (22.4 to 70.3)
SD, standard deviation.
a Observed (hypoxia, SaO2 < 90%; hypotension, systolic blood pressure < 90 mmHg) or strongly suspected.
b Summaries presented are after multiple imputation; number (%) missing each field were hypoxia 171 (6.4); 
hypotension 179 (6.7); motor score 65 (2.4); pupil reactivity 198 (7.4); Marshall CT classification 189 (7.1); traumatic 
SAH 175 (6.6); and extradural haematoma 156 (5.9).
c First recorded values after hospital presentation or, if unavailable, last recorded values pre-hospital.
d From first CT scan following presentation at hospital.
TABLE 33 Description of baseline covariates included in the risk models and additional potential confounders for 
research objective 1 (continued)
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TABLE 34 Hospital resource use up to 6 months for research objective 1
Resource
Combined neuro/general 
critical care unit (n = 1341)
Dedicated neurocritical care unit 
(n = 1324)
Index admission
Mean (SD) days in critical care 11.08 (10.83) 13.19 (15.07)
Mean (SD) days on general medical wards 26.26 (36.03) 24.69 (33.96)
Mean (SD) total hospital days 37.34 (40.49) 37.89 (39.62)
Neurosurgery,a n (%) 477 (35.57) 478 (36.10)
Readmission
n (%) readmission 66 (4.92) 100 (7.55)
Mean (SD) days on critical care 0.46 (3.27) 0.59 (2.94)
Mean (SD) days on general wards 0.22 (3.28) 0.22 (3.41)
Mean (SD) total days 0.68 (5.24) 0.80 (5.05)
Mean (SD) total hospital days up to 6 months 38.02 (41.27) 38.69 (40.49)
SD, standard deviation.
a Intracranial procedure for evacuation of mass lesion.
Source: RAIN study and CMP database.
TABLE 35 Flow of patients (n) from hospital presentation to 6-month follow-up for research objective 1
Stage of follow-up
Combined neuro/general 
critical care unit Dedicated neurocritical care unit
Hospital presentation 1341 1324
Total deaths before 6 months 331 305
Missing data on death before 6 months 42 45
Eligible for Your Health Questionnaire 968 974
GOSE questionnaire completed 750 (77%) 796 (82%)
EQ-5D-3L questionnaire completed 471 (49%) 508 (52%)
Initial hospital episode of 6 months or more 27 20
Eligible for Health Services Questionnaire 941 954
Health Services Questionnaire completed 495 (53%) 529 (55%)
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TABLE 36 Six-month outcomes for research objective 1, unadjusted and adjusted for case mix (after 
multiple imputation)
Six-month outcomes
Combined 
neuro/general 
critical care unit 
(n = 1341)
Dedicated 
neurocritical 
care unit 
(n = 1324)
Odds ratio/incremental effecta (95% CI)
Unadjusted Adjusted
Death before 6 months, 
n (%)
341 (25%) 312 (24%) 0.982 (0.95 to 1.02) 0.942 (0.77 to 1.16)
Mean (SD) EQ-5D (survivors) 0.43 (0.41) 0.48 (0.41) 0.049 (–0.001 to 0.098) 0.048 (–0.002 to 0.099)
GOSE category, n (%) 
Upper good recovery 155 (12%) 169 (13%)
Lower good recovery 76 (6%) 71 (5%)
Upper moderate disability 145 (11%) 166 (13%)
Lower moderate disability 123 (9%) 125 (9%)
Upper severe disability 181 (14%) 165 (12%)
Lower severe disability 283 (21%) 289 (22%)
Pre-existing severe 
disability
36 (3%) 27 (2%)
Dead 341 (25%) 312 (24%)
Unfavourable outcome, 
n (%)
841 (63%) 793 (60%) 0.888 (0.69 to 1.15) 0.902 (0.74 to 1.10)
Mean (SD) QALY 0.16 (0.20) 0.18 (0.21) 0.023 (0.002 to 0.043) 0.020 (–0.001 to 0.040)
SD, standard deviation.
a Odds ratio for death and unfavourable outcome, and incremental for other estimates.
TABLE 37 Mean (SD) resource use from Health Services Questionnaire between discharge from hospital and 6 months 
following the TBIa
Resource use
Combined neuro/general 
critical care unit (n = 1341)
Dedicated neurocritical care 
unit (n = 1324)
Inpatient days (general medical) 8.3 (16.7) 8.2 (17.6)
Outpatient visits 3.3 (4.6) 2.7 (3.7)
GP contacts 2.1 (2.2) 2.3 (2.4)
Nurse contacts 1.3 (2.4) 1.2 (2.1)
Occupational therapist contacts 2.3 (3.6) 2.5 (3.9)
Health visitor contacts 0.8 (2.2) 0.8 (2.1)
Clinical psychologist contacts 1.3 (3.3) 1.1 (3.0)
Speech therapist contacts 1.4 (3.5) 1.5 (3.9)
Physiotherapist contacts 3.4 (3.9) 3.4 (4.0)
Mental health service contacts 0.4 (2.0) 0.4 (1.6)
Cognitive–behavioural therapist contacts 0.3 (1.3) 0.2 (1.0)
SD, standard deviation.
a For patients with missing values who were known to be alive at 6 months, we applied imputed means for each item 
of service use.
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TABLE 38 Unadjusted mean (SD) costs (£), and incremental costs at 6 months for research objective 1, after adjusting 
for case mix
Source of costs
Combined neuro/general 
critical care unit (n = 1341)
Dedicated neurocritical care 
unit (n = 1324)
Incremental cost 
(95% CI)
Index admissiona
Critical care 15,066 (15,190) 18,225 (21,638)
General medical 6619 (9081) 6223 (8558)
Subsequent admissions
Critical carea 559 (3958) 722 (3664)
General medicala 56 (827) 55 (860)
General medicalb 757 (2468) 782 (2503)
Outpatient careb 445 (1405) 407 (1322)
Community costsb 332 (1274) 364 (1375)
Grand totalab 25,466 (21,468) 28,855 (25,970) 3694 (1899 to 5489)
SD, standard deviation.
a Source: RAIN study and CMP database.
b Source: Health Services Questionnaire.
Research objective 2: ‘early’ compared with ‘no or late’ transfer to a 
neuroscience centre
There were substantial differences in case mix between patients in the ‘early’ transfer group and the ‘no or 
late’ transfer group (Table 39). The patients in the ‘early’ transfer group were on average younger but were 
generally of less severe case mix than the ‘no or late’ transfer group. The ‘no or late’ transfer group had a 
higher proportion of patients with a GCS score of 3–8, for whom neither pupil was reactive, and who had 
a Marshall CT classification of ‘non-evacuated mass lesion’. The net effect was that the median predicted 
risk of death at 6 months was higher for the ‘no or late’ transfer group than for the ‘early’ transfer group.
Figure 31 presents a histogram of the time from initial presentation at hospital to transfer to a 
neuroscience centre, for all patients transferred. Each bin on the histogram represents a time period of 
1 hour; the vertical line at 18 hours represent the maximum time to transfer for the ‘early’ group, and the 
line at 24 hours, the minimum transfer time for the ‘late’ group. In the ‘no or late’ transfer group, 94% 
of patients were not transferred to a neuroscience centre. The majority of transfers were between 3 and 
10 hours from hospital presentation. For 77 patients transferred directly from an emergency department a 
time of transfer was not available; these patients were defined as in the ‘early’ transfer group.
The ‘early’ transfer group had mean LOS in critical care, on general wards and in total that was 
approximately double that of the ‘no or late’ transfer group (Table 40). In addition, a higher proportion of 
patients in the ‘early’ transfer group had an intracranial procedure for evacuation of a mass lesion, at least 
24 hours after initial presentation.
Table 41 shows the flow of patients through the study, and highlights that around half the eligible patients 
completed the postal questionnaires for the EQ-5D-3L and service use.
The proportion of patients who died before 6 months was substantially lower in the ‘early’ compared 
with the ‘no or late’ transfer group (odds ratio after case mix adjustment 0.52, 95% CI 0.34 to 0.80; 
Table 42). Although the CI on the odds ratio for unfavourable outcome included 1, the ‘early’ transfer 
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TABLE 39 Description of baseline covariates included in the risk models and additional potential confounders for 
research objective 2
Baseline covariates
‘No or late’ transfer to 
neuroscience centre
‘Early’ transfer to 
neuroscience centre
Number of admissions 263 584
Age (years) 
Mean (SD) 40.0 (17.4) 50.7 (20.1)
Median (IQR) 39 (24 to 53) 49 (35 to 69)
Male, n (%) 207 (78.7) 455 (77.9)
Major extracranial injury, n (%) 110 (41.8) 209 (35.8)
Pre-hospital hypoxia,a %b 15.0 13.5
Pre-hospital hypotension,a %b 9.7 5.2
Last pre-sedation GCS score, n (%)
13–14 (mild TBI) 41 (15.6) 105 (18.0)
9–12 (moderate TBI) 62 (23.6) 173 (29.6)
3–8 (Severe TBI) 160 (60.8) 306 (52.4)
Motor score from last pre-sedation GCS score, %b
6 (obeys) 14.1 20.8
5 (localises) 26.5 35.4
4 (normal flexion) 10.3 11.2
3 (abnormal flexion) 4.9 4.9
2 (extension) 7.3 5.9
1 (none) 36.7 21.8
Pupil reactivity,c %b
Both reactive 77.0 83.8
One reactive 1.4 6.1
Neither reactive 21.6 10.0
Marshall CT classification,d %b
1 (diffuse injury I) 10.9 2.4
2 (diffuse injury II) 45.6 42.4
3 (diffuse injury III) 8.4 16.7
4 (diffuse injury IV) 2.7 4.3
5 (evacuated mass lesion) 0.6 9.6
6 (non-evacuated mass lesion > 25 ml) 31.8 24.6
Traumatic SAH,d %b 47.1 60.3
Extradural haematoma,d %b 9.6 14.8
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Baseline covariates
‘No or late’ transfer to 
neuroscience centre
‘Early’ transfer to 
neuroscience centre
Predicted risk (%) at 6 months, median (IQR)b
Death (IMPACT Lab model) 24.6 (9.6 to 48.1) 18.3 (9.4 to 32.7)
Unfavourable outcome (IMPACT Lab model) 47.8 (20.8 to 73.6) 33.8 (17.7 to 54.3)
Unfavourable outcome (CRASH CT model) 56.4 (21.8 to 83.1) 35.6 (19.1 to 58.4)
SD, standard deviation.
a Observed (hypoxia, SaO2 < 90%; hypotension, systolic blood pressure < 90 mmHg) or strongly suspected.
b Summaries presented are after multiple imputation; number (%) missing each field were hypoxia 29 (3.4); 
hypotension 33 (3.9); motor score 9 (1.1); pupil reactivity 72 (8.5); Marshall CT classification 89 (10.5); traumatic SAH 
74 (8.7); and extradural haematoma 68 (8.0).
c First recorded values following presentation at hospital or, if unavailable, last recorded values pre-hospital.
d From first CT scan following presentation at hospital.
TABLE 39 Description of baseline covariates included in the risk models and additional potential confounders for 
research objective 2 (continued)
FIGURE 31 Distribution of time from initial presentation at hospital to transfer to a neuroscience centre. Note: 10 
transfers beyond 48 hours are not shown; 77 transfers direct from the emergency department had missing transfer 
times and were assumed to be early.
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group reported a higher mean EQ-5D-3L utility index score for survivors, and higher mean QALYs after case 
mix adjustment.
Table 43 shows the hospital and community health service use reported by the patients at 6 months, 
averaged across the whole sample including those who died. The ‘early’ transfer group reported higher 
average LOS after readmissions to general medical wards, and had higher mean contacts with outpatient 
and community health services.
The higher proportion of patients surviving in the early transfer arm is reflected in the estimates of the total 
costs at 6 months (Table 44); the mean costs of critical care and the total costs were twice as high in the 
early transfer group, with a positive incremental cost of approximately £15,000, after case mix adjustment.
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TABLE 40 Hospital resource use up to 6 months for research objective 2
Resource use
‘No or late’ transfer to 
neuroscience centre (n = 263)
‘Early’ transfer to 
neuroscience centre (n = 584)
Index admission
Mean (SD) days in critical care 5.67 (6.66) 13.93 (15.68)
Mean (SD) days on general medical wards 12.73 (23.94) 24.31 (34.09)
Mean (SD) total hospital days 18.40 (26.98) 38.24 (40.37)
Neurosurgery,a n (%) 1 (0.38) 48 (8.22)
Readmission
n (%) readmission 9 (3.42) 38 (6.51)
Mean (SD) days on critical care 0.28 (2.03) 0.57 (3.18)
Mean (SD) days on general wards 0.03 (0.31) 0.13 (1.55)
Mean (SD) total hospital days 0.31 (2.24) 0.69 (3.98)
Mean (SD) total hospital days up to 6 months 18.71 (27.02) 38.94 (40.86)
SD, standard deviation.
a Intracranial procedure for evacuation of mass lesion.
Source: RAIN study and CMP database.
TABLE 41 Flow of patients (n) from hospital presentation to 6-month follow-up for research objective 2
Stage of follow-up
‘No or late’ transfer to 
neuroscience centre
‘Early’ transfer to 
neuroscience centre
Hospital presentation 263 584
Total deaths before 6 months 104 106
Missing data on deaths by 6 months 7 23
Eligible for Your Health Questionnaire 152 455
GOSE questionnaire completed 114 (75%) 363 (80%)
EQ-5D-3L questionnaire completed 70 (46%) 233 (51%)
Initial hospital episode of 6 months or more 2 7
Eligible for Health Services Questionnaire 150 448
Health Services Questionnaire completed 76 (51%) 236 (53%)
Table 45 presents the results of the subgroup analyses for the 6-month end points, after case mix 
adjustment. Patients aged > 70 years had, on average, a higher odds of death in the ‘early’ compared 
with the ‘no or late’ transfer group, but the CIs around the odds ratios were wide and included 1. For 
older survivors, the mean odds ratio for death at 6 months was < 1 whether or not patients had a major 
extracranial injury but the subgroup with major extra cranial injury had very low odds of death in the 
‘early’ transfer group.
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TABLE 42 Six-month outcomes for research objective 2, unadjusted and adjusted for case mix
Six-month outcomes
‘No or late’ 
transfer to 
neuroscience 
centre (n = 263)
‘Early’ 
transfer to 
neuroscience 
centre (n = 584)
Odds ratio/incremental effecta (95% CI)
Unadjusted Adjusted
Death before 6 months, n 
(%)
107 (41%) 109 (19%) 0.334 (0.242 to 0.462) 0.52 (0.34 to 0.80)
Mean (SD) EQ-5D (survivors) 0.44 (0.37) 0.55 (0.41) 0.108 (0.011 to 0.205) 0.129 (0.032 to 0.225)
GOSE category, n (%)
Upper good recovery 40 (15%) 80 (14%)
Lower good recovery 9 (3%) 45 (8%)
Upper moderate disability 20 (7%) 88 (15%)
Lower moderate disability 25 (9%) 65 (11%)
Upper severe disability 19 (7%) 74 (13%)
Lower severe disability 34 (13%) 117 (20%)
Pre-existing severe 
disability
11 (4%) 7 (1%)
Dead 107 (41%) 109 (19%)
Unfavourable outcome, 
n (%)
169 (65%) 307 (53%) 0.61 (0.17 to 2.15) 0.88 (0.28 to 2.79)
Mean (SD) QALY 0.13 (0.18) 0.22 (0.21) 0.093 (0.056 to 0.130) 0.051 (0.015 to 0.086)
SD, standard deviation.
a Odds ratio for death and unfavourable outcome, and incremental for other estimates.
TABLE 43 Mean (SD) resource use from Health Services Questionnaire between discharge from hospital and 6 months 
following the TBIa
Resource use
‘No or late’ transfer to 
neuroscience centre (n = 263)
‘Early’ transfer to neuroscience 
centre (n = 584)
Inpatient days (general medical) 6.4 (13.8) 7.9 (15.5)
Outpatient visits 1.8 (2.3) 2.4 (2.4)
GP contacts 2.2 (2.3) 2.3 (2.0)
Nurse contacts 1.1 (2.6) 1.1 (2.0)
Occupational therapist contacts 1.4 (3.3) 2.5 (3.7)
Health visitor contacts 0.9 (2.1) 0.7 (1.9)
Clinical psychologist contacts 0.6 (2.1) 1.0 (2.5)
Speech therapist contacts 0.5 (1.6) 1.1 (2.4)
Physiotherapist contacts 2.6 (3.2) 2.8 (3.2)
Mental health service contacts 0.4 (1.4) 0.2 (0.8)
Cognitive–behavioural therapist contacts 0.2 (1.1) 0.2 (0.8)
SD, standard deviation.
a For patients with missing values who were known to be alive at 6 months, we applied imputed means for each item 
of service use.
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TABLE 44 Unadjusted mean (SD) costs (£) and incremental costs at 6 months after adjusting for case mix
Source of costs
‘No or late’ transfer to 
neuroscience centre (n = 263)
‘Early’ transfer to 
neuroscience centre (n = 584)
Incremental cost  
(95% CI)
Index admissiona 
Critical care 8330 (10,016) 19,352 (22,874)
General medical 3209 (6033) 6126 (8589)
Subsequent admissions
Critical carea 395 (2939) 720 (3957)
General medicala 8 (79) 33 (391)
General medicalb 616 (2247) 836 (2547)
Outpatient careb 289 (1114) 573 (1740)
Community costsb 288 (1177) 604 (1885)
Grand totala,b 13,152 (14,563) 28,525 (27,100) 15,001 (11,123 to 18,880)
SD, standard deviation.
a Source: RAIN study and CMP database.
b Source: Health Services Questionnaire.
TABLE 45 Odds ratio for death, incremental EQ-5D-3L, incremental QALY and cost at 6 months (adjusted for case mix) 
of ‘early’ vs ‘no or late’ transfer, for subgroups of patients by age, major extracranial injury and GCS score
Subgroups
Odds ratio for 
death (95% CI)
Incremental EQ-
5D-3L (95% CI)
Incremental QALY 
(95% CI)
Incremental cost 
(95% CI)
Overall 0.521 (0.34 to 0.80) 0.129 (0.032 to 
0.225)
0.051 (0.015 to 
0.086)
15,001 (11,123 to 
18,880)
Age (years)
≤ 70 0.471 (0.289 to 
0.766)
0.132 (0.027 to 
0.237)
0.066 (0.014 to 
0.118)
15,770 (11,492 to 
20,047)
> 70 1.528 (0.441 to 
5.299)
0.074 (–0.334 to 
0.483)
0.037 (–0.167 to 
0.241)
5136 (–3604 to 
13,876)
Major extracranial injury
No 0.797 (0.448 to 
1.420)
0.131 (–0.001 to 
0.262)
0.066 (–0.000 to 
0.131)
11,756 (6774 to 
16,737)
Yes 0.215 (0.098 to 
0.468)
0.119 (–0.019 to 
0.256)
0.059 (–0.009 to 
0.128)
20,481 (14,374 to 
26,588)
GCS score
Mild or moderate TBI 0.733 (0.358 to 
1.498)
0.127 (–0.004 to 
0.259)
0.064 (–0.002 to 
0.130)
9195 (4076 to 
14,314)
Severe TBI 0.431 (0.237 to 
0.783)
0.135 (–0.005 to 
0.275)
0.067 (–0.003 to 
0.137)
18,293 (12,573 to 
24,013)
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Methods for the lifetime cost-effectiveness analysis
Overview
For each research objective, we reported incremental cost-effectiveness of the alternative care locations 
over the lifetime. Such lifetime CEA requires information on long-term survival, QOL and cost of 
alternative interventions. Hence, it was necessary to make assumptions about the long-term prognosis 
of patients with TBI based on the 6-month data from the RAIN study, but also drawing on evidence 
from the literature. We tested whether the results were robust to alternative assumptions in extensive 
sensitivity analyses.
To calculate lifetime QALYs, long-term survival for each patient was calculated from observed survival for 
each patient within the first 6 months, and from their predicted survival after 6 months. Survival after 
6 months was predicted for each patient by applying age-/sex-adjusted excess death rates for the RAIN 
study patients compared with those for the general population. This was undertaken in two steps. First, 
we calculated the excess death rates for RAIN study patients who survived after 6 months, compared with 
the age-/sex-matched UK general population. Second, these excess death rates were applied to predict life 
expectancy for each RAIN study patient alive at 6 months according to their age and sex.
Long-term survival
Patients in the RAIN study had their vital status followed up until September 2011, and dates of all cause 
death before that cut-off were provided by MRIS. For each patient the total survival time was calculated 
up to death or September 2011. We plotted Kaplan–Meier survival curves showing the number of patients 
who died over time until the last available time point, which was 800 days after the initial admission. For 
each comparator, the majority of deaths were within the first 30 days, as shown in Figure 32 for research 
objective 1.
We followed methodological guidance and considered alternative parametric approaches for extrapolating 
the observed survival.138 When considering alternative parametric specifications we excluded the first 
30 days of follow-up, as during this during this time period, patients had high risks of death; it was 
judged inappropriate to use this portion of the data for predicting the long-term probability of death. 
Figure 33 shows alternative parametric extrapolations for research objective 1, for the two comparator 
arms combined.
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FIGURE 32 Kaplan–Meier survival curves for research objective 1.
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We compared the relative goodness of fit of the alternative parametric survival functions, for the remaining 
period of observed survival according to the Akaike information criterion (AIC) and Bayesian information 
criterion (BIC), the fit was similar with the logistic, log-normal or Weibull models (Table 46).
We compared the survival predicted by the alternative extrapolation approaches at 6–12 months with 
that for the age-/sex-matched general population.139 We used each parametric extrapolation to report the 
predicted probability of death at 6–12 months for all the 30-day survivors included in RAIN for research 
objective 1, and report the ratio of these probabilities of death compared with those for the age-/sex-
matched general population, also over a 6-month period. Table 47 shows, for the older age group each 
of the parametric survival curves tended to predict lower mortality compared with the general population. 
Gompertz
Logistic
Weibull
Log-normal
Exponential
1.00
0.99
0.98
0.97
0.96
0.95
0.94
0.93
0.92
0.91
0.90
0 100 200 300 400 500 600 700 800 900 1000
Survival time (days)
Su
rv
iv
al
 p
ro
b
ab
ili
ty
FIGURE 33 Comparison of alternative parametric extrapolations of survival for research objective 1.
TABLE 46 Fit of alternative parametric survival functions applied to the RAIN study data after day 30 for 
research objective 1
Distribution AIC BIC
Gompertz 1302.839 1421.721
Log-normal 1285.765 1404.647
Logistic 1285.889 1404.771
Weibull 1287.583 1406.465
Exponential 1325.173 1438.394
TABLE 47 Ratios of the death rates from applying alternative parametric extrapolations for patients from the RAIN 
study for research objective 1, compared with the age-/sex-matched general populationa
Age group 
(years) Gompertz Log-normal Logistic Weibull Exponential
16–44 1.34 (1.26 to 1.43) 1.24 (1.13 to 1.35) 1.27 (1.18 to 1.36) 1.29 (1.21 to 1.38) 1.07 (1.00 to 1.14)
45–59 1.15 (1.05 to 1.25) 1.13 (1.02 to 1.23) 1.09 (0.99 to 1.19) 1.11 (1.01 to 1.21) 0.91 (0.83 to 1.00)
60+ 0.70 (0.64 to 0.76) 0.69 (0.64 to 0.74) 0.69 (0.63 to 0.74) 0.67 (0.61 to 0.73) 0.58 (0.53 to 0.64)
a Death rates are by age band and for 6–12 months following TBI for RAIN study patients, and for a 6-month period for 
the general population. Numbers in parentheses are 95% CIs.
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In the base case we therefore decided that the most plausible approach was to apply age-/sex-matched 
general population death rates after 6 months for each comparator. Hence, in each of the comparator 
arms for research objective 1, a similar proportion of patients were assumed to die each year. Of the 
alternative parametric functions, the Gompertz was judged the most plausible and so we applied this 
extrapolation as a sensitivity analysis.
For research objective 2, the Kaplan–Meier survival curves (Figure 34) highlight that differences in survival 
between the comparator groups were observed within the first 30 days, and were maintained over time. 
Here when the alternative parametric specifications were applied to the RAIN data (excluding the first 
30 days after TBI), the fit was similar (Table 48). Each of the extrapolation approaches predicted death 
rates lower than those for the general population for 6–12 months for the younger age group (Table 49). 
In the base case, we again applied age-/sex-matched general population death rates after 6 months, and 
used the Gompertz extrapolation in a sensitivity analysis. For this decision problem, both approaches 
assumed that the differences between the comparison groups observed within the RAIN study were 
maintained over time.
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FIGURE 34  Kaplan–Meier survival curves for research objective 2.
TABLE 48 Fit of alternative parametric extrapolations of survival for research objective 2
Distribution AIC BIC
Gompertz 358.0628 448.0886
Log-normal 363.7754 458.3024
Logistic 366.0875 460.6145
Weibull 368.5472 463.0743
Exponential 374.2425 464.2683
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Long-term quality of life
The lifetime CEA required estimates of QOL over time according to the initial locations of critical care. 
Ideally, CEAs are populated with longitudinal estimates of QOL reported using a generic, preference-
based utility measure such as the EQ-5D-3L. We reviewed the literature to find appropriate evidence on 
QOL for this research objective. However, we did not find any studies that reported QOL over time with 
a preference-based measure. Our review did find two studies that reported QOL assessed with the Short 
Form questionnaire-36 items (SF-36) at approximately 10 years after TBI compared with the general 
population. Jacobsson et al.140 collected data for 67 individuals in Sweden 10 years after acute TBI. This 
sample included 50% of patients defined as having had a mild TBI (GCS score of 13–15 at admission to 
the emergency department) and 50% who had either a moderate (GCS score of 9–12) or severe (GCS 
score of 3–8) TBI. However, the study did not find any differences in QOL according to initial severity. The 
main finding was that for the whole sample of patients with TBI, general health assessed by the SF-36 
was approximately 15% lower than that for the age-/sex-matched general population (n = 1224). Andelic 
et al.141 described QOL (SF-36) for a sample of 62 survivors 10 years after moderate (GCS score of 9–12; 
52%) to severe (GCS score of 3–8; 48%) TBI in Norway. The main finding was that the study patients had 
systematically lower scores on each dimension of the SF-36 than the age-/sex-matched general population 
(n = 2323). The mean SF-36 score for general health was similar to that for a moderate to severe TBI 
sample in the USA (n = 228), and approximately 15% less than that of the general Norwegian population. 
A similar decrement to the general populations was reported for the moderate and the severe TBI groups. 
Other studies have considered disability over time for TBI survivors,75 and found that in patients admitted 
to hospital 5–7 years after a TBI, rates of disability were high (53%) and similar to those reported at 1 year 
(57%). Our review did not find any studies that estimated long-term QOL or disability for TBI patients 
managed in alternative locations of neurocritical care.
In light of the lack of evidence on long-term QOL following alternative locations of critical care, our 
estimates of QOL over time for each comparator were based on the 6-month data from the RAIN study. 
However, rather than assuming that the differences in QOL between the comparators at 6 months were 
maintained, we made the conservative assumption that the differences in QOL attenuated over time. For 
each comparator we predicted the mean QOL at 6 months for patients aged 40 years (approximately the 
median age of RAIN patients) with the same risk adjustment applied as in the cost–consequence analysis. 
We predict mean QOL for each treatment arm between year 1 and year 10 with a linear interpolation, 
such that after 10 years the mean for each treatment arm was 15% lower than that for the age-matched 
general population. After 10 years we assumed that for each comparator, the 15% decrement compared 
with the age-matched population was maintained. As Figure 35 shows, this implies that the relative gains 
in QOL at 6 months attenuate over time (see also Sensitivity analyses).
For each individual, we combined their predicted life expectancy (see Long-term survival), with their 
predicted QOL over time to give their projected lifetime QALY.
TABLE 49 Ratios of the death rates from applying alternative parametric extrapolations for patients from the RAIN 
study for research objective 2, compared with the age-/sex-matched general populationa
Age group 
(years) Gompertz Log-normal Logistic Weibull Exponential
16–44 0.61 (0.55 to 0.68) 0.43 (0.35 to 0.50) 0.52 (0.45 to 0.58) 0.55 (0.49 to 0.61) 0.47 (0.41 to 0.52)
45–59 1.02 (0.80 to 1.24) 0.83 (0.62 to 1.04) 0.89 (0.66 to 1.11) 0.92 (0.72 to 1.11) 0.79 (0.61 to 0.96)
60+ 0.96 (0.78 to 1.13) 0.93 (0.78 to 1.07) 0.92 (0.76 to 1.08) 0.89 (0.72 to 1.06) 0.81 (0.64 to 0.98)
a Death rates are by age band and for 6 to 12 months following TBI for RAIN study patients, and for a 6-month period 
for the general population. Numbers in parentheses are 95% CIs.
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Long-term costs
The lifetime CEA also required costs to be projected for each individual for those surviving beyond 
6 months. We reviewed the literature but did not find any relevant information on the relative costs of 
alternative care locations for patients who were alive 6 months after TBI. We therefore considered long-
term costs based on the costs estimated in the RAIN study at 6 months. The costs considered fell into 
four categories: inpatient costs incurred after admission to critical care, inpatient costs on general wards, 
outpatient costs and community care costs.
We calculated inpatient costs incurred after critical care admission by recording ongoing admissions and 
readmissions to critical care units that participated in the RAIN study between 6 and 12 months after the 
TBI. We also considered admissions to critical care units that did not participate in the RAIN study but were 
included in the CMP, and to critical care units that participated in the CMP after patient recruitment to the 
RAIN study ended. The mean costs for each comparator group were then calculated for those patients 
who survived at least 6 months and were not censored between 6 and 12 months. These mean costs were 
used to impute mean costs between 6 and 12 months for the censored observations. For each comparator, 
these mean costs were relatively small (Tables 50 and 51). After 1 year it was assumed that there were no 
further readmissions to critical care that were attributable to the original TBI.
For the other cost categories, we took each individual’s inpatient, outpatient and community costs up to 
6 months estimated from the Health Services Questionnaires. For each comparator arm we then reported 
the mean cost between initial hospital discharge and the 6-month time point but only for those surviving 
up to 6 months. We then applied these 6 monthly costs for each survivor to each subsequent 6-month 
period up to 3 years. After 3 years we assumed that there were no further costs attributable to the acute 
TBI (see Sensitivity analyses).
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FIGURE 35 Attenuation of relative QOL over time for (a) research objective 1 and (b) research objective 2.
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Base-case analysis
We reported mean lifetime costs (£) and QALYs per patient for each comparison group by predicting costs 
and outcomes for each individual as described above. Each incremental effect was reported using the 
risk factors from the IMPACT Lab risk prediction model to adjust for case mix. For research objective 1, 
incremental QALYs and costs were estimated with bivariate multilevel models to allow for clustering and 
any correlation between the end points.133,134 For research objective 2, the correlation between the end 
points was recognised with Seemingly Unrelated Regression.142
For each research objective, incremental net monetary benefits (INBs) were estimated by valuing 
incremental QALYs at a threshold of £20,000 per QALY and subtracting from this the incremental costs. 
For each lifetime end point (costs, QALYs and INBs) we used bivariate regression analysis to recognise 
correlation between individuals’ costs and QALYs.77 Each of these regression models was applied to each 
of the 25 imputed data sets from the analysis of the 6-month end points (see Analysis of 6-month costs 
and consequences). We again combined the resultant estimates of the incremental effectiveness, costs and 
cost-effectiveness with Rubin’s rules. Hence, CIs for incremental costs, QALYs and INBs again recognised 
the within- and between-imputation variation. Cost-effectiveness acceptability curves (CEACs) were 
calculated by reporting the probability that each alternative was the most cost-effective (i.e. had a positive 
INB) at different levels of willingness to pay for a QALY gain (£0–50,000 per QALY gained). For research 
objective 2, analyses were repeated for the previously defined subgroups using stratified analyses.
TABLE 50 Mean (SD) costs (£) assumed for lifetime CEA for research objective 1
Source of costs
Measurement time 
frame
Combined 
neuro/general 
critical care 
unit
Dedicated 
neurocritical 
care unit
Assumptions: base case 
(sensitivity analysis)
Critical care admissionsa 6–12 months 207 (794) 398 (1602) 0 after 12 months
General medical admissionsb Discharge to 6 months 1410 (4828) 1478 (5093) For 3 years (for 5 years)
Outpatient visitsb Discharge to 6 months 337 (815) 303 (653) For 3 years (for 5/10 years)
Community careb Discharge to 6 months 176 (382) 188 (351) For 3 years (for 5/10 years)
SD, standard deviation.
a Source: RAIN study/CMP database, 12 month survivors.
b Source: Health Services Questionnaire, 6-month survivors.
TABLE 51 Mean (SD) costs (£) assumed for lifetime CEA for research objective 2
Source of costs
Measurement time 
frame
‘No or late’ 
transfer to 
neuroscience 
centre
‘Early’ 
transfer to 
neuroscience 
centre
Assumptions: base case 
(sensitivity analysis)
Critical care admissionsa 6–12 months 77 (647) 497 (2106) 0 after 12 months
General medical admissionsb Discharge to 6 months 1059 (3459) 1809 (4925) For 3 years (for 5 years)
Outpatient visitsb Discharge to 6 months 211 (359) 300 (472) For 3 years (for 5/10 years)
Community careb Discharge to 6 months 168 (361) 221 (326) For 3 years (for 5/10 years)
SD, standard deviation.
a RAIN study/CMP database, 12-month survivors.
b Health Services Questionnaire, 6-month survivors.
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Sensitivity analyses
The base case made the following assumptions that, a priori, were judged to be potentially important: 
(a) costs attributable to the TBI were only incurred for up to 3 years; (b) the differences in unit costs 
across care locations represented genuine differences in resource inputs across settings; (c) QOL from 
the 6-month follow-up applied irrespective of the actual time of follow-up (which ranged from 4 to 
10 months after initial presentation); (d) the QOL for survivors at 10 years post TBI was 15% of that of the 
general population; (e) transfers up to 18 hours following initial hospital presentation were categorised 
as ‘early’; (f) costs were normally distributed; (g) all-cause death rates applied from 6 months following 
hospital presentation; and (h) the IMPACT Lab risk prediction model was the most appropriate for case 
mix adjustment. The sensitivity analyses tested whether the base-case results were robust if the following 
alternative standpoints were taken:
(a) Extending the period over which costs were attributable to the acute TBI To test whether the results 
were sensitive to the duration over which costs were attributable to the acute TBI, we repeated the 
analysis assuming that (i) inpatient costs in general medical wards, outpatient and community costs 
were incurred for 5 years, and (ii) outpatient and community costs continued for up to 10 years.
(b) Using the same unit costs across all critical care locations We assumed that all critical care units in the 
RAIN study had the unit costs for combined neuro/general critical care units.
(c) Limiting use of QOL data from the RAIN study to those patients whose QOL was measured at close to 
6 months To assess the impact of only using QOL information from those patients in the RAIN study 
followed up between 150 and 220 days, we assumed that those patients who had QOL measured 
outside these time points had missing 6-month QOL and GOSE questionnaire data. We then applied a 
multiple imputation model to impute 6-month end points for these patients.
(d) Assuming that the QOL decrement observed in RAIN was maintained Some studies have suggested 
that the level of residual disability reported at 12 months is maintained for 5–7 years.75 Here we 
assumed that the decrement in QOL reported in the RAIN study at 6 months compared with the 
general population was maintained over the patients’ lifetime.
(e) Taking a stricter definition of ‘early’ transfer for research objective 2 To test whether or not the results 
for research objective 2 were robust to the arbitrary definition of ‘early’ transfer, we repeated the 
analyses defining an ‘early’ transfer as within 8 hours of hospital presentation and excluding patients 
transferred between 8 and 18 hours.
(f) Assuming that individual patient costs were drawn from a gamma distribution compared with a 
normal distribution The assumption that costs are normally distributed may not be plausible,143 so 
here we allow costs to follow a gamma distribution.144
(g) Using a Gompertz survival function To test whether the results were robust to the choice of 
extrapolation approach we applied age-stratified death rates using a Gompertz survival function.
(h) Undertaking risk adjustment with CRASH CT risk prediction model We reran the analytical models 
estimating incremental costs and QALYs using the variables from the CRASH CT model30 rather than 
the IMPACT Lab model35 to adjust for case mix.
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Results of the lifetime cost-effectiveness analysis
Base-case results for research objective 1
The base-case lifetime cost-effectiveness results for the first research objective are shown in Table 52. 
Dedicated neurocritical care units had higher mean lifetime QALYs at small additional mean costs, with 
an incremental cost-effectiveness ratio (ICER) of approximately £14,000 per QALY. At a ceiling ratio of 
£20,000 per QALY the INB was positive (approximately £1300). The CEAC suggested that at ceiling ratios 
of £20,000 to £30,000 per QALY, the probability that dedicated compared with combined neurocritical 
care units are cost-effective for patients following acute TBI, is around 60% (Figure 36).
TABLE 52 Lifetime cost-effectiveness: mean (SD) costs (£), QALYs and incremental net benefit for research objective 1
Parameter
Combined neuro/general 
critical care unit
Dedicated neurocritical 
care unit
Incremental effecta  
(95% CI)
Lifetime costs 31,007 (22,471) 34,909 (26,834) 3167 (–464 to 6797)
Lifetime QALYs 9.49 (6.52) 9.99 (6.56) 0.224 (–0.332 to 0.780)
Lifetime cost per QALY 14,128
INBb 1316 (–9857 to 12,489)
SD, standard deviation.
a Incremental effects are after case mix adjustment.
b INB can be calculated by following methods guidance and multiplying the mean QALY gain (or loss) by £20,000, and 
subtracting from this the incremental cost.
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FIGURE 36 Probability that care following acute TBI is more cost-effective in a dedicated neurocritical care unit vs a 
combined neuro/general critical care unit at alternative levels of willingness to pay for a QALY gain.
NIHR Journals Library www.journalslibrary.nihr.ac.uk
eValuatIOn Of tHe cOsts
102
Sensitivity analysis results for research objective 1
The sensitivity analysis shows that the base-case finding, that dedicated critical care units were on average 
more cost-effective, is robust to the alternative approaches taken (Figure 37). Where the higher mean 
QOL for the dedicated neurocritical compared with the combined units observed in the RAIN study 
is maintained for the lifetime, the positive incremental QALY and INB in favour of the dedicated units 
increased. Here, sampling uncertainty is greater than in the base case as this approach recognises more 
fully individual-level variation in QOL across the sample. However, as for the other scenarios considered, 
the point estimate of the INB is consistent with that reported in the base case.
–20,000
Incremental net benefits at £20,000 per QALY gain (dedicated neuro vs combined neuro/general)
–10,000 10,000 20,000 30,000 40,0000
CRASH risk adjustment
Gompertz survival
Gamma-distributed costs
Follow-up between 150 and 270 days
QoL from RAIN
Same unit cost across location
of care
Inpatient cost for 5 years, outpatient and
community costs up to 10 years
Inpatient, outpatient and
community costs up to 5 years
Base case
FIGURE 37 Sensitivity analyses reporting mean (95% CI) INB comparing care for dedicated neurocritical care units 
vs combined neuro/general critical care units. Vertical dashed line indicates incremental net benefits in the base case 
analysis. Solid vertical line indicates no difference in net monetary benefits between comparator groups.
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TABLE 53 Lifetime cost-effectiveness: mean (SD) costs (£), QALYs and incremental net benefit for research objective 2
Parameter
‘No or late’ transfer to 
neuroscience centre
‘Early’ transfer to 
neuroscience centre
Incremental effecta  
(95% CI)
Lifetime costs 16,105 (15,041) 36,422 (28,030) 19,209 (15,234 to 23,184)
Lifetime QALYs 7.19 (6.88) 11.55 (6.43) 1.795 (1.049 to 2.541)
Lifetime cost per QALY 10,704
INBb 16,682 (2574 to 30,791)
SD, standard deviation.
a Incremental effects are after case mix adjustment.
b INB can be calculated by following methods guidance and multiplying the mean QALY gain (or loss) by £20,000, and 
subtracting from this the incremental cost.
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FIGURE 38 Probability that ‘early’ vs ‘no or late’ transfer is cost-effective at alternative levels of willingness to pay for a 
QALY gain.
Base-case results for research objective 2
Table 53 reports the base-case results for the lifetime CEA comparing ‘early’ transfer compared with ‘no or 
late’ transfer to a neuroscience centre.
The results show that, after adjusting for differences in observed baseline characteristics the ‘early’ transfer 
group reported higher lifetime QALYs, at an additional cost, with an ICER of approximately £11,000 per 
QALY. The CEAC suggested that at the standard thresholds of £20,000–30,000 per QALY, the probability 
that early transfer was cost-effective is close to 100% (Figure 38).
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Sensitivity analysis results for research objective 2
The sensitivity analysis shows that the base-case cost-effectiveness results are relatively robust to the 
alternative methodological standpoints considered; the INB is broadly similar across scenarios (Figure 39). 
The additional scenario considered for this objective was to limit the sample for the ‘early’ transfer group 
to those patients who were transferred within 8 hours of presentation. Tightening the criteria for ‘early’ 
transfer led to slightly higher incremental QALYs and increased the cost-effectiveness of ‘early’ transfer.
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Incremental net benefits at £20,000 per QALY gain (early vs no/late transfer)
–10,000 10,000 20,000 30,000 40,000 50,000 60,0000
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Gompertz survival
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Follow-up between 150 and 270 days
QoL from RAIN
Same unit cost across location
of care
Inpatient cost for 5 years, outpatient and
community costs up to 10 years
Inpatient, outpatient and
community costs up to 5 years
Base case
FIGURE 39 Sensitivity analyses reporting mean (95% CI) INB comparing care following TBI for ‘early’ vs ‘no or late’ 
transfer to a neuroscience centre. Vertical dashed line indicates incremental net benefits in the base case analysis. Solid 
vertical line indicates no difference in net monetary benefits between comparator groups.
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Subgroup analysis results for research objective 2
The results for the subgroup analysis according to age group suggest that ‘early’ transfer has a very low 
probability of being cost-effective for patients aged > 70 years (Figure 40).
The probability that ‘early’ transfer is cost-effective is lower for the subgroup of patients defined as 
without major extracranial injury. Here the probability that ‘early’ transfer is cost-effective is around 60% 
compared with 100% for the subgroup defined as having a major extracranial injury (Figure 41).
‘Early’ transfer appears most cost-effective for patients with severe TBI according to the baseline GCS 
score; the probability that ‘early’ transfer is relatively cost-effective is between 60% and 80% at ceiling 
ratios of between £20,000 and £30,000 per QALY (Figure 42).
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FIGURE 40 Probability that ‘early’ vs ‘no or late’ transfer is cost-effective, by age group, at alternative levels of 
willingness to pay for a QALY gain.
FIGURE 41 Probability that ‘early’ vs ‘no or late’ transfer is cost-effective, by presence or absence of major extracranial 
injury, at alternative levels of willingness to pay for a QALY gain.
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Discussion
Principal findings
This aspect of the study had two research objectives. The first of these was to compare the relative costs, 
consequences and cost-effectiveness of management in a dedicated neurocritical care unit compared 
with a combined neuro/general critical care unit for critically ill adult patients with acute TBI who present 
at, or are transferred to, a neuroscience centre. The second objective was to compare the relative 
costs, consequences and cost-effectiveness of ‘early’ (within 18 hours of hospital presentation) transfer 
compared with no transfer or ‘late’ (after 24 hours) transfer, for critically ill patients with acute TBI who 
initially present at a non-neuroscience centre and do not require surgery for evacuation of a mass lesion 
within 24 hours. The main findings are that, following case mix adjustment using the variables from 
the IMPACT Lab model,35 dedicated neurocritical care units lead to higher mean QOL than combined 
units but considerable statistical uncertainty surrounds this result; and dedicated units are associated 
with additional costs. The cost-effectiveness results suggest that it is highly uncertain that dedicated 
neurocritical care units are more cost-effective than combined units; the probability that dedicated units 
are more cost-effective is around 60%. For patients presenting at non-neuroscience centres who do not 
require immediate neurosurgery, we find that, after risk adjustment, early transfer is associated with gains 
in survival, and improvements in mean QOL for survivors. Although early transfer is also associated with 
higher costs, these appear to be justified by the relatively large QALY gains, with an incremental cost per 
QALY of around £11,000. Hence, at the £20,000 per QALY threshold typically used by NICE, the probability 
that ‘early’ transfer is cost-effective is close to 100%. Although this finding is robust to all the alternative 
assumptions considered, the potential role for unobserved confounding must be recognised.
Meaning of the study and comparison with previous studies
This study extends the previous literature on the relative costs and consequences of alternative locations 
of neurocritical care.107–109 The finding that there is, on average, an improvement in risk-adjusted QOL 
if patients with acute TBI are managed in a dedicated neurocritical care unit rather than a combined 
neuro/general critical care unit has several possible explanations. First, a dedicated multidisciplinary team 
may provide more effective and immediate rehabilitation as part of acute care; they may also improve 
access to specialised neurorehabilitation after discharge from the unit, which can lead to improved 
outcomes.145 Second, dedicated units may provide more aggressive monitoring and management, which 
have been suggested to reduce morbidity.16 Although concerns have also been raised that more invasive 
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FIGURE 42 Probability that ‘early’ vs ‘no or late’ transfer is cost-effective, by baseline level of TBI severity, at alternative 
levels of willingness to pay for a QALY gain.
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approaches may increase mortality,116 the RAIN study did not find any differences in mortality at 6 months 
after TBI between patients managed in dedicated and combined units. A third explanation is that the 
differences in the mean QOL between the settings may simply reflect chance variation, and indeed the 
CIs include a difference of zero, and so the null hypothesis that there is no difference in QOL between the 
settings cannot be rejected. That said, we followed standard methods guidance for CEA, and the lifetime 
analysis incorporated the non-significant difference in the mean QOL observed at 6 months. We also 
made the conservative assumption that the gain in mean QOL for the dedicated neurocritical care units 
attenuated over time. Fourth, the improvement in average QOL for TBI patients managed in dedicated 
neurocritical care units rather than combined units could reflect unmeasured confounding between 
the settings. For this comparison, the baseline characteristics of the patients were similar between the 
groups. However, the mean improvement in QOL in favour of dedicated units is fairly small, and could 
be overturned if a factor associated with poor prognosis was somewhat more prevalent in the dedicated 
compared with combined units.
In this context, it is useful to consider the differences in patterns of care between specialist neurocritical 
care units and neuro/general critical care units that were perceived to exist at the study outset. Then, 
the published literature suggested there were between-unit differences in the ability to deliver protocol 
driven critical care according to expert guidelines.13 However, since then, the dissemination of perceived 
best practice (e.g. through NCCNet) may have reduced clinical practice variation among neuroscience 
centres. This may explain why any differences observed in costs and consequences according to dedicated 
compared with combined neuro/general critical care are small.
The finding that early transfer to a neuroscience centre for TBI patients appears cost-effective is driven by 
the gains in survival and QOL observed in the RAIN study at 6 months after hospital presentation. Previous 
work has found that there are benefits from early transfer for patients who have a space-occupying 
haematoma with worsening mass effect,115 but this study extends the evidence base to other critically ill 
patients with TBI. Previous research raised conflicting hypotheses, with some studies suggesting that, for 
non-surgical patients, early transfer and subsequently more aggressive management may lead to increase 
risks and costs that outweigh any gains,119 whereas other studies suggested that, delayed transfer may lead 
to worse outcomes.120 In the RAIN study, only a small proportion (6%) of the ‘no or late’ transfer group 
had a delayed transfer. Hence, any detrimental effects from delayed transfer would be unlikely to explain 
the findings, and the main contrast is between an intention to transfer the TBI patient to a neuroscience 
centre compared with continuing management at a non-neuroscience centre.
The definition of an ‘early’ transfer is clearly arbitrary, and may differ across contexts. For the RAIN study 
it was judged important to define the time point at which an ‘early’ transfer was made according to what 
was broadly appropriate for the NHS context. Hence, in advance of any analysis, the RAIN Study Steering 
Group defined an ‘early’ transfer as being within 18 hours of hospital presentation. This pragmatic choice 
of cut-off time recognised that there may be several alternative care pathways that patients may take from 
initial hospital presentation to transfer to a neuroscience centre. The chosen cut-off time also recognised 
that even if an early decision to transfer is made, there may be local logistical barriers to an immediate 
transfer. Hence, an 18 hours time point was chosen to be conservative and included all admissions where 
there was ‘an intention’ to made a rapid transfer. A potential concern is that the relative cost-effectiveness 
of an ‘early’ transfer policy could be highly sensitive to the cut-off point, and indeed previous evidence 
from trauma networks encourages a 4-hour time window, but for neurosurgical interventions.101 Our 
sensitivity analysis suggested that applying an 8-hour rather than an 18 hours time window from hospital 
presentation, reduced the incremental cost per QALY for early transfer from £11,000 (base case) to £9000. 
Hence, the overall finding that ‘early’ transfer appears cost-effective is not sensitive to the choice of 
time threshold.
Our evaluation considered the relative costs and consequences of ‘early’ transfer according to alternative 
pre-defined subgroup analyses. The results suggest that ‘early’ transfer is relatively cost-effective, both for 
patients defined as having mild or moderate TBI (GCS score of 9–14) as well as for patients with severe TBI 
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(GCS score of 3–8) at admission. Patients aged > 70 years have a higher odds ratio of death in the ‘early’ 
transfer group. For this subgroup the most cost-effective strategy appears to be to keep those patients 
presenting at a non-neuroscience centre within that setting. The effect of ‘early’ transfer on mortality 
appears to differ according to whether or not patients have a major extracranial injury. We observed 
large and significant gains from ‘early’ transfer in the subgroup of patients with major extracranial 
injury. However, for patients without a major extracranial injury, the improvements in mortality and QOL 
following ‘early’ transfer did not reach statistical significance, and we are, hence, unable to conclude that 
‘early’ transfer of patients in this subgroup is cost-effective.
The relative gains from ‘early’ transfer in the subgroup with major extracranial injury are somewhat 
counterintuitive as it might be expected that the risks of physiological derangement associated with 
transfer would be greater in this subgroup. One possible explanation is that the presence of significant 
extracranial injury may represent a marker of a disease mechanism or injury type that predisposes patients 
to develop the pathophysiological derangements (such as severe intracranial hypertension) that most 
benefit from the specialist critical care available at a neuroscience centre. For example, high-speed RTAs 
may not only tend to cause more extracranial injury, but also may predispose to traumatic axonal injury 
and subdural haemorrhage, and enhance the benefits of specialist critical care. Another explanation is 
that the differential gains may reflect the broad definition of major extracranial injury adopted in the RAIN 
study. Specifically, patients who would not have met a more rigorous definition of major extracranial injury 
may have been misclassified as having significant extracranial injury. These patients may be at relatively 
low risk of death following transfer. This could have been coupled with the retention of unstable patients 
with truly significant extracranial injury in referring hospitals, which might be undetected by the RAIN 
study, as we had no metric of the severity of extracranial trauma. The net effect of such misclassification 
and inadequate severity characterisation may be to overstate the cost-effectiveness of early transfer in 
those defined as having major extracranial injury and understate the gains in the subgroup defined as not 
have major extracranial injury. A final explanation is that there may be residual confounding in the major 
extracranial injury stratum. This subgroup may have included patients who, according to unmeasured 
prognostic factors, were ‘too unstable for transfer’. Further research would ideally record such potential 
confounders and use them as a basis for excluding such patients from the decision problem. That is, the 
population of interest should only include patient groups where there is equipoise as to the costs and 
benefits of ‘early’ transfer.
Strengths and weaknesses
Lifetime CEAs requires assumptions to be made about the long-term mortality, cost and QOL following 
alternative interventions – in this case, care locations. As the RAIN study was only designed to measure 
survival and QOL for all eligible patients up to 6 months, we carefully considered alternative ways of 
extrapolating from these data to the lifetime. There is no consensus from the literature on the size or the 
duration of the impact that an acute TBI has on mortality, QOL or costs. More specifically, estimates from 
the RAIN study provided the strongest basis for projecting the relative effects of alternative care locations 
on mortality, QOL and health and personal social service costs. Hence, in the base case, information from 
the RAIN study was used to support assumptions about the long-term prognosis for patients following a 
TBI, according to the location of critical care.
A potential issue raised by the results of the RAIN study is that few deaths were reported between 30 days 
and 1 year after hospital presentation; in general, the death rates reported were either similar to or lower 
than the age-/sex-matched general population. Rather, than just choosing the extrapolation approach 
that appeared to best fit the observed data, we considered which extrapolation approach would be most 
plausible according to the previous literature. Other studies have reported excess deaths for patients at 
5–7 years following a TBI,146–149 whereas a more relevant study that included patients admitted to critical 
care following TBI observed only one death between 6 and 12 months out of over 400 survivors at 
6 months.73 In the base-case analysis we judged that the most reasonable extrapolation approach was 
to apply all-cause death rates from 6 months onwards. Then, to examine whether the results would be 
robust to an alternative approach we ran sensitivity analyses in which we applied the most plausible and 
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conservative of the parametric extrapolations (using the Gompertz function). This sensitivity analysis led to 
small differences in the ICER – for example, for research objective 2, the base-case ICER reduced marginally 
from £10,704 to £10,691. More, generally, the sensitivity analyses suggested that the findings did not 
appear to change substantively when alternative assumptions were made about the time period over 
which costs attributable to the TBI were applied, or whether the decrement in QOL observed at 6 months 
was maintained over the lifetime.
Although the RAIN study has added to the literature on alternative care pathways following TBI, it does 
have some limitations. First, the RAIN study only measured costs and outcomes for up to 6 months; 
however, the sensitivity analysis suggests that results appear robust to the choice of alternative 
assumptions made in extrapolating the data over the lifetime. Second, the study followed methodological 
guidance and took a health and personal social services perspective, and so excluded any broader societal 
costs, for example from productivity losses or ongoing costs of rehabilitation or nursing home care borne 
by the patient. Third, about half of patients eligible for follow-up at 6 months were missing data on health 
service use and QOL, and these data were not missing completely at random. We tackled this issue by 
using state-of-the-art approaches to handling missing data, in that we used multiple imputation models 
that respected the hierarchical structure of the data. That said, such approaches assume that the data 
are missing conditional on baseline factors and other end point and process measures that are observed, 
hence if missingness is driven by unobserved prognostic factors this could have led to biased estimates.
Finally, the major concern in any such non-randomised comparison is residual confounding. Although 
our sensitivity analysis that used variables from the CRASH risk prediction model suggested that the 
results were robust to the choice of risk adjustment method, unobserved confounders may explain the 
differences in costs and consequences between the comparator groups. Specifically, the comparison of 
observed baseline characteristics between the ‘early’ and ‘no or late’ transfer groups suggests that the 
patients transferred early were of much less severe case mix according to observed factors. This raises the 
concern that unobserved confounders associated with worse outcome may also be more prevalent in the 
‘no or late’ transfer group. Further research is required to consider alternative approaches for handling the 
potential impact of unobserved confounders. Such approaches may include collecting data on additional 
baseline measures anticipated to be important, considering more flexible risk prediction and matching 
methods, formal sensitivity analyses that investigate whether the findings are robust to unobserved 
confounding, and alternative approaches as instrumental variable estimation that purport to handle 
unobserved confounding.
Summary
In summary, this evaluation finds that for critically ill patients with acute TBI who present at, or are 
transferred to, a neuroscience centre, management in a dedicated neurocritical care unit rather than a 
combined neuro/general critical care unit is associated with small gains in QALYs, at additional costs, but it 
remains highly uncertain whether dedicated units are more cost-effective. Overall, for adult patients with 
acute TBI who present at a non-neuroscience centre and do not require neurosurgery within 24 hours, 
‘early’ transfer appears more cost-effective than ‘no or late’ transfer to a neuroscience centre, after risk 
adjustment. However, further research is required that considers alternative approaches for handling 
differences in baseline characteristics between settings. Such research could draw on the framework 
and data presented in the RAIN study to address alternative comparisons, for example contrasting 
management in high-volume settings with management in low-volume settings, or comparing settings 
with relatively high proportions of patients with TBI with those with relatively low proportions.
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Chapter 7 Conclusions
Implications for health care
The risk prediction models evaluated in the RAIN study demonstrated sufficient statistical performance 
to support their use in research studies, for example as a basis for stratification in RCTs, but fell some 
way below the level that would be required to recommend their use to guide individual patient decision-
making, particularly where this is likely to be of a life-or-death nature, for example withdrawal of life-
sustaining therapy. The lack of calibration, particularly for models predicting unfavourable outcome at 
6 months, also currently limits their utility as a tool for communication; however, once recalibrated or 
improved, and if used appropriately, there may be scope for the use of risk predictions at the individual 
patient level both to aid communication between health-care providers and in communicating risks to 
patients and their families.
The RAIN study provides the most robust evidence to date supporting the current NICE clinical guideline 
that all patients with severe TBI (GCS score of 3–8) would benefit from transfer to a neuroscience centre, 
regardless of their need for neurosurgery.11 Indeed, the results of the RAIN study suggest that this guideline 
should potentially also extend to patients with mild or moderate TBI (GCS score of 9–14) requiring critical 
care. The only exception to this was in patients aged > 70 years, for whom transfer was associated with a 
(non-significant) increased risk of death, and the most cost-effective strategy was management within the 
hospital at which they originally presented. However, if such a strategy is to be implemented then it will be 
necessary to review neurocritical care capacity and resourcing at neuroscience centres to ensure sufficient 
capacity is available to meet the additional workload this would entail.
Although the results of the RAIN study suggest that, within a neuroscience centre, management in 
a dedicated neurocritical care unit may be cost-effective compared with management in a combined 
neuro/general critical care unit, there was considerable statistical uncertainty and these results are not 
sufficiently strong to warrant any major reconfiguration of existing neurocritical care services.
In terms of public health implications, the high proportion of critical care admissions of patients with 
TBI associated with confirmed or suspected intoxication reported in the RAIN study, and subsequent 
substantial costs of care, reinforce the importance of public health messages and interventions to attempt 
to reduce this health-care burden.
Pre-hospital data reported in the RAIN study, particularly regarding neurological dysfunction, were often 
of poor quality; GCS score was documented for around three-quarters of patients, and pupil reactivity for 
only half of patients. Better systems are required to improve the routine documentation of pre-hospital 
data and ensure these form part of the permanent patient record.
Recommendations for future research
Recommendation 1: Further research should be undertaken to explore 
the potential to improve on the current risk prediction models for acute 
traumatic brain injury
Although the existing risk prediction models demonstrated acceptable discrimination for mortality at 
6 months and, less so, for unfavourable outcome at 6 months, there appears to be considerable scope 
for further improvement. As a minimum, the risk prediction models for unfavourable outcome all require 
recalibration for use in a UK critical care setting. However, additional areas that may be explored, either 
within the RAIN study data set, by data linkage (e.g. with the TARN database), and/or by new prospective 
NIHR Journals Library www.journalslibrary.nihr.ac.uk
cOnclusIOns
112
data collection include: consideration of mechanism of injury; incorporation of pupil size in addition to 
reactivity; addressing the severity and/or site(s) of major extracranial injury; incorporating additional data 
on the physiological response to injury; and consideration of genetic factors in the host response to injury. 
Development of new risk prediction models may consider both classical statistical methods and machine 
learning approaches, such as artificial neural networks. The results of the RAIN study should be revisited in 
light of any improvements to risk modelling. A new risk prediction model may also be incorporated into 
a web-based prediction tool, as has been done for the CRASH and IMPACT models, to facilitate its use 
in practice.
Recommendation 2: Further research is required to consider alternative 
approaches for handling the potential impact of unobserved confounders 
on the RAIN study results
In addition to improving the risk prediction models used to underpin the non-randomised comparisons, 
alternative methodological approaches to complement risk adjustment include matching methods, such 
as propensity matching or GenMatch.150 Such approaches would be complementary to the risk adjustment 
methods described, in that matching could be used to pre-process the RAIN study data before applying 
risk adjustment.151 To consider unobserved confounding, future research could also be undertaken using 
instrumental variable estimation152 and formal sensitivity analyses that investigate whether the findings are 
robust to unobserved confounding.153
Recommendation 3: Options should be explored for continuing to 
follow up the RAIN study cohort to obtain data on long-term mortality, 
functional outcomes and quality of life
The RAIN study identified substantial gaps and discordance in the literature regarding the long-term 
outcomes of patients with acute TBI. The RAIN study database provides a large, representative cohort 
of critically ill adult patients following acute TBI. Continuing follow-up of the RAIN study cohort would 
provide much valuable information, both to strengthen the lifetime CEA and to address additional issues, 
such as accelerated late cognitive decline. However, this would require changes to the current research 
ethics and governance approvals for the RAIN study and, therefore, these should be addressed urgently.
Recommendation 4: Further research is required to better understand 
the alternative pathways of care for patients following acute TBI and the 
impact of these on costs and outcomes
The RAIN study addressed certain specific aspects of the alternative pathways of care for critically ill 
adult patients following acute TBI and many other aspects remain unexplored. The simple comparison 
of dedicated neurocritical care units compared with combined neuro/general critical care units may 
be expanded to model a volume–outcome relationship with the absolute number of patients with TBI 
admitted or a dose–response relationship with the proportion of admissions that are patients with TBI to 
any given neurocritical care unit (or neurosciences patients more generally), or to give consideration to 
variation across centres in the use of treatment protocols or particular interventions. Further analyses for 
patients presenting outside neuroscience centres may consider the effect of time to transfer on costs and 
outcomes – both for patients who require neurosurgery (for whom current guidelines often recommend 
transfer within 4 hours101) and those who do not. An alternative model of service delivery, not currently 
implemented in most regions of the UK, is bypass of local hospitals to transport patients with significant 
TBI directly to a neuroscience centre. A feasibility study for a cluster RCT on this intervention – the Head 
Injury Transportation Straight to Neurosurgery (HITS-NS) trial (www.hta.ac.uk/project/2223.asp) – is 
currently ongoing.
Recommendation 5: Further research should explore equity of access to 
post-critical care support for patients following acute traumatic brain injury
Improved access to specialist neurorehabilitation services has been identified as a potential driver of better 
outcomes reported from neuroscience centres.145 However, provision of and access to such services varies 
and questionnaire responses in the RAIN study indicated much dissatisfaction with the continuity of care 
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and provision of rehabilitation and follow-up after discharge from critical care. Future research should 
identify the regional and local variation in provision of post-critical care support for patients following 
acute TBI and consider the impact of such provision on subsequent recovery.
Finally, the RAIN study should inform all future research studies in the neurocritical care of adult patients 
following acute TBI through provision of reliable data for sample size calculations and exploratory analyses, 
and informing the choice of risk adjustment methods and data set design.
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Appendix 1 Search strategy for updated 
systematic review of risk prediction models
A dapted from Perel et al.9
EMBASE (Ovid interface)
1. traumatic brain injury.mp. or exp traumatic brain injury / or exp *traumatic brain injury / or brain 
injur$.ti. or exp craniocerebral trauma /
2. (brain$ or coma$ or conscious$ or cranio$ or skull$).ti. 
3. 1 and 2
4. case control study.mp. or (cohort study or cohort analysis).mp. or exp follow-up studies / or exp case 
control study / or follow-up studies.mp. or systematic review.mp. or trial.mp. or randomi$.mp. or 
(prognos$ or predict$).mp.
5. 3 and 4
6. limit 5 to yr=“2006 - 2009”
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PROJECT SUMMARY 
NHS guidelines recommend that all patients with acute traumatic brain injury (TBI) 
should be treated within a specialist neuroscience centre. Despite these guidelines, 
many patients are not. Reasons for this may include initial location post-trauma, bed 
availability, and local variation partly due to the clinical assessment of the severity of 
the TBI and likely prognosis for the patient. Although the guidelines are based on the 
best available research evidence, this research is not sufficiently robust and is only 
partly based on data from the UK. For example, the question as to what level of 
severity of TBI warrants transfer (patients may be either not severe enough, or too 
severe, to warrant transfer) has not been fully addressed. An accurate risk prediction 
model, validated on a large number of NHS patients with TBI, could be used both to 
provide sufficient robust evidence to address this issue and to ensure standard clinical 
assessment of severity. 
This project addresses these two objectives: to validate risk models for TBI and to 
compare the outcomes and costs of care for patients by location of definitive critical 
care. The project consists of four phases: 
Phase I (months 1-4): A systematic review will be used to identify suitable risk models 
and the data required for their application. 
Phase II (months 5-29): A prospective cohort study will be undertaken in neurocritical 
care units, general critical care units within a neuroscience centre, and general critical 
care units outside a neuroscience centre to collect data on consecutive adult patients 
admitted following TBI. 
Phase III (months 25-32): The risk models will be validated in the study data, and the 
strengths and weaknesses of each model will be assessed. If required, the risk models 
will be recalibrated. 
Phase IV (months 19-36): The cost-effectiveness of managing patients with TBI in 
different critical care settings will be evaluated in an economic model. 
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RESEARCH OBJECTIVES 
The primary aims of this work are to validate risk prediction models for acute TBI in 
the setting of neurocritical care in the NHS, and to use these models to evaluate the 
optimum location and comparative costs of neurocritical care in the NHS. 
Specific, detailed objectives to achieve these aims are: 
1. To identify, from the literature, the existing risk prediction models for acute TBI 
that are most likely to be applicable to a neurocritical care setting, and identify 
a full list of variables required in order to be able to calculate these models. 
2. To collect complete, valid and reliable data for the variables identified above for 
consecutive adult admissions with TBI to dedicated neurocritical care units 
within a neuroscience centre, general critical care units within a neuroscience 
centre and general critical care units outside a neuroscience centre within the 
NHS. 
3. To undertake a prospective, external validation of existing models for adult 
patients with TBI admitted to critical care, to identify the strengths and 
weaknesses of each model, and, if possible, to identify the best model to use 
for risk adjustment in this setting. 
4. To describe and compare adjusted outcomes for adult admissions with TBI from 
dedicated neurocritical care units within a neuroscience centre, general critical 
care units within a neuroscience centre and general critical care units outside a 
neuroscience centre within the NHS. 
5. To compare the cost-effectiveness of care for patients with TBI between 
dedicated neurocritical care units within a neuroscience centre, general critical 
care units within a neuroscience centre and general critical care units outside a 
neuroscience centre within the NHS. 
6. To make recommendations for policy and practice within the NHS. 
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BACKGROUND 
Risk prediction in adult, general critical care 
Risk prediction models have been in established use in adult, general critical care 
units for over 25 years, since the publication of the original Acute Physiology And 
Chronic Health Evaluation (APACHE) model in 1981.1 In the UK, the first large-scale 
validation of a risk prediction model was the Intensive Care Society’s APACHE II Study 
in Britain and Ireland (1987–1989).2;3 This study produced recalibrated coefficients for 
the APACHE II model, and led, in 1994, to the formation of the Intensive Care 
National Audit & Research Centre (ICNARC) and the Case Mix Programme, the 
national comparative audit of patient outcome in adult, general critical care units in 
England, Wales and Northern Ireland. ICNARC has continued to pioneer developments 
in risk prediction in the Case Mix Programme, most recently through the validation 
and recalibration of a number of general risk prediction models4 and subsequent 
development of a new model, the ICNARC model.5 
Risk prediction in neurocritical care – why not use a general model? 
Unlike adult, general critical care, no data are routinely collected in the NHS for risk-
adjusted comparison of outcomes from neurocritical care. Consequently, four 
dedicated neurocritical care units currently participate in the Case Mix Programme. 
However, there are significant limitations to using models developed and validated for 
general critical care for patients receiving neurocritical care. Using a spectrum of 
measures for calibration and discrimination, risk prediction models, successfully 
developed and validated for adult admissions to general critical care units showed 
significant departure from perfect calibration in admissions with head injuries to adult, 
general and dedicated neurocritical care units.6 The inclusion and handling of variables 
of specific prognostic importance in TBI is often poor.6 For example, the APACHE II 
model assumes that any patient that is sedated for the entire first 24 hours in the 
critical care unit is deemed neurologically normal, which has previously led to 
suggestions that pre-sedation values of the Glasgow Coma Scale (GCS) should be 
used for these patients.7 The only general model to take any account of changes 
detected on computed tomography (CT) scan is the Mortality Prediction Model (MPM) 
II, and the inclusion of CT information in this model is limited to the presence of an 
intracranial mass effect. Furthermore, all risk prediction models for adult, general 
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critical care use an outcome of mortality at discharge from acute hospital, which is not 
considered adequate for neurocritical care where longer term (e.g. six-month) 
mortality and morbidity are more valid outcomes.8 
Risk prediction in traumatic brain injury 
A number of specific models for TBI exist, however a recent systematic review by the 
Cochrane Injuries Group found that most models are limited by being based on small 
samples of patients, having poor methodology, and rarely being validated on external 
populations.9 Of 102 models for TBI identified in the review, only two models by 
Hukkelhoven et al10 (one for mortality and one for unfavourable outcome at six 
months) met minimal criteria of being developed using appropriate methods on data 
from at least 500 patients in multiple centres, and validated in an external population. 
These models were based on 2,269 patients with moderate or severe TBI (GCS ≤ 12) 
enrolled in two randomised controlled trials (RCTs), one in the United States and 
Canada and the other in Europe, Israel and Australia. The model for unfavourable 
outcome at six months was validated in an observational database of 796 patients 
with moderate or severe TBI in 55 European countries from the core data survey of 
the European Brain Injury Consortium (EBIC). The model for six-month mortality was 
validated in the EBIC data and also in an observational database of 746 patients with 
non-penetrating severe TBI (GCS ≤ 8) in four US centres from the Trauma Coma Data 
Bank (TCDB). 
The authors of the systematic review have also gone on to develop new models for 
14-day mortality and unfavourable outcomes at six months aimed at addressing the 
shortcomings identified in their review.11 Separate models were derived using only 
‘basic’ (demographic and clinical) variables and incorporating additional CT variables, 
and different models were reported for high-income countries and for low- and 
middle-income countries. These models were based on 10,008 patients with TBI (GCS 
≤ 14) in the Corticosteroid Randomisation After Significant Head injury (CRASH) 
RCT.12;13 Of these, 2,482 patients were recruited from high-income countries, 
including 1,391 patients from 45 centres in the UK. The models were validated in the 
International Mission for Prognosis And Clinical Trial (IMPACT) database,14;15 a 
database combining data from 9,205 patients with moderate or severe TBI from eight 
RCTs and three observational studies (including the development and validation data 
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from the Hukkelhoven models). The authors acknowledge that “further prospective 
validation in independent cohorts is needed to strengthen the generalisability of the 
models.” 
Further models for TBI have recently been developed using the IMPACT database and 
validated in CRASH data.16 Three models of increasing complexity were presented for 
both mortality and unfavourable outcome at 6 months. The ‘core’ model consists of 
weights for age, GCS motor score and pupil reactivity. The ‘extended’ model 
additionally incorporates hypoxia, hypotension, CT classification, traumatic 
subarachnoid haemorrhage and epidural haematoma. Finally, the ‘lab’ model also 
incorporates weights for glucose and haemoglobin. 
While these recent developments in risk prediction models for TBI indicate potentially 
significant improvements over previously available models, these models still have 
limitations regarding their external validity (generalisability) for use in evaluating 
neurocritical care of patients with TBI in the NHS.17 All these models were developed 
using some or all data from RCTs. Even when trials are pragmatic, as was the case for 
the CRASH trial, using data from an RCT to develop a prognostic model may impact 
on generalisability through self-selection of centres to participate in the trial, selection 
of patients enrolled in the trial, and the potential for all patients enrolled in a trial (in 
both active and control arms) to receive a better standard of care than usual.18 Much 
of the data used in developing and validating these models is old. Only the CRASH 
database contains data from within the last 10 years, with the Hukkelhoven models 
based on data from the early 1990s, and the IMPACT data collected between 1984 
and 1997. Models based on data from multiple sources are limited by differences in 
definitions of variables, timings of measurements, and inclusion criteria between the 
different data sources. The CRASH models for high-income countries are clearly of the 
most direct relevance to UK practice, as over half of all patients recruited to CRASH 
from high-income countries came from centres in the UK. However, in the CRASH trial 
as a whole, only 50% of patients were admitted to critical care.12 This figure may have 
been higher within the UK but, nonetheless, applying these models to a critical care 
setting may introduce selection bias and invalidate the model’s accuracy. It is clear 
that all these models require further prospective validation, and potentially 
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recalibration, before they can be applied with confidence for research and audit in 
neurocritical care in the NHS. 
Delivery of neurocritical care for traumatic brain injury in the NHS 
In the NHS, adult patients with TBI are rarely managed by a single service; they are 
managed by a succession of services from first contact to definitive critical care, 
definitive critical care not always being provided in a dedicated neurocritical care unit. 
Despite guidelines recommending that all patients with severe TBI be treated within a 
neuroscience centre,19 many (particularly those without surgical lesions) are currently 
neither treated in nor transferred to one. A combination of geography, bed 
availability, local variation and clinical assessment of prognosis can often determine 
the location of definitive critical care for an adult patient with TBI. The Neurocritical 
Care Stakeholder Group, established to offer expert advice to Department of Health 
and Commissioners, indicated in their audit report that, within the NHS, only 67% of 
beds ring-fenced for neurocritical care were in dedicated neurocritical care units and 
that neurocritical care unit occupancy rates exceeded 90% (especially for Level 3 
beds).20 Most neurocritical care for adult patients with TBI was delivered either in 
dedicated neurocritical care units (42%) or in general critical care units within a 
neuroscience centre (35%). However, despite clear guidelines and the progressive 
regionalisation of neurosurgical care since 1948, 23% of patients with TBI were 
treated in general critical care units outside a neuroscience centre. Local critical care 
consultant opinion indicated at least 83% of these patients required transfer to a 
neuroscience centre. No data were available, or are routinely collected, within the NHS 
for risk-adjusted comparisons. 
Where adult patients with TBI should be optimally treated is an important question for 
the NHS, both in terms of outcomes and costs. Belief and limited evidence has 
underpinned the establishment, and continuing expansion, of dedicated, neurocritical 
care facilities in the UK21;22 but no formal evaluation has been undertaken. Recent 
research has suggested benefit from managing severe head injury in specialist 
centres,23 however this is acknowledged to be inconclusive due to lack of adjustment 
for all known confounders and the use of an unvalidated risk prediction model. It also 
does not address the issue of general versus specialist critical care units within 
neuroscience centres. Research is required to determine which location(s) for 
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neurocritical care are associated with improved outcomes for adult patients with TBI, 
particularly for those who do not require surgical intervention (external ventricular 
drain and/or craniotomy/craniectomy), a NICE recommendation for future research in 
their recently revised guideline.19 A key issue for policy-makers is whether the 
additional initial costs of more specialised care are justified by subsequent reductions 
in morbidity costs and/or improvements in patient outcomes. While conventional RCT 
methodology may be impractical in this setting, the presence of variation in the way 
services are organised and delivered can allow them to be compared using 
observational methods. This is only possible if a valid, reliable, appropriate and 
accurate risk prediction model exists. 
At its inaugural meeting in February 2007, the newly formed Neurocritical Care 
Network (NCCNet), a network of units and staff providing neurocritical care to patients 
in both dedicated and general units, identified pursuing funding and establishing a risk 
prediction model to investigate and evaluate the location and outcomes of care for 
adult patients with TBI as their first, and top, priority. It was recognised that this aim 
could only be achieved through validation of an accurate risk prediction model for 
adult patients with TBI. The Society of British Neurological Surgeons, the 
Neuroanaesthesia Society of Great Britain and Ireland, the Intensive Care Society and 
the Association of British Neurologists, through the auspices of the Neurocritical Care 
Stakeholder Group, are all supportive of this. 
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STUDY DESIGN 
The project will be divided into four phases, detailed below: 
 Phase I: Identification of suitable models and definitions of dataset (objective 1; 
months 1–4) 
 Phase II: Data collection and data validation (objective 2; months 5–29) 
 Phase III: Validation of risk prediction models (objective 3; months 25–32) 
 Phase IV: Evaluation of location of neurocritical care (objectives 4–6; months 19–
36) 
The flow of patients through the project is shown in Appendix 1. 
Phase I: Identification of suitable models and definitions of dataset 
The systematic review of prognostic models for TBI9 will be updated by applying the 
same search strategy as used by the Cochrane Injuries Group (Appendix 2) to identify 
any new publications since 2005 meeting the inclusion criteria. Experts in the field, 
including the CRASH and IMPACT groups, will be approached to identify additional 
work, published or ongoing, that may be of relevance. We already have established 
research links with individuals from both the CRASH and IMPACT investigators. The 
RAIN Steering Group will review the models identified from the published systematic 
review and updated searches to select the most appropriate models for validation in 
the neurocritical care setting. These are likely to include the CRASH models for high-
income countries, and the Hukkelhoven and IMPACT models. 
Once the models have been selected, a list of all data fields required to calculate the 
models will be extracted from the published descriptions of the models, together with 
definitions, where available, clarified with the model authors where necessary. Precise 
rules and definitions for the collection of these fields will be laid out in a data 
collection manual, and the technical requirements will be defined in a detailed dataset 
specification. 
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Phase II: Data collection and data validation 
All 208 units participating in the Case Mix Programme and all critical care units in 
neuroscience centres (identified through NCCNet) will be invited to participate. For the 
units already participating in the Case Mix Programme, RAIN data collection will be 
piggybacked onto routine data collection. Neurocritical care units not participating 
may choose to join the Case Mix Programme, but this will not be a requirement of the 
study and RAIN data collection may be piggybacked onto routine data collection for 
the Department of Health mandated Critical Care Minimum Data Set (CCMDS). 
Abstraction of prospective administrative and clinical data will be undertaken by data 
collectors trained to collect a dedicated core dataset for RAIN according to precise 
rules and definitions. Depending on local infrastructure, additional data will be 
collected either by web-based data entry or by modification of existing Case Mix 
Programme Version 3.0-compliant software to incorporate the additional fields 
required. As for Case Mix Programme data, all the additional data will undergo 
extensive validation, both locally and centrally, for completeness, illogicalities and 
inconsistencies. 
Detailed data will be collected on consecutive patients with acute TBI (see: Planned 
inclusion/exclusion criteria). However, administrative and CCMDS data will be 
collected for all admissions to all participating units. Critical care data on TBI patients 
will be placed in the context of all TBI, including those not admitted to critical care, 
using data from the Trauma Audit & Research Network (TARN). 
Data collected will cover administrative (e.g. NHS Number, dates and times) and 
socio-demographic factors and factors from pre-hospital, and the first and subsequent 
hospitals as well as factors at arrival to the definitive location for neurocritical care. 
Data items collected will include all those required to calculate the models selected 
from Phase I, including: mechanism, severity and timing of TBI and other injuries; CT 
scan classification (first/last prior to admission); components of and total GCS (pre-
intubation/at admission); pupil reactions (first/worst); and physiological parameters 
(first/worst). 
The experience from the CRASH trial suggests that adequate quality CT data can be 
obtained through reports generated at contributing centres, and this will be our 
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primary method by which imaging data will be recorded. However, we are aware that 
there have been concerns expressed in the past about the validity of such peripheral 
reporting in clinical trials. It is essential to know whether the data obtained from local 
reporting of CT images is adequate for accurate risk adjustment, since this will have 
significant implications on the practicability of using any particular predictive model. 
Data collectors will therefore be asked to record appropriate identifiers to allow us to 
access CT scans for review at a later date if required, and will be requested not to 
discard or destroy the films or digital imaging data for these patients until 5 years 
after entry into the study. We will obtain copies of the admission CT scans in a 
randomly selected sample of 10% of patients, weighted to include more patients from 
outside neuroscience centres, where patient throughput will be lower. Data collectors 
will be requested to send anonymised admission CT scans to Addenbrookes Hospital 
(Cambridge University Hospitals NHS Foundation Trust) using the Image Exchange 
Portal, where possible. These will be centrally viewed and assessed by Neurosciences 
Critical Care Consultants at Addenbrookes Hospital, and the reports generated will be 
compared to the corresponding submitted data to identify any systematic 
discrepancies. If significant discrepancies are identified, we will arrange systematic 
collection and central reporting of CT scans from all patients, subject to additional 
funding. 
Data on six-month outcomes (see: Proposed outcome measures) will be collected 
centrally, using methods based on those employed in the CRASH and RESCUEicp 
RCTs. Prior to contacting patients, death registrations will be checked against the NHS 
Central Register using the ‘list cleaning’ service offered by the Medical Research 
Information Service to minimise any impact from contacting families of patients that 
have recently died. In addition, each patient’s General Practitioner and, where 
available, neurocritical care follow-up service will be contacted to establish the last 
known status of the patient immediately prior to sending the questionnaire. Patients 
will be sent two questionnaires by post, which can be completed by the patient or by a 
relative, friend or carer.  The first evaluates the Glasgow Outcome Scale (Extended) 
and EuroQol (EQ-5D) measures. Use of a postal questionnaire to collect the Glasgow 
Outcome Scale (Extended) has been found to have high reliability.24 Recent consensus 
recommendations have suggested that patients with TBI should be followed up using 
generic as well as disease-specific measures of health-related quality of life.25 The use 
NIHR Journals Library www.journalslibrary.nihr.ac.uk
appenDIx 2
144
Risk Adjustment In Neurocritical care Protocol Version 1.4  
 
 Page 14 of 30 
of EQ-5D will enable the calculation of quality-adjusted life years (QALYs) as the best 
global measure of cost-effectiveness. The second questionnaire examines which 
health services the patient has used since leaving hospital.  This will be used to 
evaluate the costs for caring for patients.  Strategies proven to improve response 
rates to postal questionnaires will be employed to ensure maximum possible 
response.26 Non-respondents will be followed up with further postal questionnaires 
and finally by telephone interview, using a standardised telephone interview schedule. 
Using this approach, CRASH and RESCUEicp achieved 93% and 92% follow-up of 
head-injured patients at six months, respectively.  In the minority of cases where the 
patient or their consultee does not respond, medical teams involved in the care of the 
patient, e.g., neurocritical care follow-up, will be contacted to determine the primary 
outcome measure for the study, whether the patient had a unfavourable or 
unfavourable outcome.  As after a head injury patients can show dramatic personality 
changes and a variety of cognitive deficits, it is important that we have data covering 
these outcomes in order to determine why some patients make a better recovery than 
others.   
Phase III: Validation of risk prediction models 
The risk prediction models selected in Phase I will be calculated from the raw data 
collected in Phase II using standardised computer algorithms. Any ambiguities in the 
precise methods for each model will be clarified by contacting the model authors. 
Models will be validated with measures of discrimination (the ability to separate 
survivors from non-survivors or those with favourable outcomes from those with 
unfavourable outcomes), calibration (the degree of agreement between the observed 
and predicted outcomes) and overall goodness-of-fit. If the calibration is poor, then 
the best model(s) will be recalibrated to provide revised coefficients specific to UK 
neurocritical care. 
Assessment of loss to follow-up 
Available data from the critical care and hospital stay will be used to compare the 
characteristics of responders and non-responders and to determine whether response 
varies by: age; severity of injury; physiological response to injury; organ monitoring 
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and support received in critical care; duration of stay in critical care and in hospital; 
destination following discharge from acute hospital; and predicted 6-month outcome. 
Provided all variables associated with missing response are included in the risk model, 
complete case analysis of data with missing responses is statistically valid, under the 
assumption that data are missing at random given the observed covariates. We 
therefore do not propose using statistical methods for missing data such as multiple 
imputation unless: (1) the observed loss to follow up is considerably higher than 
anticipated; or (2) factors relating to processes of care (e.g. duration of critical care 
stay), and therefore excluded from the risk models, are found to be independent 
predictors of missing response. 
Validation methods 
Risk prediction models will be validated for discrimination, calibration and goodness-
of-fit, based on methods used previously for the validation of risk prediction models 
for adult, general critical care4;5 and paediatric critical care,27 and for evaluating 
general risk prediction models in patients with TBI.6 
Discrimination will be assessed by the concordance (or c index),28 equivalent to the 
area under the ROC curve.29 The c index can be interpreted as the probability that a 
randomly selected patient with an unfavourable outcome will have a higher risk 
prediction than a randomly selected patient with a favourable outcome. The c index 
will be compared between different models (for the same outcome) using the non-
parametric method of DeLong, DeLong and Clarke-Pearson.30 
Calibration will be assessed graphically by dividing the patients into ten groups at the 
deciles of the predicted risk and plotting the observed outcome against the expected 
outcome in these groups. The Hosmer-Lemeshow test will be used to test the 
hypothesis of perfect calibration,31 however we note that this test is highly sensitive to 
sample size32 and so a significant test result alone will not be taken to indicate ‘poor’ 
calibration. In addition, Cox’s calibration regression will be used to relate the observed 
to the predicted outcomes.33 Cox’s calibration regression fits the model true log odds 
= α + β predicted log odds using logistic regression. If the model is perfectly 
calibrated, then α = 0 and β = 1, i.e. true log odds = predicted log odds. 
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Overall model fit will be assessed with Brier’s score,34 the mean squared error 
between the observed and predicted outcomes. 
Selection of optimum model(s) 
The strengths and weaknesses of each model will be assessed, including consideration 
of factors such as the purpose(s) for which each model is suited, the choice of 
outcome variable, and the ease of data collection in addition to statistical 
performance. 
Phase IV: Evaluation of location of neurocritical care 
The existence of a validated risk prediction model for patients with TBI admitted to 
critical care will enable both non-randomised, observational research and audit in 
neurocritical care. The first research question that we aim to address using this model, 
forming part of this proposal, is: 
“What is the clinical- and cost-effectiveness of managing of TBI in a 
dedicated neurocritical care unit within a neurosciences centre compared 
with a general critical care unit within a neurosciences centre or a general 
critical care unit not in a neurosciences centre?” 
The cost analysis will take a health and personal social services perspective.35 For 
each admission, each day during the hospital stay will be assigned to the appropriate 
healthcare resource group (HRG) using daily organ support data recorded for the 
CCMDS. For each admission, the costs per hospital bed-day for each HRG during 
critical care and for each bed-day for general medical care will be taken from the 
Payment by Results database using trust-specific unit costs.36 These unit costs will be 
combined with each patient’s resource use data to estimate the total cost of each 
initial hospital admission. Information will be collected on hospital readmissions and 
use of community health services post discharge at six-month follow-up. The study 
will report the total six-month hospital and community health service costs for each 
case. The analysis will compare mean costs across the groups recognising any 
differences in either the resource use or unit costs. 
The effect of location of neurocritical care on six-month mortality and unfavourable 
outcomes will be evaluated using multilevel logistic regression models. Using a 
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multilevel model (MLM) enables adjustment for both patient-level factors, including 
the selected risk prediction model, and unit-level factors, such as the volume of cases, 
the size of the unit and, most importantly, the type (specialist or general) and location 
(neuroscience centre or not) of the unit. 
The cost-effectiveness analysis will use the six-month EQ-5D, health services 
questionnaire and survival data to report six-month QALYs (risk adjusted). These 
endpoints will be valued at different levels of willingness to pay for a QALY gain to 
report risk-adjusted incremental net benefits of each location of neurocritical care. The 
cost and cost-effectiveness analysis will also use MLMs37;38 to report risk-adjusted 
incremental costs and cost-effectiveness according to the unit type and location. The 
bivariate cost-effectiveness models will recognise the correlation between costs and 
outcomes. The MLMs will also acknowledge the notoriously skewed nature of cost data 
by allowing the individual error terms to have non-normal distributions (e.g. gamma 
or log-normal). Finally, a cost-effectiveness model will extrapolate from the risk-
adjusted estimates of six-month cost and outcomes to project risk-adjusted cost-
effectiveness over the lifetime. An extensive sensitivity analysis will investigate 
whether the conclusions about the relative cost-effectiveness of care delivery are 
robust to assumptions made about model specification 
Planned inclusion/exclusion criteria 
All adult patients (aged 16 years or over) admitted to participating critical care units 
following TBI, and with a GCS<15 following resuscitation, will be identified by the 
treating clinicians. Confirmation reports will be sent to all units to ensure that every 
eligible admission is identified and, where possible, data will be validated against the 
Case Mix Programme database and CCMDS returns. 
Any patient initially thought to have TBI, and entered into the RAIN database, but 
subsequently found to have a different cause for their neurological impairment (e.g. 
cerebrovascular accident) will be excluded from analyses. 
When evaluating each risk prediction model, additional exclusion criteria will be 
applied to match the definitions of the population used to develop the model. For 
example, any model derived on only patients with severe head injury (GCS≤8) or 
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moderate to severe head injury (GCS≤12) would be validated on the equivalent 
population. 
Planned interventions 
None. 
Proposed outcome measures 
The primary outcomes will be mortality and unfavourable outcome, defined as death, 
vegetative state or severe disability on Glasgow Outcome Scale (Extended), at six 
months following admission to critical care. The duration of follow-up has been 
restricted to six months for the purpose of this study as this is the primary endpoint of 
the existing risk prediction models, and to limit costs, however discussions with 
service user representatives indicate that longer-term outcomes may be important. 
Further list cleaning against the NHS Central Register will enable ongoing follow-up of 
mortality beyond six months. Secondary outcome measures will include six-month 
and lifetime costs and cost-effectiveness. 
Proposed sample size 
We performed a simulation study to assess the power to detect a difference in the c 
index (area under the receiver operating characteristic, ROC, curve) between two 
different risk prediction models applied to the same population. Simulations were 
based on the following assumptions: the rate of unfavourable outcomes in the 
population will be 40% (based on the observed rate of unfavourable outcomes in high 
income countries in the CRASH trial,11 and consistent with the results of a regional 
audit in East Anglia39); statistical tests will be based on a two-sided p-value of 
P=0.05; we wish to be able to detect, with 80% power, a 10% relative difference in c 
index from the value of 0.83 observed for the CRASH model in the development 
sample.11 A total of 17,500 datasets were simulated at different sample sizes using a 
binormal model40 and the empirical power was assessed at each sample size as the 
proportion of datasets in which a statistically significant difference was detected (see 
Appendix 3). 
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Based on these simulations, a sample size of 3100 patients will be required for model 
validation. To allow for 8% loss to follow-up (based on the observed follow-up rates 
from CRASH and RESCUEicp), we will aim to recruit 3400 patients.  
Using data from the Case Mix Programme Database, we anticipate the rate of 
admission of patients with TBI to be approximately 8 per unit per month for 
neurocritical care units, 6 per unit per month for general critical care units within a 
neuroscience centre, and 0.5 per unit per month for general critical care units outside 
a neuroscience centre. We will therefore aim to recruit at least 12 neurocritical care 
units, 13 general critical care units within neuroscience centres and 30 general critical 
care units outside neuroscience centres to complete recruitment within 18 months. 
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ORGANISATION
Study Steering Group 
The Study Steering Group (SSG) responsibilities are to approve the study protocol and 
any amendments, to monitor and supervise the study towards its research objectives, 
to review relevant information from external sources, and to resolve problems 
identified by the Study Management Group. Face-to-face meetings will be held at 
regular intervals determined by need and not less than once a year, with routine 
business conducted by telephone, email and post. The SSG membership is shown 
below and terms of reference are given in Appendix 4. Representatives of the funder 
(NIHR HTA Programme) and the sponsor (ICNARC) will be invited to observe at SSG 
meetings. 
Membership
Prof Monty Mythen (Independent Chair) Director, Centre for Anaesthesia UCL 
Dr David Harrison (Chief Investigator) Statistician, Intensive Care National Audit 
& Research Centre (ICNARC) 
Dr Richard Grieve (Co-investigator) Lecturer in Health Economics, London 
School of Hygiene and Tropical Medicine 
Mr Peter Hutchinson (Co-investigator) Senior Surgical Scientist, Academic 
Neurosurgery Unit, University of 
Cambridge 
Dr Fiona Lecky (Co-investigator) Research Director, Trauma Audit and 
Research Network (TARN) 
Prof David Menon (Co-investigator) Professor of Anaesthesia, University of 
Cambridge 
Prof Kathy Rowan (Co-investigator) Director, ICNARC 
Dr Martin Smith (Co-investigator) Consultant in Neuroanaesthesia and 
Neurocritical care, The National Hospital 
for Neurology and Neurosurgery 
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Dr Patrick Yeoman (Co-investigator) Consultant in Adult Critical Care, Queen’s 
Medical Centre, Nottingham 
Mr Jonathan Hyam (Independent) Clinical Research Registrar in 
Neurosurgery, Nuffield Department of 
Surgery, Oxford 
Dr Ian Tweedie (Independent) Consultant Anaesthetist, The Walton Centre 
for Neurosurgery, Liverpool 
Miss Julie Bridgewater  Headway UK, London
(Service User Representative) 
Dr Gita Prabhu (Study Coordinator) RAIN Study Coordinator, ICNARC 
(Research Fellow) To be appointed 
Study Management Group 
The day-to-day running of the trial will be overseen by a Study Management Group 
consisting of the Chief Investigator and ICNARC-based Co-investigators, the Study 
Coordinator and the Research Fellow. 
Data monitoring 
As the study does not involve any change to usual care for patients, an independent 
Data Monitoring Committee (DMC) will not be required. The SSG will oversee those 
responsibilities usually delegated to a DMC and these have been incorporated into the 
terms of reference (Appendix 4). 
Service user involvement 
Through Headway UK, the national charity for people affected by brain injury, and 
their local Groups and Branches, a representative will be identified to take a full and 
active role in the SSG, promoting the patient’s perspective. All involvement of service 
users in RAIN will follow the guidelines and recommendations for good practice from 
INVOLVE (http://www.invo.org.uk). 
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Research Governance 
RAIN will be managed according to the Medical Research Council's Guidelines for Good 
Research Practice (http://www.mrc.ac.uk/pdf-good_research_practice.pdf), Guidelines 
for Good Clinical Practice in Clinical Trials (http://www.mrc.ac.uk/pdf-ctg.pdf) and 
Procedure for Inquiring into Allegations of Scientific Misconduct 
(http://www.mrc.ac.uk/pdf-mis_con.pdf). ICNARC has developed its own policies and 
procedures based on these MRC guidelines, which are adhered to for all research 
activities at ICNARC. In addition, ICNARC has contractual confidentiality agreements 
with all members of staff. Policies regarding alleged scientific misconduct and breach 
of confidentiality are reinforced by disciplinary procedures. 
Ethical arrangements 
Informed consent for inclusion in RAIN will be sought at the six-month follow-up. A 
patient information sheet and consent form will be included with the questionnaire. 
This will include contact details for the RAIN investigators, and the patient will be 
encouraged to contact the RAIN team if they have any questions. For patients unable 
to give their informed consent due to the nature of their head injury, the consent form 
may be completed by a consultee (as defined under the Mental Capacity Act 2005 and 
in compliance with the Adults with Incapacity (Scotland) Act 2000). Any patient, or 
the consultee, may withdraw their informed consent at any time without being 
required to give a reason. Applications to an NHS Research Ethics Committee and to 
the Patient Information Advisory Group (PIAG) under Section 251 of the NHS Act 
2006 to hold patient identifiable data prior to consent are pending. The Case Mix 
Programme already holds PIAG approval to hold limited identifiable data (date of 
birth, sex, postcode, NHS number) – approval number PIAG 2-10(f)/2005. 
Funding 
Research costs for this study have been met by a grant from the National Institute for 
Health Research (NIHR) Health Technology Assessment (HTA) Programme (project 
reference 07/37/29). There are no NHS support costs or excess treatment costs 
associated with this research as there is no deviation from usual care. 
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Indemnity
ICNARC holds professional liability insurance (certificate number A05305/0808, Markel 
International Insurance Co Ltd) to meet the potential legal liability of the sponsor for 
harm to participants arising from the management of the research. Indemnity to meet 
the potential legal liability of the sponsor and employers for harm to participants 
arising from the design of the research is provided by the NHS indemnity scheme. 
Indemnity to meet the potential legal liability of investigators/collaborators for harm 
to participants arising from the conduct of the research is provided by the NHS 
indemnity scheme or through professional indemnity. 
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Appendix 1. Flow diagram 
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Appendix 2. Search strategy for prognostic models 
Adapted from http://www.biomedcentral.com/content/supplementary/1472-6947-6-
38-S1.doc 
Medline (PUBMED version) 2006 onwards 
(("brain injuries"[MH] OR "craniocerebral trauma"[MH]) OR ("brain injuries"[TI] OR 
"traumatic brain injury"[TI] OR "brain trauma"[TI])) AND (brain[TI] OR brain*[TI] OR 
coma[TI] OR conscious*[TI] OR cranio*[TI] OR skull[TI]) AND ("Case-Control 
Studies"[MH] OR "Cohort Studies"[MH] OR "Follow-Up Studies"[MH] OR prognos*[TI] 
OR predict*[TI]) 
Embase (OVID version) 2006 onwards 
1. traumatic brain injury.mp. or exp traumatic brain injury/ or exp *traumatic brain 
injury/ or brain injur$.ti. 
2. (brain or brain$ or coma$ or conscious$ or cranio$ or skull$).ti. 
3. 1 and 2 
4. (prognos$ or predict$).mp. 
5. 3 and 4 
6. case control study.mp. or (cohort study or cohort analysis).mp. or exp follow up/ 
or exp case control study/ or follow up.mp. or systematic review.mp. or trial.mp. 
or randomi$.mp. 
7. 5 and 6 
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Appendix 3. Simulation study to assess sample size 
requirements
Empirical power to detect a difference in discrimination (c index 0.83 versus 0.80) in 
17,500 simulated datasets at different sample sizes. 
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Appendix 4. Terms of Reference for the Study Steering 
Group
The role of the Study Steering Group (SSG) is to provide overall supervision for RAIN 
on behalf of the funder (HTA) and sponsor (ICNARC) and to ensure that the study is 
conducted to the rigorous standards set out in the MRC Guidelines for Good Clinical 
Practice. The day-to-day management of the study is the responsibility of the 
Investigators, and the Chief Investigator will set up a separate Study Management 
Group (SMG) to assist with this function. 
 The SSG should approve the protocol and study documentation in a timely 
manner. 
 In particular, the SSG should concentrate on progress of the study, adherence to 
the protocol, patient safety and consideration of new information of relevance to 
the research question. 
 In the absence of a Data Monitoring Committee, the SSG should monitor the study 
data, and data emerging from other related studies, and consider whether there 
are any ethical or safety reasons why the study should not continue. 
 The safety, rights and well being of the study participants are the most important 
consideration and should prevail over the interests of science and society. 
 The SSG should provide advice, through its chair, to the Chief Investigator, the 
sponsor, and the funder, on all appropriate aspects of the study. Specifically, the 
SSG will: 
o Monitor recruitment rates and encourage the SMG to develop strategies to 
deal with any recruitment problems. 
o Monitor data completeness and comment on strategies from SMG to 
encourage satisfactory completion in the future. 
o Monitor follow-up rates and review strategies from SMG to deal with 
problems including sites that deviate from the protocol. 
o Approve any amendments to the protocol, where appropriate. 
o Approve any proposals by the SMG concerning any change to the design of 
the study. 
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o Oversee the timely reporting of study results. 
o Approve and comment on the statistical analysis plan. 
o Approve and comment on the publication policy. 
o Approve and comment on the main study manuscript. 
o Approve and comment on any abstracts and presentations of results during
the running of the study 
o Approve external or early internal requests for release of data or subsets of 
data. 
 Membership of the SSG should be limited and include an independent Chair and at 
least two other independent members. The Investigators and the study staff are 
ex-officio. 
 Representatives of the sponsor and the HTA should be invited to all SSG meetings. 
 Responsibility for calling and organising the SSG meetings lies with the Chief 
Investigator. The SSG should meet at least annually, although there may be 
periods when more frequent meetings are necessary. 
 There may be occasions when the sponsor or the HTA will wish to organise and 
administer these meetings in exceptional circumstances. 
 The SSG will provide evidence to support any requests for extensions, including 
that all practicable steps have been taken to achieve targets. 
 The SSG will maintain confidentiality of all study information that is not already in 
the public domain. 
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General rules for data collection 
Inclusion criteria
 all adult patients (aged 16 years or over) admitted to participating critical care units 
following acute TBI, and with a GCS<15 following resuscitation 
 TBI is a brain injury resulting from mechanical trauma, whether or not a patient has a TBI 
is a clinical decision 
 include both suspected and known TBI  
Data
Data are collected on all consecutive admissions meeting the inclusion criteria. Data are 
collected for readmissions as for a new admission. Data are collected for the same time 
period for all admissions - there are no exclusions and no exceptions. 
Data that are measured and/or recorded in any part of the permanent written or electronic 
patient record are acceptable, for example, data from charts, case notes or any medium that 
comprises the permanent patient record. This is based on the assumption that all clinically 
important information is documented. Such an assumption is the only realistic 
standardisation possible at this time. 
In specifying and defining the dataset, judgements have had to be made. It is recognised that 
such judgements will not comply with all opinions. It should, be emphasised, however, that it 
is better to comply with rules and definitions which you deem incorrect than to substitute 
personal rules and/or definitions. 
Missing data
If data are not available or are missing, then no value should be entered. It is not the aim of 
the RAIN Study to encourage unnecessary investigations. 
Do not enter guesses or fabricated data. Where data are missing, these fields should be left 
blank. The value “0” must not be used to indicate missing numeric data.  
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Data collection time periods  
 Patient:
o these fields specify patient details for six-month follow-up and data linkage to 
the Case Mix Programme, where relevant 
 TBI pre-hospital:
o data are collected for the period prior to attendance at the first hospital for this 
TBI
 Source:
o data describing the route to the critical care unit are collected for the period 
from attendance at the first hospital for this TBI to admission to your unit 
 TBI at hospital:
o data are collected for the period from attendance at the first hospital for this 
TBI to discharge from hospital/death 
o values required are those first recorded – first recorded is defined as within   
12 hours of attendance at the first hospital for this TBI 
 First CT:
o the results of the first CT scan performed after attendance at the first hospital 
for this TBI 
 Outcome:
o data are collected for the period from admission to your unit to discharge from 
hospital/death 
 GP:
o these fields specify information on the GP with whom this admission to your 
unit is registered 
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Additional information 
[CMP: Text]  
Field: Additional information 
Number of data items:  One 
Options:  None 
Definition for collection: 
 any additional information considered relevant to this admission   
 text data entered in this field may provide extra information about data entered 
elsewhere for a specific field in the dataset or may provide extra information on 
the admission which is not collected as part of the dataset 
 entry of data in the text field is not compulsory 
 no identifiers (patient, nurse, doctor, unit, hospital) should be included in text 
data entered into this field 
 information entered in the text field may derive from any time period during 
data collection 
 space for comments is limited, please restrict comments to clarification of data 
entered and comments to facilitate data validation 
Justification 
Despite best intentions and endeavours, no dataset can be completely 
comprehensive and unequivocally objective, information provided in this field will 
enable the dataset to be improved over time 
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Basal cisterns 
Field:   Basal cisterns 
    
Number of data items:  One 
Options:                         Absent
Compressed
Present
    
Definition for collection: 
 specifies the appearance of the basal cisterns on the first CT scan following the 
TBI
 first CT scan is defined as the first CT scan performed after attendance at the first 
hospital for this TBI 
 where there is more than one CT scan performed, the first CT scan must be used 
for data abstraction; if transferred, the first CT scan may be performed at a 
subsequent hospital 
 Absent indicates the basal cisterns are not visible on the first CT scan 
 Compressed indicates the basal cisterns appear compressed on the first CT scan 
 Present indicates the basal cisterns appear normal on the first CT scan  
Justification 
Required for risk prediction models
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Brainstem pathology present 
Field:   Brainstem pathology present 
    
Number of data items:  One 
Options:                         Yes
No
    
Definition for collection: 
 specifies if a brainstem pathology was present on the first CT scan following the 
TBI
 first CT scan is defined as the first CT scan performed after attendance at the first 
hospital for this TBI 
 where there is more than one CT scan performed, the first CT scan must be used 
for data abstraction; if transferred, the first CT scan may be performed at a 
subsequent hospital 
 Yes indicates brainstem pathology; this includes evidence of brainstem 
compression, contusion, haemorrhage or ischaemia 
 No indicates no brainstem pathology 
Justification 
Required for risk prediction models
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Cardiovascular support days   
Fields:  Basic cardiovascular support days 
 Advanced cardiovascular support days 
Number of data items: Two 
Units of measurement: Calendar days  
Definition for collection: 
 specifies the number of calendar days during which the admission received any 
basic or advanced cardiovascular support whilst on your unit  
 a calendar day is defined as any complete calendar day (00:00-23:59) or part 
thereof, e.g. a patient admitted on 1 January 2006 at 23:45 and discharged on      
3 January 2006 at 00:10 would be recorded as having received three calendar 
days of care 
 record 1, 2, 3 etc for one, two, three etc calendar days; record 998 for 998 or more 
calendar days; record 999 for support occurring but number of days not known 
 Advanced Cardiovascular - indicated by one or more of the following: 
o admissions receiving multiple intravenous and/or rhythm controlling drugs 
(e.g. inotropes, nitrates etc.) (of which, at least one must be vasoactive) when 
used simultaneously to support or control arterial pressure, cardiac output or 
organ/tissue perfusion 
o admissions receiving critical care after resuscitation following cardiac arrest 
(not usually valid for longer than one calendar day after day of resuscitation) 
o admissions receiving continuous observation of cardiac output and other 
indices (e.g. with a pulmonary artery catheter, lithium dilution, pulse contour 
analyses, oesophageal doppler etc.) 
o admissions with an intra aortic balloon pump in place and other assist devices 
o admissions with a temporary cardiac pacemaker (valid each day while 
connected for therapeutic reasons to a functioning external pacemaker unit) 
 Basic Cardiovascular - indicated by: 
o admissions with a CVP (central venous pressure) receiving monitoring or for 
central venous access to deliver titrated fluids to treat hypovolaemia 
o admissions with an arterial line receiving monitoring of arterial pressure and/or 
sampling of arterial blood 
o admissions receiving a single, intravenous, vasoactive drug to support or 
control arterial pressure, cardiac output or organ perfusion 
o admissions receiving single/multiple intravenous rhythm controlling drug(s) to 
control cardiac arrhythmias 
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o admissions receiving non-invasive measurement of cardiac output and other 
indices (e.g. with echocardiography, thoracic impedance etc.) 
 Note: If advanced and basic cardiovascular monitoring and support occur 
simultaneously, then only advanced cardiovascular monitoring and support should 
be recorded. 
Justification 
Required to describe organs supported 
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Cause of TBI  
Field: Cause of TBI 
Number of data items:  One 
Options: Road traffic accident 
Fall
Assault
Other
Unknown
Definition for collection: 
 specifies the documented cause of TBI 
 Road traffic accident is when the TBI is caused by any accident involving a vehicle 
(e.g. car, motorcycle, bike, etc.) to a driver, passenger, pedestrian etc. 
 Fall is when the TBI is caused by a fall from any height and includes tripping or 
slipping (e.g. on pavement etc.)  
 Assault is when the TBI is caused by a violent physical attack 
 Other is when the TBI cause is known but none of the above  
 Unknown is when the cause is not known 
Justification 
Required for description of TBI 
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Classification of surgery   
Field:  Classification of surgery  
Number of data items: One 
Options eMergency
Urgent
Scheduled
 eLective
Definition for collection: 
 specifies whether the admission, whose Direct source was Theatre & recovery, 
was following emergency, urgent, scheduled or elective surgery 
 surgery is defined as undergoing all or part of a surgical procedure or anaesthesia 
for a surgical procedure in an operating theatre or an anaesthetic room 
 eMergency surgery is defined as immediate surgery, where resuscitation 
(stabilisation and physiological optimisation) is simultaneous with surgical 
treatment and where surgery normally takes place within minutes of decision to 
operate
 Urgent surgery is defined as surgery as soon as possible after resuscitation 
(stabilisation and physiological optimisation) and normally takes place within hours 
of decision to operate 
 Scheduled surgery is defined as early surgery but not immediately life-saving and 
normally takes place within days of decision to operate 
 eLective surgery is defined as surgery at a time to suit both patient and surgeon 
and is booked in advance of routine admission to hospital 
 elective surgery initially postponed can subsequently become emergency, urgent 
or scheduled surgery 
 organ harvesting is not considered surgery 
Justification 
Required to describe admission with TBI
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CMP Admission number (or SICSAG key)  
Field:  CMP Admission number (or SICSAG key)   
Number of data items: One 
Units of measurement:  None  
Definition for collection: 
 unique number assigned to each admission to your unit 
 value should be automatically generated by your CMP software application as 
each admission record is created and should be inputted on the RAIN secure, 
web-based data entry system 
 use the SICSAG key generated by your Wardwatcher software application in 
Scotland
 admission to your unit is defined as the physical admission and the recording of 
that admission to a bed in your unit 
Justification 
Provides data linkage with CMP 
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Contact telephone number  
Field: Contact telephone number 
Number of data items:  One 
Definition for collection: 
 specifies the contact telephone number, including area code for this admission to 
your unit 
Justification 
Required for the six-month follow-up of admission with TBI 
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Date of birth    
Fields:  Date of birth 
 Date of birth estimated  
Number of data items: Two 
Units of measurement: Date  dd/mm/yyyy 
Options: Date of birth estimated – Yes or No
Definition for collection: 
 specifies date of birth for this admission to your unit 
 if date of birth is unobtainable, then use judgement to estimate year of birth and 
record as 1 January of estimated year i.e. 01/01/yyyy  
 if 01/01/yyyy, then record whether date of birth is estimated or not 
Justification 
Required for risk prediction models
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Date of discharge from critical care  
[CMP: Date of ultimate discharge from ICU/HDU]  
Field:  Date of discharge from critical care 
    
Number of data items: One  
Units of measurement: Date  dd/mm/yyyy   
Definition for collection: 
 specifies the latest documented date on which this admission was ultimately 
discharged from adult critical care, the critical care having been continuous since 
discharge from your unit 
 ultimate discharge is defined as the physical discharge and recording of that 
discharge from a bed in another critical care unit 
 a critical care unit is defined as an ICU or a combined ICU/HDU or an HDU 
 where more than one date of ultimate discharge from critical care is documented, 
the latest documented date is recorded 
 the date is not necessarily the date of discharge from the unit to which the 
admission was transferred from your unit 
    
Justification 
Required to describe admission with TBI  
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Date of discharge from your hospital   
Field:  Date of discharge from your hospital   
Number of data items: One  
Units of measurement: Date  dd/mm/yyyy 
Definition for collection: 
 specifies the date of discharge of the admission from your hospital 
 date of discharge from your hospital is the latest documented date of the 
admission being physically within an acute in-patient bed in your hospital or the 
date of death in your hospital 
 discharge from your hospital is defined as the physical discharge and recording of 
that discharge from an acute in-patient bed in your hospital 
 where more than one date of discharge from your hospital is documented, the 
latest documented date is recorded 
Justification 
Required to describe admission with TBI 
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Date/Time of admission to your unit    
Fields: Date of admission to your unit   
 Time of admission to your unit   
    
Number of data items: Two    
Units of measurement: Date  dd/mm/yyyy 
 Time  hh:mm 
Definition for collection: 
 specifies the date and time of admission to your unit 
 admission to your unit is defined as the physical admission and recording of that 
admission to a bed in your unit 
 date of admission to your unit is the earliest documented date of the admission 
being physically in a bed in your unit 
 time of admission to your unit may be the time first charted if not documented as 
earlier in the case notes (twenty-four hour clock) 
 where more than one date/time of admission to your unit is documented, the 
earliest documented date/time is recorded 
Justification 
Required to describe admission with TBI 
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Date/Time of attendance at/admission to your hospital  
Field:  Date of attendance at/admission to your hospital   
 Time of attendance at/admission to your hospital   
Number of data items: Two    
Units of measurement: Date  dd/mm/yyyy 
 Time  hh:mm 
                                
Definition for collection: 
 specifies the date and time the admission first attended or was admitted to your 
hospital
 attendance at hospital is defined as the physical attendance and recording of that 
attendance in your hospital, the hospital housing your unit 
 admission to hospital is defined as the physical admission and recording of that 
admission to an acute in-patient bed in your hospital, the hospital housing your unit 
 where more than one date of attendance at/admission to your hospital is 
documented, the earliest documented date and time is recorded   
 hospital care in your hospital must be continuous up to the point of admission to 
your unit 
Justification 
Required to describe admission with TBI 
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Date/Time of death 
Fields:  Date of death 
 Time of death 
    
Number of data items:  Two 
Units of measurement: Date  dd/mm/yyyy 
 Time  hh:mm 
    
Definition for collection: 
 specifies the date and time of death including brainstem death 
 date of death or brainstem death in your unit as documented in the admission’s 
clinical record 
 time of death or brainstem death in your unit as documented in the admission’s 
clinical record (twenty-four hour clock) 
 if brainstem death declared, then indicate the date on which the completion of the 
first set of tests confirming brainstem death is recorded (as per the current 
Department of Health (England) Statement on brainstem death) 
 if brainstem death declared, then indicate the time at which the completion of the 
first set of tests confirming brainstem death is recorded (as per the current 
Department of Health (England) Statement on brainstem death), (twenty-four hour 
clock)
Justification 
Required for risk prediction models 
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Date/Time of discharge from your unit   
Fields:  Date of discharge from your unit 
 Time of discharge from your unit  
    
Number of data items: Two 
Units of measurement: Date  dd/mm/yyyy 
 Time  hh:mm 
    
Definition for collection: 
 specifies the date and time of the physical discharge of an admission and that 
recording of that discharge from a bed in your unit 
 discharge does not include temporary transfer from your unit, e.g. for surgery, 
radiology, other investigation  
 date of discharge from your unit is the latest documented date of the admission 
being physically in your unit 
 time of discharge from your unit is the latest documented time of the admission 
being physically within your unit (twenty-four hour clock) 
 where more than one date/time of discharge from your unit is documented, the 
latest date/time is recorded 
Justification 
Required to describe admission with TBI 
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Date/Time of original admission to critical care 
Field:  Date of original admission to critical care 
 Time of original admission to critical care 
Number of data items: Two    
Units of measurement: Date  dd/mm/yyyy 
 Time  hh:mm  
Definition for collection: 
 specifies the earliest documented date and time on which this admission was 
originally admitted to an adult critical care unit and since when adult critical care 
has been continuous 
 a critical care unit is defined as an ICU or a combined ICU/HDU or an HDU 
 the date is not necessarily the date of admission to the critical care unit from which 
this admission has been transferred to your unit 
 admission is defined as the physical admission and recording of that admission to 
a bed in the critical care unit 
 where more than one date of original admission to critical care is documented, the 
earliest documented date is recorded 
    
Justification 
Required to describe admission with TBI 
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Date/Time of original attendance at/admission to acute hospital  
Field:  Date of original attendance at/admission to acute hospital   
 Time of original attendance at/admission to acute hospital   
Number of data items: Two    
Units of measurement: Date  dd/mm/yyyy 
 Time  hh:mm 
                    
Definition for collection: 
 specifies the earliest documented date and time on which this admission originally 
attended or was admitted to the first acute hospital for the current period of 
continuous in-patient treatment 
 an acute hospital is defined as any hospital providing a range of acute hospital 
services to diagnose, treat and care for seriously ill or injured patients; some acute 
hospitals may provide only specialist services while others will provide general 
services 
 attendance at acute hospital is defined as the physical attendance and recording 
of that attendance in another acute hospital, not your hospital i.e. not the hospital 
housing your unit 
 admission to acute hospital is defined as the physical admission and recording of 
that admission to an acute in-patient bed in another acute hospital, not your 
hospital i.e. not the hospital housing your unit 
 the date is not necessarily the date of attendance at/admission to the acute 
hospital from which the admission has been transferred to your unit 
 where more than one date of original attendance at/admission to at an acute 
hospital is documented, the earliest documented date is recorded 
    
Justification 
Required to describe admission with TBI 
NIHR Journals Library www.journalslibrary.nihr.ac.uk
appenDIx 3
184
Version 1.6 RAIN / February 2010 25
Date/Time of TBI  
Fields: Date of TBI   
 Date of TBI estimated 
 Time of TBI 
 Time of TBI estimated 
    
Number of data items:  Four 
Units of measurement: Date  dd/mm/yyyy 
 Time  hh:mm 
Options: Date of TBI estimated – Yes or No
 Time of TBI estimated – Yes or No
Definition for collection: 
 specifies the date and time of TBI 
 date of TBI is the documented date of TBI 
 time of TBI is the documented time of TBI 
 if the date and/or time of TBI is imprecise, then use judgement to estimate the date 
and/or time and record whether the date and/or time of TBI is estimated 
Justification 
Required for risk prediction models 
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Date/Time when fully ready to discharge  
Fields:  Date when fully ready to discharge 
 Time when fully ready to discharge 
    
Number of data items: Two 
Units of measurement: Date  dd/mm/yyyy 
 Time  hh:mm 
Definition for collection: 
 specifies the date and time when the admission was declared fully clinically ready 
for discharge 
 the documented date when the admission was declared fully clinically ready for 
discharge
 the documented time when the admission was declared fully clinically ready for 
discharge (twenty-four hour clock) 
 includes the documented date/time when a formal request was made to the 
appropriate staff with authority to admit at the intended destination (e.g. hospital 
bed management system, PICU staff for retrieval, transfer for more-specialist care 
etc.)
 where discharge planning occurs in the expectation of, and in advance of, the 
admission being fully clinically ready for discharge – the latter date/time when fully 
clinically ready is recorded 
 where more than one date/time when fully ready to discharge is documented, the 
earliest documented date/time is recorded 
 where date/time when fully ready to discharge equals date/time of discharge from 
your unit, enter the same values for both dates and times 
 these fields should be left blank for admissions discharged early or where 
date/time when fully ready to discharge is not recorded 
Justification 
Required to describe admission with TBI 
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Dependency prior to admission to acute hospital 
Field:  Dependency prior to admission to acute hospital 
    
Number of data items:  One 
Options: Able to live without assistance in daily activities 
 miNor assistance with some daily activities 
 maJor assistance with majority of/all daily activities 
Total assistance with all daily activities 
Definition for collection: 
 specifies what the admission could do before the TBI 
 assess as best description for the dependency of this admission in the two weeks 
prior to admission to acute hospital and prior to the TBI, i.e. “usual” dependency 
 Able – receives no assistance with daily activities 
 miNor – receives some assistance with some daily activities 
 maJor – receives considerable assistance with majority of/all daily activities 
 Total – receives total assistance with all daily activities  
 assistance means personal assistance 
 daily activities include bathing, dressing, going to the toilet, moving in/out of 
bed/chair, continence and eating 
 it is recognised that these data are subjective, the important distinction is between 
total independence (able to live without assistance in daily activities), some level of 
dependence (minor/major limitations) and total dependence (total assistance with all 
daily activities) – the difference between minor or major assistance in daily activities 
is difficult to standardise and this lack of specificity is acknowledged 
Justification 
Required to describe admission with TBI
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Dermatological support days  
Field:  Dermatological support days 
    
Number of data items:  One 
Units of measurement:  Calendar days 
    
Definition for collection: 
 specifies the number of calendar days during which the admission received any 
dermatological support whilst on your unit 
 a calendar day is defined as any complete calendar day (00:00-23:59) or part 
thereof, e.g. a patient admitted on 1 January 2006 at 23:45 and discharged on      
3 January 2006 at 00:10 would be recorded as having received three calendar 
days of care 
 record 1, 2, 3 etc for one, two, three etc calendar days; record 998 for 998 or more 
calendar days; record 999 for support occurring but number of days not known 
 Dermatological – indicated by one or more of the following: 
o admissions with major (e.g. greater than 30% body surface area affected) 
skin rashes, exfoliation or burns 
o admissions receiving complex dressings (e.g. major – greater than 30% body 
surface area affected – skin dressings, open abdomen, vacuum dressings or 
large – multiple limb or limb and head – trauma dressings) 
Justification 
Required to describe organs supported 
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Destination post-discharge    
[CMP: Destination post-discharge from your hospital] 
Field:  Destination post-discharge 
    
Number of data items:  One 
Options:  other Acute hospital 
 nOn-acute hospital 
Not in hospital 
Definition for collection: 
 specifies the destination to which the admission was directly transferred post-
discharge from your hospital, the hospital housing your unit 
 other Acute hospital, one that does not house your unit, is defined as another 
hospital (can be in the same or a different NHS Trust) that provides a range of 
acute hospital services to diagnose, treat and care for seriously ill or injured 
patients; some acute hospitals may provide only specialist services while others 
will provide general services 
 nOn-acute hospital is defined as another hospital (can be in the same or a different 
NHS Trust) that provides a range of short or long-term non-acute services 
 Not in hospital is defined as discharge to a location that is no longer within a 
hospital
   
Justification 
Required to describe admission with TBI
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Harrison et al. under the terms of a commissioning contract issued by the Secretary of State for 
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
DOI: 10.3310/hta17230 HealtH tecHnOlOgy assessment 2013 VOl. 17 nO. 23
189
Version 1.6 RAIN / February 2010 30
Diagnosis of TBI confirmed 
Field: Diagnosis of TBI confirmed  
Number of data items: One    
Options: Yes
No
                        
Definition for collection: 
 specifies whether the admission had a TBI 
 TBI is defined as a brain injury resulting from mechanical trauma  
Justification 
Required for risk prediction models 
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Direct source   
[CMP: Location (in)]  
Field: Direct source  
    
Number of data items: One    
Options: Ward
 oBstetrics area  
 other interMediate care area 
Paediatric ICU/HDU  
 level 3 bed in adult ICU or ICU/HDU 
 level 2 bed in adult ICU or ICU/HDU
 adult HDU
Theatre & recovery 
 accident & Emergency
Recovery only 
 imaGing department 
Specialist treatment area 
Clinic
Not in hospital 
    
                                
Definition for collection: 
 specifies the direct source from which this admission was admitted directly to your 
unit
 Ward is a ward in the hospital 
 oBstetrics area is a delivery suite, labour ward or obstetrics ward in the hospital 
 other interMediate care area is a CCU or other area in the hospital where the level 
of care is greater than the normal ward but is not an ICU or combined ICU/HDU or 
HDU (use text box to specify where) 
 Paediatric ICU/HDU is a paediatric ICU or combined ICU/HDU or HDU in the 
hospital
 level 3 bed in adult ICU or ICU/HDU is a level 3 bed in either an adult ICU or a 
combined ICU/HDU in the hospital 
 level 2 bed in adult ICU or ICU/HDU is a level 2 bed in either an adult ICU or a 
combined ICU/HDU in the hospital 
 adult HDU is an adult HDU or equivalent step-up/step-down unit in the hospital, 
where the Critical Care Minimum Data Set (CCMDS) is collected 
 Theatre and recovery is a theatre in the hospital, the admission having undergone 
all or part of a surgical procedure or anaesthesia for a surgical procedure 
 accident & Emergency is an accident & emergency department in the hospital 
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 Recovery only is a recovery room used as a temporary critical care facility 
 imaGing department is an X-ray, CT, MRI, PET or other department in the hospital 
dedicated to providing diagnostic imaging or interventional radiology 
 Specialist treatment area includes endoscopy and catheter suites in the hospital 
 Clinic is defined as an out-patient or other clinic in the hospital 
 Not in hospital is defined as not in hospital 
Justification 
Required to describe admission with TBI
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Discharge location  
[CMP: Hospital housing location (out)]  
Field: Discharge location  
    
Number of data items: One 
Options: Same hospital 
 other Acute hospital  
 nOn-acute hospital 
    
   
Definition for collection: 
 specifies the hospital housing the destination to which this admission was 
discharged from your unit 
 Same hospital is defined as the hospital that houses your unit 
 other Acute hospital, one that does not house your unit, is defined as another 
hospital (can be in the same or a different NHS Trust) that provides a range of 
acute hospital services to diagnose, treat and care for seriously ill or injured 
patients; some acute hospitals may provide only specialist services while others 
will provide general services 
 nOn-acute hospital is defined as another hospital (can be in the same or a different 
NHS Trust) that provides a range of short or long-term non-acute services 
    
Justification 
Required to describe admission with TBI
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Discharged to   
[CMP: Location (out)]   
Field:  Discharged to  
    
Number of data items: One 
Options:                         Ward
 oBstetrics area 
 other interMediate care area 
 Recovery only 
 Paediatric ICU/HDU 
 level 3 bed in adult ICU or ICU/HDU 
 level 2 bed in adult ICU or ICU/HDU
 adult HDU
Not in hospital 
Definition for collection: 
 specifies the destination to which this admission was discharged from your unit 
 Ward is a ward in the hospital  
 oBstetrics area is a delivery suite, labour ward or obstetrics ward in the hospital  
 other interMediate care area is a CCU or other area where the level of care is 
greater than the normal ward but is not an ICU or combined ICU/HDU or HDU (use 
text box to specify where) 
 Recovery only is a recovery room used as a temporary critical care facility 
 Paediatric ICU/HDU is a paediatric ICU or ICU/HDU or HDU in the hospital 
 level 3 bed in adult ICU or ICU/HDU is a level 3 bed in either an adult ICU or a 
combined ICU/HDU in the hospital 
 level 2 bed in adult ICU or ICU/HDU is a level 2 bed in either an adult ICU or a 
combined ICU/HDU in the hospital 
 adult HDU is an adult HDU or equivalent step-up/step-down unit in the hospital, 
where the Critical Care Minimum Data Set (CCMDS) is collected 
 Not in hospital is defined as discharge to a location that is no longer within a 
hospital
Justification 
Required to describe admission with TBI
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Evacuation of haematoma
Fields:   Evacuation of haematoma  
 Evacuation of haematoma date 
 Evacuation of haematoma time 
    
Number of data items:  Three 
Units of measurement: Date  dd/mm/yyyy 
 Time  hh:mm 
Options:                         Evacuation of haematoma – Yes or No
    
Definition for collection: 
 specifies if there was surgical evacuation of any haematoma after the first CT scan 
 first CT scan is defined as the first CT scan performed after attendance at the first 
hospital for this TBI 
 Yes indicates surgical evacuation of a haematoma after the first CT scan 
 No indicates no surgical evacuation of a haematoma after the first CT scan 
 evacuation of haematoma date is the documented date the surgery commenced 
 evacuation of haematoma time is the documented time the surgery commenced 
Justification 
Required for risk prediction models
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Expected outcome at six months  
Field:   Expected outcome at six months 
    
Number of data items: One    
Options: Good recovery 
Moderate disability 
Severe disability
Persistent vegetative state 
Death
    
                       
Definition for collection: 
 specifies the expected outcome of the admission six months following the TBI 
 expected outcome should be determined at unit discharge by the consultant 
responsible for care at the point of discharge 
 assess as best description for the expected outcome for this admission six months 
following the TBI (i.e. the predicted recovery)  
 Good recovery – expected resumption of normal life or expected resumption of 
normal life despite minor deficits 
 Moderate disability – expected disabled but independent (i.e. might work in a 
sheltered setting etc.) 
 Severe disability – expected conscious but disabled, dependent for daily support 
 Persistent vegetative state – expected minimal responsiveness  
 Death – expected non-survival  
Justification 
Required to describe admission with TBI 
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Fall height  
Field: Fall height 
Number of data items:  One 
Options: Less than or equal to two metres 
Greater than two metres  
Unknown height 
Definition for collection: 
 specifies height from which admission fell and includes tripping or slipping (e.g. on 
pavement etc.) and falling from a building, a high wall or bridge 
 where fall was Less than or equal to two metres; the height may be documented 
as explicit text allowing assessment of the height of fall  
 where fall was Greater than two metres; the height may be documented as explicit 
text allowing assessment of the height of fall 
 Unknown is when fall height not known 
Justification 
Required for description of TBI 
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Harrison et al. under the terms of a commissioning contract issued by the Secretary of State for 
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
DOI: 10.3310/hta17230 HealtH tecHnOlOgy assessment 2013 VOl. 17 nO. 23
197
Version 1.6 RAIN / February 2010 38
First CT scan 
Fields:   First CT scan available  
 First CT scan date 
 First CT scan time  
 First CT scan Radiology Number  
Number of data items:  Four 
Units of measurement: Date  dd/mm/yyyy 
 Time  hh:mm 
Options:                         First CT scan available – Yes or No
Definition for collection: 
 specifies the availability, date, time and Radiology Number of the first CT scan 
following the TBI 
 first CT scan is defined as the first CT scan performed after attendance at the first 
hospital for this TBI 
 where there is more than one CT scan performed, the first CT scan must be used 
for data abstraction; if transferred, the first CT scan may be performed at a 
subsequent hospital 
 if the first CT scan is available then indicate Yes, if not available then indicate No
 first CT scan date is the documented date of the first CT scan 
 first CT scan time is the documented time of the first CT scan 
 first CT scan Radiology Number is the documented Radiology Number of the first 
CT scan 
Justification 
Required for risk prediction models
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First CT scan assessed by/on 
Fields:   First CT scan assessed by – specialty 
 First CT scan assessed by – grade 
 Date first CT scan assessed 
Number of data items:  Three 
Units of measurement: Date  dd/mm/yyyy 
Options:                         First CT scan assessed by – specialty – Critical care, 
Neurocritical care, Emergency medicine, Anaesthesia, 
NeUroanaesthesia, Radiology, neurOradiology, Surgery or 
neurosurGery
 First CT scan assessed by – grade – Consultant,         
Specialist registrar or Other clinician 
Definition for collection: 
 specifies who assessed the first CT scan, following the TBI, for the RAIN Study 
and when this CT scan was assessed  
 first CT scan is defined as the first CT scan performed after attendance at the first 
hospital for this TBI 
 where there is more than one CT scan performed, the first CT scan must be used 
for data abstraction; if transferred, the first CT scan may be performed at a 
subsequent hospital 
 first CT scan assessed by – specialty, specifies the area of expertise of the 
clinician that provided the data to input for the CT results for this admission  
 first CT scan assessed by – grade, specifies the grade of the clinician that 
provided the data to input for the CT results for this admission 
 date first CT scan assessed provides the date on which the clinician that provided 
the data to input for the CT results for this admission 
Justification 
Required for risk prediction models
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First CT scan result 
Field:   First CT scan result 
    
Number of data items:  One 
Options:                         Abnormal
 Normal
    
Definition for collection: 
 specifies whether the first CT scan result following the TBI was normal or 
abnormal
 first CT scan is defined as the first CT scan performed after attendance at the first 
hospital for this TBI 
 where there is more than one CT scan performed, the first CT scan must be used 
for data abstraction; if transferred, the first CT scan may be performed at a 
subsequent hospital 
 Abnormal indicates the first CT scan result showed one or more abnormalities  
 Normal indicates the first CT scan result showed no abnormality 
Justification 
Acts as a filter field for CT findings
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First recorded at hospital activated partial thromboplastin time (APTT) (ratio) 
Fields:   First recorded at hospital APTT (ratio) 
 or 
 First recorded at hospital APTT missing 
    
Number of data items:  Two 
Units of measurement:  Ratio 
Options: First recorded at hospital APTT missing – Yes or No
    
Definition for collection: 
 specifies the first APTT from blood sampled within 12 hours of attendance at the 
first hospital for this TBI 
 the APTT must be documented 
 the first APTT may not be measured and recorded at the first hospital and, if 
transferred, may be measured and recorded at a subsequent hospital within         
12 hours of attendance at first hospital for this TBI 
 laboratory results only - laboratory results are defined as results of tests performed 
either in the departments of Clinical Chemistry or Haematology or in the near-
patient testing/point of care testing laboratories with formal quality control 
programmes in operation 
 record the APTT as a ratio 
 if no blood was sampled for APTT measurement within 12 hours of being at or in 
the first hospital, then record APTT as missing 
Justification
Required for risk prediction models
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Harrison et al. under the terms of a commissioning contract issued by the Secretary of State for 
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
DOI: 10.3310/hta17230 HealtH tecHnOlOgy assessment 2013 VOl. 17 nO. 23
201
Version 1.6 RAIN / February 2010 42
First recorded at hospital activated partial thromboplastin time (APTT) (seconds) 
Fields:   First recorded at hospital APTT (seconds) 
 First recorded at hospital APTT (seconds) 
 or 
 First recorded at hospital APTT missing 
    
Number of data items:  Three 
Units of measurement:  Seconds 
Options: First recorded at hospital APTT missing – Yes or No
    
Definition for collection: 
 specifies the first APTT from blood sampled within 12 hours of attendance at the 
first hospital for this TBI 
 the APTT must be documented 
 the first APTT may not be measured and recorded at the first hospital and, if 
transferred, may be measured and recorded at a subsequent hospital within         
12 hours of attendance at first hospital for this TBI 
 laboratory results only - laboratory results are defined as results of tests performed 
either in the departments of Clinical Chemistry or Haematology or in the near-
patient testing/point of care testing laboratories with formal quality control 
programmes in operation 
 record the APTT in seconds and the control time in seconds 
 if no blood was sampled for APTT measurement within 12 hours of being at or in 
the first hospital, then record APTT as missing 
Justification
Required for risk prediction models
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First recorded at hospital arterial blood gas  
Fields:   First recorded at hospital PaO2
 Associated FiO2
 Associated PaCO2
 Associated pH/H+
 First at hospital arterial blood gas missing 
    
Number of data items:  Five 
Units of measurement:  PaO2  kPa or mmHg 
 FiO2  fraction 
 PaCO2  kPa or mmHg 
 pH/H+  pH or nmol l-1
Options:    First at hospital arterial blood gas missing – Yes or No
    
Definition for collection: 
 specifies the first arterial blood gas values measured and recorded within 12 hours
of attendance at the first hospital for this TBI  
 the arterial blood gas values must be documented 
 the first arterial blood gas values may not be measured and recorded at the first 
hospital and, if transferred, may be measured and recorded at a subsequent 
hospital within 12 hours of attendance at first hospital for this TBI 
 all values assessed and recorded from same arterial blood gas
 if no arterial blood gas values are measured and recorded, then record arterial 
blood gas as missing 
 see Appendix: Table of FiO2 approximations for non-intubated admissions 
receiving oxygen treatment 
Justification 
Required for risk prediction models
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First recorded at hospital blood pressure   
Fields:  First recorded at hospital systolic blood pressure 
  First recorded at hospital paired diastolic blood pressure 
Number of data items:  Two (one pair) 
Units of measurement:  mmHg 
Definition for collection: 
 specifies the first blood pressure measured and recorded within 12 hours of 
attendance at the first hospital for this TBI 
 the first blood pressure may not be measured and recorded at the first hospital 
and, if transferred, may be measured and recorded at, or en route to (i.e. on the 
transfer form), a subsequent hospital within 12 hours of attendance at first hospital 
for this TBI 
 record first at hospital systolic blood pressure measured and its paired diastolic 
blood pressure (i.e. values from same blood pressure measurement)
 blood pressure values are included irrespective of the measurement method used  
 where blood pressure values are not detectable or measurable, the value zero 
should be recorded 
 if only the systolic blood pressure value was measured and recorded (i.e. paired 
diastolic is missing), then enter this value 
Justification 
Required for risk prediction models
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First recorded at hospital Glasgow Coma Score (GCS) 
Fields:   First recorded at hospital GCS recorded? 
 First recorded at hospital total GCS 
                           Associated eye component  
  Associated motor component  
  Associated verbal component  
 Was this the last pre-sedation GCS? 
    
Number of data items:  Six 
Units of measurement:  None 
Options:                         First recorded at hospital GCS recorded? – Yes or No
 Was this the last pre-sedation GCS? – Yes or No
    
Definition for collection: 
 specifies the first pre-sedation GCS assessed and recorded within 12 hours of 
attendance at the first hospital for this TBI 
 the first GCS may not be assessed and recorded at the first hospital and, if 
transferred, may be assessed and recorded at, or en route to (i.e. on the transfer 
form), a subsequent hospital within 12 hours of attendance at first hospital for this 
TBI
 if GCS assessed and recorded within 12 hours of attendance at the first hospital 
then indicate Yes, if not, then indicate No
 all values assessed and recorded from the same assessment of the first total GCS 
following attendance at first hospital 
 only GCS assessed when the admission is free from the effects of sedative and/or 
paralysing or neuromuscular blocking agents are valid 
 the determination as to whether an admission is free from the effects of sedative 
and/or paralysing or neuromuscular blocking agents is left to clinical judgement, as 
this is the only realistic standardisation for collection of these data at this time 
 admissions with self-sedation through deliberate or accidental overdose/poisoning 
should have a GCS assessed as seen 
 the GCS may be either documented as a score (for example, as numbers) or as 
explicit text allowing precise assignment of the score (e.g. “fully alert and 
orientated” equals 15).  
 see Appendix: How to assess the Glasgow Coma Score (GCS) 
 indicate whether this was the most recent or last pre-sedation GCS recorded (i.e. 
is there another pre-sedation GCS recorded since this value?) 
Justification
Required for risk prediction models
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First recorded at hospital haemoglobin  
Fields:  First recorded at hospital haemoglobin  
 or 
 First recorded at hospital haemoglobin missing 
    
Number of data items: Two 
Units of measurement:  g dl-1
Options: First recorded at hospital haemoglobin missing – Yes or No
    
Definition for collection: 
 specifies the first haemoglobin value from blood sampled within 12 hours of 
attendance at the first hospital for this TBI 
 the haemoglobin value must be documented 
 the first haemoglobin value may not be measured and recorded at the first hospital 
and, if transferred, may be measured and recorded at a subsequent hospital within 
12 hours of attendance at first hospital for this TBI 
 laboratory results only - laboratory results are defined as results of tests performed 
either in the departments of Clinical Chemistry or Haematology or in near-patient 
testing/point-of-care testing laboratories with formal quality control programmes in 
operation
 if no blood was sampled for haemoglobin measurement within 12 hours of being at 
or in the first hospital, then record haemoglobin values as missing 
Justification 
Required for risk prediction models
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First recorded at hospital heart rate  
Field:  First recorded at hospital heart rate  
    
Number of data items:  One 
Units of measurement:  beats min-1
Definition for collection: 
 specifies the first heart (ventricular) rate measured and recorded within 12 hours of 
attendance at the first hospital for this TBI 
 the first heart (ventricular) rate may not be measured and recorded at the first 
hospital and, if transferred, may be measured and recorded at, or en route to (i.e. 
on the transfer form), a subsequent hospital within 12 hours of attendance at first 
hospital for this TBI 
 where no heart rate was detectable or measurable, then the value zero should be 
recorded
    
Justification 
Required for risk prediction models
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First recorded at hospital oxygen saturation   
Fields:    First recorded at hospital oxygen saturation 
    
Number of data items:  One 
Units of measurement:  % 
    
Definition for collection: 
 specifies the first oxygen saturation measured and recorded within 12 hours of 
attendance at the first hospital for this TBI 
 the first oxygen saturation may not be measured and recorded at the first hospital 
and, if transferred, may be measured and recorded at, or en route to (i.e. on the 
transfer form), a subsequent hospital within 12 hours of attendance at first hospital 
for this TBI 
 oxygen saturation is normally recorded with pulse oximeter 
Justification 
Required for risk prediction models
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First recorded at hospital platelet count  
Fields:   First recorded at hospital platelet count  
 or 
 First recorded at hospital platelet count missing 
    
Number of data items:  Two 
Units of measurement:  x109 l-1
Options: First recorded at hospital platelet count missing – Yes or No
    
Definition for collection: 
 specifies the first platelet count from blood sampled within 12 hours of attendance 
at the first hospital for this TBI 
 the platelet count must be documented 
 the first platelet count may not be measured and recorded at the first hospital and, 
if transferred, may be measured and recorded at a subsequent hospital within      
12 hours of attendance at first hospital for this TBI 
 laboratory results only - laboratory results are defined as results of tests performed 
either in the departments of Clinical Chemistry or Haematology or in the near-
patient testing/point of care testing laboratories with formal quality control 
programmes in operation 
 if no blood was sampled for platelet count measurement within 12 hours of being 
at or in the first hospital, then record platelet count as missing 
Justification
Required for risk prediction models
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First recorded at hospital prothrombin time (PT) (ratio) 
Fields:   First recorded at hospital PT (ratio) 
 or 
 First recorded at hospital PT missing 
    
Number of data items:  Two 
Units of measurement:  Ratio 
Options: First recorded at hospital PT missing – Yes or No
    
Definition for collection: 
 specifies the first PT from blood sampled within 12 hours of attendance at the first 
hospital for this TBI 
 the PT must be documented 
 the first PT may not be measured and recorded at the first hospital and, if 
transferred, may be measured and recorded at a subsequent hospital within        
12 hours of attendance at first hospital for this TBI 
 laboratory results only - laboratory results are defined as results of tests performed 
either in the departments of Clinical Chemistry or Haematology or in the near-
patient testing/point of care testing laboratories with formal quality control 
programmes in operation 
 record first PT as a ratio 
 the INR (International Normalised Ratio) may be entered for the PT ratio 
 if no blood was sampled for PT measurement within 12 hours of being at or in the 
first hospital, then record PT as missing 
Justification
Required for risk prediction models
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First recorded at hospital prothrombin time (PT) (seconds) 
Fields:   First recorded at hospital PT (seconds) 
  First recorded at hospital PT control time (seconds) 
 or 
 First recorded at hospital PT missing 
    
Number of data items:  Three 
Units of measurement:  Seconds 
Options: First recorded at hospital PT missing – Yes or No
    
Definition for collection: 
 specifies the first PT from blood sampled within 12 hours of attendance at the first 
hospital for this TBI 
 the PT must be documented 
 the first PT may not be measured and recorded at the first hospital and, if 
transferred, may be measured and recorded at a subsequent hospital within        
12 hours of attendance at first hospital for this TBI 
 laboratory results only - laboratory results are defined as results of tests performed 
either in the departments of Clinical Chemistry or Haematology or in the near-
patient testing/point of care testing laboratories with formal quality control 
programmes in operation 
 record first PT in seconds and the control time in seconds 
 if no blood was sampled for PT measurement within 12 hours of being at or in the 
first hospital, then record PT as missing 
Justification
Required for risk prediction models
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First recorded at hospital pupil reactivity and size of pupils 
Field: First recorded at hospital pupil reactivity and/or size recorded? 
First recorded at hospital pupil reactivity (left eye) 
First recorded at hospital size of pupils (left eye) 
First recorded at hospital pupil reactivity (right eye) 
First recorded at hospital size of pupils (right eye) 
Number of data items: Five  
Units of measurements: mm 
Options: First recorded at hospital pupil reactivity and/or size recorded? 
– Yes – both, yes – Reactivity, yes – Size or No
 First recorded at hospital pupil reactivity – Reactive, Unreactive
or uNable to assess
 First recorded at hospital size of pupils – 1 mm, 2 mm, 3 mm,    
4 mm, 5 mm, 6 mm or greater than or equal to 7 mm 
                               
Definition for collection: 
 specifies the first pupil reactivity and size of pupils assessed and recorded, for 
both eyes, within 12 hours of attendance at the first hospital for this TBI 
 the first pupil reactivity and size of pupils may not be assessed and recorded at the 
first hospital and, if transferred, may be assessed and recorded at, or en route to 
(i.e. on the transfer form), a subsequent hospital within 12 hours of attendance at 
first hospital for this TBI 
 if pupil reactivity and size were assessed and recorded within 12 hours of 
attendance at the first hospital for this TBI then indicate Yes - both, if neither 
recorded then indicate No, if reactivity was assessed but not size then record yes 
– Reactivity, if size was measured but not reactivity then record yes - Size
 Reactive is defined as pupillary contraction to strong direct light, Unreactive is 
defined as no pupillary contraction to strong direct light 
 uNable to assess is where pupils cannot be inspected (e.g. eyes are closed due to 
facial injury or swelling, etc) 
 pupils are recorded regardless of whether admission is ventilated or sedated 
 chronically altered pupils from previous disease should be recorded as unable to 
assess
 only assess pupil reactivity and size when an admission is free from iatrogenic 
drug effects (e.g. drops given for dilation) 
 size of pupils is the diameter of the right and left pupil in mm; if pupils are equal to 
or more than 7 mm then record as greater than or equal to 7 mm 
Justification 
Required for risk prediction models
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First recorded at hospital serum glucose  
Fields:   First recorded at hospital serum glucose  
 or 
 First recorded at hospital serum glucose missing 
    
Number of data items:  Two 
Units of measurement:  mmol l-1
Options: First recorded at hospital serum glucose missing – Yes or No
    
Definition for collection: 
 specifies the first serum glucose value from blood sampled within 12 hours of 
attendance at the first hospital for this TBI 
 the serum glucose value must be documented 
 the first serum glucose value may not be measured and recorded at the first 
hospital and, if transferred, may be measured and recorded at a subsequent 
hospital within 12 hours of attendance at first hospital for this TBI 
 laboratory results only - laboratory results are defined as results of tests performed 
either in the departments of Clinical Chemistry or Haematology or in the near-
patient testing/point of care testing laboratories with formal quality control 
programmes in operation 
 serum glucose values can be taken from the blood gas analyser 
 if no blood was sampled for serum glucose measurement within 12 hours of being 
at or in the first hospital, then record serum glucose as missing 
Justification
Required for risk prediction models
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First recorded at hospital temperature 
Fields: First recorded at hospital temperature 
 First recorded at hospital temperature site 
Number of data items:  Two 
Units of measurement:  °C 
Options: First recorded at hospital temperature site – Central or   
Non-central
Definition for collection:  
 specifies the first temperature measured and recorded within 12 hours of 
attendance at the first hospital for this TBI 
 the first temperature may not be measured and recorded at the first hospital 
and, if transferred, may be measured and recorded at, or en route to (i.e. on 
the transfer form), a subsequent hospital within 12 hours of attendance at first 
hospital for this TBI 
 central are preferred to non-central temperatures, so if first temperature 
measured and recorded is non-central value, then use subsequent central if 
measured and recorded within one hour 
 central sites include tympanic membrane, nasopharyngeal, oesophageal, 
rectal, pulmonary artery and bladder; all other sites are considered to be     
non-central
 temperature values are included irrespective of whether the value was 
artificially manipulated through treatment such as central cooling 
 temperature values measured and recorded for the purpose of estimating 
perfusion e.g. toe or ear lobe, are not to be included 
 first recorded at hospital temperature site specifies whether site at which 
temperature was taken is Central or Non-central
Justification
Required for risk prediction models
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Gastrointestinal support days  
Field:  Gastrointestinal support days 
    
Number of data items:  One 
Units of measurement:  Calendar days 
Definition for collection: 
 specifies the number of calendar days during which the admission received any 
gastrointestinal support  whilst on your unit 
 a calendar day is defined as any complete calendar day (00:00-23:59) or part 
thereof, e.g. a patient admitted on 1 January 2006 at 23:45 and discharged on      
3 January 2006 at 00:10 would be recorded as having received three calendar 
days of care 
 record 1, 2, 3 etc for one, two, three etc calendar days; record 998 for 998 or more 
calendar days; record 999 for support occurring but number of days not known 
 Gastrointestinal – indicated by the following: 
o admissions receiving parenteral or enteral nutrition (i.e. any method of feeding 
other than normal oral intake) 
    
Justification 
Required to describe organs supported 
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GP Practice name   
Fields:  GP Practice name  
Number of data items:  One 
                       
Definition for collection: 
 specifies the name of the GP practice to which this admission to your unit is 
registered
 if the GP practice name is unobtainable, then leave field blank 
Justification 
Required for the six-month follow-up of admission with TBI
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GP Practice postcode   
Field:  GP Practice postcode  
Number of data items:  One 
                       
Definition for collection: 
 specifies the postcode of the GP practice to which this admission to your unit is 
registered
 if outcode (first half of postcode) is obtainable, then record this 
 if postcode is unobtainable, then record UNKNOWN 
Justification 
Required for the six-month follow-up of admission with TBI 
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GP’s initial(s)   
Field: GP’s initial(s)  
Number of data items:  One 
Definition for collection: 
 specifies the initial(s) of the GP to whom this admission to your unit is registered 
 if the initial(s) of the GP are not available, then please leave the field blank 
Justification 
Required for the six-month follow-up of admission with TBI
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GP’s surname   
Field: GP’s surname 
Number of data items:  One 
Definition for collection: 
 specifies the surname (family name) of the GP to whom this admission to your unit 
is registered 
Justification 
Required for the six-month follow-up of admission with TBI
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Has the patient been recruited into any other research study 
Field: Has the patient been recruited into any other research 
study?
Number of data items:  Four 
Options:  RESCUEicp – Yes or No
 Eurotherm3235 – Yes or No
 STITCH – Yes or No
 Other – Yes or No
Definition for collection: 
 specifies if the admission has been recruited into another research study or 
studies that involve(s) a six-month follow-up or multiple follow-ups 
 if the admission has been recruited into a research study that involves a six-
month follow-up or multiple follow-ups that has not been listed (e.g. Balti-2 
etc.), then select Other and enter the name of the research study in the 
Additional information text box 
 participation in another study does not prevent recruitment into RAIN, as RAIN 
is entirely observational and does not affect treatment 
Justification 
To ensure that follow up is streamlined so that patients are not contacted more often 
than is necessary 
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High/mixed density lesion greater than one millilitre present 
Field:   High/mixed density lesion greater than one millilitre present 
    
Number of data items:  One 
Options:                         Yes
No
    
Definition for collection: 
 specifies if there is a high/mixed density lesion greater than one millilitre on the 
first CT scan following the TBI 
 first CT scan is defined as the first CT scan performed after attendance at the first 
hospital for this TBI 
 where there is more than one CT scan performed, the first CT scan must be used 
for data abstraction; if transferred, the first CT scan may be performed at a 
subsequent hospital 
 Yes indicates there is a high/mixed density lesion of greater than one millilitre 
 No indicates there is no high/mixed density lesion of greater than one millilitre 
Justification 
Required for risk prediction models
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Hospital number   
Field: Hospital number  
    
Number of data items:  One 
    
Definition for collection: 
 unique number assigned by your hospital to each NHS hospital admission/patient 
Justification 
Provides a unique identifier that can be used to identify the patient on other hospital systems 
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Intoxication at time of TBI  
Field: Intoxication at time of TBI 
Number of data items:  One 
Options: Yes
Suspected
No
Definition for collection: 
 specifies whether admission was intoxicated (e.g. with drugs, alcohol etc.) at the 
time of TBI 
 Yes where evidence of intoxication recorded 
 Suspected where evidence indicates the admission may have been intoxicated 
(e.g., found outside pub, smells of alcohol etc.) 
 No where no evidence of intoxication recorded 
Justification 
Required for description of TBI 
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Last pre-sedation Glasgow Coma Score (GCS)  
Fields:   Last pre-sedation total GCS  
                          Associated eye component  
 Associated motor component  
 Associated verbal component  
 Location of last pre-sedation GCS 
    
Number of data items:  Five  
Units of measurement:  None 
Options:                         Location – Accident & Emergency, Ward, Critical care, Acute 
Assessment unit or Not in hospital 
    
Definition for collection: 
 specifies the last pre-sedation GCS assessed and recorded following admission to 
hospital or last GCS prior to or at admission to your unit, if never sedated 
 all values assessed and recorded from the same assessment of the last              
pre-sedation total GCS following admission to hospital 
 only GCS assessed when the admission is free from the effects of sedative and/or 
paralysing or neuromuscular blocking agents are valid 
 the determination as to whether an admission is free from the effects of sedative 
and/or paralysing or neuromuscular blocking agents is left to clinical judgement, as 
this is the only realistic standardisation for collection of these data at this time 
 admissions with self-sedation through deliberate or accidental overdose/poisoning 
should have a GCS assessed as seen 
 the GCS may be either documented as a score (for example, as numbers) or as 
explicit text allowing precise assignment of the score (e.g. “fully alert and 
orientated” equals 15).  
 see Appendix: How to assess the Glasgow Coma Score (GCS) 
 location of last pre-sedation GCS specifies where the last pre-sedation GCS was 
recorded
 Accident & Emergency is the Accident and Emergency department 
 Ward is any ward in the hospital 
 Critical care includes the intensive care unit, high dependency unit or equivalent 
step-up/down unit in the hospital and a recovery room used as a temporary critical 
care facility 
 Acute assessment Unit includes a medical or surgical admissions/assessment 
unit, or clinical decision unit in the hospital 
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 Not in hospital includes when the patient is being transferred (e.g. in an ambulance 
etc.)
 if the admission had the GCS recorded in specialist treatment area (e.g. 
endoscopy, catheter suites), imaging area (e.g. X-ray, CT, MRI or PET) or other 
transient locations, record the previous location from which the admission was 
sent from (A&E, Ward, Critical care or Acute assessment unit) 
Justification 
Required for risk prediction models
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Lesion(s) present 
Field:   Lesion(s) present 
    
Number of data items:  One 
Options:                         Yes
No
    
Definition for collection: 
 specifies if lesions(s) are present on the first CT scan following the TBI 
 first CT scan is defined as the first CT scan performed after attendance at the first 
hospital for this TBI 
 where there is more than one CT scan performed, the first CT scan must be used 
for data abstraction; if transferred, the first CT scan may be performed at a 
subsequent hospital 
 a lesion is defined as a high density or mixed density abnormality which may be 
within or outside the brain; it includes abnormalities referred to as haematoma, 
intracerebral haemorrhage, contusion, or shearing injuries 
 Yes indicates one or more lesions 
 No indicates no lesions 
Justification 
Acts as a filter field for CT findings
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Level of care at discharge  
[CMP: Level of care received at discharge from your unit]  
Field:  Level of care at discharge 
    
Number of data items:  One 
Options:                         Level 3
Level 2
Level 1
Level 0
Definition for collection: 
 level of care refers to the type of care received by the admission immediately prior 
to discharge from your unit  
 location of an admission does not determine level of care 
 Level 3 – indicated by one or more of the following: 
o admissions receiving advanced respiratory monitoring and support due to an 
acute illness 
o admissions receiving monitoring and support for two or more organ system 
dysfunctions (excluding gastrointestinal support) due to an acute illness 
 admissions solely receiving basic respiratory monitoring and support 
and basic cardiovascular monitoring and support due to an acute 
illness only meet Level 2 
 Level 2 – indicated by one or more of the following: 
o admissions receiving monitoring and support for one organ system dysfunction 
(excluding gastrointestinal support) due to an acute illness
 admissions solely receiving advanced respiratory monitoring and 
support due to an acute illness meet Level 3 
 admissions solely receiving basic respiratory and basic cardiovascular 
monitoring and support due to an acute illness meet Level 2 
o admissions receiving pre-surgical optimisation including invasive monitoring 
and treatment to improve organ system function 
o admissions receiving extended post-surgical care either because of the 
procedure and/or the condition of the admission  
o admissions stepping down to Level 2 from Level 3 care 
 Level 1 – indicated by one or more of the following: 
o admission recently discharged from a higher level of care 
o admissions receiving a greater degree of observation, monitoring, 
intervention(s), clinical input or advice than Level 0 care 
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o admissions receiving critical care outreach service support fulfilling the 
medium-score group, or higher, as defined by NICE Guidelines 50 
 Level 0 – indicated by the following: 
o admissions in hospital and receiving normal ward care 
Justification 
Required to describe admission with TBI 
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Levels of care
Fields:  Level 3 days 
 Level 2 days 
 Level 1 days 
 Level 0 days
    
Number of data items:  Four 
Units of measurement:  Calendar days 
Definition for collection: 
 a calendar day is defined as any complete calendar day (00:00-23:59) or part 
thereof e.g. a patient admitted on 1 January 2006 at 23:45 and discharged on       
3 January 2006 at 00:10 would be recorded as having received three calendar 
days of care 
 specifies the total number of calendar days during which the admission received
care at a specific level of care whilst on your unit 
 record 1, 2, 3 etc for one, two, three etc calendar days; record 998 for 998 or more 
calendar days; record 999 for support occurring but number of days not known 
 the highest level of care within a calendar day is recorded such that if an 
admission changes from level 2 care to level 3 care, or vice versa, during a 
calendar day, then the level of care recorded is level 3 e.g. a complete calendar 
day on which an admission receives 30 minutes of level 3 care and 23 hours,      
30 minutes of level 2 care is recorded as one calendar day of level 3 care 
 location of an admission does not determine level of care 
 Level 3 – indicated by one or more of the following: 
o admissions receiving advanced respiratory monitoring and support due to an 
acute illness  
o admissions receiving monitoring and support for two or more organ system 
dysfunctions (excluding gastrointestinal support) due to an acute illness  
 admissions solely receiving basic respiratory monitoring and support 
and basic cardiovascular monitoring and support due to an acute 
illness only meet Level 2 
 Level 2 – indicated by one or more of the following: 
o admissions receiving monitoring and support for one organ system dysfunction 
(excluding gastrointestinal support) due to an acute illness 
 admissions solely receiving advanced respiratory monitoring and 
support due to an acute illness meet Level 3 
 admissions solely receiving basic respiratory and basic cardiovascular 
monitoring and support due to an acute illness meet Level 2 
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o admissions receiving pre-surgical optimisation including invasive monitoring 
and treatment to improve organ system function 
o admissions receiving extended post-surgical care either because of the 
procedure and/or the condition of the admission  
o admissions stepping down to Level 2 from Level 3 care 
 Level 1 – indicated by one or more of the following: 
o admission recently discharged from a higher level of care 
o admissions receiving a greater degree of observation, monitoring, 
intervention(s), clinical input or advice than Level 0 care 
o admissions receiving critical care outreach service support fulfilling the 
medium-score group, or higher, as defined by NICE Guidelines 50 
 Level 0 – indicated by the following: 
o admissions in hospital and receiving normal ward care 
Justification 
Required to describe admission with TBI
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Liver support days  
Field:  Liver support days 
    
Number of data items:  One 
Units of measurement:  Calendar days 
    
Definition for collection: 
 specifies the number of calendar days during which the admission received liver 
support whilst on your unit 
 a calendar day is defined as any complete calendar day (00:00-23:59) or part 
thereof e.g. a patient admitted on 1 January 2006 at 23:45 and discharged on       
3 January 2006 at 00:10 would be recorded as having received three calendar 
days of care 
 record 1, 2, 3 etc for one, two, three etc calendar days; record 998 for 998 or more 
calendar days; record 999 for support occurring but number of days not known 
 Liver – indicated by the following: 
o admissions receiving management of coagulopathy (including liver purification 
and detoxification techniques) for acute on chronic hepatocellular failure, for 
portal hypertension, or for primary acute hepatocellular failure admissions 
being considered for transplantation 
Justification 
Required to describe organs supported 
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Major extracranial injury   
Field: Major extracranial injury  
Number of data items:  One 
Options: Present
Absent
Definition for collection: 
 specifies whether major extracranial injury or injuries exist  
 major injury is defined as an injury that would require hospital admission in its own 
right
 extracranial injury is defined as injury to any part of the body (excludes skull, but 
includes face, limbs, torso etc.) 
 major extracranial injures may have been diagnosed pre-hospital or within              
12 hours of attendance at first hospital for this TBI admission 
 Present when major extracranial injury or injuries are recorded 
 Absent when major extracranial injury or injuries are not recorded 
Justification 
Required for risk prediction models 
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Midline shift present 
Field:   Midline shift present 
    
Number of data items:  One 
Options:                         Yes – greater than five millimetres 
No – less than or equal to five millimetres 
Definition for collection: 
 specifies if a midline shift of the brain is present on the first CT scan following the 
TBI
 first CT scan is defined as the first CT scan performed after attendance at the first 
hospital for this TBI 
 where there is more than one CT scan performed, the first CT scan must be used 
for data abstraction; if transferred, the first CT scan may be performed at a 
subsequent hospital 
 Yes indicates a midline shift of greater than five millimetres is present i.e. when the 
degree of displacement of the midline is more than 5 millimetres 
 No indicates a midline shift of less than or equal to five millimetres is present i.e. 
when the degree of displacement of midline is from 0-5 millimetres 
 see Appendix: How to measure the midline shift 
Justification 
Required for risk prediction models
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Neurological support days  
Field:  Neurological support days 
    
Number of data items:  One 
Units of measurement:  Calendar days  
Definition for collection: 
 specifies the number of calendar days during which the admission received any 
neurological support whilst on your unit 
 a calendar day is defined as any complete calendar day (00:00-23:59) or part 
thereof e.g. a patient admitted on 1 January 2006 at 23:45 and discharged on       
3 January 2006 at 00:10 would be recorded as having received three calendar 
days of care 
 record 1, 2, 3 etc. for one, two, three etc. calendar days; record 998 for 998 or 
more calendar days; record 999 for support occurring but number of days not 
known
 Neurological – indicated by one or more of the following: 
o admissions with central nervous system depression sufficient to prejudice their 
airway and protective reflexes, except central nervous system depression 
caused by sedation prescribed to facilitate mechanical ventilation; or, except 
poisoning (e.g. deliberate or accidental self-administered overdose, alcohol, 
drugs etc.) 
o admissions receiving invasive neurological monitoring or treatment (e.g. ICP 
(intracranial pressure), jugular bulb sampling, external ventricular drain etc.) 
o admissions receiving continuous intravenous medication to control seizures 
and/or for continuous cerebral monitoring 
o admissions receiving therapeutic hypothermia using cooling protocols or 
devices
Justification 
Required to describe organs supported 
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NHS number (or CHI number)  
Field: NHS number (or CHI number) 
    
Number of data items:  One 
    
Definition for collection: 
 unique number assigned by the NHS as a numeric ten digit code to each NHS 
patient
 use the Community Health Index (CHI) number in Scotland 
Justification 
Required to record the patient journey across hospitals allowing us to investigate transfers 
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One or more small petechial haemorrhages less than or equal to one millilitre present 
Field:   One or more small petechial haemorrhages less than or equal 
to one millilitre present 
    
Number of data items:  One 
Options:                         Yes
No
    
Definition for collection: 
 specifies if there are one or more small petechial haemorrhages less than or equal 
to one millilitre present on the first CT scan following the TBI  
 first CT scan is defined as the first CT scan performed after attendance at the first 
hospital for this TBI 
 where there is more than one CT scan performed, the first CT scan must be used 
for data abstraction; if transferred, the first CT scan may be performed at a 
subsequent hospital 
 small petechial haemorrhages includes small petechial haemorrhages at gray-
white matter junction, hemispheric white matter, corpus callosum or brainstem 
 Yes indicates there are one or more small petechial haemorrhages less than or 
equal to one millilitre present 
 No indicates there are no small petechial haemorrhages present 
Justification 
Required for risk prediction models
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Patient’s full name   
Fields: Patient’s first name 
 Patient’s surname 
Number of data items:  Two 
Definition for collection: 
 specifies the first name and surname (family name) of this admission to your unit 
Justification 
Required for the six-month follow-up of admission with TBI
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Patient’s house number or name   
Fields:  Patient’s house number or name 
Number of data items:  One 
                       
Definition for collection: 
 specifies the normal residential house number/name for this admission to your unit 
 for visitors to area, use normal residential address for admission’s permanent 
place of residence 
 if address is unobtainable, then leave field blank 
Justification 
Required for the six-month follow-up of admission with TBI
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Patient’s postcode   
Field:  Patient’s postcode  
Number of data items:  One 
                       
Definition for collection: 
 specifies the normal residential postcode for this admission to your unit 
 for visitors to area, use normal residential postcode for admission’s permanent 
place of residence in United Kingdom 
 if admission is not a resident of the United Kingdom and Ireland, then use the 
drop-down list of countries 
 if outcode (first half of postcode) is obtainable, then record this 
 if postcode is unobtainable, then record UNKNOWN 
Justification 
Required for the six-month follow-up of admission with TBI 
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Patient’s title   
Field: Patient’s title  
Number of data items:  One 
Definition for collection: 
 specifies the title (Mr, Mrs, Ms etc) of this admission to your unit 
Justification 
Required for the six-month follow-up of admission with TBI
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Pre-hospital AVPU 
Fields:  Pre-hospital AVPU recorded? 
  Pre-hospital AVPU 
Number of data items:  Two 
Options:  Pre-hospital AVPU recorded? – Yes or No
Pre-hospital AVPU – Alert, Voice, Pain or Unresponsive
Definition for collection: 
 specifies the last AVPU assessed and recorded prior to attendance at first hospital 
for this TBI   
 if AVPU assessed and recorded prior to attendance at first hospital for this TBI, 
then indicate Yes, if not, then indicate No
 Alert indicates that the admission was fully awake (although may be confused or 
disorientated etc.), spontaneously opened eyes, responded to voice and had 
bodily motor function 
 Voice indicates that the admission made a response when spoken to, this may be 
a verbal response (speech, a groan etc.) or movement of a limb 
 Pain indicates that the admission made a response to a painful stimulus (e.g. limb 
withdrawal from the painful stimulus etc.) 
 Unresponsive indicates that the admission did not give any eye, voice or motor 
response when spoken to or to a painful stimulus, i.e. unconscious 
Justification 
Required for risk prediction models 
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Pre-hospital blood pressure   
Fields:  Pre-hospital blood pressure recorded? 
 Pre-hospital systolic blood pressure  
  Pre-hospital paired diastolic blood pressure  
 Pre-hospital hypotension strongly suspected? 
Number of data items:  Four 
Units of measurement:  mmHg 
Options: Pre-hospital blood pressure recorded? – Yes or No
 Hypotension strongly suspected? – Yes or No
Definition for collection: 
 specifies the first blood pressure measured and recorded and whether the 
admission was hypotensive prior to attendance at the first hospital for this TBI 
 if pre-hospital blood pressure was measured and recorded prior to attendance at 
the first hospital for this TBI, then indicate Yes, if not, then indicate No
 if pre-hospital blood pressure values recorded, then record first systolic blood 
pressure measured and recorded (i.e. prior to attendance at the first hospital for 
this TBI) plus paired diastolic blood pressure (i.e. values from same measurement)
 blood pressure values are included irrespective of the measurement method used  
 where blood pressure values are not detectable or measurable, the value zero 
should be recorded 
 if only the systolic blood pressure value was measured and recorded (i.e. paired 
diastolic is missing), then enter this value 
 if pre-hospital hypotension strongly suspected, then indicate Yes, if not, then 
indicate No
 hypotension strongly suspected specifies that admission had poor peripheral 
perfusion, a major haemorrhage (or other injuries likely to have caused a major 
bleed, such as a serious fracture to the pelvis or major long bones), increased 
lactate levels, admission appeared to be in shock, or if admission was recorded as  
"blood pressure low" etc but actual numbers were not recorded 
Justification
Required for risk prediction models
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Pre-hospital Glasgow Coma Score (GCS)  
Fields:   Pre-hospital GCS recorded? 
 Pre-hospital total GCS 
                          Associated eye component  
 Associated motor component  
 Associated verbal component  
 Was this the last pre-sedation GCS? 
    
Number of data items:  Six 
Units of measurement:  None 
Options:                         Pre-hospital GCS recorded? – Yes or No
 Was this the last pre-sedation GCS? – Yes or No
    
Definition for collection: 
 specifies the last pre-sedation GCS assessed and recorded prior to attendance at 
first hospital for this TBI 
 if GCS assessed and recorded prior to attendance at first hospital for this TBI, then 
indicate Yes, if not, then indicate No
 all values assessed and recorded from the same assessment of the last total GCS 
prior to attendance at first hospital 
 only GCS assessed when the admission is free from the effects of sedative and/or 
paralysing or neuromuscular blocking agents are valid 
 the determination as to whether an admission is free from the effects of sedative 
and/or paralysing or neuromuscular blocking agents is left to clinical judgement, as 
this is the only realistic standardisation for collection of these data at this time 
 admissions with self-sedation through deliberate or accidental overdose/poisoning 
should have a GCS assessed as seen 
 the GCS may be either documented as a score (for example, as numbers) or as 
explicit text allowing precise assignment of the score (e.g. “fully alert and 
orientated” equals 15) 
 if only the total GCS prior to admission to first hospital was recorded (i.e. the 
associated components are missing), then enter this value 
 see Appendix: How to assess the Glasgow Coma Score (GCS) 
 indicate whether this was the most recent or last pre-sedation GCS recorded (i.e. 
is there another pre-sedation GCS recorded since this value?) 
Justification 
Required for risk prediction models
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Pre-hospital oxygen saturation  
Fields:   Pre-hospital oxygen saturation recorded? 
  Pre-hospital oxygen saturation  
  Pre-hospital hypoxia strongly suspected? 
Number of data items:  Three 
Units of measurement:  % 
Options: Pre-hospital oxygen saturation recorded? – Yes or No
 Pre-hospital hypoxia strongly suspected? – Yes or No
Definition for collection: 
 specifies the first oxygen saturation measured and recorded and whether the 
admission was hypoxic prior to attendance at the first hospital for this TBI 
 if pre-hospital oxygen saturation measured and recorded prior to attendance at the 
first hospital for this TBI, then indicate Yes, if not then indicate No
 if pre-hospital oxygen saturation measured and recorded, then record the first 
oxygen saturation measured and recorded (i.e. prior to attendance at the first 
hospital for this TBI) 
 oxygen saturation is normally recorded with pulse oximeter 
 if pre-hospital hypoxia strongly suspected, then indicate Yes, if not, then indicate 
No
 pre-hospital hypoxia strongly suspected specifies that admission was recorded as, 
for example, cyanosed, had a blocked airway, had aspirated gastrointestinal 
contents, had clinical evidence of tension pneumothorax etc. 
Justification 
Required for risk prediction models
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Pre-hospital pupil reactivity and size of pupils 
Field: Pre-hospital pupil reactivity and/or size recorded? 
Pre-hospital pupil reactivity (left eye)   
Pre-hospital size of pupils (left eye) 
Pre-hospital pupil reactivity (right eye) 
Pre-hospital size of pupils (right eye) 
Number of data items: Five  
Units of measurement:  mm  
Options: Pre-hospital pupil reactivity and/or size recorded?                      
– Yes – both, yes – Reactivity, yes – Size or No
 Pre-hospital pupil reactivity – Reactive, Unreactive or
uNable to assess 
 Pre-hospital size of pupils – 1 mm, 2 mm, 3 mm, 4 mm, 5 mm,   
6 mm or greater than or equal to 7 mm 
                                
Definition for collection: 
 specifies first pupil reactivity and size of pupils assessed and recorded, for both 
eyes, prior to attendance at the first hospital for this TBI 
 if pupil reactivity and size were assessed and recorded prior to attendance at the 
first hospital for this TBI then indicate Yes - both, if neither recorded then indicate 
No, if reactivity was assessed but not size then record yes – Reactivity, if size was 
measured but not reactivity then record yes - Size
 Reactive is defined as pupillary contraction to strong direct light, Unreactive is 
defined as no pupillary contraction to strong direct light 
 uNable to assess is defined where pupils cannot be inspected (e.g. eyes are 
closed due to facial injury or swelling, etc) 
 pupils are recorded regardless of whether admission is ventilated or sedated 
 chronically altered pupils from previous disease should be recorded as unable to 
assess
 only assess pupil reactivity and size when an admission is free from iatrogenic 
drug effects (e.g. drops given for dilation)  
 size of pupils is the diameter of the right and left pupil in mm; if pupils are equal to 
or more than 7 mm then record as greater than or equal to 7 mm 
Justification   
Required for risk prediction models
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Previous RAIN Study Admission number   
Field:  Previous RAIN Study Admission number   
Number of data items: One 
Units of measurement:  None 
Definition for collection: 
 specifies the previous RAIN Study Admission number for this admission  
 if the admission was previously admitted to your unit and entered on the RAIN 
secure, web-based data entry system, then enter the RAIN Study Admission 
number for this admission 
 admission to your unit is defined as the physical admission and the recording of 
that admission to a bed in your unit 
Justification 
Acts as a filter field for all RAIN Study screens 
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Prior source    
[CMP: Prior location (in)] 
Field: Prior source  
Number of data items: One    
Options: Ward
 oBstetrics area  
 other interMediate care area 
 Paediatric ICU/HDU 
 level 3 bed in adult ICU or ICU/HDU 
 level 2 bed in adult ICU or ICU/HDU
 adult HDU
Not in hospital 
                                
Definition for collection: 
 specifies the non-transient prior source for admissions where the Direct source is 
transient (i.e. theatre & recovery, accident & emergency, recovery only, imaging 
department, specialist treatment area, clinic) 
 Ward is a ward in the hospital 
 oBstetrics area is a delivery suite, labour ward or obstetrics ward in the hospital 
 other interMediate care area is a CCU or other area in the hospital where the level 
of care is greater than the normal ward but is not an ICU or combined ICU/HDU or 
HDU (use text box to specify where) 
 Paediatric ICU/HDU is a paediatric ICU or combined ICU/HDU or HDU in the 
hospital
 level 3 bed in adult ICU or ICU/HDU is a level 3 bed in either an adult ICU or a 
combined ICU/HDU in the hospital 
 level 2 bed in adult ICU or ICU/HDU is a level 2 bed in either an adult ICU or a 
combined ICU/HDU in the hospital 
 adult HDU is an adult HDU or equivalent step-up/step-down unit in the hospital, 
where the Critical Care Minimum Data Set (CCMDS) is collected 
 Not in hospital is defined as not in hospital 
Justification 
Required to describe admission with TBI
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Prior source location  
[CMP: Hospital housing non-transient location (in)] 
Field: Prior source location  
    
Number of data items: One 
Options: Same hospital 
 other Acute hospital  
 nOn-acute hospital 
    
   
Definition for collection: 
 specifies the hospital housing the non-transient (Ward, Obstetrics area, Level 3 
bed in adult ICU or ICU/HDU, Adult HDU etc) prior source for admission where the 
Direct source is transient 
 Same hospital is defined as the hospital that houses your unit 
 other Acute hospital, one that does not house your unit, is defined as another 
hospital (can be in the same or a different NHS Trust) that provides a range of 
acute hospital services to diagnose, treat and care for seriously ill or injured 
patients; some acute hospitals may provide only specialist services while others 
will provide general services 
 nOn-acute hospital is defined as another hospital (can be in the same or a different 
NHS Trust) that provides a range of short or long-term non-acute services 
    
Justification 
Required to describe admission with TBI
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Pupil reactivity and size of pupils on admission to your unit 
Field: Pupil reactivity and/or size on admission to your unit recorded? 
Admission pupil reactivity (left eye) 
Admission size of pupils (left eye) 
Admission pupil reactivity (right eye) 
Admission size of pupils (right eye) 
Number of data items: Five  
Units of measurements: mm 
Options: Pupil reactivity and/or size on admission to your unit recorded? 
– Yes – both, yes – Reactivity, yes – Size or No
 Pupil reactivity on admission to your unit – Reactive, Unreactive
or uNable to assess
 Admission size of pupils – 1 mm, 2 mm, 3 mm, 4 mm, 5 mm,     
6 mm or greater than or equal to 7 mm
    
                                
Definition for collection: 
 specifies pupil reactivity and size of pupils assessed and recorded, for both eyes, 
following admission to your unit 
 if pupil reactivity and size were measured and assessed following admission to 
your unit then indicate Yes - both, if neither recorded then indicate No, if reactivity 
was assessed but not size then record yes – Reactivity, if size was measured but 
not reactivity then record yes - Size
 Reactive is defined as pupillary contraction to strong direct light, Unreactive is 
defined as no pupillary contraction to strong direct light 
 uNable to assess is defined where pupils cannot be inspected (e.g. eyes are 
closed due to facial injury or swelling, etc) 
 pupil reactivity and size of pupils must be measured and recorded within one hour
of admission to your unit 
 if pupil reactivity and size is measured and recorded more than once within one 
hour of admission to your unit, then enter the values closest to the time of 
admission
 pupils are recorded regardless of whether admission is ventilated or sedated 
 chronically altered pupils from previous disease should be recorded as unable to 
assess
 only assess pupil reactivity and size when an admission is free from iatrogenic 
drug effects (e.g. drops given for dilation)  
 size of pupils is the diameter of the right and left pupil in mm; if pupils are equal to 
or more than 7 mm then record as greater than or equal to 7 mm 
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Justification 
Required for risk prediction models
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RAIN Study Admission number   
Field:  RAIN Study Admission number   
Number of data items: One 
Units of measurement:  None 
Definition for collection: 
 unique number assigned to each admission to your unit with TBI  
 value will be automatically generated by secure, web-based data entry system as 
each admission record is created 
 admission to your unit is defined as the physical admission and the recording of 
that admission to a bed in your unit 
Justification 
Provides a unique confidential identifier for each admission with TBI to each unit participating 
in the RAIN Study 
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RAIN Study Centre number   
Field: RAIN Study Centre number   
Number of data items: One 
Definition for collection: 
 unique unit identifier supplied by ICNARC to each unit participating in the RAIN 
Study
 value will be automatically generated by secure web-based data entry system 
Justification 
Provides a unique, confidential identifier for each unit participating in the RAIN Study 
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Registered GP Practice Code  
Field:  Registered GP Practice Code  
Number of data items:  One 
                       
Definition for collection: 
 specifies the Registered GP Practice Code of the GP to whom this admission to 
your unit is registered 
 this consists of a letter followed by five numerals 
 if there is no Registered GP Practice Code leave the field blank 
Justification 
Required for the six-month follow-up of admission with TBI 
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Renal support days   
Field:  Renal support days 
Number of data items:  One 
Units of measurement:  Calendar days  
Definition for collection: 
 specifies the number of calendar days during which the admission received renal 
support whilst on your unit 
 a calendar day is defined as any complete calendar day (00:00-23:59) or part 
thereof e.g. a patient admitted on 1 January 2006 at 23:45 and discharged on       
3 January 2006 at 00:10 would be recorded as having received three calendar 
days of care 
 record 1, 2, 3 etc for one, two, three etc calendar days; record 998 for 998 or more 
calendar days; record 999 for support occurring but number of days not known 
 Renal - indicated by the following: 
o admissions receiving acute renal replacement therapy (e.g. haemodialysis, 
haemofiltration etc.) 
o admissions receiving renal replacement therapy for chronic renal failure where 
other acute organ support is received 
 last day of renal support is the date and time of completion of final renal 
replacement treatment 
Justification 
Required to describe organs supported 
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Residence post-discharge   
[CMP: Residence post-discharge from acute hospital]   
Field: Residence post-discharge  
Number of data items: One 
Options: hoMe
 nUrsing home or equivalent 
 health-related institution – Short-term rehabilitation 
  health-related institution – Long-term rehabilitation 
other Health-related institution 
 nOn-health-related institution   
Residential place of work/education  
 hosPice or equivalent 
No fixed address/abode or temporary abode  
                 
Definition for collection: 
 specifies the admission’s permanent/semi-permanent place of residence post-
discharge from acute hospital 
 hoMe includes owner occupied and rented property, sheltered housing, safe 
housing, warden-controlled housing, mobile homes, houseboats, bed and 
breakfast (if not on holiday and on a semi-permanent basis) etc. 
 nUrsing home or equivalent is an establishment providing nursing or personal care 
services to the older or infirm or chronically-ill population 
 health-related institution – Short-term rehabilitation includes a short-term care 
facility where rehabilitation (active promotion of recovery) care is focused on 
restoring and optimizing the admission's functional independence and health for a 
defined period with a view to subsequent discharge to a permanent/semi-
permanent place of residence
 health-related institution – Long-term rehabilitation includes a long-term care 
facility where rehabilitation (active promotion of recovery) care is intertwined with 
maintenance (active prevention of deterioration) and other care (support for 
disabilities) focused on stabilising the admission’s functional independence and 
health for an undefined period and with only the possibility of subsequent 
discharge to a permanent/semi-permanent place of residence  
 other Health-related institution includes any other health-related institution (not 
short-term or long-term rehabilitation) from which there is no possibility of 
subsequent discharge to a permanent/ semi-permanent place of residence (e.g. 
institution for chronically sick etc.) 
 nOn-health-related institution includes prison, correctional facility, children’s home 
etc.
 Residential place of work/education includes barracks, oil rig, lighthouse, 
monastery, trawler, embassy, cruise ship, boarding school, university etc. 
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 hosPice or equivalent is an establishment providing medical care and support 
services to terminally-ill persons 
 No fixed address/abode or temporary abode includes homeless or in hostels, bed 
and breakfast (if not on holiday and on a temporary basis) 
Justification
Required to describe admission with TBI 
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Residence prior to admission to acute hospital    
Field: Residence prior to admission to acute hospital  
Number of data items: One 
Options: hoMe
 nUrsing home or equivalent 
Health-related institution  
 nOn-health-related institution   
Residential place of work/education  
 hosPice or equivalent 
No fixed address/abode or temporary abode  
                
Definition for collection: 
 specifies admission’s permanent/semi-permanent place of residence prior to 
admission to acute hospital 
 for transient locations e.g. on holiday, in the pub, on the tennis court, in a car park, 
in a hotel (medical tourist), outside etc. use admission’s permanent/semi-
permanent place of residence 
 hoMe includes owner occupied and rented property, sheltered housing, safe 
housing, warden-controlled housing, mobile homes, houseboats, bed and 
breakfast (if not on holiday and on a semi-permanent basis) etc. 
 nUrsing home or equivalent is an establishment providing nursing or personal care 
services to the older or infirm or chronically-ill population 
 Health-related institution includes psychiatric hospital, hospital or institution for 
chronically sick etc. 
 nOn-health-related institution includes prison, correctional facility, children’s home 
etc.
 Residential place of work/education includes barracks, oil rig, lighthouse, 
monastery, trawler, embassy, cruise ship, boarding school, university etc. 
 hosPice or equivalent is an establishment providing medical care and support 
services to terminally-ill persons 
 No fixed address/abode or temporary abode includes homeless or in hostels, bed 
and breakfast (if not on holiday and on a temporary basis) 
Justification
Required to describe admission with TBI 
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Respiratory support days   
Fields:  Basic respiratory support days 
 Advanced respiratory support days 
Number of data items:  Two  
Units of measurement:  Calendar days  
Definition for collection: 
 specifies the number of calendar days during which the admission received any 
basic or advanced respiratory support whilst on your unit  
 a calendar day is defined as any complete calendar day (00:00-23:59) or part 
thereof e.g. a patient admitted on 1 January 2006 at 23:45 and discharged on       
3 January 2006 at 00:10 would be recorded as having received three calendar 
days of care 
 record 1, 2, 3 etc for one, two, three etc calendar days; record 998 for 998 or more 
calendar days; record 999 for support occurring but number of days not known 
 Advanced Respiratory - indicated by one or more of the following (see diagram): 
o admissions receiving invasive mechanical ventilatory support applied via a 
trans-laryngeal tube or applied via a tracheostomy 
o admissions receiving BiPAP (bilevel positive airway pressure) applied via a 
trans-laryngeal tracheal tube or applied via a tracheostomy  
o admissions receiving CPAP (continuous positive airway pressure) via a trans-
laryngeal tracheal tube
o admissions receiving extracorporeal respiratory support 
o admissions receiving mask/hood CPAP or mask/hood BiPAP is not
considered advanced respiratory support 
 Basic Respiratory - indicated by one or more of the following (see diagram): 
o admissions receiving more than 50% oxygen delivered by a face mask 
(except those receiving short-term increases in FiO2, e.g. during transfer, for 
physiotherapy, etc.) 
o admissions receiving close observation due to the potential for acute 
deterioration to the point of requiring advanced respiratory monitoring and 
support e.g. severely compromised airway, deteriorating respiratory muscle 
function, etc. 
o admissions receiving physiotherapy or suction to clear secretions, at least two 
hourly, either via a tracheostomy, a minitracheostomy or in the absence of an 
artificial airway 
o admissions recently (i.e. within 24 hours) extubated after a period of intubation 
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o admissions recently (i.e. within 24 hours) extubated after a period (i.e. more 
than 24 hours) of mechanical ventilation via an endotracheal tube 
o admissions receiving mask/hood CPAP or mask/hood BiPAP or non-invasive 
ventilation
o admissions receiving CPAP via a tracheostomy 
o admissions intubated to protect their airway but receiving no ventilatory 
support and who are otherwise stable. 
 Note: If advanced and basic respiratory monitoring and support occur 
simultaneously, then only advanced respiratory monitoring and support should be 
recorded.
 The following diagram may aid categorisation to advanced or basic respiratory 
support
Justification 
Required to describe organs supported 
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Road traffic accident details 
Field: Road traffic accident details 
Number of data items:  One 
Options: Vehicle occupant 
Motorcyclist
 Cyclist
Pedestrian
Other
Definition for collection: 
 specifies road traffic accident details 
 Vehicle occupant includes driver or passenger in vehicle  
 Motorcyclist includes driver or passenger on motorcycle or sidecar (e.g. motorised 
two-wheeled vehicle) etc. 
 Cyclist includes cyclist or passenger on pedal bike 
 Pedestrian includes someone on foot 
 Other is where road traffic accident details do not fit into above categories  
Justification 
Required to describe admission with TBI 
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Sex   
Field: Sex  
Number of data items:  One 
Options: Female
Male
Definition for collection: 
 specifies the genotypical (i.e. sex they were born as) sex of the admission 
Justification 
Required to describe admission with TBI 
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Site(s) of major extracranial injury   
Fields: Spine 
 Limb 
 Head and neck 
 Chest 
 Pelvis 
 Abdomen 
Number of data items:  Six 
Options: Present
Absent
Definition for collection: 
 specifies site(s) of major extracranial injury or injuries 
 major injury is defined as an injury that would require hospital admission in its own 
right
 extracranial injury is defined as injury to any part of the body (excludes skull, but 
includes face, limbs, torso etc) 
 spine specifies injury to nerve tissue in spinal canal and/or damage to the spinal 
vertebrae
 limb specifies injury to arms (including hands) or legs (including feet) 
 head and neck specifies extracranial injury to scalp, face or neck 
 chest specifies injury to area between the neck and diaphragm (heart and lungs 
area)
 pelvis specifies injury to skeletal structure that joins spine and lower limbs 
 abdomen specifies injury to lower torso (excluding pelvis) 
Justification 
Required for risk prediction models
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Source location  
[CMP: Hospital housing non-transient location (in) or Hospital housing transient location (in)] 
Field: Source location  
    
Number of data items: One 
Options: Same hospital 
 other Acute hospital  
 nOn-acute hospital 
    
   
Definition for collection: 
 specifies the hospital housing the Direct source from which this admission was 
admitted to your unit 
 Same hospital is defined as the hospital that houses your unit 
 other Acute hospital, one that does not house your unit, is defined as another 
hospital (can be in the same or a different NHS Trust) that provides a range of 
acute hospital services to diagnose, treat and care for seriously ill or injured 
patients; some acute hospitals may provide only specialist services while others 
will provide general services 
 nOn-acute hospital is defined as another hospital (can be in the same or a different 
NHS Trust) that provides a range of short or long-term non-acute services 
    
Justification 
Required to describe admission with TBI
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Spinal cord injury present   
Fields: Spinal cord injury present 
Number of data items:  One 
Options: Yes
No
Definition for collection: 
 specifies if there was a spinal cord injury consistent with major neurological deficit 
 Yes indicates injury to the nerve tissue in spinal canal consistent with major 
neurological deficit 
 No indicates no injury to the nerve tissue in spinal canal or any injury that is not 
consistent with major neurological deficit 
Justification 
Required to describe admission with TBI
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Status at discharge from your hospital  
Field:  Status at discharge from your hospital 
Number of data items: One 
Options: Alive
Dead
Definition for collection: 
 specifies the status of the admission at discharge from the hospital housing your 
unit
Justification 
Required for risk prediction models 
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Status at discharge from your unit    
Field:  Status at discharge from your unit  
Number of data items: One 
Options: Alive
Dead
Definition for collection: 
 specifies the status of the admission at discharge from your unit 
 Dead includes admissions who leave your unit to become heartbeating organ 
donors
Justification 
Required for risk prediction models 
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Third ventricle 
Field:   Third ventricle 
    
Number of data items:  One 
Options:                         Obliterated
 Present
    
Definition for collection: 
 specifies the appearance of the third ventricle on the first CT scan following the 
TBI
 first CT scan is defined as the first CT scan performed after attendance at the first 
hospital for this TBI 
 where there is more than one CT scan performed, the first CT scan must be used 
for data abstraction; if transferred, the first CT scan may be performed at a 
subsequent hospital 
 Obliterated indicates the third ventricle is not present 
 Present indicates the third ventricle appears normal on the first CT scan  
Justification 
Required for risk prediction models
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Traumatic subarachnoid haemorrhage present 
Field:   Traumatic subarachnoid haemorrhage present 
    
Number of data items:  One 
Options:                         Yes
No
    
Definition for collection: 
 specifies if a traumatic subarachnoid haemorrhage was present on the first CT 
scan following the TBI 
 first CT scan is defined as the first CT scan performed after attendance at the first 
hospital for this TBI  
 where there is more than one CT scan performed, the first CT scan must be used 
for data abstraction; if transferred, the first CT scan may be performed at a 
subsequent hospital 
 traumatic subarachnoid haemorrhage is defined as a collection of blood between 
the arachnoid and pia mater either over the convexity or in the basal cisterns 
 Yes indicates there is a traumatic subarachnoid haemorrhage  
 No indicates no traumatic subarachnoid haemorrhage 
 if there is uncertainty on whether subarachnoid haemorrhage is caused by the TBI, 
then record as Yes
Justification 
Required for risk prediction model
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Type of high/mixed density lesion(s) present 
Field:   Extradural haematoma(s) present 
 Subdural haematoma(s) present 
 Intracerebral haematoma(s) haemorrhage(s) or contusion(s) 
present
 Posterior fossa haematoma(s) present 
 Main mass lesion 
Number of data items:  Five 
Options:                         Type of high/mixed density lesion(s) present – Yes or No
 Main mass lesion – Extradural, Subdural, Intracerebral or 
Posterior fossa haematoma
Definition for collection: 
 specifies the type(s) of haematoma(s) present on the first CT scan following the 
TBI
 first CT scan is defined as the first CT scan performed after attendance at the first 
hospital for this TBI  
 where there is more than one CT scan performed, the first CT scan must be used 
for data abstraction; if transferred, the first CT scan may be performed at a 
subsequent hospital 
 extradural haematoma (or epidural haematoma or extradural haemorrhage) is 
defined as an accumulation of blood between the skull and dura mater 
 subdural haematoma (or subdural haemorrhage) is defined as a collection of blood 
between the dura and the arachnoid mater 
 intracerebral haematoma (or intracerebral haemorrhage or contusion) is defined as 
bleeding within the cerebral hemispheres 
 posterior fossa haematoma is defined as a collection of blood in the intracranial 
cavity in posterior fossa  
 main mass lesion indicates which is the main (largest volume) mass lesion  
Justification 
Required for risk prediction models
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Type of TBI   
Field: Type of TBI  
Number of data items:  One 
Options: Penetrating
Non-penetrating
Definition for collection: 
 specifies type of TBI  
 Penetrating head injury is defined as when an object/projectile penetrates the 
skull; the skull may have a fracture, but if an object has not penetrated the skull it 
is classed as non-penetrating 
 Non-penetrating head injury is when an object/projectile does not penetrate the 
skull and includes closed head injury; the skull may have a fracture, but if an object 
has not penetrated the skull it is classed as non-penetrating 
Justification 
Required for risk prediction models 
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Type of unit (in)   
[CMP: Type of adult ICU/HDU (in)]    
Field:                  Type of unit (in) 
Number of data items:       One 
Options:                             General
Cardiac
Thoracic
Liver
Spinal injury 
Burns & plastic 
Renal
Neurosciences
Medical
 sUrgical
Obstetric
Definition for collection: 
 specifies the type of adult ICU or combined ICU/HDU or HDU from which the 
admission was transferred prior to admission to your unit 
 specifies the principal clinical service or predominant patient population 
 for mixed units use either General or the predominant specialty 
Justification 
Required to describe admission with TBI   
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Type of unit (out)   
[CMP: Type of adult ICU/HDU (out)]    
Field:  Type of unit (out)  
Number of data items:  One 
Options:                         General
Cardiac
Thoracic
Liver
Spinal injury 
Burns & plastic 
Renal
Neurosciences
Medical
 sUrgical
Obstetric
Definition for collection: 
 specifies the type of adult ICU or combined ICU/HDU or HDU to which the 
admission was transferred post-discharge from your unit 
 specifies the principal clinical service or predominant patient population 
 for mixed units use either General or the predominant specialty 
Justification 
Required to describe admission with TBI 
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Ultimate date of discharge   
[CMP: Date of ultimate discharge from hospital] 
Field:  Ultimate date of discharge 
Number of data items: One    
Units of measurement: Date  dd/mm/yyyy 
Definition for collection: 
 specifies the latest documented date of the admission being physically within an 
acute in-patient bed in an acute hospital, or the date of death 
 ultimate discharge from hospital is defined as the physical discharge and recording 
of that discharge from an acute in-patient bed in an acute hospital  
 an acute hospital is defined as any hospital providing a range of acute hospital 
services to diagnose, treat and care for seriously ill or injured patients; some acute 
hospitals may provide only specialist services while others will provide general 
services 
 where more than one date of discharge from hospital is documented, the latest 
documented date is recorded   
 this is not necessarily the date of discharge from the acute hospital to which the 
admission was directly transferred  
    
Justification 
Required to describe admission with TBI 
NIHR Journals Library www.journalslibrary.nihr.ac.uk
appenDIx 3
272
Version 1.6 RAIN / February 2010 114
Ultimate status at discharge   
[CMP: Status at ultimate discharge from hospital] 
Field:  Ultimate status at discharge 
Number of data items:  One 
Options:                         Alive
Dead
Definition for collection: 
 specifies the status at ultimate discharge from acute hospital 
 the hospital is another acute hospital, not the hospital housing your unit 
Justification 
Required for the risk prediction models 
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Ultimate status at discharge from critical care  
[CMP: Status at ultimate discharge from ICU/HDU]    
Field:  Ultimate status at discharge from critical care 
Number of data items:  One 
Options:                         Alive
Dead
Definition for collection: 
 specifies the status of the admission on ultimate discharge from adult critical care, 
the ultimate discharge is defined as the physical discharge and recording of that 
discharge from a bed in another critical care unit 
 critical care unit is defined as an ICU or a combined ICU/HDU or an HDU 
Justification 
Required for risk prediction models
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Unit in your critical care transfer group (in) 
[CMP: Adult ICU/HDU within your critical care transfer group (in)] 
Field:  Unit in your critical care transfer group (in) 
Number of data items:  One 
Options: Yes
No
Definition for collection: 
 specifies whether the critical care unit (adult ICU or combined ICU/HDU or HDU) is 
part of your critical care transfer group 
 a critical care transfer group is defined as the group, recommended by 
“Comprehensive Critical Care” and supported by “Quality Critical Care”, specified 
and developed to reduce the number of long distance transfers that take place and 
to ensure that transfers are contained within the critical care network or, by special 
agreement, between hospitals at the borders of adjacent networks 
Justification 
Required to describe admission with TBI
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Unit in your critical care transfer group (out) 
[CMP: Adult ICU/HDU within your critical care transfer group (out)]  
Field:  Unit within your critical care transfer group (out)  
Number of data items:  One 
Options: Yes
No
Definition for collection: 
 specifies whether the critical care unit (adult ICU or combined ICU/HDU or HDU) is 
part of your critical care transfer group 
 a critical care transfer group is defined as the group, recommended by 
“Comprehensive Critical Care” and supported by “Quality Critical Care”, specified 
and developed to reduce the number of long distance transfers that take place and 
to ensure that transfers are contained within the critical care network or, by special 
agreement, between hospitals at the borders of adjacent networks 
Justification 
Required to describe admission with TBI
NIHR Journals Library www.journalslibrary.nihr.ac.uk
appenDIx 3
276
Version 1.6 RAIN / February 2010 118
Volume of largest high/mixed density lesion 
Field:   Volume of largest high/mixed density lesion 
    
Number of data items:  One 
Options:                         Greater than 25 millilitres 
Less than or equal to 25 millilitres 
    
Definition for collection: 
 specifies if the volume of the largest high/mixed density lesion, present on the first 
CT scan following the TBI, is greater than 25 millilitres  
 first CT scan is defined as the first CT scan performed after attendance at the first 
hospital for this TBI 
 where there is more than one CT scan performed, the first CT scan must be used 
for data abstraction; if transferred, the first CT scan may be performed at a 
subsequent hospital 
 Greater than 25 millilitres specifies that the volume of the largest high/mixed 
density lesion is greater than 25 millilitres 
 Less than or equal to 25 millilitres specifies that the volume of the largest 
high/mixed density lesion is less than or equal to 25 millilitres 
 volume of lesion is estimated by using the formula: 
Volume (ml) = (length x breadth x height) divided by 2 
All measurements are in cm, in relation to the scale displayed on   
each CT image.  Any blood in contiguity with the lesion is considered
part of it and included in the measurement 
-  length is measured on the CT slice where the lesion is largest  
-  breadth is the measurement of the lesion at right angles to the length,  
measured on the same slice as the length
-  height is calculated by multiplying the CT slice thickness by the number    
       of CT slices on which the lesion is visible    
Justification 
Required for risk prediction models
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Harrison et al. under the terms of a commissioning contract issued by the Secretary of State for 
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
DOI: 10.3310/hta17230 HealtH tecHnOlOgy assessment 2013 VOl. 17 nO. 23
277
V
er
si
on
 1
.6
 R
A
IN
 / 
Fe
br
ua
ry
 2
01
0
11
9
A
pp
en
di
x:
 T
ab
le
 o
f F
iO
2 a
pp
ro
xi
m
at
io
ns
 
C
on
ve
rs
io
n 
ta
bl
e 
fo
r F
iO
2 w
he
n 
m
ea
su
re
d 
on
 n
as
al
 c
an
nu
la
 o
r m
as
k 
(s
ee
 re
fe
re
nc
es
 o
ve
rle
af
): 
V
al
ue
s 
gi
ve
n 
re
pr
es
en
t 
an
 e
st
im
at
io
n 
of
 t
he
 li
ke
ly
 o
ve
ra
ll 
Fi
O
2 
in
 t
he
 a
irw
ay
, 
no
t 
ju
st
 t
he
 c
on
ce
nt
ra
tio
n 
in
 t
he
 m
as
k,
 a
ss
um
in
g 
a 
re
la
tiv
el
y 
no
rm
al
 
re
sp
ira
to
ry
 p
at
te
rn
. 
N
as
al
 c
an
nu
la
 
Fa
ce
 m
as
k 
Fa
ce
 m
as
k 
w
ith
 re
se
rv
oi
r 
ba
g
“V
en
tu
ri”
 ty
pe
 fa
ce
 m
as
k
e.
g.
 V
en
tim
as
k 
A
er
os
ol
 fa
ce
 m
as
k 
 
O
2 
15
 l 
m
in
-1
vi
a 
ne
bu
liz
er
 
l m
in
-1
FI
O
2 
l m
in
-1
 
Fi
O
2 
l m
in
-1
 
Fi
O
2 
S
et
 %
 
Fi
O
2 
S
et
 %
 
Fi
O
2
1 
0.
22
 
2*
 
0.
25
 
6 
0.
60
 
24
 
0.
24
 
35
 
0.
28
 
2 
0.
25
 
3*
 
0.
27
 
7 
0.
70
 
28
 
0.
28
 
40
 
0.
30
 
3 
0.
27
 
4 
0.
30
 
8 
0.
80
 
35
 
0.
35
 
70
 
0.
50
 
4 
0.
30
 
5 
0.
35
 
9 
0.
85
 
40
 
0.
40
 
10
0 
0.
60
 
5 
0.
35
 
6 
0.
40
 
10
+ 
0.
90
 
60
 
0.
50
 
 
 
 
 
7 
0.
45
 
 
 
 
 
 
 
 
 
8+
 
0.
50
 
 
 
 
 
 
 
* 
w
e 
ac
kn
ow
le
dg
e 
th
at
 th
er
e 
is
 s
om
e 
fre
sh
 e
vi
de
nc
e 
th
at
 fr
es
h 
ga
s 
flo
w
s 
le
ss
 th
an
 4
 l 
m
in
-1
 a
re
 n
ot
 re
co
m
m
en
de
d 
be
ca
us
e 
of
 th
e 
ris
k 
of
 C
O
2
re
te
nt
io
n.
NIHR Journals Library www.journalslibrary.nihr.ac.uk
appenDIx 3
278
V
er
si
on
 1
.6
 R
A
IN
 / 
Fe
br
ua
ry
 2
01
0
12
0
R
ef
er
en
ce
s 
C
ox
 D
, G
ill
be
 C
. F
ix
ed
 p
er
fo
rm
an
ce
 o
xy
ge
n 
m
as
ks
.  
H
yp
ox
ic
 h
az
ar
d 
of
 lo
w
-c
ap
ac
ity
 d
es
ig
ns
. A
na
es
th
es
ia
 1
98
1;
 3
6:
95
8-
96
4.
  
Fr
ou
st
 G
N
, P
ot
te
r 
W
A
, W
ilo
ns
 M
D
, G
ol
de
n 
E
B
.  
S
ho
rtc
om
in
gs
 o
f u
si
ng
 tw
o 
je
t n
eb
ul
iz
er
s 
in
 ta
nd
em
 w
ith
 a
n 
ae
ro
so
l f
ac
e 
m
as
k 
fo
r 
op
tim
al
 o
xy
ge
n 
th
er
ap
y.
  C
he
st
 1
99
1;
  9
9:
13
46
-1
35
1.
 
G
ol
ds
te
in
 R
S
, Y
ou
ng
 J
, R
eb
uc
k 
A
S
.  
E
ffe
ct
 o
f b
re
at
hi
ng
 p
at
te
rn
s 
on
 o
xy
ge
n 
co
nc
en
tra
tio
n 
re
ce
iv
ed
 fr
om
 s
ta
nd
ar
d 
fa
ce
 m
as
ks
.  
La
nc
et
 1
98
2;
 ii
:1
18
8-
11
90
.
G
re
en
 ID
.  
C
ho
ic
e 
of
 m
et
ho
d 
fo
r a
dm
in
is
tra
tio
n 
of
 o
xy
ge
n.
  B
rit
is
h 
M
ed
ic
al
 J
ou
rn
al
 1
96
7;
 3
:5
93
-5
96
. 
H
ill
 S
L,
 B
ar
ne
s 
P
K
, H
ol
lw
ay
 T
, T
en
na
nt
 R
.  
Fi
xe
d 
pe
rfo
rm
an
ce
 o
xy
ge
n 
m
as
ks
: a
n 
ev
al
ua
tio
n.
  B
rit
is
h 
M
ed
ic
al
 J
ou
rn
al
 1
98
4;
 2
88
:1
26
1-
12
63
.
Jo
ne
s 
H
A
, T
ur
ne
r S
L,
 H
ug
he
s 
JM
B
.  
P
er
fo
rm
an
ce
 o
f t
he
 la
rg
e-
re
se
rv
oi
r o
xy
ge
n 
m
as
k 
(V
en
tim
as
k)
.  
La
nc
et
 1
98
4;
 i:
14
27
-1
43
1.
 
Le
ig
h 
JM
. V
ar
ia
tio
n 
in
 p
er
fo
rm
an
ce
 o
f o
xy
ge
n 
th
er
ap
y 
de
vi
ce
s.
  A
nn
al
s 
of
 th
e 
R
oy
al
 C
ol
le
ge
 o
f S
ur
ge
on
s 
of
 E
ng
la
nd
 1
97
3;
 5
2:
23
4-
25
3.
S
ha
pi
ro
 B
A
, 
P
er
uz
zi
 W
T,
 T
em
pl
in
 R
. 
 H
yp
ox
em
ia
 a
nd
 o
xy
ge
n 
th
er
ap
y.
  
In
: 
S
ha
pi
ro
 B
A
, 
ed
ito
r. 
 C
lin
ic
al
 a
pp
lic
at
io
n 
of
 b
lo
od
 g
as
es
. 
 5
th
 e
di
tio
n.
  
C
hi
ca
go
: M
os
by
, 1
99
5:
12
7-
15
5.
 
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Harrison et al. under the terms of a commissioning contract issued by the Secretary of State for 
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
DOI: 10.3310/hta17230 HealtH tecHnOlOgy assessment 2013 VOl. 17 nO. 23
279
Version 1.6 RAIN / February 2010 121
Appendix: How to assess the Glasgow Coma Score (GCS)   
The GCS is assessed for adults1 as follows: 
The best eye opening response: GCS
Spontaneous 4
To verbal command 3
To pain 2
No response 1
The best motor response:
Obeys verbal command 6
Localises pain 5
Flexion withdrawal 4
Flexion-abnormal/decorticate rigidity 3
Extension/decerebrate rigidity 2
No response 1
The best verbal response:
Oriented and converses 5
Disoriented and converses 4
Inappropriate words 3
Incomprehensible sounds (not words) 2
No response 1
If an admission is intubated, use clinical judgement to score verbal response 
as follows:
Appears oriented and able to converse 5
Responsive but ability to converse questionable 3
Generally unresponsive 1
Reference
1 Knaus WA et al. Data Dictionary for Introduction to Data Collection, The APACHE II 
System: A severity of disease classification system 
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Appendix: How to measure the midline shift    
Stage 1: Identifying anatomical landmarks (left image) 
1. Choose a slice on which the septum pellucidim is clearly seen between the two lateral 
ventricles.
2. Identify the attachment of the falx cerebri to the front and back of the skull. 
3. In some cases the falx will split at the back to encase the superior sagittal sinus (as in 
picture on left). 
4. If the falx does split, the posterior midline is between the two leaves of the falx (as 
above).
5. Identify the septum pellucidum (between the lateral ventricles). 
Stage 2: Drawing the midline (right image) 
6. Draw a line between the point of attachment of the falx to the front and back of the skull. 
7. This is the midline (the dashed line on the image on the right). 
8. In some instances, the falx may not be seen clearly – if this is the case, draw the midline 
between the bony prominences that represent the points of attachment of the falx on the 
inside of the skull (the frontal crest and internal occipital crest). 
Stage 3: Measuring midline shift (right image) 
9. Check by eye on more than one CT slice and choose the one where midline shift is most 
pronounced. 
10. Measure the lateral (horizontal) displacement of the septum pellucidum from the midline 
at the point where such lateral displacement is maximal (on the image on the right, the 
distorted midline is identified by the dotted line, which goes through the septum 
pellucidum). 
11. Measurement on image archiving systems (e.g. PACS) can be done by drawing the 
midline using the scale/ruler tool, and then drawing  a second line (as in the image 
above) to measure midline shift – the software will give you a measurement 
automatically.
12. Where the measurement is being done on CT film, calibrate the midline shift against the 
CT scale bar which will be there on every CT image (as above). 
13. Report the midline shift in millimetre
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Appendix 4 Risk Adjustment In Neurocritical care 
study data collection form and data set flow
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Flows
Order
 the RAIN Dataset Specification (RAINDS) Version 1.4 contains the following sections, which 
appear in this order in the flows: 
o Patient 
o TBI pre-hospital 
o Source 
o TBI at hospital 
o CT 
o Outcome 
o GP 
Display 
 flows run from left to right displaying the field 
 sections are indicated in the header of each page 
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GP letter, Version 4.4, 08/01/10 
 
 
 
 
<Name of GP> 
<Address1> 
<Address2> 
<City> 
<County> 
<Postcode> 
<Date> 
 
 
Dear <Name of GP> 
 
Re: <Patient’s name>, NHS number: <NHS number>, RAIN Study number: <RAIN 
number> 
 
As I’m sure you are aware, five months ago, <name> spent time in intensive care following an 
acute traumatic brain injury.  In two weeks time, we intend to write to them to invite them to 
participate in the above research study.  RAIN aims to better understand recovery from head 
injury to inform care for future patients (NHS Research Ethics Committee Reference Number: 
09/MRE09/10).  Patient participation is entirely voluntary. 
 
Naturally, to avoid the distress of receiving a letter addressed to a recently deceased 
family member, we would be very grateful if you would inform us as to whether your 
records indicate if  <Patient’s name> is alive or not and if alive confirm that <Patient 
name> is currently residing at the address shown on the attached form.  We will not 
contact them until we hear back from you. 
 
There are four possible ways to inform us, please either: 
 
• enter these data onto the web based form (<web address>), using the confidential RAIN 
Study number <RAIN number> assigned to <Patient name>, or 
• post the form to the above address; or  
• fax the completed form to 020 7388 3759; or 
• telephone Dr Gita Prabhu, RAIN Study Coordinator on 020 7554 9770. 
 
<Patient name> (or their carer) will be asked to complete a health survey questionnaire 
(incorporating the Extended Glasgow Outcome Score and the EQ-5D) so we can assess their 
recovery and use of health services. 
 
If you have any questions about the RAIN Study, then please do not hesitate to contact us on 
020 7554 9770.   
 
Thank you for your time. 
 
Yours sincerely 
 
 
 
Dr Gita Prabhu (RAIN Study Coordinator) 
Dr David Harrison (Chief Investigator) 
Intensive Care National Audit & Research Centre (ICNARC) 
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GP Form, Version 1.4, 08/01/10 
 
 
Understanding recovery from head injury  
to inform care 
 
NHS Research Ethics Committee (Reference Number: 09/MRE09/10) 
Chief Investigator: Dr David Harrison, RAIN Study Coordinator: Dr Gita Prabhu 
 
 
We would be very grateful if you would provide the following information. 
 
Our records indicate that <Name of patient> (<ref number>) is: 
 
 
If alive, our records indicate that this patient is currently residing at: 
<Address1> 
<Address2> 
<City> 
<County>  <Postcode> 
 
If no please provide the patient’s current address below: 
 
 
 
 
 
 
Date form was completed:  / / 
 
Completed by :      
On behalf of <Name of GP> 
<Address1> 
<Address2> 
<City> 
<County>  <Postcode> 
 
Please either: 
• enter these data onto the secure web based form (<web address>); or 
• post the form to the above address; or  
• fax the completed form to 020 7388 3759; or 
• telephone Dr Gita Prabhu, RAIN Study Coordinator on 020 7554 9770. 
 
Thank you for your time 
Alive   Dead   
Yes   No   
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RAIN letter, Version 5.2, 08/01/10 


 
 
<Name of participant> 
<Address1> 
<Address2> 
<City> 
<County> 
<Postcode> 
<Date> 
 
 
Dear <Name of participant> 
 
I am <Name of Local Investigator>, <job title> and I was involved in your care when 
you were admitted to our intensive care unit six months ago at <Name of hospital>.  
Our intensive care unit is participating, with other units, in a research study aiming to 
better understand recovery from head injury to inform care for future patients.  As part 
of this study, we would like to know about your recovery.  All we need you to do is to 
answer the enclosed, two, short questionnaires.   
 
If you do not wish to take part, then please return the uncompleted 
questionnaires in the FREEPOST envelope and you will receive no further 
contact about the Study.  Please note: your current and future care will not be 
affected whether you decide to, or not to, participate in this Study. 
 
If you are the carer for the person to whom this letter is addressed and they are 
unable to read it, we would be very grateful if you would take the time to look through 
this letter and Information Sheet on their behalf.  If you feel that they would like to 
participate, then please complete the questionnaires on their behalf.  By better 
understanding the recovery of the person you care for, we hope to improve the care 
for future patients with head injuries.   
 
The RAIN Study is being conducted by a health research charity called ICNARC (the 
Intensive Care National Audit & Research Centre).  The aim of the Study is to 
investigate why some patients make a better recovery than others.  To do this, we 
need to know about your recovery. We will compare the information you provide us in 
these questionnaires to information about your head injury and treatment that was 
collected by staff from the critical care unit during your stay in intensive care.  I have 
included an Information Sheet with this letter.  This will give you more detailed 
information about the Study.  The Study has been approved by an NHS Research 
Ethics Committee (Reference Number: 09/MRE09/10). 
 
• If you agree to participate, please sign the Consent Form (yellow sheet) and then we 
would be grateful if you would complete the enclosed questionnaires (blue and 
green sheets); this should only take around 15 minutes.  Please return all of these 
in the FREEPOST envelope. 
• If you are unable to complete the questionnaires on your own, then please ask one 
of your relatives/carers/friends to help you.  Please return all of these in the 
FREEPOST envelope.  
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<date> 
 
 
Page 2 

• If you do not wish to take part then please return the uncompleted questionnaires in 
the FREEPOST envelope and you will receive no further contact about the Study.  
 
If you have any questions regarding the RAIN Study, then please do not hesitate to 
contact Dr Gita Prabhu, the RAIN Study Co-ordinator, on 020 7554 9770.   
 
Finally, if you would like some information about head injuries or support in your 
recovery, Headway is a charity that provides this help and support to people and to 
those who care for them.  Headway can be contacted on this freephone number:  
0808 800 2244 or by email to helpline@headway.org.uk.  Alternatively, your local 
rehabilitation unit may be able to offer advice (<tel: >).  
 
Thank you very much for your time. 
 
 
Yours sincerely 
 
 
 
 
 
<Name of Principal/Local Investigator> 
<Job title>, <hospital> 
On behalf of the RAIN Study group. 
 
 
Enclosed:   
 
• Information Sheet 
• Consent Form (yellow sheet) 
• Your Health - Questionnaire (blue sheets) 
• Health Services Questionnaire (green sheets) 
• FREEPOST envelope  
• Pen 
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INFORMATION SHEET  
 
Understanding recovery from head injury to inform care 
 
NHS Research Ethics Committee (09/MRE09/10) 
Chief Investigator: Dr David Harrison, RAIN Study Coordinator: Dr Gita Prabhu 
 
 
We would like to invite you to take part in a research study to help improve the care of patients 
who have suffered a traumatic brain injury (TBI).  To do this we need you to fill out two short 
health questionnaires.  The information below explains why we are doing this research and 
what it involves.  Please read this information carefully so you can make an informed decision.  
If you have any questions please contact the RAIN Study team who will be more than happy 
to help.  Please note: your current and future care will not be affected whether you 
decide to, or not to, participate in this study. 
 
What is Traumatic Brain Injury? 
Traumatic brain injury (TBI) is when a strike or knock to the head affects the normal 
functioning of the brain.  There are many causes of TBI, such as a fall or a road traffic 
accident.  The symptoms can vary from feeling sick or dizzy, to a brief loss of consciousness, 
to coma.  Recovery after TBI is also varied.  Some patients make a full recovery but others are 
left with a disability.  If you would like some information about head injuries or support in your 
recovery, Headway is a charity that provides this help and support to people and to those who 
care for them.  Headway can be contacted on this freephone number: 0808 800 2244 or by 
email to helpline@headway.org.uk.  Alternatively, your local rehabilitation unit may be able to 
offer advice (<tel: >) 
 
How will RAIN help TBI patients? 
The overall aim of the Risk Adjustment In Neurocritical care (RAIN) Study is to improve the 
outcome and care given to patients who had a TBI.   We are looking at patients who were 
admitted to critical care units to find why some people make a better recovery than others. 
 
Many factors contribute to whether a person makes a good recovery.  These include the type 
of injury, the health and age of the patient, where they were cared for and the medical 
treatment given.  As every patient is different it can be difficult to know when/if a patient should 
be moved to another critical care unit, or when to start a particular treatment.  We need to 
analyse data from thousands of patients to find what links the patients who have a positive 
outcome.  The information that you provide us is vital for us to help improve the care for 
patients who have a TBI.  
 
What would I have to do to take part in the study? 
1. You would need to sign the Consent Form (yellow sheet).   
This allows us to use information collected during your stay in hospital.  This includes the 
type of injury you had, the treatments you received for that injury and which hospital(s) 
you stayed in.   
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2. You would need to fill out the health questionnaires (blue and green sheets).   
This will help us understand how well you are since your injury.  This should only take 
about 15 minutes to complete. 
 
Enclosed is a pen to fill out the forms and a FREEPOST envelope to return the Consent Form 
and questionnaires to us. 
 
Do I have to take part? 
No.  It is up to you whether or not you take part. 
• If you agree to participate, then please sign the Consent Form (yellow sheet) and then we 
would be grateful if you would complete the enclosed questionnaires (blue and green 
sheets); this should only take around 15 minutes.   
• If you do not wish to take part then please return the uncompleted questionnaires in the 
FREEPOST envelope and you will receive no further contact about the Study. 
 
How safe is my information? 
The information collected is sent to a health research charity called ICNARC (the Intensive 
Care National Audit & Research Centre) for analysis.  ICNARC has a secure computer system 
and a strict information security policy (approved by the Department of Health).  All ICNARC 
staff sign a contract agreeing to keep data secure and confidential.  It is forbidden to remove 
patient data from the premises.  ICNARC is registered under the Data Protection Act (Reg. 
No.: Z6289325).  Anonymised data collected as part of this study will be stored securely for 
five years following the end of the study. 
 
What will happen to the results of the study? 
The results may help improve the care of TBI patients in critical care.  We hope these data will 
answer questions such as: When are treatments effective?  When should TBI patients be 
moved to another critical care unit?  How do the patient’s initial symptoms relate to their 
outcome?  The Study should be completed in February 2012.  If you would like to be sent a 
copy of the results please contact the RAIN Study team.   
 
Who do I contact about the study? 
If you have any questions, concerns or complaints, please contact the RAIN Study 
Coordinator, Dr Gita Prabhu (address and telephone number overleaf). 
 
IF THE PERSON YOU CARE FOR IS UNABLE TO GIVE INFORMED CONSENT 
 
We would like the person you care for to take part in a research study.  This study will help 
future patients who suffer a traumatic brain injury.  If the person you care for is not well 
enough to decide for himself/herself whether or not to participate, we ask if you could read 
through this sheet carefully.  We would like you to give your opinion as to whether or not you 
think your relative/friend/partner would object to taking part in this research.   
 
If you feel that the person you are caring for would agree to take part in this research, please 
could you sign the yellow Consent Form and state your name and relationship to the patient in 
the ‘consultee’ section, then complete the questionnaires.  A FREEPOST envelope is provided 
for you to return the Consent Form and questionnaires.  Thank you for your time and 
consideration. 
 
Thank you for taking the time to read this sheet 
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
 
CONSENT FORM  
Chief Investigator: Dr David Harrison 
 
Improving the treatment of adult patients with  
acute traumatic brain injury  
  
Please initial boxes 
 
1 I confirm that I have read and understood the Information Sheet (v1.8) 
for the above study and have had the opportunity to ask questions.  
2 I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason and without any future 
medical care or legal rights being affected. 
 
3 I understand that sections of my care record have been looked at by 
responsible individuals involved with the study. I give my permission 
for these individuals to use this information for the Study. 
 
4 I understand that information held by the NHS and records maintained 
by The NHS Information Centre may be used to keep in touch with me 
and follow up my health status. 
 
5 I agree to take part in the above Study. 
 













Where patients are unable to sign, a consultee should sign here and state 
their name and relationship to the participant below
















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© 1990 EuroQol GroupEQ-5D™ is a trade mark of the EuroQol Group 
 
By placing a tick in one box in each group below, please indicate which statements 
best describe your own health state today. 
 
Mobility 
I have no problems in walking about  
I have some problems in walking about  
I am confined to bed  
 
Self-Care 
I have no problems with self-care  
I have some problems washing or dressing myself  
I am unable to wash or dress myself  
 
Usual Activities (e.g. work, study, housework, family or 
leisure activities) 
I have no problems with performing my usual activities  
I have some problems with performing my usual activities  
I am unable to perform my usual activities  
 
Pain/Discomfort 
I have no pain or discomfort  
I have moderate pain or discomfort  
I have extreme pain or discomfort  
 
Anxiety/Depression 
I am not anxious or depressed  
I am moderately anxious or depressed  
I am extremely anxious or depressed  
2 
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© 1990 EuroQol GroupEQ-5D™ is a trade mark of the EuroQol Group 
 
 
To help people say how good or bad a health state is, we 
have drawn a scale (rather like a thermometer) on which 
the best state you can imagine is marked 100 and the 
worst state you can imagine is marked 0. 
 
We would like you to indicate on this scale how good 
or bad your own health is today, in your opinion. 
Please do this by drawing a line from the box below to 
whichever point on the scale indicates how good or 
bad your health state is today. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Your own 
health state 
today 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
   Worst 
    imaginable 
     health state 
0 
Best  
imaginable 
health state 
3 
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GOSQ 8-point  © LW, LP, GT 1999. All rights reserved.  
 
The following questions are about changes in your lifestyle since your injury.  There 
are also some questions about how things were before the injury. The questions can 
be answered by you, or by a close relative or friend, or by you both together. We are 
interested in the recovery you have made up to now. 
 
Please answer each question by ticking one box  which is true for you.  
 
 
 
1. Before the injury were you able to look after yourself at home?  
 
 
 
 
 
 
Yes  
 
 
 
 
 
 
No  
 
2. As a result of your injury do you now need help in the home?          
 
 
 
 
 
 
I do not need help or supervision in the home 
 
 
 
 
 
 
I need some help in the home,  but not every day  
 
 
 
 
 
I need help in the home every day, but I could look after myself for at least 8 hours if 
necessary 
 
 
 
 
 
 
I could not look after myself for 8 hours during the day 
 
 
 
 
 
 
I need help in the home, but not because of the injury 
 
 
3. Before the injury did you need help to shop? 
 
 
 
 
 
 
Yes  
 
 
 
 
 
 
No  
 
4. As a result of your injury do you now need help to shop? 
 
 
 
 
 
 
I do not need help to shop 
 
 
 
 
 
 
I need some help, but I can go to local shops on my own 
 
 
 
 
 
 
I need help to shop even locally, or I cannot shop at all 
 
 
 
 
 
 
I need help to shop, but not because of the injury 
4 
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GOSQ 8-point  © LW, LP, GT 1999. All rights reserved.  
 
5. Before the injury did you need help to travel? 
 
 
 
 
 
 
Yes  
 
 
 
 
 
 
No  
 
6. As a result of your injury do you now need help to travel?  
 
 
 
 
 
 
I do not need help to travel 
 
 
 
 
 
 
I need some help,  but can travel locally on my own (e.g. by arranging a taxi) 
 
 
 
 
 
 
I need help to travel even locally, or I cannot travel at all 
 
 
 
 
 
 
I need help to travel but not because of the injury 
 
 
7. Employment before the injury: 
 
 
 
 
 
 
 
 
Working 
 
 
 
 
 
 
 
 
 
 
Caring for family   
 
 
 
 
 
 
Retired   
 
 
 
 
 
 
 
Looking for work  
 
 
 
 
 
 
 
 
 
 
Studying as a student  
 
 
 
 
 
 
 
None of these (e.g. unfit for work) 
 
8. As a result of your injury has there been a change in your ability to work?  
(or to study if you were a student; or to care for your family if you were the main caregiver)  
 
 
 
 
 
 
I can still do the same work 
 
 
 
 
 
I can still work, but at a reduced level (e.g. change from full-time to part-time,  or change 
in level of responsibility) 
 
 
 
 
 
 
I am unable to work, or only able to work in sheltered workshop 
 
 
 
 
 
 
My ability to work has changed, but not because of the injury 
 
 
9.  Before the injury did you take part in regular social and leisure activities outside 
home (at least once a week)? 
Social and leisure activities include: going out to a pub or club, visiting friends, going to the cinema or 
bingo, going out for a walk, attending a football match, taking part in sport 
 
 
 
 
 
 
Yes  
 
 
 
 
 
 
No  
 
10. As a result of your injury has there been a change in your ability to take part in 
social and leisure activities outside home?            
 
 
 
 
 
 
I take part about as often as before (the activities may be different from before) 
 
 
 
 
 
 
I take part a bit less, but at least half as often 
 
 
 
 
 
 
I take part much less, less than half as often 
 
 
 
 
 
 
I do not take part at all 
  
 
 
 
My ability to take part has changed for some other reason, not because of the injury 
5 
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GOSQ 8-point  © LW, LP, GT 1999. All rights reserved.  
 
11. Before the injury did you have any problems in getting on with friends or 
relatives? 
 
 
 
 
 
 
Yes  
 
 
 
 
 
 
No  
 
12. As a result of your injury are there now problems in how you get on with friends 
or relatives?           
 
 
 
 
 
 
Things are still much the same 
 
 
 
 
 
 
There are occasional problems (less than once a week) 
 
 
 
 
 
 
There are frequent problems (once a week or more) 
 
 
 
 
 
 
There are constant problems (problems every day) 
 
 
 
 
 
 
There are problems for some other reason, not because of the injury 
 
 
13. Are there any other problems resulting from your injury which have interfered 
with your daily life over the past week?   
 
(Problems sometimes reported after head injury:  headaches, dizziness, tiredness, sensitivity to  
noise or light, slowness, memory failures, and concentration problems.) 
 
 
 
 
 
 
I have no current problems 
 
 
 
 
 
 
I have some problems, but these do not interfere with my daily life 
 
 
 
 
 
 
I have some problems, and these have affected my daily life 
 
 
 
 
 
 
I have some problems for other reasons, not because of the head injury 
 
 
14. Before the injury were similar problems present?            
 
 
 
 
 
 
I had no problems before, I had minor problems 
 
 
 
 
 
 
I had similar problems before 
 
 
Are there any other comments that you would like to make? 
(Please continue on a separate sheet if you wish) 
 
 
6 
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 2 
 
The questions refer to ALL health services that you have used since leaving the hospital on 
[insert date], and before [insert date]. 
Since you left the hospital on [insert date] have you visited hospital outpatients about 
ANY ASPECT of your health? 
Since you left hospital on [insert date] have you stayed overnight in hospital for any 
reason (this includes hospital stays that were not due to your head injury)? 
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 3 
  
 
Since you left the hospital on [insert date] have you VISITED any of the health care 
providers listed below? 
Since you left the hospital on [insert date] have you had HOME VISITS from any the 
following health care providers about ANY ASPECTS of your health? 
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 4 
  
Since you left the hospital on [insert date] please indicate whether you have had ANY 
contact (either visits to the provider or home visits) with any of the following service 
providers about ANY ASPECT of your health? 
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 5 
 
Since you left the hospital on [insert date] have you had further hospital stays or used 
ANY other health care services for ANY ASPECT of your health that you haven’t 
included above? 
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 1 
Telephone Interview Schedule 
RAIN Study six month follow-up 
 
 
1. Hello.  I am (interviewer’s  name).  I am calling about a medical research 
study we are carrying out to improve the care of people who have suffered a 
head injury.  Can I speak to (name)? 
 
If (name) did not answer the phone say the first two lines of 1., when he/she picks up 
the telephone and then continue through the numbered points. 
 
If (name) is unable to consent go to the red sheet. 
 
If you are speaking to (name): 
 
2. The study is being carried out by ICNARC, the Intensive Care National Audit 
& Research Centre.  It involves answering a few questions about your current 
health to help us improve the care of people who have had a head injury.  
Would you have time for me to tell you a little about what is involved now, 
this would only take a few minutes, or could I phone you back at a time that is 
more convenient to you? Would you be interested in hearing more about the 
Study?  
 
If the patient does not want to take part in the study, thank them for their time.  
Interview ends. 
 
If the patient would prefer to be called back at another time go to the green sheet. 
 
If the patient is happy to continue: 
 
3. We have been contacting people who have suffered a head injury to find out 
how well they have recovered since leaving the Intensive Care Unit.  This will 
help us improve the care of future patients.   By linking the medical treatments 
you received in hospital and the type of injury you had to how well you feel 
now, we can discover why some people make a better recovery than others.  
For instance this could then help doctors understand which treatments are best 
for which patients.  
 
4. If you agree to take part in the study all you need to do is answer a few 
questions on how you have been feeling since your head injury.  This will take 
about 10 minutes to complete.  We would then link this information to which 
hospitals you stayed in and the medical treatments you received. 
 
5. We are covered by the Data Protection Act.  All information is kept on secure 
servers and no personal data is allowed off the premises.  The results of the 
study will be published and if you would like a copy of the final results I can 
send this to you. 
 
If yes note the participant’s request. 
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 2 
6. Importantly, taking part in the study would not affect your medical care, but it 
will help future patients who suffer a head injury. 
 
7. Would you be interested in taking part in the study?  
 
If the patient says ‘no’, thank them for their time.  Interview ends. 
 
If the patient says ‘yes’: 
 
8. Thank you for agreeing to take part. Would you be happy to answer the 
questions now?  It will only take about 10 minutes to complete. 
 
If the participant would prefer to arrange another time - go to the box at the end of 
this page: 
 
9. Before we start the questions, remember there are no right or wrong answers. 
We have found that the best way to answer the questions is to go with your 
first instinct, whatever you think is the correct response for you. 
 
10. The questions are about changes in your lifestyle since your injury.  There are 
also some questions about how things were before the injury. We are 
interested in the recovery you have made up to now. 
 
 
Fill out the questionnaire (blue sheet) 
 
 
1. When would be a convenient time for me to call back? 
 
Time 
 
Date 
 
When calling the participant back: 
 
1.  This is (interviewer’s name) I called on date about a research study we are 
carrying out looking at people that suffered a head injury.  You mentioned that you 
would be interested in taking part in the study and asked me to call you back today.    
 
2.  The questions will take about 10 minutes to complete, would you be happy to 
answer the questions now?   
 
If yes go to question 9 above 
 
If no rearrange another time 
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 1 
Patient is unable to consent 
 
 
1. Is there someone I could speak to someone who cares for (name)? 
 
If the person who we need to speak to is not available, then arrange a time to call 
back later.  Go to green sheet. 
 
If the carer is happy to continue/the appropriate carer is given the phone: 
 
2. This study is being carried out by ICNARC, the Intensive Care National Audit 
& Research Centre.  It involves answering a few questions about the current 
health of (name) to help us improve the care of people who have had a head 
injury.  Would you have time for me to tell you a little about what is involved 
now, it will only take a few minutes, or could I phone you back at a time that 
is more convenient to you? 
 
If the carer does not want to take part in the study, thank them for their time.  
Interview ends. 
 
3. If you agree to take part in the study all you need to do is answer a few 
questions on how (name) has been since his/her head injury.  This will take 
about 10 minutes to complete.  We would then link this information to which 
hospitals (name) stayed in and the medical treatments he/she received. 
 
4. We are covered by the Data Protection Act.  All information is kept on secure 
servers and no personal data is allowed off the premises.  The results of the 
study will be published and if you would like a copy of the final results I can 
send this to you. 
 
If yes note the carer’s request. 
 
5. Importantly, taking part in the study would not affect (name’s) medical care, 
but it will help future patients who suffer a head injury. 
 
6. If (name) is not well enough to decide for himself/herself whether or not to 
participate.  We would like you to give your opinion as to whether or not you 
think (name) would object to taking part in this research. If you feel that 
(name) would be interested in taking part in the study, would you be willing to 
answer a few questions about his/her health?  
 
If the carer says ‘no’, thank them for their time.  Interview ends. 
 
If the carer says ‘yes’: 
 
7. Thank you for agreeing to take part. Would you be happy to answer the 
questions now?  It will only take about 10 minutes to complete. 
 
If the carer would prefer to arrange another time - go to the box at the end of this 
page 
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If the carer is happy to continue: 
 
8. Before we start the questions remember there are no right or wrong answers. 
We have found that the best way to answer the questions is to go with your 
first instinct, whatever you think is the correct response. 
 
9. The questions are about changes in (name’s) lifestyle since the injury.  There 
are also some questions about how things were before the injury. We are 
interested in the recovery (name) has made up to now. 
 
 
Fill out the questionnaire (blue sheet) 
 
 
1. When would be a convenient time for me to call back? 
 
Name: 
 
Relationship to participant: 
 
Time 
 
Date 
 
When calling the participant back: 
 
1.  This is (interviewer’s name) I called on date about a research study we are 
carrying out looking at people that suffered a head injury.  You mentioned that you 
would be interested in taking part in the study on behalf of (name) and asked me to 
call you back today.    
 
2.  The questions will take about 10 minutes to complete, would you be happy to 
answer the questions now?   
 
If ‘yes’ go to question 8 above 
 
If ‘no’ rearrange another time 
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 1 
Patient/Carer wishes to be called back 
 
 
If patient: 
 
1. What time would be best for me to call you? 
 
Time: 
 
Date: 
 
If carer: 
 
1. Could you tell me the name of the person I should call concerning the care of 
(name)? 
 
Name: 
 
Relationship to patient:  
 
2. What time would be best for me to call (name)? 
 
Time: 
 
Date: 
 
 
When calling back: 
 
1. This is (interviewer’s name) could I speak to (name)? 
 
2. I called on date about a research study aiming to help patients who have 
suffered a traumatic brain injury.  You asked if I could all you back today.  II 
would like to ask you a few questions about you current health to help us 
improve the care of people who have had a head injury.  Would you have time 
for me to tell you a little about the study? 
 
If the patient/carer does not want to take part in the study, thank them for their 
time.  Interview ends. 
 
If the patient would prefer to be called back at another time go to the start of this 
sheet. 
 
If the patient is happy to continue go to question 3 (front sheet). 
 
If the carer is happy to continue go to question 2 (red sheet). 
 
 
If the patient says ‘no’, thank them for their time.  Interview ends. 
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 1 
Patient/carer agrees to take part in the RAIN Study 
 
 
This form was completed via telephone interview by: 
 
Name (interviewer): 
 
Name (interviewee): 
 
If a carer, state the relationship of interviewee to participant: 
 
Date: 
 
 
 
1. Before the injury were you able to look after yourself at home? Yes  No   
 
2. As a result of your injury do you now need help in the home?           (please tick  one box) 
 
 
 
I do not need help or supervision in the home  
 
 
 
I need some help in the home,  but not every day  
 
 
 
I need help in the home every day, but I could look after myself for 
at least 8 hours if necessary 
 
 
 
 
I could not look after myself for 8 hours during the day  
 
 
 
I need help in the home, but not because of the injury  
 
 
 
3. Before the injury did you need help to shop? Yes  No  
 
4. As a result of your injury do you now need help to shop?                  (please tick  one box) 
 
 
 
I do not need help to shop  
 
 
 
I need some help, but I can go to local shops on my own  
 
 
 
I need help to shop even locally, or I cannot shop at all  
 
 
 
I need help to shop, but not because of the injury  
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5. Before the injury did you need help to travel? Yes  No   
 
6. As a result of your injury do you now need help to travel?                 (please tick  one box) 
 
 
 
I do not need help to travel  
 
 
 
I need some help,  but can travel locally on my own 
(e.g. by arranging a taxi) 
 
 
 
 
I need help to travel even locally, or I cannot travel at all  
 
 
 
I need help to travel but not because of the injury  
 
7. Employment before the injury: (please tick  one box) 
Working   
Caring for family  
Retired   
Looking for work   
Studying as a student  
None of these (e.g. unfit for work)   
 
 
8. As a result of your injury has there been a change in your ability to work? (or to study if 
you were a student; or to care for your family if you were the main caregiver)  
 
 
 
I can still do the same work  
 
 
 
I can still work, but at a reduced level (e.g. change from full-time to part-
time,  or change in level of responsibility) 
 
 
 
 
I am unable to work, or only able to work in sheltered workshop  
 
 
 
My ability to work has changed, but not because of the injury  
 
 
9.  Before the injury did you take part in regular social and leisure activities outside home 
(at least once a week)? Yes  No   
Social and leisure activities include: going out to a pub or club, visiting friends, going to 
the cinema or bingo, going out for a walk, attending a football match, taking part in sport. 
 
10. As a result of your injury has there been a change in your ability to take part in social 
and leisure activities outside home?                                                  (please tick  one box) 
 
 
 
I take part about as often as before 
(the activities may be different from before) 
 
 
 
 
I take part a bit less, but at least half as often  
 
 
 
I take part much less, less than half as often  
 
 
 
I do not take part at all  
  
My ability to take part has changed for some other reason, not 
because of the injury 
 
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11. Before the injury did you have any problems in getting on with friends or relatives? 
 Yes  No   
 
12. As a result of your injury are there now problems in how you get on with friends or 
relatives?  (please tick  one box) 
 
 
 
Things are still much the same  
 
 
 
There are occasional problems (less than once a week)  
 
 
 
There are frequent problems (once a week or more)  
 
 
 
There are constant problems (problems every day)  
 
 
 
There are problems for some other reason, not because of the 
injury 
 
 
 
13. Are there any other problems resulting from your injury which have interfered with 
your daily life over the past week?  (Problems sometimes reported after head injury:  
headaches, dizziness, tiredness, sensitivity to noise or light, slowness, memory 
failures, and concentration problems.) 
    (please tick  one box) 
 
 
 
I have no current problems  
 
 
 
I have some problems, but these do not interfere with my daily life  
 
 
 
I have some problems, and these have affected my daily life  
 
 
 
I have some problems for other reasons, not because of the head 
injury 
 
 
 
14. Before the injury were similar problems present?                            (please tick  one box) 
 
 
 
I had no problems before, I had minor problems  
 
 
 
I had similar problems before  
 
 
Are there any other comments that you would like to make? 
(Please continue overleaf if you wish) 
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Appendix 6 Sensitivity analysis: external 
validation of risk prediction models in original (non-
imputed) data sets
TABLE 54 Numbers of admissions and events included in validation data sets: mortality at 6 months
Risk model All patients Eligible for model Complete data
Number of admissions
Hukkelhoven 2881 1744 1459
IMPACT Core 2881 2455 2281
IMPACT Extended 2881 2330 1994
IMPACT Lab 2881 1951 1724
Mortality at 6 months, n (%)
Hukkelhoven 748 (26.0) 398 (22.8) 333 (22.8)
IMPACT Core 748 (26.0) 685 (27.9) 636 (27.9)
IMPACT Extended 748 (26.0) 648 (27.8) 559 (28.0)
IMPACT Lab 748 (26.0) 538 (27.6) 475 (27.6)
TABLE 55 Discrimination: mortality at 6 months
Risk model All patients Eligible for model Complete data
c-index (95% CI)
Hukkelhoven 0.782 (0.763 to 0.801) 0.771 (0.744 to 0.797) 0.793 (0.765 to 0.821)
IMPACT Core 0.755 (0.735 to 0.776) 0.752 (0.730 to 0.774) 0.756 (0.733 to 0.778)
IMPACT Extended 0.779 (0.760 to 0.798) 0.784 (0.764 to 0.805) 0.794 (0.772 to 0.816)
IMPACT Lab 0.773 (0.754 to 0.792) 0.790 (0.768 to 0.812) 0.798 (0.774 to 0.821)
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TABLE 56 Calibration: mortality at 6 months
Risk model All patients Eligible for model Complete data
Hosmer–Lemeshow test, chi-squared statistic [p-value]
Hukkelhoven 15.7 [0.11] 16.6 [0.08] 21.0 [0.02]
IMPACT Core 101 [< 0.001] 98 [< 0.001] 102 [< 0.001]
IMPACT Extended 52 [< 0.001] 68 [< 0.001] 62 [< 0.001]
IMPACT Lab 7.3 [0.69] 14.0 [0.17] 13.5 [0.20]
Cox calibration regression, α (95% CI) β (95% CI) [p-value]
Hukkelhoven 0.06 (–0.07 to 0.18)  
1.04 (0.94 to 1.14)  
[0.64]
–0.06 (–0.23 to 0.11) 
1.04 (0.91 to 1.17) 
[0.21]
–0.03 (–0.21 to 0.15)  
1.18 (1.02 to 1.33)  
[0.003]
IMPACT Core –0.46 (–0.56 to –0.36)  
0.98 (0.89 to 1.08)  
[< 0.001]
–0.47 (–0.57 to –0.37)  
0.97 (0.87 to 1.08)  
[< 0.001]
–0.49 (–0.59 to –0.38)  
0.98 (0.88 to 1.09)  
[< 0.001]
IMPACT Extended –0.30 (–0.41 to –0.20)  
1.03 (0.93 to 1.12)  
[< 0.001]
–0.34 (–0.45 to –0.23)  
1.07 (0.96 to 1.18)  
[< 0.001]
–0.34 (–0.46 to –0.22)  
1.12 (1.00 to 1.24)  
[< 0.001]
IMPACT Lab –0.01 (–0.13 to 1.07)  
0.98 (0.88 to 1.07)  
[0.89]
–0.08 (–0.21 to 0.06)  
1.05 (0.93 to 1.17)  
[0.10]
–0.04 (–0.19 to 0.10)  
1.12 (0.99 to 1.25)  
[0.029]
TABLE 57 Overall fit: mortality at 6 months
Risk model All patients Eligible for model Complete data
Brier’s score
Hukkelhoven 0.153 0.143 0.138
IMPACT Core 0.166 0.174 0.173
IMPACT Extended 0.156 0.161 0.159
IMPACT Lab 0.155 0.156 0.154
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TABLE 58 Numbers of admissions and events included in validation data sets: unfavourable outcome at 6 months
Risk model All patients Eligible for model Complete data
Number of admissions
Hukkelhoven 2422 1447 1206
CRASH Basic 2422 2206 2050
CRASH CT 2422 2111 1940
IMPACT Core 2422 2060 1914
IMPACT Extended 2422 1959 1675
IMPACT Lab 2422 1639 1447
Unfavourable outcome at 6 months, n (%)
Hukkelhoven 1481 (61.1) 868 (60.0) 730 (60.5)
CRASH Basic 1481 (61.1) 1340 (60.7) 1241 (60.5)
CRASH CT 1481 (61.1) 1278 (60.5) 1171 (60.4)
IMPACT Core 1481 (61.1) 1323 (64.2) 1228 (64.2)
IMPACT Extended 1481 (61.1) 1256 (64.1) 1077 (64.3)
IMPACT Lab 1481 (61.1) 1052 (64.2) 931 (64.3)
TABLE 59 Discrimination: unfavourable outcome at 6 months
Risk model All patients Eligible for model Complete data
c-index (95% CI)
Hukkelhoven 0.740 (0.721 to 0.760) 0.726 (0.700 to 0.752) 0.731 (0.703 to 0.759)
CRASH Basic 0.733 (0.712 to 0.753) 0.731 (0.710 to 0.752) 0.732 (0.710 to 0.754)
CRASH CT 0.739 (0.719 to 0.759) 0.745 (0.724 to 0.766) 0.745 (0.723 to 0.766)
IMPACT Core 0.731 (0.710 to 0.751) 0.725 (0.703 to 0.748) 0.726 (0.703 to 0.749)
IMPACT Extended 0.744 (0.724 to 0.763) 0.743 (0.721 to 0.765) 0.745 (0.721 to 0.769)
IMPACT Lab 0.749 (0.730 to 0.769) 0.753 (0.729 to 0.777) 0.753 (0.727 to 0.778)
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TABLE 60 Calibration: unfavourable outcome at 6 months
Risk model All patients Eligible for model Complete data
Hosmer–Lemeshow test, chi-squared statistic [p-value]
Hukkelhoven 412 [< 0.001] 248 [< 0.001] 184 [< 0.001]
CRASH Basic 996 [< 0.001] 896 [< 0.001] 795 [< 0.001]
CRASH CT 400 [< 0.001] 291 [< 0.001] 254 [< 0.001]
IMPACT Core 242 [< 0.001] 220 [< 0.001] 193 [< 0.001]
IMPACT Extended 336 [< 0.001] 239 [< 0.001] 201 [< 0.001]
IMPACT Lab 560 [< 0.001] 320 [< 0.001] 286 [< 0.001]
Cox calibration regression, α (95% CI) β (95% CI) [p-value]
Hukkelhoven 0.67 (0.57 to 0.76)  
0.71 (0.57 to 0.76)  
[< 0.001]
0.61 (0.49 to 0.73)  
0.70 (0.60 to 0.80)  
[< 0.001]
0.59 (0.46 to 0.73)  
0.71 (0.46 to 0.73)  
[< 0.001]
CRASH Basic 0.99 (0.88 to 1.10)  
0.71 (0.63 to 0.78)  
[< 0.001]
0.98 (0.86 to 1.10)  
0.71 (0.63 to 0.79)  
[< 0.001]
0.95 (0.83 to 1.08)  
0.71 (0.62 to 0.79)  
[< 0.001]
CRASH CT 0.59 (0.50 to 0.69)  
0.65 (0.58 to 0.72)  
[< 0.001]
0.55 (0.45 to 0.65)  
0.68 (0.60 to 0.75)  
[< 0.001]
0.52 (0.42 to 0.62)  
0.67 (0.59 to 0.75)  
[< 0.001]
IMPACT Core 0.61 (0.51 to 0.70)  
0.82 (0.73 to 0.91)  
[< 0.001]
0.63 (0.53 to 0.73)  
0.80 (0.70 to 0.90)  
[< 0.001]
0.61 (0.51 to 0.71)  
0.80 (0.69 to 0.90)  
[< 0.001]
IMPACT Extended 0.70 (0.60 to 0.79)  
0.81 (0.72 to 0.90)  
[< 0.001]
0.69 (0.59 to 0.80)  
0.81 (0.71 to 0.90)  
[< 0.001]
0.68 (0.57 to 0.79)  
0.81 (0.70 to 0.91)  
[< 0.001]
IMPACT Lab 0.87 (0.77 to 0.98)  
0.79 (0.71 to 0.87)  
[< 0.001]
0.84 (0.72 to 0.96)  
0.79 (0.69 to 0.89)  
[< 0.001]
0.84 (0.71 to 0.97)  
0.79 (0.68 to 0.90)  
[< 0.001]
TABLE 61 Overall fit: unfavourable at 6 months
Risk model All patients Eligible for model Complete data
Brier’s score
Hukkelhoven 0.222 0.228 0.223
CRASH Basic 0.258 0.258 0.255
CRASH CT 0.222 0.217 0.216
IMPACT Core 0.220 0.217 0.216
IMPACT Extended 0.221 0.215 0.213
IMPACT Lab 0.234 0.222 0.222
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